Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'lorazépam'
(id=623 ; fe=lorazépam ; type=1 ; niveau=199 ; luminosité=64 ; somme entrante=12138.679992675781 creation date=2007-06-21 touchdate=2025-07-27 01:22:16.000)
≈ 2743 relations sortantes

  1. lorazépam -- r_associated #0: 194 / 1 -> médecine
    n1=lorazépam | n2=médecine | rel=r_associated | relid=0 | w=194
  2. lorazépam -- r_associated #0: 144 / 0.742 -> anxiolytique
    n1=lorazépam | n2=anxiolytique | rel=r_associated | relid=0 | w=144
  3. lorazépam -- r_associated #0: 144 / 0.742 -> pharmacovigilance
    n1=lorazépam | n2=pharmacovigilance | rel=r_associated | relid=0 | w=144
  4. lorazépam -- r_associated #0: 143 / 0.737 -> pharmacie
    n1=lorazépam | n2=pharmacie | rel=r_associated | relid=0 | w=143
  5. lorazépam -- r_associated #0: 141 / 0.727 -> maladie
    n1=lorazépam | n2=maladie | rel=r_associated | relid=0 | w=141
  6. lorazépam -- r_associated #0: 141 / 0.727 -> psychotrope
    n1=lorazépam | n2=psychotrope | rel=r_associated | relid=0 | w=141
  7. lorazépam -- r_associated #0: 139 / 0.716 -> myorelaxant
    n1=lorazépam | n2=myorelaxant | rel=r_associated | relid=0 | w=139
  8. lorazépam -- r_associated #0: 138 / 0.711 -> anticonvulsant
    n1=lorazépam | n2=anticonvulsant | rel=r_associated | relid=0 | w=138
  9. lorazépam -- r_associated #0: 138 / 0.711 -> hypnotique
    n1=lorazépam | n2=hypnotique | rel=r_associated | relid=0 | w=138
  10. lorazépam -- r_associated #0: 138 / 0.711 -> médicament
    n1=lorazépam | n2=médicament | rel=r_associated | relid=0 | w=138
  11. lorazépam -- r_associated #0: 135 / 0.696 -> sédatif
    n1=lorazépam | n2=sédatif | rel=r_associated | relid=0 | w=135
  12. lorazépam -- r_associated #0: 125 / 0.644 -> benzodiazépine
    n1=lorazépam | n2=benzodiazépine | rel=r_associated | relid=0 | w=125
  13. lorazépam -- r_associated #0: 108 / 0.557 -> chimie
    n1=lorazépam | n2=chimie | rel=r_associated | relid=0 | w=108
  14. lorazépam -- r_associated #0: 90 / 0.464 -> en:benzodiazepine
    n1=lorazépam | n2=en:benzodiazepine | rel=r_associated | relid=0 | w=90
  15. lorazépam -- r_associated #0: 67 / 0.345 -> en:apo-lorazepam
    n1=lorazépam | n2=en:apo-lorazepam | rel=r_associated | relid=0 | w=67
  16. lorazépam -- r_associated #0: 66 / 0.34 -> en:temesta
    n1=lorazépam | n2=en:temesta | rel=r_associated | relid=0 | w=66
  17. lorazépam -- r_associated #0: 65 / 0.335 -> en:lorazepam-neuraxpharm
    n1=lorazépam | n2=en:lorazepam-neuraxpharm | rel=r_associated | relid=0 | w=65
  18. lorazépam -- r_associated #0: 65 / 0.335 -> en:sinestron
    n1=lorazépam | n2=en:sinestron | rel=r_associated | relid=0 | w=65
  19. lorazépam -- r_associated #0: 64 / 0.33 -> en:lorazepam-ratiopharm
    n1=lorazépam | n2=en:lorazepam-ratiopharm | rel=r_associated | relid=0 | w=64
  20. lorazépam -- r_associated #0: 64 / 0.33 -> en:somagerol
    n1=lorazépam | n2=en:somagerol | rel=r_associated | relid=0 | w=64
  21. lorazépam -- r_associated #0: 62 / 0.32 -> en:nu-loraz
    n1=lorazépam | n2=en:nu-loraz | rel=r_associated | relid=0 | w=62
  22. lorazépam -- r_associated #0: 61 / 0.314 -> en:laubeel
    n1=lorazépam | n2=en:laubeel | rel=r_associated | relid=0 | w=61
  23. lorazépam -- r_associated #0: 61 / 0.314 -> en:lorazep von ct
    n1=lorazépam | n2=en:lorazep von ct | rel=r_associated | relid=0 | w=61
  24. lorazépam -- r_associated #0: 61 / 0.314 -> toxicologie
    n1=lorazépam | n2=toxicologie | rel=r_associated | relid=0 | w=61
  25. lorazépam -- r_associated #0: 60 / 0.309 -> en:novo-lorazem
    n1=lorazépam | n2=en:novo-lorazem | rel=r_associated | relid=0 | w=60
  26. lorazépam -- r_associated #0: 60 / 0.309 -> médication
    n1=lorazépam | n2=médication | rel=r_associated | relid=0 | w=60
  27. lorazépam -- r_associated #0: 59 / 0.304 -> en:tolid
    n1=lorazépam | n2=en:tolid | rel=r_associated | relid=0 | w=59
  28. lorazépam -- r_associated #0: 58 / 0.299 -> en:idalprem
    n1=lorazépam | n2=en:idalprem | rel=r_associated | relid=0 | w=58
  29. lorazépam -- r_associated #0: 57 / 0.294 -> en:duralozam
    n1=lorazépam | n2=en:duralozam | rel=r_associated | relid=0 | w=57
  30. lorazépam -- r_associated #0: 55 / 0.284 -> ordonnance
    n1=lorazépam | n2=ordonnance | rel=r_associated | relid=0 | w=55
  31. lorazépam -- r_associated #0: 55 / 0.284 -> posologie
    n1=lorazépam | n2=posologie | rel=r_associated | relid=0 | w=55
  32. lorazépam -- r_associated #0: 55 / 0.284 -> prescription
    n1=lorazépam | n2=prescription | rel=r_associated | relid=0 | w=55
  33. lorazépam -- r_associated #0: 53 / 0.273 -> Lexomil
    n1=lorazépam | n2=Lexomil | rel=r_associated | relid=0 | w=53
  34. lorazépam -- r_associated #0: 52 / 0.268 -> somnifère
    n1=lorazépam | n2=somnifère | rel=r_associated | relid=0 | w=52
  35. lorazépam -- r_associated #0: 52 / 0.268 -> traitement
    n1=lorazépam | n2=traitement | rel=r_associated | relid=0 | w=52
  36. lorazépam -- r_associated #0: 45 / 0.232 -> anxiété
    n1=lorazépam | n2=anxiété | rel=r_associated | relid=0 | w=45
  37. lorazépam -- r_associated #0: 45 / 0.232 -> insomnie
    n1=lorazépam | n2=insomnie | rel=r_associated | relid=0 | w=45
  38. lorazépam -- r_associated #0: 42 / 0.216 -> anticonvulsivant
    n1=lorazépam | n2=anticonvulsivant | rel=r_associated | relid=0 | w=42
  39. lorazépam -- r_associated #0: 42 / 0.216 -> tranquillisant
    n1=lorazépam | n2=tranquillisant | rel=r_associated | relid=0 | w=42
  40. lorazépam -- r_associated #0: 41 / 0.211 -> calmant
    n1=lorazépam | n2=calmant | rel=r_associated | relid=0 | w=41
  41. lorazépam -- r_associated #0: 40 / 0.206 -> anti-dépresseur
    n1=lorazépam | n2=anti-dépresseur | rel=r_associated | relid=0 | w=40
  42. lorazépam -- r_associated #0: 40 / 0.206 -> médicaments
    n1=lorazépam | n2=médicaments | rel=r_associated | relid=0 | w=40
  43. lorazépam -- r_associated #0: 35 / 0.18 -> benzodiazépines (effets secondaires des) e
    n1=lorazépam | n2=benzodiazépines (effets secondaires des) e | rel=r_associated | relid=0 | w=35
  44. lorazépam -- r_associated #0: 35 / 0.18 -> dépendance
    n1=lorazépam | n2=dépendance | rel=r_associated | relid=0 | w=35
  45. lorazépam -- r_associated #0: 35 / 0.18 -> somnifèr
    n1=lorazépam | n2=somnifèr | rel=r_associated | relid=0 | w=35
  46. lorazépam -- r_associated #0: 34 / 0.175 -> en:lorazepam medical
    n1=lorazépam | n2=en:lorazepam medical | rel=r_associated | relid=0 | w=34
  47. lorazépam -- r_associated #0: 32 / 0.165 -> effets secondaires
    n1=lorazépam | n2=effets secondaires | rel=r_associated | relid=0 | w=32
  48. lorazépam -- r_associated #0: 32 / 0.165 -> en:donix
    n1=lorazépam | n2=en:donix | rel=r_associated | relid=0 | w=32
  49. lorazépam -- r_associated #0: 32 / 0.165 -> traitement
    (médecine)
    n1=lorazépam | n2=traitement
    (médecine)
    | rel=r_associated | relid=0 | w=32
  50. lorazépam -- r_associated #0: 31 / 0.16 -> en:sedicepan
    n1=lorazépam | n2=en:sedicepan | rel=r_associated | relid=0 | w=31
  51. lorazépam -- r_associated #0: 31 / 0.16 -> somnolence
    n1=lorazépam | n2=somnolence | rel=r_associated | relid=0 | w=31
  52. lorazépam -- r_associated #0: 30 / 0.155 -> molécule
    n1=lorazépam | n2=molécule | rel=r_associated | relid=0 | w=30
  53. lorazépam -- r_associated #0: 29 / 0.149 -> angoisse
    n1=lorazépam | n2=angoisse | rel=r_associated | relid=0 | w=29
  54. lorazépam -- r_associated #0: 26 / 0.134 -> en:lorazepam
    n1=lorazépam | n2=en:lorazepam | rel=r_associated | relid=0 | w=26
  55. lorazépam -- r_associated #0: 21 / 0.108 -> composé chimique
    n1=lorazépam | n2=composé chimique | rel=r_associated | relid=0 | w=21
  56. lorazépam -- r_associated #0: 20 / 0.103 -> barbiturique
    n1=lorazépam | n2=barbiturique | rel=r_associated | relid=0 | w=20
  57. lorazépam -- r_associated #0: 20 / 0.103 -> consolant
    n1=lorazépam | n2=consolant | rel=r_associated | relid=0 | w=20
  58. lorazépam -- r_associated #0: 20 / 0.103 -> en:benzodiazepine compound
    n1=lorazépam | n2=en:benzodiazepine compound | rel=r_associated | relid=0 | w=20
  59. lorazépam -- r_associated #0: 20 / 0.103 -> en:solacing
    n1=lorazépam | n2=en:solacing | rel=r_associated | relid=0 | w=20
  60. lorazépam -- r_associated #0: 15 / 0.077 -> en:dosage
    n1=lorazépam | n2=en:dosage | rel=r_associated | relid=0 | w=15
  61. lorazépam -- r_associated #0: 15 / 0.077 -> en:dose range
    n1=lorazépam | n2=en:dose range | rel=r_associated | relid=0 | w=15
  62. lorazépam -- r_associated #0: 15 / 0.077 -> en:dose schedule
    n1=lorazépam | n2=en:dose schedule | rel=r_associated | relid=0 | w=15
  63. lorazépam -- r_associated #0: 15 / 0.077 -> en:liqueur d'expédition
    n1=lorazépam | n2=en:liqueur d'expédition | rel=r_associated | relid=0 | w=15
  64. lorazépam -- r_associated #0: 15 / 0.077 -> en:posology
    n1=lorazépam | n2=en:posology | rel=r_associated | relid=0 | w=15
  65. lorazépam -- r_associated #0: 15 / 0.077 -> liqueur d'expédition
    n1=lorazépam | n2=liqueur d'expédition | rel=r_associated | relid=0 | w=15
  66. lorazépam -- r_associated #0: 15 / 0.077 -> liqueur de dosage
    n1=lorazépam | n2=liqueur de dosage | rel=r_associated | relid=0 | w=15
  67. lorazépam -- r_associated #0: 15 / 0.077 -> Looser-Milkman (syndrome de)
    n1=lorazépam | n2=Looser-Milkman (syndrome de) | rel=r_associated | relid=0 | w=15
  68. lorazépam -- r_associated #0: 13 / 0.067 -> en:medicament
    n1=lorazépam | n2=en:medicament | rel=r_associated | relid=0 | w=13
  69. lorazépam -- r_associated #0: 11 / 0.057 -> cortisol
    n1=lorazépam | n2=cortisol | rel=r_associated | relid=0 | w=11
  70. lorazépam -- r_associated #0: 11 / 0.057 -> dépression respiratoire
    n1=lorazépam | n2=dépression respiratoire | rel=r_associated | relid=0 | w=11
  71. lorazépam -- r_associated #0: 10 / 0.052 -> 3TC
    n1=lorazépam | n2=3TC | rel=r_associated | relid=0 | w=10
  72. lorazépam -- r_associated #0: 10 / 0.052 -> abatacept
    n1=lorazépam | n2=abatacept | rel=r_associated | relid=0 | w=10
  73. lorazépam -- r_associated #0: 10 / 0.052 -> acarbose
    n1=lorazépam | n2=acarbose | rel=r_associated | relid=0 | w=10
  74. lorazépam -- r_associated #0: 10 / 0.052 -> acénocoumarol
    n1=lorazépam | n2=acénocoumarol | rel=r_associated | relid=0 | w=10
  75. lorazépam -- r_associated #0: 10 / 0.052 -> acétaminophène
    n1=lorazépam | n2=acétaminophène | rel=r_associated | relid=0 | w=10
  76. lorazépam -- r_associated #0: 10 / 0.052 -> acétylcystéine
    n1=lorazépam | n2=acétylcystéine | rel=r_associated | relid=0 | w=10
  77. lorazépam -- r_associated #0: 10 / 0.052 -> acide docosahexaénoïque
    n1=lorazépam | n2=acide docosahexaénoïque | rel=r_associated | relid=0 | w=10
  78. lorazépam -- r_associated #0: 10 / 0.052 -> acide lactique
    n1=lorazépam | n2=acide lactique | rel=r_associated | relid=0 | w=10
  79. lorazépam -- r_associated #0: 10 / 0.052 -> Acide lactique
    n1=lorazépam | n2=Acide lactique | rel=r_associated | relid=0 | w=10
  80. lorazépam -- r_associated #0: 10 / 0.052 -> acide tranexamique
    n1=lorazépam | n2=acide tranexamique | rel=r_associated | relid=0 | w=10
  81. lorazépam -- r_associated #0: 10 / 0.052 -> acide valproïque
    n1=lorazépam | n2=acide valproïque | rel=r_associated | relid=0 | w=10
  82. lorazépam -- r_associated #0: 10 / 0.052 -> acitrétine
    n1=lorazépam | n2=acitrétine | rel=r_associated | relid=0 | w=10
  83. lorazépam -- r_associated #0: 10 / 0.052 -> adinazolam
    n1=lorazépam | n2=adinazolam | rel=r_associated | relid=0 | w=10
  84. lorazépam -- r_associated #0: 10 / 0.052 -> agent antibactérien
    n1=lorazépam | n2=agent antibactérien | rel=r_associated | relid=0 | w=10
  85. lorazépam -- r_associated #0: 10 / 0.052 -> agent antinéoplasique
    n1=lorazépam | n2=agent antinéoplasique | rel=r_associated | relid=0 | w=10
  86. lorazépam -- r_associated #0: 10 / 0.052 -> agent biologique
    n1=lorazépam | n2=agent biologique | rel=r_associated | relid=0 | w=10
  87. lorazépam -- r_associated #0: 10 / 0.052 -> agent tensioactif
    n1=lorazépam | n2=agent tensioactif | rel=r_associated | relid=0 | w=10
  88. lorazépam -- r_associated #0: 10 / 0.052 -> agent tératogène
    n1=lorazépam | n2=agent tératogène | rel=r_associated | relid=0 | w=10
  89. lorazépam -- r_associated #0: 10 / 0.052 -> aller ensemble
    n1=lorazépam | n2=aller ensemble | rel=r_associated | relid=0 | w=10
  90. lorazépam -- r_associated #0: 10 / 0.052 -> allergie à un médicament
    n1=lorazépam | n2=allergie à un médicament | rel=r_associated | relid=0 | w=10
  91. lorazépam -- r_associated #0: 10 / 0.052 -> allergie aux médicaments
    n1=lorazépam | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=10
  92. lorazépam -- r_associated #0: 10 / 0.052 -> allergie médicamenteuse
    n1=lorazépam | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=10
  93. lorazépam -- r_associated #0: 10 / 0.052 -> amifampridine
    n1=lorazépam | n2=amifampridine | rel=r_associated | relid=0 | w=10
  94. lorazépam -- r_associated #0: 10 / 0.052 -> amifostine
    n1=lorazépam | n2=amifostine | rel=r_associated | relid=0 | w=10
  95. lorazépam -- r_associated #0: 10 / 0.052 -> anæsthésique
    n1=lorazépam | n2=anæsthésique | rel=r_associated | relid=0 | w=10
  96. lorazépam -- r_associated #0: 10 / 0.052 -> anesthésique
    n1=lorazépam | n2=anesthésique | rel=r_associated | relid=0 | w=10
  97. lorazépam -- r_associated #0: 10 / 0.052 -> angiostatine
    n1=lorazépam | n2=angiostatine | rel=r_associated | relid=0 | w=10
  98. lorazépam -- r_associated #0: 10 / 0.052 -> anhydride arsénieux
    n1=lorazépam | n2=anhydride arsénieux | rel=r_associated | relid=0 | w=10
  99. lorazépam -- r_associated #0: 10 / 0.052 -> anomalie respiratoire non précisée
    n1=lorazépam | n2=anomalie respiratoire non précisée | rel=r_associated | relid=0 | w=10
  100. lorazépam -- r_associated #0: 10 / 0.052 -> antibiotique
    n1=lorazépam | n2=antibiotique | rel=r_associated | relid=0 | w=10
  101. lorazépam -- r_associated #0: 10 / 0.052 -> antienzyme
    n1=lorazépam | n2=antienzyme | rel=r_associated | relid=0 | w=10
  102. lorazépam -- r_associated #0: 10 / 0.052 -> antimétabolite
    n1=lorazépam | n2=antimétabolite | rel=r_associated | relid=0 | w=10
  103. lorazépam -- r_associated #0: 10 / 0.052 -> apixaban
    n1=lorazépam | n2=apixaban | rel=r_associated | relid=0 | w=10
  104. lorazépam -- r_associated #0: 10 / 0.052 -> arrêt respiratoire
    n1=lorazépam | n2=arrêt respiratoire | rel=r_associated | relid=0 | w=10
  105. lorazépam -- r_associated #0: 10 / 0.052 -> Arrêt respiratoire
    n1=lorazépam | n2=Arrêt respiratoire | rel=r_associated | relid=0 | w=10
  106. lorazépam -- r_associated #0: 10 / 0.052 -> arsenic blanc
    n1=lorazépam | n2=arsenic blanc | rel=r_associated | relid=0 | w=10
  107. lorazépam -- r_associated #0: 10 / 0.052 -> artésunate
    n1=lorazépam | n2=artésunate | rel=r_associated | relid=0 | w=10
  108. lorazépam -- r_associated #0: 10 / 0.052 -> asparaginase
    n1=lorazépam | n2=asparaginase | rel=r_associated | relid=0 | w=10
  109. lorazépam -- r_associated #0: 10 / 0.052 -> astringent
    n1=lorazépam | n2=astringent | rel=r_associated | relid=0 | w=10
  110. lorazépam -- r_associated #0: 10 / 0.052 -> astringente
    n1=lorazépam | n2=astringente | rel=r_associated | relid=0 | w=10
  111. lorazépam -- r_associated #0: 10 / 0.052 -> aténolol
    n1=lorazépam | n2=aténolol | rel=r_associated | relid=0 | w=10
  112. lorazépam -- r_associated #0: 10 / 0.052 -> auranofine
    n1=lorazépam | n2=auranofine | rel=r_associated | relid=0 | w=10
  113. lorazépam -- r_associated #0: 10 / 0.052 -> axitinib
    n1=lorazépam | n2=axitinib | rel=r_associated | relid=0 | w=10
  114. lorazépam -- r_associated #0: 10 / 0.052 -> Azadirachta indica
    n1=lorazépam | n2=Azadirachta indica | rel=r_associated | relid=0 | w=10
  115. lorazépam -- r_associated #0: 10 / 0.052 -> azidothymidine
    n1=lorazépam | n2=azidothymidine | rel=r_associated | relid=0 | w=10
  116. lorazépam -- r_associated #0: 10 / 0.052 -> baclofen
    n1=lorazépam | n2=baclofen | rel=r_associated | relid=0 | w=10
  117. lorazépam -- r_associated #0: 10 / 0.052 -> baclofène
    n1=lorazépam | n2=baclofène | rel=r_associated | relid=0 | w=10
  118. lorazépam -- r_associated #0: 10 / 0.052 -> baricitinib
    n1=lorazépam | n2=baricitinib | rel=r_associated | relid=0 | w=10
  119. lorazépam -- r_associated #0: 10 / 0.052 -> belimumab
    n1=lorazépam | n2=belimumab | rel=r_associated | relid=0 | w=10
  120. lorazépam -- r_associated #0: 10 / 0.052 -> bevacizumab
    n1=lorazépam | n2=bevacizumab | rel=r_associated | relid=0 | w=10
  121. lorazépam -- r_associated #0: 10 / 0.052 -> bléomycine sulfate
    n1=lorazépam | n2=bléomycine sulfate | rel=r_associated | relid=0 | w=10
  122. lorazépam -- r_associated #0: 10 / 0.052 -> bromazépam
    n1=lorazépam | n2=bromazépam | rel=r_associated | relid=0 | w=10
  123. lorazépam -- r_associated #0: 10 / 0.052 -> brotizolam
    n1=lorazépam | n2=brotizolam | rel=r_associated | relid=0 | w=10
  124. lorazépam -- r_associated #0: 10 / 0.052 -> busulfan
    n1=lorazépam | n2=busulfan | rel=r_associated | relid=0 | w=10
  125. lorazépam -- r_associated #0: 10 / 0.052 -> cabergoline
    n1=lorazépam | n2=cabergoline | rel=r_associated | relid=0 | w=10
  126. lorazépam -- r_associated #0: 10 / 0.052 -> cancérigène
    n1=lorazépam | n2=cancérigène | rel=r_associated | relid=0 | w=10
  127. lorazépam -- r_associated #0: 10 / 0.052 -> cannabidiol
    n1=lorazépam | n2=cannabidiol | rel=r_associated | relid=0 | w=10
  128. lorazépam -- r_associated #0: 10 / 0.052 -> cannabinol
    n1=lorazépam | n2=cannabinol | rel=r_associated | relid=0 | w=10
  129. lorazépam -- r_associated #0: 10 / 0.052 -> capécitabine
    n1=lorazépam | n2=capécitabine | rel=r_associated | relid=0 | w=10
  130. lorazépam -- r_associated #0: 10 / 0.052 -> capsaïcine
    n1=lorazépam | n2=capsaïcine | rel=r_associated | relid=0 | w=10
  131. lorazépam -- r_associated #0: 10 / 0.052 -> carbendazime
    n1=lorazépam | n2=carbendazime | rel=r_associated | relid=0 | w=10
  132. lorazépam -- r_associated #0: 10 / 0.052 -> carbonate de lithium
    n1=lorazépam | n2=carbonate de lithium | rel=r_associated | relid=0 | w=10
  133. lorazépam -- r_associated #0: 10 / 0.052 -> carbonate lithium
    n1=lorazépam | n2=carbonate lithium | rel=r_associated | relid=0 | w=10
  134. lorazépam -- r_associated #0: 10 / 0.052 -> carcinogène
    n1=lorazépam | n2=carcinogène | rel=r_associated | relid=0 | w=10
  135. lorazépam -- r_associated #0: 10 / 0.052 -> carmustine
    n1=lorazépam | n2=carmustine | rel=r_associated | relid=0 | w=10
  136. lorazépam -- r_associated #0: 10 / 0.052 -> cefpodoxime proxétil
    n1=lorazépam | n2=cefpodoxime proxétil | rel=r_associated | relid=0 | w=10
  137. lorazépam -- r_associated #0: 10 / 0.052 -> ceritinib
    n1=lorazépam | n2=ceritinib | rel=r_associated | relid=0 | w=10
  138. lorazépam -- r_associated #0: 10 / 0.052 -> certolizumab
    n1=lorazépam | n2=certolizumab | rel=r_associated | relid=0 | w=10
  139. lorazépam -- r_associated #0: 10 / 0.052 -> cétirizine
    n1=lorazépam | n2=cétirizine | rel=r_associated | relid=0 | w=10
  140. lorazépam -- r_associated #0: 10 / 0.052 -> cetuximab
    n1=lorazépam | n2=cetuximab | rel=r_associated | relid=0 | w=10
  141. lorazépam -- r_associated #0: 10 / 0.052 -> chélateur
    n1=lorazépam | n2=chélateur | rel=r_associated | relid=0 | w=10
  142. lorazépam -- r_associated #0: 10 / 0.052 -> chlorhydrate d'hydralazine
    n1=lorazépam | n2=chlorhydrate d'hydralazine | rel=r_associated | relid=0 | w=10
  143. lorazépam -- r_associated #0: 10 / 0.052 -> chlorhydrate de doxorubicine
    n1=lorazépam | n2=chlorhydrate de doxorubicine | rel=r_associated | relid=0 | w=10
  144. lorazépam -- r_associated #0: 10 / 0.052 -> chlorhydrate de métronidazole
    n1=lorazépam | n2=chlorhydrate de métronidazole | rel=r_associated | relid=0 | w=10
  145. lorazépam -- r_associated #0: 10 / 0.052 -> cimétidine
    n1=lorazépam | n2=cimétidine | rel=r_associated | relid=0 | w=10
  146. lorazépam -- r_associated #0: 10 / 0.052 -> cis-diaminedichloroplatine
    n1=lorazépam | n2=cis-diaminedichloroplatine | rel=r_associated | relid=0 | w=10
  147. lorazépam -- r_associated #0: 10 / 0.052 -> cisplatine
    n1=lorazépam | n2=cisplatine | rel=r_associated | relid=0 | w=10
  148. lorazépam -- r_associated #0: 10 / 0.052 -> citrate de clomifène
    n1=lorazépam | n2=citrate de clomifène | rel=r_associated | relid=0 | w=10
  149. lorazépam -- r_associated #0: 10 / 0.052 -> citrate de clomiphène
    n1=lorazépam | n2=citrate de clomiphène | rel=r_associated | relid=0 | w=10
  150. lorazépam -- r_associated #0: 10 / 0.052 -> citrate de magnésium
    n1=lorazépam | n2=citrate de magnésium | rel=r_associated | relid=0 | w=10
  151. lorazépam -- r_associated #0: 10 / 0.052 -> citrulline
    n1=lorazépam | n2=citrulline | rel=r_associated | relid=0 | w=10
  152. lorazépam -- r_associated #0: 10 / 0.052 -> clarithromycine
    n1=lorazépam | n2=clarithromycine | rel=r_associated | relid=0 | w=10
  153. lorazépam -- r_associated #0: 10 / 0.052 -> clé à fourche
    n1=lorazépam | n2=clé à fourche | rel=r_associated | relid=0 | w=10
  154. lorazépam -- r_associated #0: 10 / 0.052 -> clé à fourches
    n1=lorazépam | n2=clé à fourches | rel=r_associated | relid=0 | w=10
  155. lorazépam -- r_associated #0: 10 / 0.052 -> clé à molette
    n1=lorazépam | n2=clé à molette | rel=r_associated | relid=0 | w=10
  156. lorazépam -- r_associated #0: 10 / 0.052 -> clé ouverte
    n1=lorazépam | n2=clé ouverte | rel=r_associated | relid=0 | w=10
  157. lorazépam -- r_associated #0: 10 / 0.052 -> clef
    n1=lorazépam | n2=clef | rel=r_associated | relid=0 | w=10
  158. lorazépam -- r_associated #0: 10 / 0.052 -> clef à fourche
    n1=lorazépam | n2=clef à fourche | rel=r_associated | relid=0 | w=10
  159. lorazépam -- r_associated #0: 10 / 0.052 -> clef à fourches
    n1=lorazépam | n2=clef à fourches | rel=r_associated | relid=0 | w=10
  160. lorazépam -- r_associated #0: 10 / 0.052 -> clef ouverte
    n1=lorazépam | n2=clef ouverte | rel=r_associated | relid=0 | w=10
  161. lorazépam -- r_associated #0: 10 / 0.052 -> clobazam
    n1=lorazépam | n2=clobazam | rel=r_associated | relid=0 | w=10
  162. lorazépam -- r_associated #0: 10 / 0.052 -> clorazépate
    n1=lorazépam | n2=clorazépate | rel=r_associated | relid=0 | w=10
  163. lorazépam -- r_associated #0: 10 / 0.052 -> cobalamine
    n1=lorazépam | n2=cobalamine | rel=r_associated | relid=0 | w=10
  164. lorazépam -- r_associated #0: 10 / 0.052 -> coumaphène
    n1=lorazépam | n2=coumaphène | rel=r_associated | relid=0 | w=10
  165. lorazépam -- r_associated #0: 10 / 0.052 -> créatine phosphate
    n1=lorazépam | n2=créatine phosphate | rel=r_associated | relid=0 | w=10
  166. lorazépam -- r_associated #0: 10 / 0.052 -> curcumine
    n1=lorazépam | n2=curcumine | rel=r_associated | relid=0 | w=10
  167. lorazépam -- r_associated #0: 10 / 0.052 -> cycloleucine
    n1=lorazépam | n2=cycloleucine | rel=r_associated | relid=0 | w=10
  168. lorazépam -- r_associated #0: 10 / 0.052 -> cyclophosphamide
    n1=lorazépam | n2=cyclophosphamide | rel=r_associated | relid=0 | w=10
  169. lorazépam -- r_associated #0: 10 / 0.052 -> dabrafenib
    n1=lorazépam | n2=dabrafenib | rel=r_associated | relid=0 | w=10
  170. lorazépam -- r_associated #0: 10 / 0.052 -> daclatasvir
    n1=lorazépam | n2=daclatasvir | rel=r_associated | relid=0 | w=10
  171. lorazépam -- r_associated #0: 10 / 0.052 -> dactinomycine
    n1=lorazépam | n2=dactinomycine | rel=r_associated | relid=0 | w=10
  172. lorazépam -- r_associated #0: 10 / 0.052 -> dapsone
    n1=lorazépam | n2=dapsone | rel=r_associated | relid=0 | w=10
  173. lorazépam -- r_associated #0: 10 / 0.052 -> dasatinib
    n1=lorazépam | n2=dasatinib | rel=r_associated | relid=0 | w=10
  174. lorazépam -- r_associated #0: 10 / 0.052 -> défaillance respiratoire
    n1=lorazépam | n2=défaillance respiratoire | rel=r_associated | relid=0 | w=10
  175. lorazépam -- r_associated #0: 10 / 0.052 -> défaillance respiratoire chronique
    n1=lorazépam | n2=défaillance respiratoire chronique | rel=r_associated | relid=0 | w=10
  176. lorazépam -- r_associated #0: 10 / 0.052 -> dépression ventilatoire
    n1=lorazépam | n2=dépression ventilatoire | rel=r_associated | relid=0 | w=10
  177. lorazépam -- r_associated #0: 10 / 0.052 -> dextran
    n1=lorazépam | n2=dextran | rel=r_associated | relid=0 | w=10
  178. lorazépam -- r_associated #0: 10 / 0.052 -> dextrane
    n1=lorazépam | n2=dextrane | rel=r_associated | relid=0 | w=10
  179. lorazépam -- r_associated #0: 10 / 0.052 -> dichlorhydrate d'histamine
    n1=lorazépam | n2=dichlorhydrate d'histamine | rel=r_associated | relid=0 | w=10
  180. lorazépam -- r_associated #0: 10 / 0.052 -> dicumarol
    n1=lorazépam | n2=dicumarol | rel=r_associated | relid=0 | w=10
  181. lorazépam -- r_associated #0: 10 / 0.052 -> diéthylstilbestrol
    n1=lorazépam | n2=diéthylstilbestrol | rel=r_associated | relid=0 | w=10
  182. lorazépam -- r_associated #0: 10 / 0.052 -> diéthylstilboestrol
    n1=lorazépam | n2=diéthylstilboestrol | rel=r_associated | relid=0 | w=10
  183. lorazépam -- r_associated #0: 10 / 0.052 -> digitoxine
    n1=lorazépam | n2=digitoxine | rel=r_associated | relid=0 | w=10
  184. lorazépam -- r_associated #0: 10 / 0.052 -> diminution de la fonction respiratoire
    n1=lorazépam | n2=diminution de la fonction respiratoire | rel=r_associated | relid=0 | w=10
  185. lorazépam -- r_associated #0: 10 / 0.052 -> diminution de la respiration
    n1=lorazépam | n2=diminution de la respiration | rel=r_associated | relid=0 | w=10
  186. lorazépam -- r_associated #0: 10 / 0.052 -> diphenhydramine
    n1=lorazépam | n2=diphenhydramine | rel=r_associated | relid=0 | w=10
  187. lorazépam -- r_associated #0: 10 / 0.052 -> diphénhydramine
    n1=lorazépam | n2=diphénhydramine | rel=r_associated | relid=0 | w=10
  188. lorazépam -- r_associated #0: 10 / 0.052 -> dobutamine
    n1=lorazépam | n2=dobutamine | rel=r_associated | relid=0 | w=10
  189. lorazépam -- r_associated #0: 10 / 0.052 -> docusate
    n1=lorazépam | n2=docusate | rel=r_associated | relid=0 | w=10
  190. lorazépam -- r_associated #0: 10 / 0.052 -> dronabinol
    n1=lorazépam | n2=dronabinol | rel=r_associated | relid=0 | w=10
  191. lorazépam -- r_associated #0: 10 / 0.052 -> dysfonction respiratoire
    n1=lorazépam | n2=dysfonction respiratoire | rel=r_associated | relid=0 | w=10
  192. lorazépam -- r_associated #0: 10 / 0.052 -> E100
    n1=lorazépam | n2=E100 | rel=r_associated | relid=0 | w=10
  193. lorazépam -- r_associated #0: 10 / 0.052 -> E100(i)
    n1=lorazépam | n2=E100(i) | rel=r_associated | relid=0 | w=10
  194. lorazépam -- r_associated #0: 10 / 0.052 -> E1200
    n1=lorazépam | n2=E1200 | rel=r_associated | relid=0 | w=10
  195. lorazépam -- r_associated #0: 10 / 0.052 -> E1521
    n1=lorazépam | n2=E1521 | rel=r_associated | relid=0 | w=10
  196. lorazépam -- r_associated #0: 10 / 0.052 -> E270
    n1=lorazépam | n2=E270 | rel=r_associated | relid=0 | w=10
  197. lorazépam -- r_associated #0: 10 / 0.052 -> E553(iii)
    n1=lorazépam | n2=E553(iii) | rel=r_associated | relid=0 | w=10
  198. lorazépam -- r_associated #0: 10 / 0.052 -> eau distillée
    n1=lorazépam | n2=eau distillée | rel=r_associated | relid=0 | w=10
  199. lorazépam -- r_associated #0: 10 / 0.052 -> échinomycine
    n1=lorazépam | n2=échinomycine | rel=r_associated | relid=0 | w=10
  200. lorazépam -- r_associated #0: 10 / 0.052 -> emtricitabine
    n1=lorazépam | n2=emtricitabine | rel=r_associated | relid=0 | w=10
  201. lorazépam -- r_associated #0: 10 / 0.052 -> en:[18f]-labeled substance p antagonist receptor quantifier
    n1=lorazépam | n2=en:[18f]-labeled substance p antagonist receptor quantifier | rel=r_associated | relid=0 | w=10
  202. lorazépam -- r_associated #0: 10 / 0.052 -> en:[18f]l-fac
    n1=lorazépam | n2=en:[18f]l-fac | rel=r_associated | relid=0 | w=10
  203. lorazépam -- r_associated #0: 10 / 0.052 -> en:1 ml lorazepam 4 mg/ml injection
    n1=lorazépam | n2=en:1 ml lorazepam 4 mg/ml injection | rel=r_associated | relid=0 | w=10
  204. lorazépam -- r_associated #0: 10 / 0.052 -> en:1,2-carbon c 13-labeled glucose
    n1=lorazépam | n2=en:1,2-carbon c 13-labeled glucose | rel=r_associated | relid=0 | w=10
  205. lorazépam -- r_associated #0: 10 / 0.052 -> en:11 epicortisol
    n1=lorazépam | n2=en:11 epicortisol | rel=r_associated | relid=0 | w=10
  206. lorazépam -- r_associated #0: 10 / 0.052 -> en:13-deoxydoxorubicin
    n1=lorazépam | n2=en:13-deoxydoxorubicin | rel=r_associated | relid=0 | w=10
  207. lorazépam -- r_associated #0: 10 / 0.052 -> en:14c bms-275183
    n1=lorazépam | n2=en:14c bms-275183 | rel=r_associated | relid=0 | w=10
  208. lorazépam -- r_associated #0: 10 / 0.052 -> en:16,16-dimethyl prostaglandin e2
    n1=lorazépam | n2=en:16,16-dimethyl prostaglandin e2 | rel=r_associated | relid=0 | w=10
  209. lorazépam -- r_associated #0: 10 / 0.052 -> en:17-hydroxycorticosterone
    n1=lorazépam | n2=en:17-hydroxycorticosterone | rel=r_associated | relid=0 | w=10
  210. lorazépam -- r_associated #0: 10 / 0.052 -> en:18-f-fluoroacetate
    n1=lorazépam | n2=en:18-f-fluoroacetate | rel=r_associated | relid=0 | w=10
  211. lorazépam -- r_associated #0: 10 / 0.052 -> en:18f-fhbg
    n1=lorazépam | n2=en:18f-fhbg | rel=r_associated | relid=0 | w=10
  212. lorazépam -- r_associated #0: 10 / 0.052 -> en:18f-fluoroazomycin arabinoside
    n1=lorazépam | n2=en:18f-fluoroazomycin arabinoside | rel=r_associated | relid=0 | w=10
  213. lorazépam -- r_associated #0: 10 / 0.052 -> en:18f-labeled mini-peg spacered rgd dimer
    n1=lorazépam | n2=en:18f-labeled mini-peg spacered rgd dimer | rel=r_associated | relid=0 | w=10
  214. lorazépam -- r_associated #0: 10 / 0.052 -> en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide
    n1=lorazépam | n2=en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide | rel=r_associated | relid=0 | w=10
  215. lorazépam -- r_associated #0: 10 / 0.052 -> en:2-hydroxyoleic acid
    n1=lorazépam | n2=en:2-hydroxyoleic acid | rel=r_associated | relid=0 | w=10
  216. lorazépam -- r_associated #0: 10 / 0.052 -> en:2-methoxyestradiol
    n1=lorazépam | n2=en:2-methoxyestradiol | rel=r_associated | relid=0 | w=10
  217. lorazépam -- r_associated #0: 10 / 0.052 -> en:2-methoxyestradiol nanocrystal colloidal dispersion
    n1=lorazépam | n2=en:2-methoxyestradiol nanocrystal colloidal dispersion | rel=r_associated | relid=0 | w=10
  218. lorazépam -- r_associated #0: 10 / 0.052 -> en:2'-f-ara-deoxyuridine
    n1=lorazépam | n2=en:2'-f-ara-deoxyuridine | rel=r_associated | relid=0 | w=10
  219. lorazépam -- r_associated #0: 10 / 0.052 -> en:2g-1 tcr retroviral vector-transduced lymphocytes
    n1=lorazépam | n2=en:2g-1 tcr retroviral vector-transduced lymphocytes | rel=r_associated | relid=0 | w=10
  220. lorazépam -- r_associated #0: 10 / 0.052 -> en:3-deazauridine
    n1=lorazépam | n2=en:3-deazauridine | rel=r_associated | relid=0 | w=10
  221. lorazépam -- r_associated #0: 10 / 0.052 -> en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine
    n1=lorazépam | n2=en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine | rel=r_associated | relid=0 | w=10
  222. lorazépam -- r_associated #0: 10 / 0.052 -> en:3'-c-ethynylcytidine
    n1=lorazépam | n2=en:3'-c-ethynylcytidine | rel=r_associated | relid=0 | w=10
  223. lorazépam -- r_associated #0: 10 / 0.052 -> en:4-1bb agonist monoclonal antibody pf-05082566
    n1=lorazépam | n2=en:4-1bb agonist monoclonal antibody pf-05082566 | rel=r_associated | relid=0 | w=10
  224. lorazépam -- r_associated #0: 10 / 0.052 -> en:4-peptide melanoma vaccine
    n1=lorazépam | n2=en:4-peptide melanoma vaccine | rel=r_associated | relid=0 | w=10
  225. lorazépam -- r_associated #0: 10 / 0.052 -> en:5-fitc-labeled gi-heptapeptide
    n1=lorazépam | n2=en:5-fitc-labeled gi-heptapeptide | rel=r_associated | relid=0 | w=10
  226. lorazépam -- r_associated #0: 10 / 0.052 -> en:5-fluorouracil/salicylic acid topical solution
    n1=lorazépam | n2=en:5-fluorouracil/salicylic acid topical solution | rel=r_associated | relid=0 | w=10
  227. lorazépam -- r_associated #0: 10 / 0.052 -> en:5-ht3 receptor antagonist
    n1=lorazépam | n2=en:5-ht3 receptor antagonist | rel=r_associated | relid=0 | w=10
  228. lorazépam -- r_associated #0: 10 / 0.052 -> en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158
    n1=lorazépam | n2=en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 | rel=r_associated | relid=0 | w=10
  229. lorazépam -- r_associated #0: 10 / 0.052 -> en:6,8-bis(benzylthio)octanoic acid
    n1=lorazépam | n2=en:6,8-bis(benzylthio)octanoic acid | rel=r_associated | relid=0 | w=10
  230. lorazépam -- r_associated #0: 10 / 0.052 -> en:7-cyanoquinocarcinol
    n1=lorazépam | n2=en:7-cyanoquinocarcinol | rel=r_associated | relid=0 | w=10
  231. lorazépam -- r_associated #0: 10 / 0.052 -> en:7-hydroxystaurosporine
    n1=lorazépam | n2=en:7-hydroxystaurosporine | rel=r_associated | relid=0 | w=10
  232. lorazépam -- r_associated #0: 10 / 0.052 -> en:8-hydroxyquinoline sulfate ointment
    n1=lorazépam | n2=en:8-hydroxyquinoline sulfate ointment | rel=r_associated | relid=0 | w=10
  233. lorazépam -- r_associated #0: 10 / 0.052 -> en:abagovomab
    n1=lorazépam | n2=en:abagovomab | rel=r_associated | relid=0 | w=10
  234. lorazépam -- r_associated #0: 10 / 0.052 -> en:abarelix
    n1=lorazépam | n2=en:abarelix | rel=r_associated | relid=0 | w=10
  235. lorazépam -- r_associated #0: 10 / 0.052 -> en:abatacept
    n1=lorazépam | n2=en:abatacept | rel=r_associated | relid=0 | w=10
  236. lorazépam -- r_associated #0: 10 / 0.052 -> en:abbv-221
    n1=lorazépam | n2=en:abbv-221 | rel=r_associated | relid=0 | w=10
  237. lorazépam -- r_associated #0: 10 / 0.052 -> en:abexinostat
    n1=lorazépam | n2=en:abexinostat | rel=r_associated | relid=0 | w=10
  238. lorazépam -- r_associated #0: 10 / 0.052 -> en:abiraterone acetate
    n1=lorazépam | n2=en:abiraterone acetate | rel=r_associated | relid=0 | w=10
  239. lorazépam -- r_associated #0: 10 / 0.052 -> en:abnormal breathing
    n1=lorazépam | n2=en:abnormal breathing | rel=r_associated | relid=0 | w=10
  240. lorazépam -- r_associated #0: 10 / 0.052 -> en:abortifacient agents
    n1=lorazépam | n2=en:abortifacient agents | rel=r_associated | relid=0 | w=10
  241. lorazépam -- r_associated #0: 10 / 0.052 -> en:abr-217620
    n1=lorazépam | n2=en:abr-217620 | rel=r_associated | relid=0 | w=10
  242. lorazépam -- r_associated #0: 10 / 0.052 -> en:absorbable adhesion barrier gel
    n1=lorazépam | n2=en:absorbable adhesion barrier gel | rel=r_associated | relid=0 | w=10
  243. lorazépam -- r_associated #0: 10 / 0.052 -> en:absorbable fibrin sealant patch
    n1=lorazépam | n2=en:absorbable fibrin sealant patch | rel=r_associated | relid=0 | w=10
  244. lorazépam -- r_associated #0: 10 / 0.052 -> en:absorbable gelatin sponge
    n1=lorazépam | n2=en:absorbable gelatin sponge | rel=r_associated | relid=0 | w=10
  245. lorazépam -- r_associated #0: 10 / 0.052 -> en:absorbable modified polymer hemostatic powder
    n1=lorazépam | n2=en:absorbable modified polymer hemostatic powder | rel=r_associated | relid=0 | w=10
  246. lorazépam -- r_associated #0: 10 / 0.052 -> en:abt-751
    n1=lorazépam | n2=en:abt-751 | rel=r_associated | relid=0 | w=10
  247. lorazépam -- r_associated #0: 10 / 0.052 -> en:abvd regimen
    n1=lorazépam | n2=en:abvd regimen | rel=r_associated | relid=0 | w=10
  248. lorazépam -- r_associated #0: 10 / 0.052 -> en:abve regimen
    n1=lorazépam | n2=en:abve regimen | rel=r_associated | relid=0 | w=10
  249. lorazépam -- r_associated #0: 10 / 0.052 -> en:ac regimen
    n1=lorazépam | n2=en:ac regimen | rel=r_associated | relid=0 | w=10
  250. lorazépam -- r_associated #0: 10 / 0.052 -> en:acai berry juice
    n1=lorazépam | n2=en:acai berry juice | rel=r_associated | relid=0 | w=10
  251. lorazépam -- r_associated #0: 10 / 0.052 -> en:acalabrutinib
    n1=lorazépam | n2=en:acalabrutinib | rel=r_associated | relid=0 | w=10
  252. lorazépam -- r_associated #0: 10 / 0.052 -> en:acarbose
    n1=lorazépam | n2=en:acarbose | rel=r_associated | relid=0 | w=10
  253. lorazépam -- r_associated #0: 10 / 0.052 -> en:acenocoumarol
    n1=lorazépam | n2=en:acenocoumarol | rel=r_associated | relid=0 | w=10
  254. lorazépam -- r_associated #0: 10 / 0.052 -> en:acetaminophen
    n1=lorazépam | n2=en:acetaminophen | rel=r_associated | relid=0 | w=10
  255. lorazépam -- r_associated #0: 10 / 0.052 -> en:acetylcysteine
    n1=lorazépam | n2=en:acetylcysteine | rel=r_associated | relid=0 | w=10
  256. lorazépam -- r_associated #0: 10 / 0.052 -> en:acid of milk
    n1=lorazépam | n2=en:acid of milk | rel=r_associated | relid=0 | w=10
  257. lorazépam -- r_associated #0: 10 / 0.052 -> en:acitretin
    n1=lorazépam | n2=en:acitretin | rel=r_associated | relid=0 | w=10
  258. lorazépam -- r_associated #0: 10 / 0.052 -> en:acivicin
    n1=lorazépam | n2=en:acivicin | rel=r_associated | relid=0 | w=10
  259. lorazépam -- r_associated #0: 10 / 0.052 -> en:acodazole
    n1=lorazépam | n2=en:acodazole | rel=r_associated | relid=0 | w=10
  260. lorazépam -- r_associated #0: 10 / 0.052 -> en:acolbifene hydrochloride
    n1=lorazépam | n2=en:acolbifene hydrochloride | rel=r_associated | relid=0 | w=10
  261. lorazépam -- r_associated #0: 10 / 0.052 -> en:activin type 2b receptor fc fusion protein stm 434
    n1=lorazépam | n2=en:activin type 2b receptor fc fusion protein stm 434 | rel=r_associated | relid=0 | w=10
  262. lorazépam -- r_associated #0: 10 / 0.052 -> en:acyclovir sodium
    n1=lorazépam | n2=en:acyclovir sodium | rel=r_associated | relid=0 | w=10
  263. lorazépam -- r_associated #0: 10 / 0.052 -> en:ad-hcmv-flt3l
    n1=lorazépam | n2=en:ad-hcmv-flt3l | rel=r_associated | relid=0 | w=10
  264. lorazépam -- r_associated #0: 10 / 0.052 -> en:ad-isf35
    n1=lorazépam | n2=en:ad-isf35 | rel=r_associated | relid=0 | w=10
  265. lorazépam -- r_associated #0: 10 / 0.052 -> en:ad-sig-hmuc-1/ecdcd40l vaccine
    n1=lorazépam | n2=en:ad-sig-hmuc-1/ecdcd40l vaccine | rel=r_associated | relid=0 | w=10
  266. lorazépam -- r_associated #0: 10 / 0.052 -> en:ad5-ycd/muttk(sr39)rep-adp
    n1=lorazépam | n2=en:ad5-ycd/muttk(sr39)rep-adp | rel=r_associated | relid=0 | w=10
  267. lorazépam -- r_associated #0: 10 / 0.052 -> en:ad5.sstr/tk.rgd
    n1=lorazépam | n2=en:ad5.sstr/tk.rgd | rel=r_associated | relid=0 | w=10
  268. lorazépam -- r_associated #0: 10 / 0.052 -> en:ad5cmv-p53 gene
    n1=lorazépam | n2=en:ad5cmv-p53 gene | rel=r_associated | relid=0 | w=10
  269. lorazépam -- r_associated #0: 10 / 0.052 -> en:adecatumumab
    n1=lorazépam | n2=en:adecatumumab | rel=r_associated | relid=0 | w=10
  270. lorazépam -- r_associated #0: 10 / 0.052 -> en:adefovir dipivoxil
    n1=lorazépam | n2=en:adefovir dipivoxil | rel=r_associated | relid=0 | w=10
  271. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenosine a2a receptor antagonist pbf-509
    n1=lorazépam | n2=en:adenosine a2a receptor antagonist pbf-509 | rel=r_associated | relid=0 | w=10
  272. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovector encoding mda7
    n1=lorazépam | n2=en:adenovector encoding mda7 | rel=r_associated | relid=0 | w=10
  273. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201
    n1=lorazépam | n2=en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 | rel=r_associated | relid=0 | w=10
  274. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus 5-cd40 ligand
    n1=lorazépam | n2=en:adenovirus 5-cd40 ligand | rel=r_associated | relid=0 | w=10
  275. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus 5-human guanylyl cyclase c-padre vaccine
    n1=lorazépam | n2=en:adenovirus 5-human guanylyl cyclase c-padre vaccine | rel=r_associated | relid=0 | w=10
  276. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus b7-1
    n1=lorazépam | n2=en:adenovirus b7-1 | rel=r_associated | relid=0 | w=10
  277. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus encoding rat her-2/neu
    n1=lorazépam | n2=en:adenovirus encoding rat her-2/neu | rel=r_associated | relid=0 | w=10
  278. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus encoding recombinant human endostatin
    n1=lorazépam | n2=en:adenovirus encoding recombinant human endostatin | rel=r_associated | relid=0 | w=10
  279. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus-mediated human interleukin-12
    n1=lorazépam | n2=en:adenovirus-mediated human interleukin-12 | rel=r_associated | relid=0 | w=10
  280. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001
    n1=lorazépam | n2=en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=10
  281. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus-p53 transduced dendritic cell vaccine
    n1=lorazépam | n2=en:adenovirus-p53 transduced dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  282. lorazépam -- r_associated #0: 10 / 0.052 -> en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes
    n1=lorazépam | n2=en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  283. lorazépam -- r_associated #0: 10 / 0.052 -> en:adgmcaix-transduced autologous dendritic cells
    n1=lorazépam | n2=en:adgmcaix-transduced autologous dendritic cells | rel=r_associated | relid=0 | w=10
  284. lorazépam -- r_associated #0: 10 / 0.052 -> en:adh-1
    n1=lorazépam | n2=en:adh-1 | rel=r_associated | relid=0 | w=10
  285. lorazépam -- r_associated #0: 10 / 0.052 -> en:adinazolam
    n1=lorazépam | n2=en:adinazolam | rel=r_associated | relid=0 | w=10
  286. lorazépam -- r_associated #0: 10 / 0.052 -> en:adipose-derived regenerative cells
    n1=lorazépam | n2=en:adipose-derived regenerative cells | rel=r_associated | relid=0 | w=10
  287. lorazépam -- r_associated #0: 10 / 0.052 -> en:adrtvp-1-transduced prostate cancer cell-based vaccine
    n1=lorazépam | n2=en:adrtvp-1-transduced prostate cancer cell-based vaccine | rel=r_associated | relid=0 | w=10
  288. lorazépam -- r_associated #0: 10 / 0.052 -> en:ae37 peptide/gm-csf vaccine
    n1=lorazépam | n2=en:ae37 peptide/gm-csf vaccine | rel=r_associated | relid=0 | w=10
  289. lorazépam -- r_associated #0: 10 / 0.052 -> en:aee788
    n1=lorazépam | n2=en:aee788 | rel=r_associated | relid=0 | w=10
  290. lorazépam -- r_associated #0: 10 / 0.052 -> en:aeg35156
    n1=lorazépam | n2=en:aeg35156 | rel=r_associated | relid=0 | w=10
  291. lorazépam -- r_associated #0: 10 / 0.052 -> en:afatinib dimaleate
    n1=lorazépam | n2=en:afatinib dimaleate | rel=r_associated | relid=0 | w=10
  292. lorazépam -- r_associated #0: 10 / 0.052 -> en:afimoxifene
    n1=lorazépam | n2=en:afimoxifene | rel=r_associated | relid=0 | w=10
  293. lorazépam -- r_associated #0: 10 / 0.052 -> en:afp gene hepatocellular carcinoma vaccine
    n1=lorazépam | n2=en:afp gene hepatocellular carcinoma vaccine | rel=r_associated | relid=0 | w=10
  294. lorazépam -- r_associated #0: 10 / 0.052 -> en:afp464
    n1=lorazépam | n2=en:afp464 | rel=r_associated | relid=0 | w=10
  295. lorazépam -- r_associated #0: 10 / 0.052 -> en:afuresertib
    n1=lorazépam | n2=en:afuresertib | rel=r_associated | relid=0 | w=10
  296. lorazépam -- r_associated #0: 10 / 0.052 -> en:ag-024322
    n1=lorazépam | n2=en:ag-024322 | rel=r_associated | relid=0 | w=10
  297. lorazépam -- r_associated #0: 10 / 0.052 -> en:agatolimod sodium
    n1=lorazépam | n2=en:agatolimod sodium | rel=r_associated | relid=0 | w=10
  298. lorazépam -- r_associated #0: 10 / 0.052 -> en:agerafenib
    n1=lorazépam | n2=en:agerafenib | rel=r_associated | relid=0 | w=10
  299. lorazépam -- r_associated #0: 10 / 0.052 -> en:agonists
    n1=lorazépam | n2=en:agonists | rel=r_associated | relid=0 | w=10
  300. lorazépam -- r_associated #0: 10 / 0.052 -> en:ak 3012
    n1=lorazépam | n2=en:ak 3012 | rel=r_associated | relid=0 | w=10
  301. lorazépam -- r_associated #0: 10 / 0.052 -> en:akt 1/2 inhibitor bay1125976
    n1=lorazépam | n2=en:akt 1/2 inhibitor bay1125976 | rel=r_associated | relid=0 | w=10
  302. lorazépam -- r_associated #0: 10 / 0.052 -> en:akt inhibitor azd5363
    n1=lorazépam | n2=en:akt inhibitor azd5363 | rel=r_associated | relid=0 | w=10
  303. lorazépam -- r_associated #0: 10 / 0.052 -> en:akt inhibitor gsk2141795
    n1=lorazépam | n2=en:akt inhibitor gsk2141795 | rel=r_associated | relid=0 | w=10
  304. lorazépam -- r_associated #0: 10 / 0.052 -> en:akt inhibitor ly2780301
    n1=lorazépam | n2=en:akt inhibitor ly2780301 | rel=r_associated | relid=0 | w=10
  305. lorazépam -- r_associated #0: 10 / 0.052 -> en:akt inhibitor mk2206
    n1=lorazépam | n2=en:akt inhibitor mk2206 | rel=r_associated | relid=0 | w=10
  306. lorazépam -- r_associated #0: 10 / 0.052 -> en:akt inhibitor sr13668
    n1=lorazépam | n2=en:akt inhibitor sr13668 | rel=r_associated | relid=0 | w=10
  307. lorazépam -- r_associated #0: 10 / 0.052 -> en:akt/erk inhibitor onc201
    n1=lorazépam | n2=en:akt/erk inhibitor onc201 | rel=r_associated | relid=0 | w=10
  308. lorazépam -- r_associated #0: 10 / 0.052 -> en:al-721
    n1=lorazépam | n2=en:al-721 | rel=r_associated | relid=0 | w=10
  309. lorazépam -- r_associated #0: 10 / 0.052 -> en:al721
    n1=lorazépam | n2=en:al721 | rel=r_associated | relid=0 | w=10
  310. lorazépam -- r_associated #0: 10 / 0.052 -> en:albuterol sulfate
    n1=lorazépam | n2=en:albuterol sulfate | rel=r_associated | relid=0 | w=10
  311. lorazépam -- r_associated #0: 10 / 0.052 -> en:aldesleukin
    n1=lorazépam | n2=en:aldesleukin | rel=r_associated | relid=0 | w=10
  312. lorazépam -- r_associated #0: 10 / 0.052 -> en:aldoxorubicin
    n1=lorazépam | n2=en:aldoxorubicin | rel=r_associated | relid=0 | w=10
  313. lorazépam -- r_associated #0: 10 / 0.052 -> en:alectinib
    n1=lorazépam | n2=en:alectinib | rel=r_associated | relid=0 | w=10
  314. lorazépam -- r_associated #0: 10 / 0.052 -> en:alefacept
    n1=lorazépam | n2=en:alefacept | rel=r_associated | relid=0 | w=10
  315. lorazépam -- r_associated #0: 10 / 0.052 -> en:alfuzosin hydrochloride
    n1=lorazépam | n2=en:alfuzosin hydrochloride | rel=r_associated | relid=0 | w=10
  316. lorazépam -- r_associated #0: 10 / 0.052 -> en:algenpantucel-l
    n1=lorazépam | n2=en:algenpantucel-l | rel=r_associated | relid=0 | w=10
  317. lorazépam -- r_associated #0: 10 / 0.052 -> en:alisertib
    n1=lorazépam | n2=en:alisertib | rel=r_associated | relid=0 | w=10
  318. lorazépam -- r_associated #0: 10 / 0.052 -> en:alk inhibitor x-396
    n1=lorazépam | n2=en:alk inhibitor x-396 | rel=r_associated | relid=0 | w=10
  319. lorazépam -- r_associated #0: 10 / 0.052 -> en:alk/ros1 inhibitor pf-06463922
    n1=lorazépam | n2=en:alk/ros1 inhibitor pf-06463922 | rel=r_associated | relid=0 | w=10
  320. lorazépam -- r_associated #0: 10 / 0.052 -> en:alk/trk inhibitor tsr-011
    n1=lorazépam | n2=en:alk/trk inhibitor tsr-011 | rel=r_associated | relid=0 | w=10
  321. lorazépam -- r_associated #0: 10 / 0.052 -> en:alk5 inhibitor tew-7197
    n1=lorazépam | n2=en:alk5 inhibitor tew-7197 | rel=r_associated | relid=0 | w=10
  322. lorazépam -- r_associated #0: 10 / 0.052 -> en:allodepleted haploidentical t cells-expressing inducible caspase 9
    n1=lorazépam | n2=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | rel=r_associated | relid=0 | w=10
  323. lorazépam -- r_associated #0: 10 / 0.052 -> en:allodepleted t cell immunotherapeutic atir101
    n1=lorazépam | n2=en:allodepleted t cell immunotherapeutic atir101 | rel=r_associated | relid=0 | w=10
  324. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic aml antigen-expressing dendritic cell vaccine
    n1=lorazépam | n2=en:allogeneic aml antigen-expressing dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  325. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine
    n1=lorazépam | n2=en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine | rel=r_associated | relid=0 | w=10
  326. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells
    n1=lorazépam | n2=en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells | rel=r_associated | relid=0 | w=10
  327. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic cd56-positive cd3-negative natural killer cells
    n1=lorazépam | n2=en:allogeneic cd56-positive cd3-negative natural killer cells | rel=r_associated | relid=0 | w=10
  328. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic cmv/adv-specific cytotoxic t lymphocytes
    n1=lorazépam | n2=en:allogeneic cmv/adv-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  329. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes
    n1=lorazépam | n2=en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  330. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic dendritic cell vaccine combig-dc
    n1=lorazépam | n2=en:allogeneic dendritic cell vaccine combig-dc | rel=r_associated | relid=0 | w=10
  331. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic dendritic cell-myeloma idiotype vaccine
    n1=lorazépam | n2=en:allogeneic dendritic cell-myeloma idiotype vaccine | rel=r_associated | relid=0 | w=10
  332. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes
    n1=lorazépam | n2=en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  333. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic gm-csf-based myeloma cell vaccine
    n1=lorazépam | n2=en:allogeneic gm-csf-based myeloma cell vaccine | rel=r_associated | relid=0 | w=10
  334. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine
    n1=lorazépam | n2=en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine | rel=r_associated | relid=0 | w=10
  335. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo
    n1=lorazépam | n2=en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo | rel=r_associated | relid=0 | w=10
  336. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic large multivalent immunogen breast cancer vaccine
    n1=lorazépam | n2=en:allogeneic large multivalent immunogen breast cancer vaccine | rel=r_associated | relid=0 | w=10
  337. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes
    n1=lorazépam | n2=en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  338. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  339. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic natural killer cell line mg4101
    n1=lorazépam | n2=en:allogeneic natural killer cell line mg4101 | rel=r_associated | relid=0 | w=10
  340. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic natural killer cell line nk-92
    n1=lorazépam | n2=en:allogeneic natural killer cell line nk-92 | rel=r_associated | relid=0 | w=10
  341. lorazépam -- r_associated #0: 10 / 0.052 -> en:allogeneic tumor cell vaccine
    n1=lorazépam | n2=en:allogeneic tumor cell vaccine | rel=r_associated | relid=0 | w=10
  342. lorazépam -- r_associated #0: 10 / 0.052 -> en:allosteric bcr-abl tyrosine kinase inhibitor abl001
    n1=lorazépam | n2=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | rel=r_associated | relid=0 | w=10
  343. lorazépam -- r_associated #0: 10 / 0.052 -> en:almazine
    n1=lorazépam | n2=en:almazine | rel=r_associated | relid=0 | w=10
  344. lorazépam -- r_associated #0: 10 / 0.052 -> en:aloe vera gel
    n1=lorazépam | n2=en:aloe vera gel | rel=r_associated | relid=0 | w=10
  345. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha fetoprotein adenoviral vector vaccine
    n1=lorazépam | n2=en:alpha fetoprotein adenoviral vector vaccine | rel=r_associated | relid=0 | w=10
  346. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha fetoprotein plasmid dna vaccine
    n1=lorazépam | n2=en:alpha fetoprotein plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  347. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha galactosylceramide
    n1=lorazépam | n2=en:alpha galactosylceramide | rel=r_associated | relid=0 | w=10
  348. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-1-proteinase inhibitor human
    n1=lorazépam | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=10
  349. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine
    n1=lorazépam | n2=en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine | rel=r_associated | relid=0 | w=10
  350. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801
    n1=lorazépam | n2=en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 | rel=r_associated | relid=0 | w=10
  351. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-gal glycosphingolipids
    n1=lorazépam | n2=en:alpha-gal glycosphingolipids | rel=r_associated | relid=0 | w=10
  352. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-galactosylceramide-pulsed autologous dendritic cells
    n1=lorazépam | n2=en:alpha-galactosylceramide-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=10
  353. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-lipoic acid-palladium/vitamin/mineral supplement
    n1=lorazépam | n2=en:alpha-lipoic acid-palladium/vitamin/mineral supplement | rel=r_associated | relid=0 | w=10
  354. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-tocopheryloxyacetic acid
    n1=lorazépam | n2=en:alpha-tocopheryloxyacetic acid | rel=r_associated | relid=0 | w=10
  355. lorazépam -- r_associated #0: 10 / 0.052 -> en:alpha-type-1 polarized dendritic cells
    n1=lorazépam | n2=en:alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=10
  356. lorazépam -- r_associated #0: 10 / 0.052 -> en:altiratinib
    n1=lorazépam | n2=en:altiratinib | rel=r_associated | relid=0 | w=10
  357. lorazépam -- r_associated #0: 10 / 0.052 -> en:alvac-cea b7.1 vaccine
    n1=lorazépam | n2=en:alvac-cea b7.1 vaccine | rel=r_associated | relid=0 | w=10
  358. lorazépam -- r_associated #0: 10 / 0.052 -> en:alvac-eso-1 vaccine
    n1=lorazépam | n2=en:alvac-eso-1 vaccine | rel=r_associated | relid=0 | w=10
  359. lorazépam -- r_associated #0: 10 / 0.052 -> en:alvac-hb7.1
    n1=lorazépam | n2=en:alvac-hb7.1 | rel=r_associated | relid=0 | w=10
  360. lorazépam -- r_associated #0: 10 / 0.052 -> en:alvac-mart-1 vaccine
    n1=lorazépam | n2=en:alvac-mart-1 vaccine | rel=r_associated | relid=0 | w=10
  361. lorazépam -- r_associated #0: 10 / 0.052 -> en:alvelestat
    n1=lorazépam | n2=en:alvelestat | rel=r_associated | relid=0 | w=10
  362. lorazépam -- r_associated #0: 10 / 0.052 -> en:alvespimycin hydrochloride
    n1=lorazépam | n2=en:alvespimycin hydrochloride | rel=r_associated | relid=0 | w=10
  363. lorazépam -- r_associated #0: 10 / 0.052 -> en:alvocidib hydrochloride
    n1=lorazépam | n2=en:alvocidib hydrochloride | rel=r_associated | relid=0 | w=10
  364. lorazépam -- r_associated #0: 10 / 0.052 -> en:amantadine hydrochloride
    n1=lorazépam | n2=en:amantadine hydrochloride | rel=r_associated | relid=0 | w=10
  365. lorazépam -- r_associated #0: 10 / 0.052 -> en:amatuximab
    n1=lorazépam | n2=en:amatuximab | rel=r_associated | relid=0 | w=10
  366. lorazépam -- r_associated #0: 10 / 0.052 -> en:american ginseng
    n1=lorazépam | n2=en:american ginseng | rel=r_associated | relid=0 | w=10
  367. lorazépam -- r_associated #0: 10 / 0.052 -> en:American ginseng
    n1=lorazépam | n2=en:American ginseng | rel=r_associated | relid=0 | w=10
  368. lorazépam -- r_associated #0: 10 / 0.052 -> en:ametantrone
    n1=lorazépam | n2=en:ametantrone | rel=r_associated | relid=0 | w=10
  369. lorazépam -- r_associated #0: 10 / 0.052 -> en:amifampridine
    n1=lorazépam | n2=en:amifampridine | rel=r_associated | relid=0 | w=10
  370. lorazépam -- r_associated #0: 10 / 0.052 -> en:amifostine
    n1=lorazépam | n2=en:amifostine | rel=r_associated | relid=0 | w=10
  371. lorazépam -- r_associated #0: 10 / 0.052 -> en:amikacin sulfate
    n1=lorazépam | n2=en:amikacin sulfate | rel=r_associated | relid=0 | w=10
  372. lorazépam -- r_associated #0: 10 / 0.052 -> en:aminobenzoate potassium
    n1=lorazépam | n2=en:aminobenzoate potassium | rel=r_associated | relid=0 | w=10
  373. lorazépam -- r_associated #0: 10 / 0.052 -> en:aminocamptothecin
    n1=lorazépam | n2=en:aminocamptothecin | rel=r_associated | relid=0 | w=10
  374. lorazépam -- r_associated #0: 10 / 0.052 -> en:aminocamptothecin colloidal dispersion
    n1=lorazépam | n2=en:aminocamptothecin colloidal dispersion | rel=r_associated | relid=0 | w=10
  375. lorazépam -- r_associated #0: 10 / 0.052 -> en:aminocaproic acid
    n1=lorazépam | n2=en:aminocaproic acid | rel=r_associated | relid=0 | w=10
  376. lorazépam -- r_associated #0: 10 / 0.052 -> en:aminosyn
    n1=lorazépam | n2=en:aminosyn | rel=r_associated | relid=0 | w=10
  377. lorazépam -- r_associated #0: 10 / 0.052 -> en:amitriptyline hydrochloride
    n1=lorazépam | n2=en:amitriptyline hydrochloride | rel=r_associated | relid=0 | w=10
  378. lorazépam -- r_associated #0: 10 / 0.052 -> en:ammonia n-13
    n1=lorazépam | n2=en:ammonia n-13 | rel=r_associated | relid=0 | w=10
  379. lorazépam -- r_associated #0: 10 / 0.052 -> en:ammonium glycyrrhizate
    n1=lorazépam | n2=en:ammonium glycyrrhizate | rel=r_associated | relid=0 | w=10
  380. lorazépam -- r_associated #0: 10 / 0.052 -> en:amnion-derived cellular cytokine solution
    n1=lorazépam | n2=en:amnion-derived cellular cytokine solution | rel=r_associated | relid=0 | w=10
  381. lorazépam -- r_associated #0: 10 / 0.052 -> en:amolimogene bepiplasmid
    n1=lorazépam | n2=en:amolimogene bepiplasmid | rel=r_associated | relid=0 | w=10
  382. lorazépam -- r_associated #0: 10 / 0.052 -> en:amonafide dihydrochloride
    n1=lorazépam | n2=en:amonafide dihydrochloride | rel=r_associated | relid=0 | w=10
  383. lorazépam -- r_associated #0: 10 / 0.052 -> en:amonafide l-malate
    n1=lorazépam | n2=en:amonafide l-malate | rel=r_associated | relid=0 | w=10
  384. lorazépam -- r_associated #0: 10 / 0.052 -> en:amphotericin b deoxycholate
    n1=lorazépam | n2=en:amphotericin b deoxycholate | rel=r_associated | relid=0 | w=10
  385. lorazépam -- r_associated #0: 10 / 0.052 -> en:amrubicin hydrochloride
    n1=lorazépam | n2=en:amrubicin hydrochloride | rel=r_associated | relid=0 | w=10
  386. lorazépam -- r_associated #0: 10 / 0.052 -> en:amsilarotene
    n1=lorazépam | n2=en:amsilarotene | rel=r_associated | relid=0 | w=10
  387. lorazépam -- r_associated #0: 10 / 0.052 -> en:amuvatinib
    n1=lorazépam | n2=en:amuvatinib | rel=r_associated | relid=0 | w=10
  388. lorazépam -- r_associated #0: 10 / 0.052 -> en:anagrelide hydrochloride
    n1=lorazépam | n2=en:anagrelide hydrochloride | rel=r_associated | relid=0 | w=10
  389. lorazépam -- r_associated #0: 10 / 0.052 -> en:anagrelide prolonged-release formulation
    n1=lorazépam | n2=en:anagrelide prolonged-release formulation | rel=r_associated | relid=0 | w=10
  390. lorazépam -- r_associated #0: 10 / 0.052 -> en:analgesic agent
    n1=lorazépam | n2=en:analgesic agent | rel=r_associated | relid=0 | w=10
  391. lorazépam -- r_associated #0: 10 / 0.052 -> en:anamorelin hydrochloride
    n1=lorazépam | n2=en:anamorelin hydrochloride | rel=r_associated | relid=0 | w=10
  392. lorazépam -- r_associated #0: 10 / 0.052 -> en:anaxirone
    n1=lorazépam | n2=en:anaxirone | rel=r_associated | relid=0 | w=10
  393. lorazépam -- r_associated #0: 10 / 0.052 -> en:ancestim
    n1=lorazépam | n2=en:ancestim | rel=r_associated | relid=0 | w=10
  394. lorazépam -- r_associated #0: 10 / 0.052 -> en:androgen antagonist apc-100
    n1=lorazépam | n2=en:androgen antagonist apc-100 | rel=r_associated | relid=0 | w=10
  395. lorazépam -- r_associated #0: 10 / 0.052 -> en:androgen receptor antagonist arn-509
    n1=lorazépam | n2=en:androgen receptor antagonist arn-509 | rel=r_associated | relid=0 | w=10
  396. lorazépam -- r_associated #0: 10 / 0.052 -> en:androgen receptor antagonist shr3680
    n1=lorazépam | n2=en:androgen receptor antagonist shr3680 | rel=r_associated | relid=0 | w=10
  397. lorazépam -- r_associated #0: 10 / 0.052 -> en:androgen receptor antisense oligonucleotide azd5312
    n1=lorazépam | n2=en:androgen receptor antisense oligonucleotide azd5312 | rel=r_associated | relid=0 | w=10
  398. lorazépam -- r_associated #0: 10 / 0.052 -> en:androgen receptor antisense oligonucleotide ezn-4176
    n1=lorazépam | n2=en:androgen receptor antisense oligonucleotide ezn-4176 | rel=r_associated | relid=0 | w=10
  399. lorazépam -- r_associated #0: 10 / 0.052 -> en:androgen receptor inhibitor epi-506
    n1=lorazépam | n2=en:androgen receptor inhibitor epi-506 | rel=r_associated | relid=0 | w=10
  400. lorazépam -- r_associated #0: 10 / 0.052 -> en:androstane steroid he3235
    n1=lorazépam | n2=en:androstane steroid he3235 | rel=r_associated | relid=0 | w=10
  401. lorazépam -- r_associated #0: 10 / 0.052 -> en:anesthetic agent
    n1=lorazépam | n2=en:anesthetic agent | rel=r_associated | relid=0 | w=10
  402. lorazépam -- r_associated #0: 10 / 0.052 -> en:angiogenesis inhibitor gt-111
    n1=lorazépam | n2=en:angiogenesis inhibitor gt-111 | rel=r_associated | relid=0 | w=10
  403. lorazépam -- r_associated #0: 10 / 0.052 -> en:angiogenesis inhibitor ji-101
    n1=lorazépam | n2=en:angiogenesis inhibitor ji-101 | rel=r_associated | relid=0 | w=10
  404. lorazépam -- r_associated #0: 10 / 0.052 -> en:angiostatin
    n1=lorazépam | n2=en:angiostatin | rel=r_associated | relid=0 | w=10
  405. lorazépam -- r_associated #0: 10 / 0.052 -> en:angle closure glaucoma
    n1=lorazépam | n2=en:angle closure glaucoma | rel=r_associated | relid=0 | w=10
  406. lorazépam -- r_associated #0: 10 / 0.052 -> en:anhydrovinblastine
    n1=lorazépam | n2=en:anhydrovinblastine | rel=r_associated | relid=0 | w=10
  407. lorazépam -- r_associated #0: 10 / 0.052 -> en:aniline mustard
    n1=lorazépam | n2=en:aniline mustard | rel=r_associated | relid=0 | w=10
  408. lorazépam -- r_associated #0: 10 / 0.052 -> en:annamycin liposomal
    n1=lorazépam | n2=en:annamycin liposomal | rel=r_associated | relid=0 | w=10
  409. lorazépam -- r_associated #0: 10 / 0.052 -> en:annonaceous acetogenins
    n1=lorazépam | n2=en:annonaceous acetogenins | rel=r_associated | relid=0 | w=10
  410. lorazépam -- r_associated #0: 10 / 0.052 -> en:answer
    n1=lorazépam | n2=en:answer | rel=r_associated | relid=0 | w=10
  411. lorazépam -- r_associated #0: 10 / 0.052 -> en:answer sb back
    n1=lorazépam | n2=en:answer sb back | rel=r_associated | relid=0 | w=10
  412. lorazépam -- r_associated #0: 10 / 0.052 -> en:answer somebody back
    n1=lorazépam | n2=en:answer somebody back | rel=r_associated | relid=0 | w=10
  413. lorazépam -- r_associated #0: 10 / 0.052 -> en:anthocyanin-rich corn extract
    n1=lorazépam | n2=en:anthocyanin-rich corn extract | rel=r_associated | relid=0 | w=10
  414. lorazépam -- r_associated #0: 10 / 0.052 -> en:anthramycin
    n1=lorazépam | n2=en:anthramycin | rel=r_associated | relid=0 | w=10
  415. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti c-kit antibody-drug conjugate lop628
    n1=lorazépam | n2=en:anti c-kit antibody-drug conjugate lop628 | rel=r_associated | relid=0 | w=10
  416. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-a33 monoclonal antibody krn330
    n1=lorazépam | n2=en:anti-a33 monoclonal antibody krn330 | rel=r_associated | relid=0 | w=10
  417. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-a5b1 integrin monoclonal antibody pf-04605412
    n1=lorazépam | n2=en:anti-a5b1 integrin monoclonal antibody pf-04605412 | rel=r_associated | relid=0 | w=10
  418. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ags-5 antibody-drug conjugate asg-5me
    n1=lorazépam | n2=en:anti-ags-5 antibody-drug conjugate asg-5me | rel=r_associated | relid=0 | w=10
  419. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ags-8 monoclonal antibody ags-8m4
    n1=lorazépam | n2=en:anti-ags-8 monoclonal antibody ags-8m4 | rel=r_associated | relid=0 | w=10
  420. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-alk-1 monoclonal antibody pf-03446962
    n1=lorazépam | n2=en:anti-alk-1 monoclonal antibody pf-03446962 | rel=r_associated | relid=0 | w=10
  421. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-allergic agents
    n1=lorazépam | n2=en:anti-allergic agents | rel=r_associated | relid=0 | w=10
  422. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-alpha5beta1 integrin antibody mint1526a
    n1=lorazépam | n2=en:anti-alpha5beta1 integrin antibody mint1526a | rel=r_associated | relid=0 | w=10
  423. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-alphavbeta3 monoclonal antibody emd 525797
    n1=lorazépam | n2=en:anti-alphavbeta3 monoclonal antibody emd 525797 | rel=r_associated | relid=0 | w=10
  424. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ang2 monoclonal antibody medi-3617
    n1=lorazépam | n2=en:anti-ang2 monoclonal antibody medi-3617 | rel=r_associated | relid=0 | w=10
  425. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-b4 blocked ricin immunotoxin
    n1=lorazépam | n2=en:anti-b4 blocked ricin immunotoxin | rel=r_associated | relid=0 | w=10
  426. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-c-fms monoclonal antibody amg 820
    n1=lorazépam | n2=en:anti-c-fms monoclonal antibody amg 820 | rel=r_associated | relid=0 | w=10
  427. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-c-kit monoclonal antibody ktn0158
    n1=lorazépam | n2=en:anti-c-kit monoclonal antibody ktn0158 | rel=r_associated | relid=0 | w=10
  428. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-c-met monoclonal antibody abt-700
    n1=lorazépam | n2=en:anti-c-met monoclonal antibody abt-700 | rel=r_associated | relid=0 | w=10
  429. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-c-met monoclonal antibody argx-111
    n1=lorazépam | n2=en:anti-c-met monoclonal antibody argx-111 | rel=r_associated | relid=0 | w=10
  430. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-c-met monoclonal antibody ly2875358
    n1=lorazépam | n2=en:anti-c-met monoclonal antibody ly2875358 | rel=r_associated | relid=0 | w=10
  431. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-c-met monoclonal antibody sait301
    n1=lorazépam | n2=en:anti-c-met monoclonal antibody sait301 | rel=r_associated | relid=0 | w=10
  432. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ca19-9 monoclonal antibody 5b1
    n1=lorazépam | n2=en:anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=10
  433. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ca6-dm4 immunoconjugate sar566658
    n1=lorazépam | n2=en:anti-ca6-dm4 immunoconjugate sar566658 | rel=r_associated | relid=0 | w=10
  434. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd123 monoclonal antibody csl360
    n1=lorazépam | n2=en:anti-cd123 monoclonal antibody csl360 | rel=r_associated | relid=0 | w=10
  435. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd123 monoclonal antibody csl362
    n1=lorazépam | n2=en:anti-cd123 monoclonal antibody csl362 | rel=r_associated | relid=0 | w=10
  436. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd123 x anti-cd3 bispecific antibody xmab1404
    n1=lorazépam | n2=en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 | rel=r_associated | relid=0 | w=10
  437. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd123/cd3 monoclonal antibody mgd006
    n1=lorazépam | n2=en:anti-cd123/cd3 monoclonal antibody mgd006 | rel=r_associated | relid=0 | w=10
  438. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd157 monoclonal antibody men1112
    n1=lorazépam | n2=en:anti-cd157 monoclonal antibody men1112 | rel=r_associated | relid=0 | w=10
  439. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19 monoclonal antibody mdx-1342
    n1=lorazépam | n2=en:anti-cd19 monoclonal antibody mdx-1342 | rel=r_associated | relid=0 | w=10
  440. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19 monoclonal antibody xmab5574
    n1=lorazépam | n2=en:anti-cd19 monoclonal antibody xmab5574 | rel=r_associated | relid=0 | w=10
  441. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes
    n1=lorazépam | n2=en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=10
  442. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19-car retroviral vector-transduced autologous t cells
    n1=lorazépam | n2=en:anti-cd19-car retroviral vector-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  443. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells
    n1=lorazépam | n2=en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells | rel=r_associated | relid=0 | w=10
  444. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19-dm4 immunoconjugate sar3419
    n1=lorazépam | n2=en:anti-cd19-dm4 immunoconjugate sar3419 | rel=r_associated | relid=0 | w=10
  445. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl
    n1=lorazépam | n2=en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl | rel=r_associated | relid=0 | w=10
  446. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd19/cd3 tetravalent antibody afm11
    n1=lorazépam | n2=en:anti-cd19/cd3 tetravalent antibody afm11 | rel=r_associated | relid=0 | w=10
  447. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20 b9e9 scfv-streptavidin fusion protein
    n1=lorazépam | n2=en:anti-cd20 b9e9 scfv-streptavidin fusion protein | rel=r_associated | relid=0 | w=10
  448. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20 monoclonal antibody pro131921
    n1=lorazépam | n2=en:anti-cd20 monoclonal antibody pro131921 | rel=r_associated | relid=0 | w=10
  449. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20 monoclonal antibody sct400
    n1=lorazépam | n2=en:anti-cd20 monoclonal antibody sct400 | rel=r_associated | relid=0 | w=10
  450. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20 monoclonal antibody tl011
    n1=lorazépam | n2=en:anti-cd20 monoclonal antibody tl011 | rel=r_associated | relid=0 | w=10
  451. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002
    n1=lorazépam | n2=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | rel=r_associated | relid=0 | w=10
  452. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells
    n1=lorazépam | n2=en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells | rel=r_associated | relid=0 | w=10
  453. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20-engineered toxin body mt-3724
    n1=lorazépam | n2=en:anti-cd20-engineered toxin body mt-3724 | rel=r_associated | relid=0 | w=10
  454. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd20/cd3 monoclonal antibody regn1979
    n1=lorazépam | n2=en:anti-cd20/cd3 monoclonal antibody regn1979 | rel=r_associated | relid=0 | w=10
  455. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd200 monoclonal antibody alxn6000
    n1=lorazépam | n2=en:anti-cd200 monoclonal antibody alxn6000 | rel=r_associated | relid=0 | w=10
  456. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd22 car-expressing t lymphocytes
    n1=lorazépam | n2=en:anti-cd22 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  457. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s
    n1=lorazépam | n2=en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s | rel=r_associated | relid=0 | w=10
  458. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes
    n1=lorazépam | n2=en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  459. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd25-pbd antibody-drug conjugate adct-301
    n1=lorazépam | n2=en:anti-cd25-pbd antibody-drug conjugate adct-301 | rel=r_associated | relid=0 | w=10
  460. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd27l antibody-drug conjugate amg 172
    n1=lorazépam | n2=en:anti-cd27l antibody-drug conjugate amg 172 | rel=r_associated | relid=0 | w=10
  461. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1)
    n1=lorazépam | n2=en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | rel=r_associated | relid=0 | w=10
  462. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes
    n1=lorazépam | n2=en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes | rel=r_associated | relid=0 | w=10
  463. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05
    n1=lorazépam | n2=en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 | rel=r_associated | relid=0 | w=10
  464. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes
    n1=lorazépam | n2=en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  465. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd30 monoclonal antibody mdx-1401
    n1=lorazépam | n2=en:anti-cd30 monoclonal antibody mdx-1401 | rel=r_associated | relid=0 | w=10
  466. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd33 antibody-drug conjugate imgn779
    n1=lorazépam | n2=en:anti-cd33 antibody-drug conjugate imgn779 | rel=r_associated | relid=0 | w=10
  467. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633
    n1=lorazépam | n2=en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 | rel=r_associated | relid=0 | w=10
  468. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd33/cd3 bite antibody amg 330
    n1=lorazépam | n2=en:anti-cd33/cd3 bite antibody amg 330 | rel=r_associated | relid=0 | w=10
  469. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd37 monoclonal antibody bi 836826
    n1=lorazépam | n2=en:anti-cd37 monoclonal antibody bi 836826 | rel=r_associated | relid=0 | w=10
  470. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd38 monoclonal antibody mor03087
    n1=lorazépam | n2=en:anti-cd38 monoclonal antibody mor03087 | rel=r_associated | relid=0 | w=10
  471. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd38 monoclonal antibody sar650984
    n1=lorazépam | n2=en:anti-cd38 monoclonal antibody sar650984 | rel=r_associated | relid=0 | w=10
  472. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd40 monoclonal antibody chi lob 7/4
    n1=lorazépam | n2=en:anti-cd40 monoclonal antibody chi lob 7/4 | rel=r_associated | relid=0 | w=10
  473. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd40 monoclonal antibody sea-cd40
    n1=lorazépam | n2=en:anti-cd40 monoclonal antibody sea-cd40 | rel=r_associated | relid=0 | w=10
  474. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd44 monoclonal antibody ro5429083
    n1=lorazépam | n2=en:anti-cd44 monoclonal antibody ro5429083 | rel=r_associated | relid=0 | w=10
  475. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate
    n1=lorazépam | n2=en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate | rel=r_associated | relid=0 | w=10
  476. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd45 monoclonal antibody bc8
    n1=lorazépam | n2=en:anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=10
  477. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd47 monoclonal antibody cc-90002
    n1=lorazépam | n2=en:anti-cd47 monoclonal antibody cc-90002 | rel=r_associated | relid=0 | w=10
  478. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd47 monoclonal antibody hu5f9-g4
    n1=lorazépam | n2=en:anti-cd47 monoclonal antibody hu5f9-g4 | rel=r_associated | relid=0 | w=10
  479. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd7 immunotoxin
    n1=lorazépam | n2=en:anti-cd7 immunotoxin | rel=r_associated | relid=0 | w=10
  480. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd70 antibody-drug conjugate mdx-1203
    n1=lorazépam | n2=en:anti-cd70 antibody-drug conjugate mdx-1203 | rel=r_associated | relid=0 | w=10
  481. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd70 antibody-drug conjugate sgn-cd70a
    n1=lorazépam | n2=en:anti-cd70 antibody-drug conjugate sgn-cd70a | rel=r_associated | relid=0 | w=10
  482. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd70 monoclonal antibody argx-110
    n1=lorazépam | n2=en:anti-cd70 monoclonal antibody argx-110 | rel=r_associated | relid=0 | w=10
  483. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd73 monoclonal antibody medi9447
    n1=lorazépam | n2=en:anti-cd73 monoclonal antibody medi9447 | rel=r_associated | relid=0 | w=10
  484. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cd98 monoclonal antibody ign523
    n1=lorazépam | n2=en:anti-cd98 monoclonal antibody ign523 | rel=r_associated | relid=0 | w=10
  485. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cea bite monoclonal antibody amg211
    n1=lorazépam | n2=en:anti-cea bite monoclonal antibody amg211 | rel=r_associated | relid=0 | w=10
  486. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cea igcd28tcr-transduced autologous t cells
    n1=lorazépam | n2=en:anti-cea igcd28tcr-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  487. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=lorazépam | n2=en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  488. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cea-car autologous t lymphocytes
    n1=lorazépam | n2=en:anti-cea-car autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  489. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cea/anti-hsg bispecific monoclonal antibody tf2
    n1=lorazépam | n2=en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 | rel=r_associated | relid=0 | w=10
  490. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cea/cd3 bispecific antibody ro6958688
    n1=lorazépam | n2=en:anti-cea/cd3 bispecific antibody ro6958688 | rel=r_associated | relid=0 | w=10
  491. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ceacam1 monoclonal antibody cm-24
    n1=lorazépam | n2=en:anti-ceacam1 monoclonal antibody cm-24 | rel=r_associated | relid=0 | w=10
  492. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ceacam5 antibody-drug conjugate sar408701
    n1=lorazépam | n2=en:anti-ceacam5 antibody-drug conjugate sar408701 | rel=r_associated | relid=0 | w=10
  493. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-cldn6 monoclonal antibody imab027
    n1=lorazépam | n2=en:anti-cldn6 monoclonal antibody imab027 | rel=r_associated | relid=0 | w=10
  494. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-csf1r monoclonal antibody fpa008
    n1=lorazépam | n2=en:anti-csf1r monoclonal antibody fpa008 | rel=r_associated | relid=0 | w=10
  495. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-csf1r monoclonal antibody imc-cs4
    n1=lorazépam | n2=en:anti-csf1r monoclonal antibody imc-cs4 | rel=r_associated | relid=0 | w=10
  496. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ctgf monoclonal antibody fg-3019
    n1=lorazépam | n2=en:anti-ctgf monoclonal antibody fg-3019 | rel=r_associated | relid=0 | w=10
  497. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine
    n1=lorazépam | n2=en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  498. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ctla-4 monoclonal antibody agen1884
    n1=lorazépam | n2=en:anti-ctla-4 monoclonal antibody agen1884 | rel=r_associated | relid=0 | w=10
  499. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine
    n1=lorazépam | n2=en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  500. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-denatured collagen monoclonal antibody trc093
    n1=lorazépam | n2=en:anti-denatured collagen monoclonal antibody trc093 | rel=r_associated | relid=0 | w=10
  501. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-dkk-1 monoclonal antibody ly2812176
    n1=lorazépam | n2=en:anti-dkk-1 monoclonal antibody ly2812176 | rel=r_associated | relid=0 | w=10
  502. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-dkk1 monoclonal antibody bhq880
    n1=lorazépam | n2=en:anti-dkk1 monoclonal antibody bhq880 | rel=r_associated | relid=0 | w=10
  503. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-dll4 monoclonal antibody medi0639
    n1=lorazépam | n2=en:anti-dll4 monoclonal antibody medi0639 | rel=r_associated | relid=0 | w=10
  504. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83
    n1=lorazépam | n2=en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 | rel=r_associated | relid=0 | w=10
  505. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr monoclonal antibody gc1118
    n1=lorazépam | n2=en:anti-egfr monoclonal antibody gc1118 | rel=r_associated | relid=0 | w=10
  506. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr monoclonal antibody mixture mm-151
    n1=lorazépam | n2=en:anti-egfr monoclonal antibody mixture mm-151 | rel=r_associated | relid=0 | w=10
  507. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr monoclonal antibody mixture sym004
    n1=lorazépam | n2=en:anti-egfr monoclonal antibody mixture sym004 | rel=r_associated | relid=0 | w=10
  508. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr monoclonal antibody ro5083945
    n1=lorazépam | n2=en:anti-egfr monoclonal antibody ro5083945 | rel=r_associated | relid=0 | w=10
  509. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr monoclonal antibody sct200
    n1=lorazépam | n2=en:anti-egfr monoclonal antibody sct200 | rel=r_associated | relid=0 | w=10
  510. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr monoclonal antibody syn004
    n1=lorazépam | n2=en:anti-egfr monoclonal antibody syn004 | rel=r_associated | relid=0 | w=10
  511. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr tap antibody-drug conjugate imgn289
    n1=lorazépam | n2=en:anti-egfr tap antibody-drug conjugate imgn289 | rel=r_associated | relid=0 | w=10
  512. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfr/c-met bispecific antibody jnj-61186372
    n1=lorazépam | n2=en:anti-egfr/c-met bispecific antibody jnj-61186372 | rel=r_associated | relid=0 | w=10
  513. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfrviii antibody drug conjugate amg 595
    n1=lorazépam | n2=en:anti-egfrviii antibody drug conjugate amg 595 | rel=r_associated | relid=0 | w=10
  514. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfrviii car-transduced allogeneic t-lymphocytes
    n1=lorazépam | n2=en:anti-egfrviii car-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=10
  515. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-egfrviii immunotoxin mr1-1
    n1=lorazépam | n2=en:anti-egfrviii immunotoxin mr1-1 | rel=r_associated | relid=0 | w=10
  516. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-endosialin monoclonal antibody morab-004
    n1=lorazépam | n2=en:anti-endosialin monoclonal antibody morab-004 | rel=r_associated | relid=0 | w=10
  517. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-enpp3 antibody-drug conjugate ags-16c3f
    n1=lorazépam | n2=en:anti-enpp3 antibody-drug conjugate ags-16c3f | rel=r_associated | relid=0 | w=10
  518. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f
    n1=lorazépam | n2=en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f | rel=r_associated | relid=0 | w=10
  519. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein
    n1=lorazépam | n2=en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein | rel=r_associated | relid=0 | w=10
  520. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-epha2 monoclonal antibody ds-8895a
    n1=lorazépam | n2=en:anti-epha2 monoclonal antibody ds-8895a | rel=r_associated | relid=0 | w=10
  521. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547
    n1=lorazépam | n2=en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 | rel=r_associated | relid=0 | w=10
  522. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes
    n1=lorazépam | n2=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=10
  523. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111
    n1=lorazépam | n2=en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 | rel=r_associated | relid=0 | w=10
  524. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-erbb3 monoclonal antibody av-203
    n1=lorazépam | n2=en:anti-erbb3 monoclonal antibody av-203 | rel=r_associated | relid=0 | w=10
  525. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-erbb3 monoclonal antibody ktn3379
    n1=lorazépam | n2=en:anti-erbb3 monoclonal antibody ktn3379 | rel=r_associated | relid=0 | w=10
  526. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-etbr/mmae antibody-drug conjugate dedn6526a
    n1=lorazépam | n2=en:anti-etbr/mmae antibody-drug conjugate dedn6526a | rel=r_associated | relid=0 | w=10
  527. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-fgf23 igg1 monoclonal antibody krn23
    n1=lorazépam | n2=en:anti-fgf23 igg1 monoclonal antibody krn23 | rel=r_associated | relid=0 | w=10
  528. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-fgfr2 antibody bay1179470
    n1=lorazépam | n2=en:anti-fgfr2 antibody bay1179470 | rel=r_associated | relid=0 | w=10
  529. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-fgfr2 antibody-drug conjugate bay1187982
    n1=lorazépam | n2=en:anti-fgfr2 antibody-drug conjugate bay1187982 | rel=r_associated | relid=0 | w=10
  530. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-fgfr2 monoclonal antibody fpa144
    n1=lorazépam | n2=en:anti-fgfr2 monoclonal antibody fpa144 | rel=r_associated | relid=0 | w=10
  531. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-fgfr3 antibody-drug conjugate ly3076226
    n1=lorazépam | n2=en:anti-fgfr3 antibody-drug conjugate ly3076226 | rel=r_associated | relid=0 | w=10
  532. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-fgfr3 monoclonal antibody b-701
    n1=lorazépam | n2=en:anti-fgfr3 monoclonal antibody b-701 | rel=r_associated | relid=0 | w=10
  533. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-flt3 monoclonal antibody imc-eb10
    n1=lorazépam | n2=en:anti-flt3 monoclonal antibody imc-eb10 | rel=r_associated | relid=0 | w=10
  534. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-fucosyl-gm1 monoclonal antibody bms-986012
    n1=lorazépam | n2=en:anti-fucosyl-gm1 monoclonal antibody bms-986012 | rel=r_associated | relid=0 | w=10
  535. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ganglioside gm2 monoclonal antibody biw-8962
    n1=lorazépam | n2=en:anti-ganglioside gm2 monoclonal antibody biw-8962 | rel=r_associated | relid=0 | w=10
  536. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gcc antibody-drug conjugate mln0264
    n1=lorazépam | n2=en:anti-gcc antibody-drug conjugate mln0264 | rel=r_associated | relid=0 | w=10
  537. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gd2 monoclonal antibody morab-028
    n1=lorazépam | n2=en:anti-gd2 monoclonal antibody morab-028 | rel=r_associated | relid=0 | w=10
  538. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gitr agonistic monoclonal antibody incagn01876
    n1=lorazépam | n2=en:anti-gitr agonistic monoclonal antibody incagn01876 | rel=r_associated | relid=0 | w=10
  539. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gitr monoclonal antibody gwn 323
    n1=lorazépam | n2=en:anti-gitr monoclonal antibody gwn 323 | rel=r_associated | relid=0 | w=10
  540. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gitr monoclonal antibody mk-4166
    n1=lorazépam | n2=en:anti-gitr monoclonal antibody mk-4166 | rel=r_associated | relid=0 | w=10
  541. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gnrh vaccine pep223
    n1=lorazépam | n2=en:anti-gnrh vaccine pep223 | rel=r_associated | relid=0 | w=10
  542. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gpa33/cd3 monoclonal antibody mgd007
    n1=lorazépam | n2=en:anti-gpa33/cd3 monoclonal antibody mgd007 | rel=r_associated | relid=0 | w=10
  543. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gpc3 monoclonal antibody gc33
    n1=lorazépam | n2=en:anti-gpc3 monoclonal antibody gc33 | rel=r_associated | relid=0 | w=10
  544. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-gpc3-car autologous t lymphocytes
    n1=lorazépam | n2=en:anti-gpc3-car autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  545. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-hb-egf monoclonal antibody khk2866
    n1=lorazépam | n2=en:anti-hb-egf monoclonal antibody khk2866 | rel=r_associated | relid=0 | w=10
  546. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-hbegf monoclonal antibody u3-1565
    n1=lorazépam | n2=en:anti-hbegf monoclonal antibody u3-1565 | rel=r_associated | relid=0 | w=10
  547. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=lorazépam | n2=en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  548. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-her2 antibody-drug conjugate arx788
    n1=lorazépam | n2=en:anti-her2 antibody-drug conjugate arx788 | rel=r_associated | relid=0 | w=10
  549. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-her2 monoclonal antibody ct-p6
    n1=lorazépam | n2=en:anti-her2 monoclonal antibody ct-p6 | rel=r_associated | relid=0 | w=10
  550. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes
    n1=lorazépam | n2=en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  551. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-her3 monoclonal antibody gsk2849330
    n1=lorazépam | n2=en:anti-her3 monoclonal antibody gsk2849330 | rel=r_associated | relid=0 | w=10
  552. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-her3 monoclonal antibody ljm716
    n1=lorazépam | n2=en:anti-her3 monoclonal antibody ljm716 | rel=r_associated | relid=0 | w=10
  553. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-hgf monoclonal antibody tak-701
    n1=lorazépam | n2=en:anti-hgf monoclonal antibody tak-701 | rel=r_associated | relid=0 | w=10
  554. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968
    n1=lorazépam | n2=en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 | rel=r_associated | relid=0 | w=10
  555. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes
    n1=lorazépam | n2=en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  556. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-hla-dr monoclonal antibody immu-114
    n1=lorazépam | n2=en:anti-hla-dr monoclonal antibody immu-114 | rel=r_associated | relid=0 | w=10
  557. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-human chorionic gonadotropin vaccine
    n1=lorazépam | n2=en:anti-human chorionic gonadotropin vaccine | rel=r_associated | relid=0 | w=10
  558. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-human gitr monoclonal antibody trx518
    n1=lorazépam | n2=en:anti-human gitr monoclonal antibody trx518 | rel=r_associated | relid=0 | w=10
  559. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-icam-1 monoclonal antibody bi-505
    n1=lorazépam | n2=en:anti-icam-1 monoclonal antibody bi-505 | rel=r_associated | relid=0 | w=10
  560. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-icos agonist antibody gsk3359609
    n1=lorazépam | n2=en:anti-icos agonist antibody gsk3359609 | rel=r_associated | relid=0 | w=10
  561. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-icos monoclonal antibody medi-570
    n1=lorazépam | n2=en:anti-icos monoclonal antibody medi-570 | rel=r_associated | relid=0 | w=10
  562. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-igf-1r monoclonal antibody ave1642
    n1=lorazépam | n2=en:anti-igf-1r monoclonal antibody ave1642 | rel=r_associated | relid=0 | w=10
  563. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-igf-1r recombinant monoclonal antibody biib022
    n1=lorazépam | n2=en:anti-igf-1r recombinant monoclonal antibody biib022 | rel=r_associated | relid=0 | w=10
  564. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-igf1/2 monoclonal antibody medi-573
    n1=lorazépam | n2=en:anti-igf1/2 monoclonal antibody medi-573 | rel=r_associated | relid=0 | w=10
  565. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-il-1 alpha monoclonal antibody mabp1
    n1=lorazépam | n2=en:anti-il-1 alpha monoclonal antibody mabp1 | rel=r_associated | relid=0 | w=10
  566. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-il-13 humanized monoclonal antibody tnx-650
    n1=lorazépam | n2=en:anti-il-13 humanized monoclonal antibody tnx-650 | rel=r_associated | relid=0 | w=10
  567. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-il-4/il-13 combination agent qbx258
    n1=lorazépam | n2=en:anti-il-4/il-13 combination agent qbx258 | rel=r_associated | relid=0 | w=10
  568. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-il-8 monoclonal antibody humax-il8
    n1=lorazépam | n2=en:anti-il-8 monoclonal antibody humax-il8 | rel=r_associated | relid=0 | w=10
  569. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-inflammatory agents
    n1=lorazépam | n2=en:anti-inflammatory agents | rel=r_associated | relid=0 | w=10
  570. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388
    n1=lorazépam | n2=en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 | rel=r_associated | relid=0 | w=10
  571. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-kir monoclonal antibody iph 2101
    n1=lorazépam | n2=en:anti-kir monoclonal antibody iph 2101 | rel=r_associated | relid=0 | w=10
  572. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-lag-3 monoclonal antibody bms-986016
    n1=lorazépam | n2=en:anti-lag-3 monoclonal antibody bms-986016 | rel=r_associated | relid=0 | w=10
  573. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-lag-3 monoclonal antibody lag525
    n1=lorazépam | n2=en:anti-lag-3 monoclonal antibody lag525 | rel=r_associated | relid=0 | w=10
  574. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-lamp1 antibody-drug conjugate sar428926
    n1=lorazépam | n2=en:anti-lamp1 antibody-drug conjugate sar428926 | rel=r_associated | relid=0 | w=10
  575. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ly6e antibody-drug conjugate dlye5953a
    n1=lorazépam | n2=en:anti-ly6e antibody-drug conjugate dlye5953a | rel=r_associated | relid=0 | w=10
  576. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-masp-2 monoclonal antibody oms721
    n1=lorazépam | n2=en:anti-masp-2 monoclonal antibody oms721 | rel=r_associated | relid=0 | w=10
  577. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-melanin monoclonal antibody pti-6d2
    n1=lorazépam | n2=en:anti-melanin monoclonal antibody pti-6d2 | rel=r_associated | relid=0 | w=10
  578. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes
    n1=lorazépam | n2=en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  579. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100
    n1=lorazépam | n2=en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 | rel=r_associated | relid=0 | w=10
  580. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-met monoclonal antibody mixture sym015
    n1=lorazépam | n2=en:anti-met monoclonal antibody mixture sym015 | rel=r_associated | relid=0 | w=10
  581. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-met/egfr monoclonal antibody ly3164530
    n1=lorazépam | n2=en:anti-met/egfr monoclonal antibody ly3164530 | rel=r_associated | relid=0 | w=10
  582. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-mmp-9 monoclonal antibody gs-5745
    n1=lorazépam | n2=en:anti-mmp-9 monoclonal antibody gs-5745 | rel=r_associated | relid=0 | w=10
  583. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-muc1 car-transduced autologous t-lymphocytes
    n1=lorazépam | n2=en:anti-muc1 car-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  584. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-muc1 monoclonal antibody bth1704
    n1=lorazépam | n2=en:anti-muc1 monoclonal antibody bth1704 | rel=r_associated | relid=0 | w=10
  585. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062
    n1=lorazépam | n2=en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 | rel=r_associated | relid=0 | w=10
  586. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-myostatin monoclonal antibody ly2495655
    n1=lorazépam | n2=en:anti-myostatin monoclonal antibody ly2495655 | rel=r_associated | relid=0 | w=10
  587. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-napi2b/mmae antibody-drug conjugate dnib0600a
    n1=lorazépam | n2=en:anti-napi2b/mmae antibody-drug conjugate dnib0600a | rel=r_associated | relid=0 | w=10
  588. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-nectin 4 antibody-drug conjugate asg-22ce
    n1=lorazépam | n2=en:anti-nectin 4 antibody-drug conjugate asg-22ce | rel=r_associated | relid=0 | w=10
  589. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e
    n1=lorazépam | n2=en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e | rel=r_associated | relid=0 | w=10
  590. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-neuropilin-1 monoclonal antibody mnrp1685a
    n1=lorazépam | n2=en:anti-neuropilin-1 monoclonal antibody mnrp1685a | rel=r_associated | relid=0 | w=10
  591. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-nf-p2x7 antibody ointment bil-010t
    n1=lorazépam | n2=en:anti-nf-p2x7 antibody ointment bil-010t | rel=r_associated | relid=0 | w=10
  592. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-nucleolin aptamer as1411
    n1=lorazépam | n2=en:anti-nucleolin aptamer as1411 | rel=r_associated | relid=0 | w=10
  593. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ofa immunotherapeutic bb-mpi-03
    n1=lorazépam | n2=en:anti-ofa immunotherapeutic bb-mpi-03 | rel=r_associated | relid=0 | w=10
  594. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ox40 monoclonal antibody
    n1=lorazépam | n2=en:anti-ox40 monoclonal antibody | rel=r_associated | relid=0 | w=10
  595. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ox40 monoclonal antibody gsk3174998
    n1=lorazépam | n2=en:anti-ox40 monoclonal antibody gsk3174998 | rel=r_associated | relid=0 | w=10
  596. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ox40 monoclonal antibody medi0562
    n1=lorazépam | n2=en:anti-ox40 monoclonal antibody medi0562 | rel=r_associated | relid=0 | w=10
  597. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes
    n1=lorazépam | n2=en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  598. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pd-1 fusion protein amp-224
    n1=lorazépam | n2=en:anti-pd-1 fusion protein amp-224 | rel=r_associated | relid=0 | w=10
  599. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pd-1 monoclonal antibody bgb-a317
    n1=lorazépam | n2=en:anti-pd-1 monoclonal antibody bgb-a317 | rel=r_associated | relid=0 | w=10
  600. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pd-1 monoclonal antibody medi0680
    n1=lorazépam | n2=en:anti-pd-1 monoclonal antibody medi0680 | rel=r_associated | relid=0 | w=10
  601. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pd-1 monoclonal antibody regn2810
    n1=lorazépam | n2=en:anti-pd-1 monoclonal antibody regn2810 | rel=r_associated | relid=0 | w=10
  602. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pd-1 monoclonal antibody shr-1210
    n1=lorazépam | n2=en:anti-pd-1 monoclonal antibody shr-1210 | rel=r_associated | relid=0 | w=10
  603. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pd-l1 monoclonal antibody ly3300054
    n1=lorazépam | n2=en:anti-pd-l1 monoclonal antibody ly3300054 | rel=r_associated | relid=0 | w=10
  604. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pd-l1/tgfbetarii fusion protein msb0011359c
    n1=lorazépam | n2=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | rel=r_associated | relid=0 | w=10
  605. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pdgfr alpha monoclonal antibody medi-575
    n1=lorazépam | n2=en:anti-pdgfr alpha monoclonal antibody medi-575 | rel=r_associated | relid=0 | w=10
  606. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pgf monoclonal antibody ro5323441
    n1=lorazépam | n2=en:anti-pgf monoclonal antibody ro5323441 | rel=r_associated | relid=0 | w=10
  607. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-pkn3 sirna atu027
    n1=lorazépam | n2=en:anti-pkn3 sirna atu027 | rel=r_associated | relid=0 | w=10
  608. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-plgf monoclonal antibody tb-403
    n1=lorazépam | n2=en:anti-plgf monoclonal antibody tb-403 | rel=r_associated | relid=0 | w=10
  609. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes
    n1=lorazépam | n2=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=10
  610. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-prolactin receptor antibody lfa102
    n1=lorazépam | n2=en:anti-prolactin receptor antibody lfa102 | rel=r_associated | relid=0 | w=10
  611. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-psma monoclonal antibody mdx1201-a488
    n1=lorazépam | n2=en:anti-psma monoclonal antibody mdx1201-a488 | rel=r_associated | relid=0 | w=10
  612. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-psma monoclonal antibody-mmae conjugate
    n1=lorazépam | n2=en:anti-psma monoclonal antibody-mmae conjugate | rel=r_associated | relid=0 | w=10
  613. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-psma/cd3 bite monoclonal antibody mt112
    n1=lorazépam | n2=en:anti-psma/cd3 bite monoclonal antibody mt112 | rel=r_associated | relid=0 | w=10
  614. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-psma/cd3 monoclonal antibody mor209/es414
    n1=lorazépam | n2=en:anti-psma/cd3 monoclonal antibody mor209/es414 | rel=r_associated | relid=0 | w=10
  615. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-rspo3 monoclonal antibody omp-131r10
    n1=lorazépam | n2=en:anti-rspo3 monoclonal antibody omp-131r10 | rel=r_associated | relid=0 | w=10
  616. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-sclu monoclonal antibody ab-16b5
    n1=lorazépam | n2=en:anti-sclu monoclonal antibody ab-16b5 | rel=r_associated | relid=0 | w=10
  617. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-sema4d monoclonal antibody vx15/2503
    n1=lorazépam | n2=en:anti-sema4d monoclonal antibody vx15/2503 | rel=r_associated | relid=0 | w=10
  618. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e
    n1=lorazépam | n2=en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e | rel=r_associated | relid=0 | w=10
  619. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-ta-muc1 monoclonal antibody pankomab
    n1=lorazépam | n2=en:anti-ta-muc1 monoclonal antibody pankomab | rel=r_associated | relid=0 | w=10
  620. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-tf monoclonal antibody alt-836
    n1=lorazépam | n2=en:anti-tf monoclonal antibody alt-836 | rel=r_associated | relid=0 | w=10
  621. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-tgf-beta rii monoclonal antibody imc-tr1
    n1=lorazépam | n2=en:anti-tgf-beta rii monoclonal antibody imc-tr1 | rel=r_associated | relid=0 | w=10
  622. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes
    n1=lorazépam | n2=en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  623. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-tim-3 monoclonal antibody mbg453
    n1=lorazépam | n2=en:anti-tim-3 monoclonal antibody mbg453 | rel=r_associated | relid=0 | w=10
  624. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-tumor necrosis factor alpha drug
    n1=lorazépam | n2=en:anti-tumor necrosis factor alpha drug | rel=r_associated | relid=0 | w=10
  625. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-tweak monoclonal antibody ro5458640
    n1=lorazépam | n2=en:anti-tweak monoclonal antibody ro5458640 | rel=r_associated | relid=0 | w=10
  626. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-vegf anticalin prs-050-peg40
    n1=lorazépam | n2=en:anti-vegf anticalin prs-050-peg40 | rel=r_associated | relid=0 | w=10
  627. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-vegf/ang2 nanobody bi 836880
    n1=lorazépam | n2=en:anti-vegf/ang2 nanobody bi 836880 | rel=r_associated | relid=0 | w=10
  628. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-vegfc monoclonal antibody vgx-100
    n1=lorazépam | n2=en:anti-vegfc monoclonal antibody vgx-100 | rel=r_associated | relid=0 | w=10
  629. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-vegfr3 monoclonal antibody imc-3c5
    n1=lorazépam | n2=en:anti-vegfr3 monoclonal antibody imc-3c5 | rel=r_associated | relid=0 | w=10
  630. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-vista monoclonal antibody jnj 61610588
    n1=lorazépam | n2=en:anti-vista monoclonal antibody jnj 61610588 | rel=r_associated | relid=0 | w=10
  631. lorazépam -- r_associated #0: 10 / 0.052 -> en:anti-von willebrand factor nanobody
    n1=lorazépam | n2=en:anti-von willebrand factor nanobody | rel=r_associated | relid=0 | w=10
  632. lorazépam -- r_associated #0: 10 / 0.052 -> en:antiangiogenic drug combination tl-118
    n1=lorazépam | n2=en:antiangiogenic drug combination tl-118 | rel=r_associated | relid=0 | w=10
  633. lorazépam -- r_associated #0: 10 / 0.052 -> en:antianxiety agent
    n1=lorazépam | n2=en:antianxiety agent | rel=r_associated | relid=0 | w=10
  634. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibacterial agent
    n1=lorazépam | n2=en:antibacterial agent | rel=r_associated | relid=0 | w=10
  635. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibiotic
    n1=lorazépam | n2=en:antibiotic | rel=r_associated | relid=0 | w=10
  636. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibiotic sq109
    n1=lorazépam | n2=en:antibiotic sq109 | rel=r_associated | relid=0 | w=10
  637. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate abbv-085
    n1=lorazépam | n2=en:antibody-drug conjugate abbv-085 | rel=r_associated | relid=0 | w=10
  638. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate abbv-399
    n1=lorazépam | n2=en:antibody-drug conjugate abbv-399 | rel=r_associated | relid=0 | w=10
  639. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate adct-402
    n1=lorazépam | n2=en:antibody-drug conjugate adct-402 | rel=r_associated | relid=0 | w=10
  640. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate bay79-4620
    n1=lorazépam | n2=en:antibody-drug conjugate bay79-4620 | rel=r_associated | relid=0 | w=10
  641. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate dfrf4539a
    n1=lorazépam | n2=en:antibody-drug conjugate dfrf4539a | rel=r_associated | relid=0 | w=10
  642. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate sc-002
    n1=lorazépam | n2=en:antibody-drug conjugate sc-002 | rel=r_associated | relid=0 | w=10
  643. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate sc-003
    n1=lorazépam | n2=en:antibody-drug conjugate sc-003 | rel=r_associated | relid=0 | w=10
  644. lorazépam -- r_associated #0: 10 / 0.052 -> en:antibody-drug conjugate sc16ld6.5
    n1=lorazépam | n2=en:antibody-drug conjugate sc16ld6.5 | rel=r_associated | relid=0 | w=10
  645. lorazépam -- r_associated #0: 10 / 0.052 -> en:antienzyme
    n1=lorazépam | n2=en:antienzyme | rel=r_associated | relid=0 | w=10
  646. lorazépam -- r_associated #0: 10 / 0.052 -> en:antigen-targeted personalized breast cancer vaccine
    n1=lorazépam | n2=en:antigen-targeted personalized breast cancer vaccine | rel=r_associated | relid=0 | w=10
  647. lorazépam -- r_associated #0: 10 / 0.052 -> en:antihypertensive agent
    n1=lorazépam | n2=en:antihypertensive agent | rel=r_associated | relid=0 | w=10
  648. lorazépam -- r_associated #0: 10 / 0.052 -> en:antilipemic agent
    n1=lorazépam | n2=en:antilipemic agent | rel=r_associated | relid=0 | w=10
  649. lorazépam -- r_associated #0: 10 / 0.052 -> en:antimetabolite
    n1=lorazépam | n2=en:antimetabolite | rel=r_associated | relid=0 | w=10
  650. lorazépam -- r_associated #0: 10 / 0.052 -> en:antimetabolite ff-10502
    n1=lorazépam | n2=en:antimetabolite ff-10502 | rel=r_associated | relid=0 | w=10
  651. lorazépam -- r_associated #0: 10 / 0.052 -> en:antineoplastic agent
    n1=lorazépam | n2=en:antineoplastic agent | rel=r_associated | relid=0 | w=10
  652. lorazépam -- r_associated #0: 10 / 0.052 -> en:antineoplastic agent combination sm-88
    n1=lorazépam | n2=en:antineoplastic agent combination sm-88 | rel=r_associated | relid=0 | w=10
  653. lorazépam -- r_associated #0: 10 / 0.052 -> en:antineoplastic agent trx-818
    n1=lorazépam | n2=en:antineoplastic agent trx-818 | rel=r_associated | relid=0 | w=10
  654. lorazépam -- r_associated #0: 10 / 0.052 -> en:antineoplaston a10
    n1=lorazépam | n2=en:antineoplaston a10 | rel=r_associated | relid=0 | w=10
  655. lorazépam -- r_associated #0: 10 / 0.052 -> en:antineoplaston as2-1
    n1=lorazépam | n2=en:antineoplaston as2-1 | rel=r_associated | relid=0 | w=10
  656. lorazépam -- r_associated #0: 10 / 0.052 -> en:antiperspirant cream f511
    n1=lorazépam | n2=en:antiperspirant cream f511 | rel=r_associated | relid=0 | w=10
  657. lorazépam -- r_associated #0: 10 / 0.052 -> en:antirheumatic agents
    n1=lorazépam | n2=en:antirheumatic agents | rel=r_associated | relid=0 | w=10
  658. lorazépam -- r_associated #0: 10 / 0.052 -> en:antispasmodic agent
    n1=lorazépam | n2=en:antispasmodic agent | rel=r_associated | relid=0 | w=10
  659. lorazépam -- r_associated #0: 10 / 0.052 -> en:antrodia cinnamomea supplement
    n1=lorazépam | n2=en:antrodia cinnamomea supplement | rel=r_associated | relid=0 | w=10
  660. lorazépam -- r_associated #0: 10 / 0.052 -> en:apatinib
    n1=lorazépam | n2=en:apatinib | rel=r_associated | relid=0 | w=10
  661. lorazépam -- r_associated #0: 10 / 0.052 -> en:apatorsen
    n1=lorazépam | n2=en:apatorsen | rel=r_associated | relid=0 | w=10
  662. lorazépam -- r_associated #0: 10 / 0.052 -> en:apaziquone
    n1=lorazépam | n2=en:apaziquone | rel=r_associated | relid=0 | w=10
  663. lorazépam -- r_associated #0: 10 / 0.052 -> en:apc8015f
    n1=lorazépam | n2=en:apc8015f | rel=r_associated | relid=0 | w=10
  664. lorazépam -- r_associated #0: 10 / 0.052 -> en:apf530
    n1=lorazépam | n2=en:apf530 | rel=r_associated | relid=0 | w=10
  665. lorazépam -- r_associated #0: 10 / 0.052 -> en:apilimod dimesylate capsule
    n1=lorazépam | n2=en:apilimod dimesylate capsule | rel=r_associated | relid=0 | w=10
  666. lorazépam -- r_associated #0: 10 / 0.052 -> en:apixaban
    n1=lorazépam | n2=en:apixaban | rel=r_associated | relid=0 | w=10
  667. lorazépam -- r_associated #0: 10 / 0.052 -> en:apomab
    n1=lorazépam | n2=en:apomab | rel=r_associated | relid=0 | w=10
  668. lorazépam -- r_associated #0: 10 / 0.052 -> en:apomine
    n1=lorazépam | n2=en:apomine | rel=r_associated | relid=0 | w=10
  669. lorazépam -- r_associated #0: 10 / 0.052 -> en:apoptosis inducer bzl101
    n1=lorazépam | n2=en:apoptosis inducer bzl101 | rel=r_associated | relid=0 | w=10
  670. lorazépam -- r_associated #0: 10 / 0.052 -> en:apoptosis inducer mpc-2130
    n1=lorazépam | n2=en:apoptosis inducer mpc-2130 | rel=r_associated | relid=0 | w=10
  671. lorazépam -- r_associated #0: 10 / 0.052 -> en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells
    n1=lorazépam | n2=en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=10
  672. lorazépam -- r_associated #0: 10 / 0.052 -> en:aprepitant
    n1=lorazépam | n2=en:aprepitant | rel=r_associated | relid=0 | w=10
  673. lorazépam -- r_associated #0: 10 / 0.052 -> en:aprepitant 80mg capsule
    n1=lorazépam | n2=en:aprepitant 80mg capsule | rel=r_associated | relid=0 | w=10
  674. lorazépam -- r_associated #0: 10 / 0.052 -> en:apricoxib
    n1=lorazépam | n2=en:apricoxib | rel=r_associated | relid=0 | w=10
  675. lorazépam -- r_associated #0: 10 / 0.052 -> en:ar antagonist bms-641988
    n1=lorazépam | n2=en:ar antagonist bms-641988 | rel=r_associated | relid=0 | w=10
  676. lorazépam -- r_associated #0: 10 / 0.052 -> en:ar antagonist odm-201
    n1=lorazépam | n2=en:ar antagonist odm-201 | rel=r_associated | relid=0 | w=10
  677. lorazépam -- r_associated #0: 10 / 0.052 -> en:arginine butyrate
    n1=lorazépam | n2=en:arginine butyrate | rel=r_associated | relid=0 | w=10
  678. lorazépam -- r_associated #0: 10 / 0.052 -> en:arginine/omega-3 fatty acids/nucleotides oral supplement
    n1=lorazépam | n2=en:arginine/omega-3 fatty acids/nucleotides oral supplement | rel=r_associated | relid=0 | w=10
  679. lorazépam -- r_associated #0: 10 / 0.052 -> en:armodafinil
    n1=lorazépam | n2=en:armodafinil | rel=r_associated | relid=0 | w=10
  680. lorazépam -- r_associated #0: 10 / 0.052 -> en:arnebia indigo jade pearl topical cream
    n1=lorazépam | n2=en:arnebia indigo jade pearl topical cream | rel=r_associated | relid=0 | w=10
  681. lorazépam -- r_associated #0: 10 / 0.052 -> en:arsanilic acid
    n1=lorazépam | n2=en:arsanilic acid | rel=r_associated | relid=0 | w=10
  682. lorazépam -- r_associated #0: 10 / 0.052 -> en:arsenic trioxide
    n1=lorazépam | n2=en:arsenic trioxide | rel=r_associated | relid=0 | w=10
  683. lorazépam -- r_associated #0: 10 / 0.052 -> en:artemether sublingual spray
    n1=lorazépam | n2=en:artemether sublingual spray | rel=r_associated | relid=0 | w=10
  684. lorazépam -- r_associated #0: 10 / 0.052 -> en:artesunate
    n1=lorazépam | n2=en:artesunate | rel=r_associated | relid=0 | w=10
  685. lorazépam -- r_associated #0: 10 / 0.052 -> en:artichoke whole phytocomplex concentrate
    n1=lorazépam | n2=en:artichoke whole phytocomplex concentrate | rel=r_associated | relid=0 | w=10
  686. lorazépam -- r_associated #0: 10 / 0.052 -> en:arzoxifene hydrochloride
    n1=lorazépam | n2=en:arzoxifene hydrochloride | rel=r_associated | relid=0 | w=10
  687. lorazépam -- r_associated #0: 10 / 0.052 -> en:as03-adjuvanted h1n1 pandemic influenza vaccine
    n1=lorazépam | n2=en:as03-adjuvanted h1n1 pandemic influenza vaccine | rel=r_associated | relid=0 | w=10
  688. lorazépam -- r_associated #0: 10 / 0.052 -> en:asaley
    n1=lorazépam | n2=en:asaley | rel=r_associated | relid=0 | w=10
  689. lorazépam -- r_associated #0: 10 / 0.052 -> en:asfotase alfa
    n1=lorazépam | n2=en:asfotase alfa | rel=r_associated | relid=0 | w=10
  690. lorazépam -- r_associated #0: 10 / 0.052 -> en:ashwagandha root powder extract
    n1=lorazépam | n2=en:ashwagandha root powder extract | rel=r_associated | relid=0 | w=10
  691. lorazépam -- r_associated #0: 10 / 0.052 -> en:asian ginseng
    n1=lorazépam | n2=en:asian ginseng | rel=r_associated | relid=0 | w=10
  692. lorazépam -- r_associated #0: 10 / 0.052 -> en:ask1 inhibitor gs-4997
    n1=lorazépam | n2=en:ask1 inhibitor gs-4997 | rel=r_associated | relid=0 | w=10
  693. lorazépam -- r_associated #0: 10 / 0.052 -> en:asp4132
    n1=lorazépam | n2=en:asp4132 | rel=r_associated | relid=0 | w=10
  694. lorazépam -- r_associated #0: 10 / 0.052 -> en:asp9853
    n1=lorazépam | n2=en:asp9853 | rel=r_associated | relid=0 | w=10
  695. lorazépam -- r_associated #0: 10 / 0.052 -> en:asparaginase
    n1=lorazépam | n2=en:asparaginase | rel=r_associated | relid=0 | w=10
  696. lorazépam -- r_associated #0: 10 / 0.052 -> en:asparaginase erwinia chrysanthemi
    n1=lorazépam | n2=en:asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=10
  697. lorazépam -- r_associated #0: 10 / 0.052 -> en:astringent
    n1=lorazépam | n2=en:astringent | rel=r_associated | relid=0 | w=10
  698. lorazépam -- r_associated #0: 10 / 0.052 -> en:astuprotimut-r
    n1=lorazépam | n2=en:astuprotimut-r | rel=r_associated | relid=0 | w=10
  699. lorazépam -- r_associated #0: 10 / 0.052 -> en:asulacrine isethionate
    n1=lorazépam | n2=en:asulacrine isethionate | rel=r_associated | relid=0 | w=10
  700. lorazépam -- r_associated #0: 10 / 0.052 -> en:atamestane
    n1=lorazépam | n2=en:atamestane | rel=r_associated | relid=0 | w=10
  701. lorazépam -- r_associated #0: 10 / 0.052 -> en:atenolol
    n1=lorazépam | n2=en:atenolol | rel=r_associated | relid=0 | w=10
  702. lorazépam -- r_associated #0: 10 / 0.052 -> en:atezolizumab
    n1=lorazépam | n2=en:atezolizumab | rel=r_associated | relid=0 | w=10
  703. lorazépam -- r_associated #0: 10 / 0.052 -> en:atiprimod
    n1=lorazépam | n2=en:atiprimod | rel=r_associated | relid=0 | w=10
  704. lorazépam -- r_associated #0: 10 / 0.052 -> en:atn-161
    n1=lorazépam | n2=en:atn-161 | rel=r_associated | relid=0 | w=10
  705. lorazépam -- r_associated #0: 10 / 0.052 -> en:atomoxetine hydrochloride
    n1=lorazépam | n2=en:atomoxetine hydrochloride | rel=r_associated | relid=0 | w=10
  706. lorazépam -- r_associated #0: 10 / 0.052 -> en:atorvastatin calcium
    n1=lorazépam | n2=en:atorvastatin calcium | rel=r_associated | relid=0 | w=10
  707. lorazépam -- r_associated #0: 10 / 0.052 -> en:atr kinase inhibitor azd6738
    n1=lorazépam | n2=en:atr kinase inhibitor azd6738 | rel=r_associated | relid=0 | w=10
  708. lorazépam -- r_associated #0: 10 / 0.052 -> en:atr kinase inhibitor vx-970
    n1=lorazépam | n2=en:atr kinase inhibitor vx-970 | rel=r_associated | relid=0 | w=10
  709. lorazépam -- r_associated #0: 10 / 0.052 -> en:atr-101
    n1=lorazépam | n2=en:atr-101 | rel=r_associated | relid=0 | w=10
  710. lorazépam -- r_associated #0: 10 / 0.052 -> en:atrasentan hydrochloride
    n1=lorazépam | n2=en:atrasentan hydrochloride | rel=r_associated | relid=0 | w=10
  711. lorazépam -- r_associated #0: 10 / 0.052 -> en:attenuated chimpanzee adenovirus 5t4 vaccine
    n1=lorazépam | n2=en:attenuated chimpanzee adenovirus 5t4 vaccine | rel=r_associated | relid=0 | w=10
  712. lorazépam -- r_associated #0: 10 / 0.052 -> en:attenuated corynebacterium parvum
    n1=lorazépam | n2=en:attenuated corynebacterium parvum | rel=r_associated | relid=0 | w=10
  713. lorazépam -- r_associated #0: 10 / 0.052 -> en:attenuated listeria monocytogenes crs-100
    n1=lorazépam | n2=en:attenuated listeria monocytogenes crs-100 | rel=r_associated | relid=0 | w=10
  714. lorazépam -- r_associated #0: 10 / 0.052 -> en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001
    n1=lorazépam | n2=en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 | rel=r_associated | relid=0 | w=10
  715. lorazépam -- r_associated #0: 10 / 0.052 -> en:auranofin
    n1=lorazépam | n2=en:auranofin | rel=r_associated | relid=0 | w=10
  716. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora a kinase inhibitor tas-119
    n1=lorazépam | n2=en:aurora a kinase inhibitor tas-119 | rel=r_associated | relid=0 | w=10
  717. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora b serine/threonine kinase inhibitor tak-901
    n1=lorazépam | n2=en:aurora b serine/threonine kinase inhibitor tak-901 | rel=r_associated | relid=0 | w=10
  718. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora b/c kinase inhibitor gsk1070916a
    n1=lorazépam | n2=en:aurora b/c kinase inhibitor gsk1070916a | rel=r_associated | relid=0 | w=10
  719. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora kinase inhibitor amg 900
    n1=lorazépam | n2=en:aurora kinase inhibitor amg 900 | rel=r_associated | relid=0 | w=10
  720. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora kinase inhibitor bi 811283
    n1=lorazépam | n2=en:aurora kinase inhibitor bi 811283 | rel=r_associated | relid=0 | w=10
  721. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora kinase inhibitor mln8054
    n1=lorazépam | n2=en:aurora kinase inhibitor mln8054 | rel=r_associated | relid=0 | w=10
  722. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora kinase inhibitor ttp607
    n1=lorazépam | n2=en:aurora kinase inhibitor ttp607 | rel=r_associated | relid=0 | w=10
  723. lorazépam -- r_associated #0: 10 / 0.052 -> en:aurora kinase/vegfr2 inhibitor cyc116
    n1=lorazépam | n2=en:aurora kinase/vegfr2 inhibitor cyc116 | rel=r_associated | relid=0 | w=10
  724. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ad-cd154-transduced cll b cells
    n1=lorazépam | n2=en:autologous ad-cd154-transduced cll b cells | rel=r_associated | relid=0 | w=10
  725. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014
    n1=lorazépam | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 | rel=r_associated | relid=0 | w=10
  726. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017
    n1=lorazépam | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 | rel=r_associated | relid=0 | w=10
  727. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes
    n1=lorazépam | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  728. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=lorazépam | n2=en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  729. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=lorazépam | n2=en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  730. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous anti-psma gene-modified t-lymphocytes
    n1=lorazépam | n2=en:autologous anti-psma gene-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  731. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes
    n1=lorazépam | n2=en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  732. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  733. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes
    n1=lorazépam | n2=en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  734. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes
    n1=lorazépam | n2=en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes | rel=r_associated | relid=0 | w=10
  735. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells
    n1=lorazépam | n2=en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells | rel=r_associated | relid=0 | w=10
  736. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides
    n1=lorazépam | n2=en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides | rel=r_associated | relid=0 | w=10
  737. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cd8+ melanoma specific t cells
    n1=lorazépam | n2=en:autologous cd8+ melanoma specific t cells | rel=r_associated | relid=0 | w=10
  738. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous colon cancer cell vaccine
    n1=lorazépam | n2=en:autologous colon cancer cell vaccine | rel=r_associated | relid=0 | w=10
  739. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine
    n1=lorazépam | n2=en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  740. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells
    n1=lorazépam | n2=en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells | rel=r_associated | relid=0 | w=10
  741. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells
    n1=lorazépam | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells | rel=r_associated | relid=0 | w=10
  742. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells
    n1=lorazépam | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells | rel=r_associated | relid=0 | w=10
  743. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous dendritic cell vaccine act2001
    n1=lorazépam | n2=en:autologous dendritic cell vaccine act2001 | rel=r_associated | relid=0 | w=10
  744. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous dendritic cell-adenovirus ccl21 vaccine
    n1=lorazépam | n2=en:autologous dendritic cell-adenovirus ccl21 vaccine | rel=r_associated | relid=0 | w=10
  745. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
    n1=lorazépam | n2=en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine | rel=r_associated | relid=0 | w=10
  746. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine
    n1=lorazépam | n2=en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine | rel=r_associated | relid=0 | w=10
  747. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous dendritic cell-based immunotherapeutic av0113
    n1=lorazépam | n2=en:autologous dendritic cell-based immunotherapeutic av0113 | rel=r_associated | relid=0 | w=10
  748. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous dendritic cell-tumor fusion vaccine
    n1=lorazépam | n2=en:autologous dendritic cell-tumor fusion vaccine | rel=r_associated | relid=0 | w=10
  749. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous dinitrophenyl-modified ovarian cancer vaccine
    n1=lorazépam | n2=en:autologous dinitrophenyl-modified ovarian cancer vaccine | rel=r_associated | relid=0 | w=10
  750. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ebv-ctl cd19car zeta
    n1=lorazépam | n2=en:autologous ebv-ctl cd19car zeta | rel=r_associated | relid=0 | w=10
  751. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine
    n1=lorazépam | n2=en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine | rel=r_associated | relid=0 | w=10
  752. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous glioma cell lysate
    n1=lorazépam | n2=en:autologous glioma cell lysate | rel=r_associated | relid=0 | w=10
  753. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine
    n1=lorazépam | n2=en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine | rel=r_associated | relid=0 | w=10
  754. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine
    n1=lorazépam | n2=en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine | rel=r_associated | relid=0 | w=10
  755. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous gm-csf-secreting melanoma vaccine
    n1=lorazépam | n2=en:autologous gm-csf-secreting melanoma vaccine | rel=r_associated | relid=0 | w=10
  756. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous heat-shock protein 70 peptide vaccine ag-858
    n1=lorazépam | n2=en:autologous heat-shock protein 70 peptide vaccine ag-858 | rel=r_associated | relid=0 | w=10
  757. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=lorazépam | n2=en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=10
  758. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes
    n1=lorazépam | n2=en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes | rel=r_associated | relid=0 | w=10
  759. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes
    n1=lorazépam | n2=en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes | rel=r_associated | relid=0 | w=10
  760. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous il-21-modulated cd8+ mart1-specific t cells
    n1=lorazépam | n2=en:autologous il-21-modulated cd8+ mart1-specific t cells | rel=r_associated | relid=0 | w=10
  761. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous immunoglobulin idiotype-klh conjugate vaccine
    n1=lorazépam | n2=en:autologous immunoglobulin idiotype-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  762. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous interferon-producing killer dendritic cells
    n1=lorazépam | n2=en:autologous interferon-producing killer dendritic cells | rel=r_associated | relid=0 | w=10
  763. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes
    n1=lorazépam | n2=en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  764. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  765. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
    n1=lorazépam | n2=en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=10
  766. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine
    n1=lorazépam | n2=en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=10
  767. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine
    n1=lorazépam | n2=en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine | rel=r_associated | relid=0 | w=10
  768. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes
    n1=lorazépam | n2=en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes | rel=r_associated | relid=0 | w=10
  769. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  770. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  771. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  772. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous mesenchymal stem cells apceth_101
    n1=lorazépam | n2=en:autologous mesenchymal stem cells apceth_101 | rel=r_associated | relid=0 | w=10
  773. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine
    n1=lorazépam | n2=en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  774. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=lorazépam | n2=en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=10
  775. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous nsclc peptide-specific dendritic cell vaccine
    n1=lorazépam | n2=en:autologous nsclc peptide-specific dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  776. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes
    n1=lorazépam | n2=en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=10
  777. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ofa-ilrp rna-transfected dendritic cell vaccine
    n1=lorazépam | n2=en:autologous ofa-ilrp rna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  778. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine
    n1=lorazépam | n2=en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  779. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr
    n1=lorazépam | n2=en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr | rel=r_associated | relid=0 | w=10
  780. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous pluripotent aldhbr stem cells ald-451
    n1=lorazépam | n2=en:autologous pluripotent aldhbr stem cells ald-451 | rel=r_associated | relid=0 | w=10
  781. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine
    n1=lorazépam | n2=en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  782. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous sarcoma lysate-pulsed dendritic cell vaccine
    n1=lorazépam | n2=en:autologous sarcoma lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  783. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors
    n1=lorazépam | n2=en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors | rel=r_associated | relid=0 | w=10
  784. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous tns9.3.55-transduced cd34-positive cells
    n1=lorazépam | n2=en:autologous tns9.3.55-transduced cd34-positive cells | rel=r_associated | relid=0 | w=10
  785. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine
    n1=lorazépam | n2=en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | rel=r_associated | relid=0 | w=10
  786. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous tumor cell vaccine
    n1=lorazépam | n2=en:autologous tumor cell vaccine | rel=r_associated | relid=0 | w=10
  787. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous tumor infiltrating lymphocytes ln-144
    n1=lorazépam | n2=en:autologous tumor infiltrating lymphocytes ln-144 | rel=r_associated | relid=0 | w=10
  788. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine
    n1=lorazépam | n2=en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  789. lorazépam -- r_associated #0: 10 / 0.052 -> en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes
    n1=lorazépam | n2=en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes | rel=r_associated | relid=0 | w=10
  790. lorazépam -- r_associated #0: 10 / 0.052 -> en:avitinib maleate
    n1=lorazépam | n2=en:avitinib maleate | rel=r_associated | relid=0 | w=10
  791. lorazépam -- r_associated #0: 10 / 0.052 -> en:avn944
    n1=lorazépam | n2=en:avn944 | rel=r_associated | relid=0 | w=10
  792. lorazépam -- r_associated #0: 10 / 0.052 -> en:axitinib
    n1=lorazépam | n2=en:axitinib | rel=r_associated | relid=0 | w=10
  793. lorazépam -- r_associated #0: 10 / 0.052 -> en:axl inhibitor bgb324
    n1=lorazépam | n2=en:axl inhibitor bgb324 | rel=r_associated | relid=0 | w=10
  794. lorazépam -- r_associated #0: 10 / 0.052 -> en:axl inhibitor tp-0903
    n1=lorazépam | n2=en:axl inhibitor tp-0903 | rel=r_associated | relid=0 | w=10
  795. lorazépam -- r_associated #0: 10 / 0.052 -> en:Azadirachta indica
    n1=lorazépam | n2=en:Azadirachta indica | rel=r_associated | relid=0 | w=10
  796. lorazépam -- r_associated #0: 10 / 0.052 -> en:azadirachta indica
    n1=lorazépam | n2=en:azadirachta indica | rel=r_associated | relid=0 | w=10
  797. lorazépam -- r_associated #0: 10 / 0.052 -> en:azapicyl
    n1=lorazépam | n2=en:azapicyl | rel=r_associated | relid=0 | w=10
  798. lorazépam -- r_associated #0: 10 / 0.052 -> en:azathioprine sodium
    n1=lorazépam | n2=en:azathioprine sodium | rel=r_associated | relid=0 | w=10
  799. lorazépam -- r_associated #0: 10 / 0.052 -> en:azd5438
    n1=lorazépam | n2=en:azd5438 | rel=r_associated | relid=0 | w=10
  800. lorazépam -- r_associated #0: 10 / 0.052 -> en:azimexon
    n1=lorazépam | n2=en:azimexon | rel=r_associated | relid=0 | w=10
  801. lorazépam -- r_associated #0: 10 / 0.052 -> en:aziridinylbenzoquinone rh1
    n1=lorazépam | n2=en:aziridinylbenzoquinone rh1 | rel=r_associated | relid=0 | w=10
  802. lorazépam -- r_associated #0: 10 / 0.052 -> en:azurin:50-77 cell penetrating peptide p28
    n1=lorazépam | n2=en:azurin:50-77 cell penetrating peptide p28 | rel=r_associated | relid=0 | w=10
  803. lorazépam -- r_associated #0: 10 / 0.052 -> en:b-raf/vegfr-2 inhibitor raf265
    n1=lorazépam | n2=en:b-raf/vegfr-2 inhibitor raf265 | rel=r_associated | relid=0 | w=10
  804. lorazépam -- r_associated #0: 10 / 0.052 -> en:b16alphagal melanoma vaccine
    n1=lorazépam | n2=en:b16alphagal melanoma vaccine | rel=r_associated | relid=0 | w=10
  805. lorazépam -- r_associated #0: 10 / 0.052 -> en:b43-pap immunotoxin
    n1=lorazépam | n2=en:b43-pap immunotoxin | rel=r_associated | relid=0 | w=10
  806. lorazépam -- r_associated #0: 10 / 0.052 -> en:baclofen
    n1=lorazépam | n2=en:baclofen | rel=r_associated | relid=0 | w=10
  807. lorazépam -- r_associated #0: 10 / 0.052 -> en:bafetinib
    n1=lorazépam | n2=en:bafetinib | rel=r_associated | relid=0 | w=10
  808. lorazépam -- r_associated #0: 10 / 0.052 -> en:banoxantrone
    n1=lorazépam | n2=en:banoxantrone | rel=r_associated | relid=0 | w=10
  809. lorazépam -- r_associated #0: 10 / 0.052 -> en:barasertib
    n1=lorazépam | n2=en:barasertib | rel=r_associated | relid=0 | w=10
  810. lorazépam -- r_associated #0: 10 / 0.052 -> en:bardoxolone
    n1=lorazépam | n2=en:bardoxolone | rel=r_associated | relid=0 | w=10
  811. lorazépam -- r_associated #0: 10 / 0.052 -> en:baricitinib
    n1=lorazépam | n2=en:baricitinib | rel=r_associated | relid=0 | w=10
  812. lorazépam -- r_associated #0: 10 / 0.052 -> en:batanopride
    n1=lorazépam | n2=en:batanopride | rel=r_associated | relid=0 | w=10
  813. lorazépam -- r_associated #0: 10 / 0.052 -> en:bavituximab
    n1=lorazépam | n2=en:bavituximab | rel=r_associated | relid=0 | w=10
  814. lorazépam -- r_associated #0: 10 / 0.052 -> en:bay 56-3722
    n1=lorazépam | n2=en:bay 56-3722 | rel=r_associated | relid=0 | w=10
  815. lorazépam -- r_associated #0: 10 / 0.052 -> en:bazedoxifene
    n1=lorazépam | n2=en:bazedoxifene | rel=r_associated | relid=0 | w=10
  816. lorazépam -- r_associated #0: 10 / 0.052 -> en:bbr 3464
    n1=lorazépam | n2=en:bbr 3464 | rel=r_associated | relid=0 | w=10
  817. lorazépam -- r_associated #0: 10 / 0.052 -> en:bc-819 plasmid/polyethylenimine complex
    n1=lorazépam | n2=en:bc-819 plasmid/polyethylenimine complex | rel=r_associated | relid=0 | w=10
  818. lorazépam -- r_associated #0: 10 / 0.052 -> en:bcg solution
    n1=lorazépam | n2=en:bcg solution | rel=r_associated | relid=0 | w=10
  819. lorazépam -- r_associated #0: 10 / 0.052 -> en:bcl-2 inhibitor bcl201
    n1=lorazépam | n2=en:bcl-2 inhibitor bcl201 | rel=r_associated | relid=0 | w=10
  820. lorazépam -- r_associated #0: 10 / 0.052 -> en:bcma-specific car-expressing t lymphocytes
    n1=lorazépam | n2=en:bcma-specific car-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  821. lorazépam -- r_associated #0: 10 / 0.052 -> en:bcr-abl (b2a2)-derived peptide vaccine
    n1=lorazépam | n2=en:bcr-abl (b2a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=10
  822. lorazépam -- r_associated #0: 10 / 0.052 -> en:bcr-abl (b3a2)-derived peptide vaccine
    n1=lorazépam | n2=en:bcr-abl (b3a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=10
  823. lorazépam -- r_associated #0: 10 / 0.052 -> en:bcr-abl peptide vaccine
    n1=lorazépam | n2=en:bcr-abl peptide vaccine | rel=r_associated | relid=0 | w=10
  824. lorazépam -- r_associated #0: 10 / 0.052 -> en:be a counterpart to something
    n1=lorazépam | n2=en:be a counterpart to something | rel=r_associated | relid=0 | w=10
  825. lorazépam -- r_associated #0: 10 / 0.052 -> en:be the counterpart of
    n1=lorazépam | n2=en:be the counterpart of | rel=r_associated | relid=0 | w=10
  826. lorazépam -- r_associated #0: 10 / 0.052 -> en:becatecarin
    n1=lorazépam | n2=en:becatecarin | rel=r_associated | relid=0 | w=10
  827. lorazépam -- r_associated #0: 10 / 0.052 -> en:beclomethasone dipropionate
    n1=lorazépam | n2=en:beclomethasone dipropionate | rel=r_associated | relid=0 | w=10
  828. lorazépam -- r_associated #0: 10 / 0.052 -> en:beetroot juice
    n1=lorazépam | n2=en:beetroot juice | rel=r_associated | relid=0 | w=10
  829. lorazépam -- r_associated #0: 10 / 0.052 -> en:belagenpumatucel-l
    n1=lorazépam | n2=en:belagenpumatucel-l | rel=r_associated | relid=0 | w=10
  830. lorazépam -- r_associated #0: 10 / 0.052 -> en:belimumab
    n1=lorazépam | n2=en:belimumab | rel=r_associated | relid=0 | w=10
  831. lorazépam -- r_associated #0: 10 / 0.052 -> en:belinostat
    n1=lorazépam | n2=en:belinostat | rel=r_associated | relid=0 | w=10
  832. lorazépam -- r_associated #0: 10 / 0.052 -> en:belotecan hydrochloride
    n1=lorazépam | n2=en:belotecan hydrochloride | rel=r_associated | relid=0 | w=10
  833. lorazépam -- r_associated #0: 10 / 0.052 -> en:benazepril hydrochloride
    n1=lorazépam | n2=en:benazepril hydrochloride | rel=r_associated | relid=0 | w=10
  834. lorazépam -- r_associated #0: 10 / 0.052 -> en:bendamustine hydrochloride
    n1=lorazépam | n2=en:bendamustine hydrochloride | rel=r_associated | relid=0 | w=10
  835. lorazépam -- r_associated #0: 10 / 0.052 -> en:bendamustine-containing nanoparticle-based formulation rxdx-107
    n1=lorazépam | n2=en:bendamustine-containing nanoparticle-based formulation rxdx-107 | rel=r_associated | relid=0 | w=10
  836. lorazépam -- r_associated #0: 10 / 0.052 -> en:bendamustine-vorinostat fusion molecule edo-s101
    n1=lorazépam | n2=en:bendamustine-vorinostat fusion molecule edo-s101 | rel=r_associated | relid=0 | w=10
  837. lorazépam -- r_associated #0: 10 / 0.052 -> en:bentazepam
    n1=lorazépam | n2=en:bentazepam | rel=r_associated | relid=0 | w=10
  838. lorazépam -- r_associated #0: 10 / 0.052 -> en:benzodiazepine poisoning
    n1=lorazépam | n2=en:benzodiazepine poisoning | rel=r_associated | relid=0 | w=10
  839. lorazépam -- r_associated #0: 10 / 0.052 -> en:benzodiazepine sedative
    n1=lorazépam | n2=en:benzodiazepine sedative | rel=r_associated | relid=0 | w=10
  840. lorazépam -- r_associated #0: 10 / 0.052 -> en:benzodiazepinones
    n1=lorazépam | n2=en:benzodiazepinones | rel=r_associated | relid=0 | w=10
  841. lorazépam -- r_associated #0: 10 / 0.052 -> en:benzoylphenylurea
    n1=lorazépam | n2=en:benzoylphenylurea | rel=r_associated | relid=0 | w=10
  842. lorazépam -- r_associated #0: 10 / 0.052 -> en:bep regimen
    n1=lorazépam | n2=en:bep regimen | rel=r_associated | relid=0 | w=10
  843. lorazépam -- r_associated #0: 10 / 0.052 -> en:berberine chloride
    n1=lorazépam | n2=en:berberine chloride | rel=r_associated | relid=0 | w=10
  844. lorazépam -- r_associated #0: 10 / 0.052 -> en:berubicin hydrochloride
    n1=lorazépam | n2=en:berubicin hydrochloride | rel=r_associated | relid=0 | w=10
  845. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet bromodomain inhibitor zen-3694
    n1=lorazépam | n2=en:bet bromodomain inhibitor zen-3694 | rel=r_associated | relid=0 | w=10
  846. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet bromodomains 2/3/4 inhibitor mk-8628
    n1=lorazépam | n2=en:bet bromodomains 2/3/4 inhibitor mk-8628 | rel=r_associated | relid=0 | w=10
  847. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet inhibitor bay1238097
    n1=lorazépam | n2=en:bet inhibitor bay1238097 | rel=r_associated | relid=0 | w=10
  848. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet inhibitor bms-986158
    n1=lorazépam | n2=en:bet inhibitor bms-986158 | rel=r_associated | relid=0 | w=10
  849. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet inhibitor cpi-0610
    n1=lorazépam | n2=en:bet inhibitor cpi-0610 | rel=r_associated | relid=0 | w=10
  850. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet inhibitor ft-1101
    n1=lorazépam | n2=en:bet inhibitor ft-1101 | rel=r_associated | relid=0 | w=10
  851. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet inhibitor gsk525762
    n1=lorazépam | n2=en:bet inhibitor gsk525762 | rel=r_associated | relid=0 | w=10
  852. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet inhibitor incb057643
    n1=lorazépam | n2=en:bet inhibitor incb057643 | rel=r_associated | relid=0 | w=10
  853. lorazépam -- r_associated #0: 10 / 0.052 -> en:bet inhibitor ten-010
    n1=lorazépam | n2=en:bet inhibitor ten-010 | rel=r_associated | relid=0 | w=10
  854. lorazépam -- r_associated #0: 10 / 0.052 -> en:beta-elemene
    n1=lorazépam | n2=en:beta-elemene | rel=r_associated | relid=0 | w=10
  855. lorazépam -- r_associated #0: 10 / 0.052 -> en:beta-glucan mm-10-001
    n1=lorazépam | n2=en:beta-glucan mm-10-001 | rel=r_associated | relid=0 | w=10
  856. lorazépam -- r_associated #0: 10 / 0.052 -> en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion
    n1=lorazépam | n2=en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion | rel=r_associated | relid=0 | w=10
  857. lorazépam -- r_associated #0: 10 / 0.052 -> en:beta-lapachone prodrug arq 761
    n1=lorazépam | n2=en:beta-lapachone prodrug arq 761 | rel=r_associated | relid=0 | w=10
  858. lorazépam -- r_associated #0: 10 / 0.052 -> en:beta-thioguanine deoxyriboside
    n1=lorazépam | n2=en:beta-thioguanine deoxyriboside | rel=r_associated | relid=0 | w=10
  859. lorazépam -- r_associated #0: 10 / 0.052 -> en:betulinic acid
    n1=lorazépam | n2=en:betulinic acid | rel=r_associated | relid=0 | w=10
  860. lorazépam -- r_associated #0: 10 / 0.052 -> en:bevacizumab
    n1=lorazépam | n2=en:bevacizumab | rel=r_associated | relid=0 | w=10
  861. lorazépam -- r_associated #0: 10 / 0.052 -> en:bevacizumab-irdye 800cw
    n1=lorazépam | n2=en:bevacizumab-irdye 800cw | rel=r_associated | relid=0 | w=10
  862. lorazépam -- r_associated #0: 10 / 0.052 -> en:bexarotene
    n1=lorazépam | n2=en:bexarotene | rel=r_associated | relid=0 | w=10
  863. lorazépam -- r_associated #0: 10 / 0.052 -> en:bh3 mimetic abt-737
    n1=lorazépam | n2=en:bh3 mimetic abt-737 | rel=r_associated | relid=0 | w=10
  864. lorazépam -- r_associated #0: 10 / 0.052 -> en:bi 2536
    n1=lorazépam | n2=en:bi 2536 | rel=r_associated | relid=0 | w=10
  865. lorazépam -- r_associated #0: 10 / 0.052 -> en:bi 831266
    n1=lorazépam | n2=en:bi 831266 | rel=r_associated | relid=0 | w=10
  866. lorazépam -- r_associated #0: 10 / 0.052 -> en:bi 894999
    n1=lorazépam | n2=en:bi 894999 | rel=r_associated | relid=0 | w=10
  867. lorazépam -- r_associated #0: 10 / 0.052 -> en:bi-functional alkylating agent val-083
    n1=lorazépam | n2=en:bi-functional alkylating agent val-083 | rel=r_associated | relid=0 | w=10
  868. lorazépam -- r_associated #0: 10 / 0.052 -> en:bi-layered skin substitute from keratinocytes and fibroblasts
    n1=lorazépam | n2=en:bi-layered skin substitute from keratinocytes and fibroblasts | rel=r_associated | relid=0 | w=10
  869. lorazépam -- r_associated #0: 10 / 0.052 -> en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine
    n1=lorazépam | n2=en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine | rel=r_associated | relid=0 | w=10
  870. lorazépam -- r_associated #0: 10 / 0.052 -> en:biafine cream
    n1=lorazépam | n2=en:biafine cream | rel=r_associated | relid=0 | w=10
  871. lorazépam -- r_associated #0: 10 / 0.052 -> en:bibx 1382
    n1=lorazépam | n2=en:bibx 1382 | rel=r_associated | relid=0 | w=10
  872. lorazépam -- r_associated #0: 10 / 0.052 -> en:bicalutamide
    n1=lorazépam | n2=en:bicalutamide | rel=r_associated | relid=0 | w=10
  873. lorazépam -- r_associated #0: 10 / 0.052 -> en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement
    n1=lorazépam | n2=en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement | rel=r_associated | relid=0 | w=10
  874. lorazépam -- r_associated #0: 10 / 0.052 -> en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex
    n1=lorazépam | n2=en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex | rel=r_associated | relid=0 | w=10
  875. lorazépam -- r_associated #0: 10 / 0.052 -> en:binetrakin
    n1=lorazépam | n2=en:binetrakin | rel=r_associated | relid=0 | w=10
  876. lorazépam -- r_associated #0: 10 / 0.052 -> en:binimetinib
    n1=lorazépam | n2=en:binimetinib | rel=r_associated | relid=0 | w=10
  877. lorazépam -- r_associated #0: 10 / 0.052 -> en:biological agent
    n1=lorazépam | n2=en:biological agent | rel=r_associated | relid=0 | w=10
  878. lorazépam -- r_associated #0: 10 / 0.052 -> en:biological factors
    n1=lorazépam | n2=en:biological factors | rel=r_associated | relid=0 | w=10
  879. lorazépam -- r_associated #0: 10 / 0.052 -> en:biomed 101
    n1=lorazépam | n2=en:biomed 101 | rel=r_associated | relid=0 | w=10
  880. lorazépam -- r_associated #0: 10 / 0.052 -> en:birinapant
    n1=lorazépam | n2=en:birinapant | rel=r_associated | relid=0 | w=10
  881. lorazépam -- r_associated #0: 10 / 0.052 -> en:bis(choline)tetrathiomolybdate
    n1=lorazépam | n2=en:bis(choline)tetrathiomolybdate | rel=r_associated | relid=0 | w=10
  882. lorazépam -- r_associated #0: 10 / 0.052 -> en:bisantrene hydrochloride
    n1=lorazépam | n2=en:bisantrene hydrochloride | rel=r_associated | relid=0 | w=10
  883. lorazépam -- r_associated #0: 10 / 0.052 -> en:bismuth subsalicylate
    n1=lorazépam | n2=en:bismuth subsalicylate | rel=r_associated | relid=0 | w=10
  884. lorazépam -- r_associated #0: 10 / 0.052 -> en:bispecific antibody 2b1
    n1=lorazépam | n2=en:bispecific antibody 2b1 | rel=r_associated | relid=0 | w=10
  885. lorazépam -- r_associated #0: 10 / 0.052 -> en:bispecific antibody mdx-h210
    n1=lorazépam | n2=en:bispecific antibody mdx-h210 | rel=r_associated | relid=0 | w=10
  886. lorazépam -- r_associated #0: 10 / 0.052 -> en:bispecific antibody mdx447
    n1=lorazépam | n2=en:bispecific antibody mdx447 | rel=r_associated | relid=0 | w=10
  887. lorazépam -- r_associated #0: 10 / 0.052 -> en:bivalent hpv16/18 therapeutic cervical cancer vaccine
    n1=lorazépam | n2=en:bivalent hpv16/18 therapeutic cervical cancer vaccine | rel=r_associated | relid=0 | w=10
  888. lorazépam -- r_associated #0: 10 / 0.052 -> en:bizelesin
    n1=lorazépam | n2=en:bizelesin | rel=r_associated | relid=0 | w=10
  889. lorazépam -- r_associated #0: 10 / 0.052 -> en:bl22 immunotoxin
    n1=lorazépam | n2=en:bl22 immunotoxin | rel=r_associated | relid=0 | w=10
  890. lorazépam -- r_associated #0: 10 / 0.052 -> en:black cohosh
    n1=lorazépam | n2=en:black cohosh | rel=r_associated | relid=0 | w=10
  891. lorazépam -- r_associated #0: 10 / 0.052 -> en:black tea
    n1=lorazépam | n2=en:black tea | rel=r_associated | relid=0 | w=10
  892. lorazépam -- r_associated #0: 10 / 0.052 -> en:blackberry allergenic extract
    n1=lorazépam | n2=en:blackberry allergenic extract | rel=r_associated | relid=0 | w=10
  893. lorazépam -- r_associated #0: 10 / 0.052 -> en:bleomycin sulfate
    n1=lorazépam | n2=en:bleomycin sulfate | rel=r_associated | relid=0 | w=10
  894. lorazépam -- r_associated #0: 10 / 0.052 -> en:blex 404
    n1=lorazépam | n2=en:blex 404 | rel=r_associated | relid=0 | w=10
  895. lorazépam -- r_associated #0: 10 / 0.052 -> en:blue citrus-based herbal capsule
    n1=lorazépam | n2=en:blue citrus-based herbal capsule | rel=r_associated | relid=0 | w=10
  896. lorazépam -- r_associated #0: 10 / 0.052 -> en:blueberry powder supplement
    n1=lorazépam | n2=en:blueberry powder supplement | rel=r_associated | relid=0 | w=10
  897. lorazépam -- r_associated #0: 10 / 0.052 -> en:bms-188797
    n1=lorazépam | n2=en:bms-188797 | rel=r_associated | relid=0 | w=10
  898. lorazépam -- r_associated #0: 10 / 0.052 -> en:bms-275183
    n1=lorazépam | n2=en:bms-275183 | rel=r_associated | relid=0 | w=10
  899. lorazépam -- r_associated #0: 10 / 0.052 -> en:bms-817378
    n1=lorazépam | n2=en:bms-817378 | rel=r_associated | relid=0 | w=10
  900. lorazépam -- r_associated #0: 10 / 0.052 -> en:boanmycin hydrochloride
    n1=lorazépam | n2=en:boanmycin hydrochloride | rel=r_associated | relid=0 | w=10
  901. lorazépam -- r_associated #0: 10 / 0.052 -> en:boronophenylalanine-fructose complex
    n1=lorazépam | n2=en:boronophenylalanine-fructose complex | rel=r_associated | relid=0 | w=10
  902. lorazépam -- r_associated #0: 10 / 0.052 -> en:bortezomib
    n1=lorazépam | n2=en:bortezomib | rel=r_associated | relid=0 | w=10
  903. lorazépam -- r_associated #0: 10 / 0.052 -> en:bosutinib
    n1=lorazépam | n2=en:bosutinib | rel=r_associated | relid=0 | w=10
  904. lorazépam -- r_associated #0: 10 / 0.052 -> en:boswellia serrata extract
    n1=lorazépam | n2=en:boswellia serrata extract | rel=r_associated | relid=0 | w=10
  905. lorazépam -- r_associated #0: 10 / 0.052 -> en:botulinum toxin type a
    n1=lorazépam | n2=en:botulinum toxin type a | rel=r_associated | relid=0 | w=10
  906. lorazépam -- r_associated #0: 10 / 0.052 -> en:bp-cx1-platinum complex bp-c1
    n1=lorazépam | n2=en:bp-cx1-platinum complex bp-c1 | rel=r_associated | relid=0 | w=10
  907. lorazépam -- r_associated #0: 10 / 0.052 -> en:br96-doxorubicin immunoconjugate
    n1=lorazépam | n2=en:br96-doxorubicin immunoconjugate | rel=r_associated | relid=0 | w=10
  908. lorazépam -- r_associated #0: 10 / 0.052 -> en:braf inhibitor arq 736
    n1=lorazépam | n2=en:braf inhibitor arq 736 | rel=r_associated | relid=0 | w=10
  909. lorazépam -- r_associated #0: 10 / 0.052 -> en:braf inhibitor plx8394
    n1=lorazépam | n2=en:braf inhibitor plx8394 | rel=r_associated | relid=0 | w=10
  910. lorazépam -- r_associated #0: 10 / 0.052 -> en:braf(v600e) inhibitor cep-32496
    n1=lorazépam | n2=en:braf(v600e) inhibitor cep-32496 | rel=r_associated | relid=0 | w=10
  911. lorazépam -- r_associated #0: 10 / 0.052 -> en:braf(v600e) kinase inhibitor ro5212054
    n1=lorazépam | n2=en:braf(v600e) kinase inhibitor ro5212054 | rel=r_associated | relid=0 | w=10
  912. lorazépam -- r_associated #0: 10 / 0.052 -> en:braf/egfr inhibitor bgb-283
    n1=lorazépam | n2=en:braf/egfr inhibitor bgb-283 | rel=r_associated | relid=0 | w=10
  913. lorazépam -- r_associated #0: 10 / 0.052 -> en:brain tumor initiating cell vaccine
    n1=lorazépam | n2=en:brain tumor initiating cell vaccine | rel=r_associated | relid=0 | w=10
  914. lorazépam -- r_associated #0: 10 / 0.052 -> en:branched-chain amino acid supplement
    n1=lorazépam | n2=en:branched-chain amino acid supplement | rel=r_associated | relid=0 | w=10
  915. lorazépam -- r_associated #0: 10 / 0.052 -> en:brassica vegetable
    n1=lorazépam | n2=en:brassica vegetable | rel=r_associated | relid=0 | w=10
  916. lorazépam -- r_associated #0: 10 / 0.052 -> en:brd4 inhibitor plx51107
    n1=lorazépam | n2=en:brd4 inhibitor plx51107 | rel=r_associated | relid=0 | w=10
  917. lorazépam -- r_associated #0: 10 / 0.052 -> en:brequinar
    n1=lorazépam | n2=en:brequinar | rel=r_associated | relid=0 | w=10
  918. lorazépam -- r_associated #0: 10 / 0.052 -> en:briciclib sodium
    n1=lorazépam | n2=en:briciclib sodium | rel=r_associated | relid=0 | w=10
  919. lorazépam -- r_associated #0: 10 / 0.052 -> en:brigatinib
    n1=lorazépam | n2=en:brigatinib | rel=r_associated | relid=0 | w=10
  920. lorazépam -- r_associated #0: 10 / 0.052 -> en:brilacidin oral rinse
    n1=lorazépam | n2=en:brilacidin oral rinse | rel=r_associated | relid=0 | w=10
  921. lorazépam -- r_associated #0: 10 / 0.052 -> en:brivanib
    n1=lorazépam | n2=en:brivanib | rel=r_associated | relid=0 | w=10
  922. lorazépam -- r_associated #0: 10 / 0.052 -> en:brivanib alaninate
    n1=lorazépam | n2=en:brivanib alaninate | rel=r_associated | relid=0 | w=10
  923. lorazépam -- r_associated #0: 10 / 0.052 -> en:brivudine
    n1=lorazépam | n2=en:brivudine | rel=r_associated | relid=0 | w=10
  924. lorazépam -- r_associated #0: 10 / 0.052 -> en:brivudine phosphoramidate
    n1=lorazépam | n2=en:brivudine phosphoramidate | rel=r_associated | relid=0 | w=10
  925. lorazépam -- r_associated #0: 10 / 0.052 -> en:broad-spectrum human papillomavirus vaccine v505
    n1=lorazépam | n2=en:broad-spectrum human papillomavirus vaccine v505 | rel=r_associated | relid=0 | w=10
  926. lorazépam -- r_associated #0: 10 / 0.052 -> en:bromazepam
    n1=lorazépam | n2=en:bromazepam | rel=r_associated | relid=0 | w=10
  927. lorazépam -- r_associated #0: 10 / 0.052 -> en:bromelains
    n1=lorazépam | n2=en:bromelains | rel=r_associated | relid=0 | w=10
  928. lorazépam -- r_associated #0: 10 / 0.052 -> en:bromocriptine mesylate
    n1=lorazépam | n2=en:bromocriptine mesylate | rel=r_associated | relid=0 | w=10
  929. lorazépam -- r_associated #0: 10 / 0.052 -> en:brostallicin
    n1=lorazépam | n2=en:brostallicin | rel=r_associated | relid=0 | w=10
  930. lorazépam -- r_associated #0: 10 / 0.052 -> en:brotizolam
    n1=lorazépam | n2=en:brotizolam | rel=r_associated | relid=0 | w=10
  931. lorazépam -- r_associated #0: 10 / 0.052 -> en:bryostatin 1
    n1=lorazépam | n2=en:bryostatin 1 | rel=r_associated | relid=0 | w=10
  932. lorazépam -- r_associated #0: 10 / 0.052 -> en:btk inhibitor gdc-0853
    n1=lorazépam | n2=en:btk inhibitor gdc-0853 | rel=r_associated | relid=0 | w=10
  933. lorazépam -- r_associated #0: 10 / 0.052 -> en:budesonide/formoterol fumarate dihydrate inhalation aerosol
    n1=lorazépam | n2=en:budesonide/formoterol fumarate dihydrate inhalation aerosol | rel=r_associated | relid=0 | w=10
  934. lorazépam -- r_associated #0: 10 / 0.052 -> en:buparlisib
    n1=lorazépam | n2=en:buparlisib | rel=r_associated | relid=0 | w=10
  935. lorazépam -- r_associated #0: 10 / 0.052 -> en:bupivacaine hydrochloride
    n1=lorazépam | n2=en:bupivacaine hydrochloride | rel=r_associated | relid=0 | w=10
  936. lorazépam -- r_associated #0: 10 / 0.052 -> en:bupropion + naltrexone
    n1=lorazépam | n2=en:bupropion + naltrexone | rel=r_associated | relid=0 | w=10
  937. lorazépam -- r_associated #0: 10 / 0.052 -> en:buspirone hydrochloride
    n1=lorazépam | n2=en:buspirone hydrochloride | rel=r_associated | relid=0 | w=10
  938. lorazépam -- r_associated #0: 10 / 0.052 -> en:busulfan
    n1=lorazépam | n2=en:busulfan | rel=r_associated | relid=0 | w=10
  939. lorazépam -- r_associated #0: 10 / 0.052 -> en:busulfan/melphalan regimen
    n1=lorazépam | n2=en:busulfan/melphalan regimen | rel=r_associated | relid=0 | w=10
  940. lorazépam -- r_associated #0: 10 / 0.052 -> en:busulphan
    n1=lorazépam | n2=en:busulphan | rel=r_associated | relid=0 | w=10
  941. lorazépam -- r_associated #0: 10 / 0.052 -> en:c-kit inhibitor plx9486
    n1=lorazépam | n2=en:c-kit inhibitor plx9486 | rel=r_associated | relid=0 | w=10
  942. lorazépam -- r_associated #0: 10 / 0.052 -> en:c-met inhibitor jnj-38877605
    n1=lorazépam | n2=en:c-met inhibitor jnj-38877605 | rel=r_associated | relid=0 | w=10
  943. lorazépam -- r_associated #0: 10 / 0.052 -> en:c-met inhibitor mk2461
    n1=lorazépam | n2=en:c-met inhibitor mk2461 | rel=r_associated | relid=0 | w=10
  944. lorazépam -- r_associated #0: 10 / 0.052 -> en:c-met inhibitor mk8033
    n1=lorazépam | n2=en:c-met inhibitor mk8033 | rel=r_associated | relid=0 | w=10
  945. lorazépam -- r_associated #0: 10 / 0.052 -> en:c-met inhibitor msc2156119j
    n1=lorazépam | n2=en:c-met inhibitor msc2156119j | rel=r_associated | relid=0 | w=10
  946. lorazépam -- r_associated #0: 10 / 0.052 -> en:c-myb antisense oligonucleotide g4460
    n1=lorazépam | n2=en:c-myb antisense oligonucleotide g4460 | rel=r_associated | relid=0 | w=10
  947. lorazépam -- r_associated #0: 10 / 0.052 -> en:cabazitaxel
    n1=lorazépam | n2=en:cabazitaxel | rel=r_associated | relid=0 | w=10
  948. lorazépam -- r_associated #0: 10 / 0.052 -> en:cabergoline
    n1=lorazépam | n2=en:cabergoline | rel=r_associated | relid=0 | w=10
  949. lorazépam -- r_associated #0: 10 / 0.052 -> en:caix inhibitor dtp348
    n1=lorazépam | n2=en:caix inhibitor dtp348 | rel=r_associated | relid=0 | w=10
  950. lorazépam -- r_associated #0: 10 / 0.052 -> en:calamine
    n1=lorazépam | n2=en:calamine | rel=r_associated | relid=0 | w=10
  951. lorazépam -- r_associated #0: 10 / 0.052 -> en:calaspargase pegol
    n1=lorazépam | n2=en:calaspargase pegol | rel=r_associated | relid=0 | w=10
  952. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcipotriene
    n1=lorazépam | n2=en:calcipotriene | rel=r_associated | relid=0 | w=10
  953. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcitonin salmon
    n1=lorazépam | n2=en:calcitonin salmon | rel=r_associated | relid=0 | w=10
  954. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcium aluminosilicate anti-diarrheal
    n1=lorazépam | n2=en:calcium aluminosilicate anti-diarrheal | rel=r_associated | relid=0 | w=10
  955. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcium channel blocker
    n1=lorazépam | n2=en:calcium channel blocker | rel=r_associated | relid=0 | w=10
  956. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcium channel inhibitor
    n1=lorazépam | n2=en:calcium channel inhibitor | rel=r_associated | relid=0 | w=10
  957. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcium citrate
    n1=lorazépam | n2=en:calcium citrate | rel=r_associated | relid=0 | w=10
  958. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcium saccharate
    n1=lorazépam | n2=en:calcium saccharate | rel=r_associated | relid=0 | w=10
  959. lorazépam -- r_associated #0: 10 / 0.052 -> en:calcium-46 chloride aqueous solution
    n1=lorazépam | n2=en:calcium-46 chloride aqueous solution | rel=r_associated | relid=0 | w=10
  960. lorazépam -- r_associated #0: 10 / 0.052 -> en:camptothecin-20(s)-o-propionate hydrate
    n1=lorazépam | n2=en:camptothecin-20(s)-o-propionate hydrate | rel=r_associated | relid=0 | w=10
  961. lorazépam -- r_associated #0: 10 / 0.052 -> en:canarypox-hil-12 melanoma vaccine
    n1=lorazépam | n2=en:canarypox-hil-12 melanoma vaccine | rel=r_associated | relid=0 | w=10
  962. lorazépam -- r_associated #0: 10 / 0.052 -> en:cancell
    n1=lorazépam | n2=en:cancell | rel=r_associated | relid=0 | w=10
  963. lorazépam -- r_associated #0: 10 / 0.052 -> en:cancer stemness kinase inhibitor bbi503
    n1=lorazépam | n2=en:cancer stemness kinase inhibitor bbi503 | rel=r_associated | relid=0 | w=10
  964. lorazépam -- r_associated #0: 10 / 0.052 -> en:candesartan cilexetil
    n1=lorazépam | n2=en:candesartan cilexetil | rel=r_associated | relid=0 | w=10
  965. lorazépam -- r_associated #0: 10 / 0.052 -> en:canfosfamide hydrochloride
    n1=lorazépam | n2=en:canfosfamide hydrochloride | rel=r_associated | relid=0 | w=10
  966. lorazépam -- r_associated #0: 10 / 0.052 -> en:cannabidiol
    n1=lorazépam | n2=en:cannabidiol | rel=r_associated | relid=0 | w=10
  967. lorazépam -- r_associated #0: 10 / 0.052 -> en:cannabinol
    n1=lorazépam | n2=en:cannabinol | rel=r_associated | relid=0 | w=10
  968. lorazépam -- r_associated #0: 10 / 0.052 -> en:cannabis extract oil sr capsule
    n1=lorazépam | n2=en:cannabis extract oil sr capsule | rel=r_associated | relid=0 | w=10
  969. lorazépam -- r_associated #0: 10 / 0.052 -> en:cantuzumab ravtansine
    n1=lorazépam | n2=en:cantuzumab ravtansine | rel=r_associated | relid=0 | w=10
  970. lorazépam -- r_associated #0: 10 / 0.052 -> en:capecitabine
    n1=lorazépam | n2=en:capecitabine | rel=r_associated | relid=0 | w=10
  971. lorazépam -- r_associated #0: 10 / 0.052 -> en:capecitabine rapidly disintegrating tablet
    n1=lorazépam | n2=en:capecitabine rapidly disintegrating tablet | rel=r_associated | relid=0 | w=10
  972. lorazépam -- r_associated #0: 10 / 0.052 -> en:capox regimen
    n1=lorazépam | n2=en:capox regimen | rel=r_associated | relid=0 | w=10
  973. lorazépam -- r_associated #0: 10 / 0.052 -> en:capsaicin
    n1=lorazépam | n2=en:capsaicin | rel=r_associated | relid=0 | w=10
  974. lorazépam -- r_associated #0: 10 / 0.052 -> en:caracemide
    n1=lorazépam | n2=en:caracemide | rel=r_associated | relid=0 | w=10
  975. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbamazepin (benzodiazepine)
    n1=lorazépam | n2=en:carbamazepin (benzodiazepine) | rel=r_associated | relid=0 | w=10
  976. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbendazim
    n1=lorazépam | n2=en:carbendazim | rel=r_associated | relid=0 | w=10
  977. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbetimer
    n1=lorazépam | n2=en:carbetimer | rel=r_associated | relid=0 | w=10
  978. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbogen
    n1=lorazépam | n2=en:carbogen | rel=r_associated | relid=0 | w=10
  979. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 11 choline
    n1=lorazépam | n2=en:carbon c 11 choline | rel=r_associated | relid=0 | w=10
  980. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 11 n-desmethyl-loperamide
    n1=lorazépam | n2=en:carbon c 11 n-desmethyl-loperamide | rel=r_associated | relid=0 | w=10
  981. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 11 pbr-28
    n1=lorazépam | n2=en:carbon c 11 pbr-28 | rel=r_associated | relid=0 | w=10
  982. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 13 acetate
    n1=lorazépam | n2=en:carbon c 13 acetate | rel=r_associated | relid=0 | w=10
  983. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 13 lycopene
    n1=lorazépam | n2=en:carbon c 13 lycopene | rel=r_associated | relid=0 | w=10
  984. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 13 phytofluene
    n1=lorazépam | n2=en:carbon c 13 phytofluene | rel=r_associated | relid=0 | w=10
  985. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 13/nitrogen n 15-labeled valine
    n1=lorazépam | n2=en:carbon c 13/nitrogen n 15-labeled valine | rel=r_associated | relid=0 | w=10
  986. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 14 anlotinib hydrochloride
    n1=lorazépam | n2=en:carbon c 14 anlotinib hydrochloride | rel=r_associated | relid=0 | w=10
  987. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 14 ibrutinib
    n1=lorazépam | n2=en:carbon c 14 ibrutinib | rel=r_associated | relid=0 | w=10
  988. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 14 lenvatinib mesylate
    n1=lorazépam | n2=en:carbon c 14 lenvatinib mesylate | rel=r_associated | relid=0 | w=10
  989. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 14 oxaliplatin
    n1=lorazépam | n2=en:carbon c 14 oxaliplatin | rel=r_associated | relid=0 | w=10
  990. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 14 telotristat etiprate
    n1=lorazépam | n2=en:carbon c 14 telotristat etiprate | rel=r_associated | relid=0 | w=10
  991. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c 14 vemurafenib
    n1=lorazépam | n2=en:carbon c 14 vemurafenib | rel=r_associated | relid=0 | w=10
  992. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c-13 dextromethorphan
    n1=lorazépam | n2=en:carbon c-13 dextromethorphan | rel=r_associated | relid=0 | w=10
  993. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon c11 temozolomide
    n1=lorazépam | n2=en:carbon c11 temozolomide | rel=r_associated | relid=0 | w=10
  994. lorazépam -- r_associated #0: 10 / 0.052 -> en:carbon-11 acetate
    n1=lorazépam | n2=en:carbon-11 acetate | rel=r_associated | relid=0 | w=10
  995. lorazépam -- r_associated #0: 10 / 0.052 -> en:carboplatin/etoposide/melphalan regimen
    n1=lorazépam | n2=en:carboplatin/etoposide/melphalan regimen | rel=r_associated | relid=0 | w=10
  996. lorazépam -- r_associated #0: 10 / 0.052 -> en:carboxyamidotriazole orotate
    n1=lorazépam | n2=en:carboxyamidotriazole orotate | rel=r_associated | relid=0 | w=10
  997. lorazépam -- r_associated #0: 10 / 0.052 -> en:carboxylesterase-expressing allogeneic neural stem cells
    n1=lorazépam | n2=en:carboxylesterase-expressing allogeneic neural stem cells | rel=r_associated | relid=0 | w=10
  998. lorazépam -- r_associated #0: 10 / 0.052 -> en:carboxymethylcellulose sodium
    n1=lorazépam | n2=en:carboxymethylcellulose sodium | rel=r_associated | relid=0 | w=10
  999. lorazépam -- r_associated #0: 10 / 0.052 -> en:carboxyphenyl retinamide
    n1=lorazépam | n2=en:carboxyphenyl retinamide | rel=r_associated | relid=0 | w=10
  1000. lorazépam -- r_associated #0: 10 / 0.052 -> en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine
    n1=lorazépam | n2=en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine | rel=r_associated | relid=0 | w=10
  1001. lorazépam -- r_associated #0: 10 / 0.052 -> en:carcinoembryonic antigen rna-pulsed dc cancer vaccine
    n1=lorazépam | n2=en:carcinoembryonic antigen rna-pulsed dc cancer vaccine | rel=r_associated | relid=0 | w=10
  1002. lorazépam -- r_associated #0: 10 / 0.052 -> en:carcinoembryonic antigen-expressing measles virus
    n1=lorazépam | n2=en:carcinoembryonic antigen-expressing measles virus | rel=r_associated | relid=0 | w=10
  1003. lorazépam -- r_associated #0: 10 / 0.052 -> en:carcinogen
    n1=lorazépam | n2=en:carcinogen | rel=r_associated | relid=0 | w=10
  1004. lorazépam -- r_associated #0: 10 / 0.052 -> en:carfilzomib
    n1=lorazépam | n2=en:carfilzomib | rel=r_associated | relid=0 | w=10
  1005. lorazépam -- r_associated #0: 10 / 0.052 -> en:caricotamide/tretazicar
    n1=lorazépam | n2=en:caricotamide/tretazicar | rel=r_associated | relid=0 | w=10
  1006. lorazépam -- r_associated #0: 10 / 0.052 -> en:carmustine
    n1=lorazépam | n2=en:carmustine | rel=r_associated | relid=0 | w=10
  1007. lorazépam -- r_associated #0: 10 / 0.052 -> en:carmustine in ethanol
    n1=lorazépam | n2=en:carmustine in ethanol | rel=r_associated | relid=0 | w=10
  1008. lorazépam -- r_associated #0: 10 / 0.052 -> en:carrageenan-containing gel
    n1=lorazépam | n2=en:carrageenan-containing gel | rel=r_associated | relid=0 | w=10
  1009. lorazépam -- r_associated #0: 10 / 0.052 -> en:carvedilol
    n1=lorazépam | n2=en:carvedilol | rel=r_associated | relid=0 | w=10
  1010. lorazépam -- r_associated #0: 10 / 0.052 -> en:caseinate protein isolate
    n1=lorazépam | n2=en:caseinate protein isolate | rel=r_associated | relid=0 | w=10
  1011. lorazépam -- r_associated #0: 10 / 0.052 -> en:casopitant mesylate
    n1=lorazépam | n2=en:casopitant mesylate | rel=r_associated | relid=0 | w=10
  1012. lorazépam -- r_associated #0: 10 / 0.052 -> en:cathelicidin ll-37
    n1=lorazépam | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=10
  1013. lorazépam -- r_associated #0: 10 / 0.052 -> en:cationic liposome-encapsulated paclitaxel
    n1=lorazépam | n2=en:cationic liposome-encapsulated paclitaxel | rel=r_associated | relid=0 | w=10
  1014. lorazépam -- r_associated #0: 10 / 0.052 -> en:catumaxomab
    n1=lorazépam | n2=en:catumaxomab | rel=r_associated | relid=0 | w=10
  1015. lorazépam -- r_associated #0: 10 / 0.052 -> en:cb10-277
    n1=lorazépam | n2=en:cb10-277 | rel=r_associated | relid=0 | w=10
  1016. lorazépam -- r_associated #0: 10 / 0.052 -> en:cbp/beta-catenin antagonist pri-724
    n1=lorazépam | n2=en:cbp/beta-catenin antagonist pri-724 | rel=r_associated | relid=0 | w=10
  1017. lorazépam -- r_associated #0: 10 / 0.052 -> en:cc-1088
    n1=lorazépam | n2=en:cc-1088 | rel=r_associated | relid=0 | w=10
  1018. lorazépam -- r_associated #0: 10 / 0.052 -> en:cc-401
    n1=lorazépam | n2=en:cc-401 | rel=r_associated | relid=0 | w=10
  1019. lorazépam -- r_associated #0: 10 / 0.052 -> en:ccl21-expressing h1944 cell vaccine
    n1=lorazépam | n2=en:ccl21-expressing h1944 cell vaccine | rel=r_associated | relid=0 | w=10
  1020. lorazépam -- r_associated #0: 10 / 0.052 -> en:ccr2 antagonist pf-04136309
    n1=lorazépam | n2=en:ccr2 antagonist pf-04136309 | rel=r_associated | relid=0 | w=10
  1021. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine
    n1=lorazépam | n2=en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  1022. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1023. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd19/cd3 dual-affinity retargeting protein jnj-64052781
    n1=lorazépam | n2=en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 | rel=r_associated | relid=0 | w=10
  1024. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes
    n1=lorazépam | n2=en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1025. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=lorazépam | n2=en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1026. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd19car-cd3zeta-expressing autologous t lymphocytes
    n1=lorazépam | n2=en:cd19car-cd3zeta-expressing autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  1027. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc
    n1=lorazépam | n2=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | rel=r_associated | relid=0 | w=10
  1028. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=lorazépam | n2=en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1029. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd4+ cd25+ regulatory t cells
    n1=lorazépam | n2=en:cd4+ cd25+ regulatory t cells | rel=r_associated | relid=0 | w=10
  1030. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd40 agonist monoclonal antibody cp-870,893
    n1=lorazépam | n2=en:cd40 agonist monoclonal antibody cp-870,893 | rel=r_associated | relid=0 | w=10
  1031. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd40 agonist monoclonal antibody ro7009789
    n1=lorazépam | n2=en:cd40 agonist monoclonal antibody ro7009789 | rel=r_associated | relid=0 | w=10
  1032. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd40 agonistic monoclonal antibody apx005m
    n1=lorazépam | n2=en:cd40 agonistic monoclonal antibody apx005m | rel=r_associated | relid=0 | w=10
  1033. lorazépam -- r_associated #0: 10 / 0.052 -> en:cd95 ecd/igg-fc fusion protein apg101
    n1=lorazépam | n2=en:cd95 ecd/igg-fc fusion protein apg101 | rel=r_associated | relid=0 | w=10
  1034. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdc7 inhibitor tak-931
    n1=lorazépam | n2=en:cdc7 inhibitor tak-931 | rel=r_associated | relid=0 | w=10
  1035. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdc7 kinase inhibitor bms-863233
    n1=lorazépam | n2=en:cdc7 kinase inhibitor bms-863233 | rel=r_associated | relid=0 | w=10
  1036. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdk inhibitor p276-00
    n1=lorazépam | n2=en:cdk inhibitor p276-00 | rel=r_associated | relid=0 | w=10
  1037. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdk inhibitor sns-032
    n1=lorazépam | n2=en:cdk inhibitor sns-032 | rel=r_associated | relid=0 | w=10
  1038. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdk2/5/9 inhibitor cyc065
    n1=lorazépam | n2=en:cdk2/5/9 inhibitor cyc065 | rel=r_associated | relid=0 | w=10
  1039. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdk4 inhibitor p1446a-05
    n1=lorazépam | n2=en:cdk4 inhibitor p1446a-05 | rel=r_associated | relid=0 | w=10
  1040. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdk4/6 inhibitor g1t28
    n1=lorazépam | n2=en:cdk4/6 inhibitor g1t28 | rel=r_associated | relid=0 | w=10
  1041. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdki at7519
    n1=lorazépam | n2=en:cdki at7519 | rel=r_associated | relid=0 | w=10
  1042. lorazépam -- r_associated #0: 10 / 0.052 -> en:cdki r547
    n1=lorazépam | n2=en:cdki r547 | rel=r_associated | relid=0 | w=10
  1043. lorazépam -- r_associated #0: 10 / 0.052 -> en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine
    n1=lorazépam | n2=en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine | rel=r_associated | relid=0 | w=10
  1044. lorazépam -- r_associated #0: 10 / 0.052 -> en:cebpa-targeting sarna mtl-cebpa liposome
    n1=lorazépam | n2=en:cebpa-targeting sarna mtl-cebpa liposome | rel=r_associated | relid=0 | w=10
  1045. lorazépam -- r_associated #0: 10 / 0.052 -> en:cef regimen
    n1=lorazépam | n2=en:cef regimen | rel=r_associated | relid=0 | w=10
  1046. lorazépam -- r_associated #0: 10 / 0.052 -> en:cefepime hydrochloride
    n1=lorazépam | n2=en:cefepime hydrochloride | rel=r_associated | relid=0 | w=10
  1047. lorazépam -- r_associated #0: 10 / 0.052 -> en:cefpodoxim
    n1=lorazépam | n2=en:cefpodoxim | rel=r_associated | relid=0 | w=10
  1048. lorazépam -- r_associated #0: 10 / 0.052 -> en:cefpodoxime proxetil
    n1=lorazépam | n2=en:cefpodoxime proxetil | rel=r_associated | relid=0 | w=10
  1049. lorazépam -- r_associated #0: 10 / 0.052 -> en:ceftobiprole medocaril
    n1=lorazépam | n2=en:ceftobiprole medocaril | rel=r_associated | relid=0 | w=10
  1050. lorazépam -- r_associated #0: 10 / 0.052 -> en:ceftriaxone sodium
    n1=lorazépam | n2=en:ceftriaxone sodium | rel=r_associated | relid=0 | w=10
  1051. lorazépam -- r_associated #0: 10 / 0.052 -> en:cell cycle checkpoint/dna repair antagonist ic83
    n1=lorazépam | n2=en:cell cycle checkpoint/dna repair antagonist ic83 | rel=r_associated | relid=0 | w=10
  1052. lorazépam -- r_associated #0: 10 / 0.052 -> en:cemadotin hydrochloride
    n1=lorazépam | n2=en:cemadotin hydrochloride | rel=r_associated | relid=0 | w=10
  1053. lorazépam -- r_associated #0: 10 / 0.052 -> en:cenersen
    n1=lorazépam | n2=en:cenersen | rel=r_associated | relid=0 | w=10
  1054. lorazépam -- r_associated #0: 10 / 0.052 -> en:cenisertib
    n1=lorazépam | n2=en:cenisertib | rel=r_associated | relid=0 | w=10
  1055. lorazépam -- r_associated #0: 10 / 0.052 -> en:central nervous system agents
    n1=lorazépam | n2=en:central nervous system agents | rel=r_associated | relid=0 | w=10
  1056. lorazépam -- r_associated #0: 10 / 0.052 -> en:ceritinib
    n1=lorazépam | n2=en:ceritinib | rel=r_associated | relid=0 | w=10
  1057. lorazépam -- r_associated #0: 10 / 0.052 -> en:certolizumab
    n1=lorazépam | n2=en:certolizumab | rel=r_associated | relid=0 | w=10
  1058. lorazépam -- r_associated #0: 10 / 0.052 -> en:cesium cs-131
    n1=lorazépam | n2=en:cesium cs-131 | rel=r_associated | relid=0 | w=10
  1059. lorazépam -- r_associated #0: 10 / 0.052 -> en:cetirizine
    n1=lorazépam | n2=en:cetirizine | rel=r_associated | relid=0 | w=10
  1060. lorazépam -- r_associated #0: 10 / 0.052 -> en:cetuximab
    n1=lorazépam | n2=en:cetuximab | rel=r_associated | relid=0 | w=10
  1061. lorazépam -- r_associated #0: 10 / 0.052 -> en:cfms tyrosine kinase inhibitor arry-382
    n1=lorazépam | n2=en:cfms tyrosine kinase inhibitor arry-382 | rel=r_associated | relid=0 | w=10
  1062. lorazépam -- r_associated #0: 10 / 0.052 -> en:cgp-6809
    n1=lorazépam | n2=en:cgp-6809 | rel=r_associated | relid=0 | w=10
  1063. lorazépam -- r_associated #0: 10 / 0.052 -> en:checkpoint kinase inhibitor azd7762
    n1=lorazépam | n2=en:checkpoint kinase inhibitor azd7762 | rel=r_associated | relid=0 | w=10
  1064. lorazépam -- r_associated #0: 10 / 0.052 -> en:checkpoint kinase inhibitor xl844
    n1=lorazépam | n2=en:checkpoint kinase inhibitor xl844 | rel=r_associated | relid=0 | w=10
  1065. lorazépam -- r_associated #0: 10 / 0.052 -> en:chelating agent
    n1=lorazépam | n2=en:chelating agent | rel=r_associated | relid=0 | w=10
  1066. lorazépam -- r_associated #0: 10 / 0.052 -> en:chewing gum dosage form
    n1=lorazépam | n2=en:chewing gum dosage form | rel=r_associated | relid=0 | w=10
  1067. lorazépam -- r_associated #0: 10 / 0.052 -> en:chidamide
    n1=lorazépam | n2=en:chidamide | rel=r_associated | relid=0 | w=10
  1068. lorazépam -- r_associated #0: 10 / 0.052 -> en:chimeric fibril-reactive monoclonal antibody 111f4
    n1=lorazépam | n2=en:chimeric fibril-reactive monoclonal antibody 111f4 | rel=r_associated | relid=0 | w=10
  1069. lorazépam -- r_associated #0: 10 / 0.052 -> en:chimeric humanized anti-cd47 antibody
    n1=lorazépam | n2=en:chimeric humanized anti-cd47 antibody | rel=r_associated | relid=0 | w=10
  1070. lorazépam -- r_associated #0: 10 / 0.052 -> en:chinese herbal formulation changtai keli
    n1=lorazépam | n2=en:chinese herbal formulation changtai keli | rel=r_associated | relid=0 | w=10
  1071. lorazépam -- r_associated #0: 10 / 0.052 -> en:chinese herbal formulation phy906
    n1=lorazépam | n2=en:chinese herbal formulation phy906 | rel=r_associated | relid=0 | w=10
  1072. lorazépam -- r_associated #0: 10 / 0.052 -> en:chk1 inhibitor gdc-0425
    n1=lorazépam | n2=en:chk1 inhibitor gdc-0425 | rel=r_associated | relid=0 | w=10
  1073. lorazépam -- r_associated #0: 10 / 0.052 -> en:chk1 inhibitor gdc-0575
    n1=lorazépam | n2=en:chk1 inhibitor gdc-0575 | rel=r_associated | relid=0 | w=10
  1074. lorazépam -- r_associated #0: 10 / 0.052 -> en:chk1 inhibitor mk-8776
    n1=lorazépam | n2=en:chk1 inhibitor mk-8776 | rel=r_associated | relid=0 | w=10
  1075. lorazépam -- r_associated #0: 10 / 0.052 -> en:chk1 inhibitor pf-477736
    n1=lorazépam | n2=en:chk1 inhibitor pf-477736 | rel=r_associated | relid=0 | w=10
  1076. lorazépam -- r_associated #0: 10 / 0.052 -> en:chlorambucil-prednisone regimen
    n1=lorazépam | n2=en:chlorambucil-prednisone regimen | rel=r_associated | relid=0 | w=10
  1077. lorazépam -- r_associated #0: 10 / 0.052 -> en:chloroquinoxaline sulfonamide
    n1=lorazépam | n2=en:chloroquinoxaline sulfonamide | rel=r_associated | relid=0 | w=10
  1078. lorazépam -- r_associated #0: 10 / 0.052 -> en:choleretic agent
    n1=lorazépam | n2=en:choleretic agent | rel=r_associated | relid=0 | w=10
  1079. lorazépam -- r_associated #0: 10 / 0.052 -> en:choline kinase alpha inhibitor tcd-717
    n1=lorazépam | n2=en:choline kinase alpha inhibitor tcd-717 | rel=r_associated | relid=0 | w=10
  1080. lorazépam -- r_associated #0: 10 / 0.052 -> en:chp-her-2 peptide vaccine
    n1=lorazépam | n2=en:chp-her-2 peptide vaccine | rel=r_associated | relid=0 | w=10
  1081. lorazépam -- r_associated #0: 10 / 0.052 -> en:chp-ny-eso-1 peptide vaccine imf-001
    n1=lorazépam | n2=en:chp-ny-eso-1 peptide vaccine imf-001 | rel=r_associated | relid=0 | w=10
  1082. lorazépam -- r_associated #0: 10 / 0.052 -> en:chronic respiratory failure
    n1=lorazépam | n2=en:chronic respiratory failure | rel=r_associated | relid=0 | w=10
  1083. lorazépam -- r_associated #0: 10 / 0.052 -> en:ciclopirox olamine lotion
    n1=lorazépam | n2=en:ciclopirox olamine lotion | rel=r_associated | relid=0 | w=10
  1084. lorazépam -- r_associated #0: 10 / 0.052 -> en:ciclotizolam
    n1=lorazépam | n2=en:ciclotizolam | rel=r_associated | relid=0 | w=10
  1085. lorazépam -- r_associated #0: 10 / 0.052 -> en:cilengitide
    n1=lorazépam | n2=en:cilengitide | rel=r_associated | relid=0 | w=10
  1086. lorazépam -- r_associated #0: 10 / 0.052 -> en:cimetidine
    n1=lorazépam | n2=en:cimetidine | rel=r_associated | relid=0 | w=10
  1087. lorazépam -- r_associated #0: 10 / 0.052 -> en:cinacalcet hydrochloride
    n1=lorazépam | n2=en:cinacalcet hydrochloride | rel=r_associated | relid=0 | w=10
  1088. lorazépam -- r_associated #0: 10 / 0.052 -> en:cinobufagin
    n1=lorazépam | n2=en:cinobufagin | rel=r_associated | relid=0 | w=10
  1089. lorazépam -- r_associated #0: 10 / 0.052 -> en:cinolazepam
    n1=lorazépam | n2=en:cinolazepam | rel=r_associated | relid=0 | w=10
  1090. lorazépam -- r_associated #0: 10 / 0.052 -> en:cirmtuzumab
    n1=lorazépam | n2=en:cirmtuzumab | rel=r_associated | relid=0 | w=10
  1091. lorazépam -- r_associated #0: 10 / 0.052 -> en:cis-urocanic acid
    n1=lorazépam | n2=en:cis-urocanic acid | rel=r_associated | relid=0 | w=10
  1092. lorazépam -- r_associated #0: 10 / 0.052 -> en:cisplatin
    n1=lorazépam | n2=en:cisplatin | rel=r_associated | relid=0 | w=10
  1093. lorazépam -- r_associated #0: 10 / 0.052 -> en:cisplatin liposomal
    n1=lorazépam | n2=en:cisplatin liposomal | rel=r_associated | relid=0 | w=10
  1094. lorazépam -- r_associated #0: 10 / 0.052 -> en:cisplatin-e therapeutic implant
    n1=lorazépam | n2=en:cisplatin-e therapeutic implant | rel=r_associated | relid=0 | w=10
  1095. lorazépam -- r_associated #0: 10 / 0.052 -> en:cisplatinum
    n1=lorazépam | n2=en:cisplatinum | rel=r_associated | relid=0 | w=10
  1096. lorazépam -- r_associated #0: 10 / 0.052 -> en:citatuzumab bogatox
    n1=lorazépam | n2=en:citatuzumab bogatox | rel=r_associated | relid=0 | w=10
  1097. lorazépam -- r_associated #0: 10 / 0.052 -> en:citric acid + magnesium oxide + sodium picosulfate
    n1=lorazépam | n2=en:citric acid + magnesium oxide + sodium picosulfate | rel=r_associated | relid=0 | w=10
  1098. lorazépam -- r_associated #0: 10 / 0.052 -> en:citrulline
    n1=lorazépam | n2=en:citrulline | rel=r_associated | relid=0 | w=10
  1099. lorazépam -- r_associated #0: 10 / 0.052 -> en:cixutumumab
    n1=lorazépam | n2=en:cixutumumab | rel=r_associated | relid=0 | w=10
  1100. lorazépam -- r_associated #0: 10 / 0.052 -> en:ck2-targeting synthetic peptide cigb-300
    n1=lorazépam | n2=en:ck2-targeting synthetic peptide cigb-300 | rel=r_associated | relid=0 | w=10
  1101. lorazépam -- r_associated #0: 10 / 0.052 -> en:clarithromycin
    n1=lorazépam | n2=en:clarithromycin | rel=r_associated | relid=0 | w=10
  1102. lorazépam -- r_associated #0: 10 / 0.052 -> en:claudiximab
    n1=lorazépam | n2=en:claudiximab | rel=r_associated | relid=0 | w=10
  1103. lorazépam -- r_associated #0: 10 / 0.052 -> en:clevudine
    n1=lorazépam | n2=en:clevudine | rel=r_associated | relid=0 | w=10
  1104. lorazépam -- r_associated #0: 10 / 0.052 -> en:climazolam
    n1=lorazépam | n2=en:climazolam | rel=r_associated | relid=0 | w=10
  1105. lorazépam -- r_associated #0: 10 / 0.052 -> en:clino-san vaginal lubricant
    n1=lorazépam | n2=en:clino-san vaginal lubricant | rel=r_associated | relid=0 | w=10
  1106. lorazépam -- r_associated #0: 10 / 0.052 -> en:clobazam
    n1=lorazépam | n2=en:clobazam | rel=r_associated | relid=0 | w=10
  1107. lorazépam -- r_associated #0: 10 / 0.052 -> en:clofarabine
    n1=lorazépam | n2=en:clofarabine | rel=r_associated | relid=0 | w=10
  1108. lorazépam -- r_associated #0: 10 / 0.052 -> en:clomiphene citrate
    n1=lorazépam | n2=en:clomiphene citrate | rel=r_associated | relid=0 | w=10
  1109. lorazépam -- r_associated #0: 10 / 0.052 -> en:clonidine-containing mucoadhesive buccal tablet
    n1=lorazépam | n2=en:clonidine-containing mucoadhesive buccal tablet | rel=r_associated | relid=0 | w=10
  1110. lorazépam -- r_associated #0: 10 / 0.052 -> en:clorazepate
    n1=lorazépam | n2=en:clorazepate | rel=r_associated | relid=0 | w=10
  1111. lorazépam -- r_associated #0: 10 / 0.052 -> en:clostridium butyricum-containing probiotic
    n1=lorazépam | n2=en:clostridium butyricum-containing probiotic | rel=r_associated | relid=0 | w=10
  1112. lorazépam -- r_associated #0: 10 / 0.052 -> en:clostridium novyi-nt spores
    n1=lorazépam | n2=en:clostridium novyi-nt spores | rel=r_associated | relid=0 | w=10
  1113. lorazépam -- r_associated #0: 10 / 0.052 -> en:clotiazepam
    n1=lorazépam | n2=en:clotiazepam | rel=r_associated | relid=0 | w=10
  1114. lorazépam -- r_associated #0: 10 / 0.052 -> en:cmet car-mrna electroporated autologous t lymphocytes
    n1=lorazépam | n2=en:cmet car-mrna electroporated autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  1115. lorazépam -- r_associated #0: 10 / 0.052 -> en:cmv n495 peptide
    n1=lorazépam | n2=en:cmv n495 peptide | rel=r_associated | relid=0 | w=10
  1116. lorazépam -- r_associated #0: 10 / 0.052 -> en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1117. lorazépam -- r_associated #0: 10 / 0.052 -> en:cmvpp65-a*0201 peptide vaccine
    n1=lorazépam | n2=en:cmvpp65-a*0201 peptide vaccine | rel=r_associated | relid=0 | w=10
  1118. lorazépam -- r_associated #0: 10 / 0.052 -> en:cngrc peptide-tnf alpha conjugate
    n1=lorazépam | n2=en:cngrc peptide-tnf alpha conjugate | rel=r_associated | relid=0 | w=10
  1119. lorazépam -- r_associated #0: 10 / 0.052 -> en:cobalamin
    n1=lorazépam | n2=en:cobalamin | rel=r_associated | relid=0 | w=10
  1120. lorazépam -- r_associated #0: 10 / 0.052 -> en:cobimetinib
    n1=lorazépam | n2=en:cobimetinib | rel=r_associated | relid=0 | w=10
  1121. lorazépam -- r_associated #0: 10 / 0.052 -> en:cobiprostone
    n1=lorazépam | n2=en:cobiprostone | rel=r_associated | relid=0 | w=10
  1122. lorazépam -- r_associated #0: 10 / 0.052 -> en:cocculus/nux vomica/tabacum/petroleum extract
    n1=lorazépam | n2=en:cocculus/nux vomica/tabacum/petroleum extract | rel=r_associated | relid=0 | w=10
  1123. lorazépam -- r_associated #0: 10 / 0.052 -> en:code
    n1=lorazépam | n2=en:code | rel=r_associated | relid=0 | w=10
  1124. lorazépam -- r_associated #0: 10 / 0.052 -> en:codeine phosphate
    n1=lorazépam | n2=en:codeine phosphate | rel=r_associated | relid=0 | w=10
  1125. lorazépam -- r_associated #0: 10 / 0.052 -> en:coffee dietary supplement
    n1=lorazépam | n2=en:coffee dietary supplement | rel=r_associated | relid=0 | w=10
  1126. lorazépam -- r_associated #0: 10 / 0.052 -> en:cold contaminant-free iobenguane i-131
    n1=lorazépam | n2=en:cold contaminant-free iobenguane i-131 | rel=r_associated | relid=0 | w=10
  1127. lorazépam -- r_associated #0: 10 / 0.052 -> en:colloidal gold-bound tumor necrosis factor
    n1=lorazépam | n2=en:colloidal gold-bound tumor necrosis factor | rel=r_associated | relid=0 | w=10
  1128. lorazépam -- r_associated #0: 10 / 0.052 -> en:colorectal tumor-associated peptides vaccine ima910
    n1=lorazépam | n2=en:colorectal tumor-associated peptides vaccine ima910 | rel=r_associated | relid=0 | w=10
  1129. lorazépam -- r_associated #0: 10 / 0.052 -> en:combretastatin a1 diphosphate
    n1=lorazépam | n2=en:combretastatin a1 diphosphate | rel=r_associated | relid=0 | w=10
  1130. lorazépam -- r_associated #0: 10 / 0.052 -> en:complement c5 inhibitor alxn1210
    n1=lorazépam | n2=en:complement c5 inhibitor alxn1210 | rel=r_associated | relid=0 | w=10
  1131. lorazépam -- r_associated #0: 10 / 0.052 -> en:compound kushen injection
    n1=lorazépam | n2=en:compound kushen injection | rel=r_associated | relid=0 | w=10
  1132. lorazépam -- r_associated #0: 10 / 0.052 -> en:compound sodium lactate solution
    n1=lorazépam | n2=en:compound sodium lactate solution | rel=r_associated | relid=0 | w=10
  1133. lorazépam -- r_associated #0: 10 / 0.052 -> en:computer language
    n1=lorazépam | n2=en:computer language | rel=r_associated | relid=0 | w=10
  1134. lorazépam -- r_associated #0: 10 / 0.052 -> en:conatumumab
    n1=lorazépam | n2=en:conatumumab | rel=r_associated | relid=0 | w=10
  1135. lorazépam -- r_associated #0: 10 / 0.052 -> en:concentrated beet crystals
    n1=lorazépam | n2=en:concentrated beet crystals | rel=r_associated | relid=0 | w=10
  1136. lorazépam -- r_associated #0: 10 / 0.052 -> en:conditionally replicative adenovirus 5/3-delta24
    n1=lorazépam | n2=en:conditionally replicative adenovirus 5/3-delta24 | rel=r_associated | relid=0 | w=10
  1137. lorazépam -- r_associated #0: 10 / 0.052 -> en:conjugated estrogens/bazedoxifene
    n1=lorazépam | n2=en:conjugated estrogens/bazedoxifene | rel=r_associated | relid=0 | w=10
  1138. lorazépam -- r_associated #0: 10 / 0.052 -> en:controlled substance
    n1=lorazépam | n2=en:controlled substance | rel=r_associated | relid=0 | w=10
  1139. lorazépam -- r_associated #0: 10 / 0.052 -> en:copanlisib
    n1=lorazépam | n2=en:copanlisib | rel=r_associated | relid=0 | w=10
  1140. lorazépam -- r_associated #0: 10 / 0.052 -> en:copovithane
    n1=lorazépam | n2=en:copovithane | rel=r_associated | relid=0 | w=10
  1141. lorazépam -- r_associated #0: 10 / 0.052 -> en:copp regimen
    n1=lorazépam | n2=en:copp regimen | rel=r_associated | relid=0 | w=10
  1142. lorazépam -- r_associated #0: 10 / 0.052 -> en:copper cu 62-atsm
    n1=lorazépam | n2=en:copper cu 62-atsm | rel=r_associated | relid=0 | w=10
  1143. lorazépam -- r_associated #0: 10 / 0.052 -> en:copper gluconate
    n1=lorazépam | n2=en:copper gluconate | rel=r_associated | relid=0 | w=10
  1144. lorazépam -- r_associated #0: 10 / 0.052 -> en:cord blood-derived expanded natural killer cell infusion pnk-007
    n1=lorazépam | n2=en:cord blood-derived expanded natural killer cell infusion pnk-007 | rel=r_associated | relid=0 | w=10
  1145. lorazépam -- r_associated #0: 10 / 0.052 -> en:cordycepin
    n1=lorazépam | n2=en:cordycepin | rel=r_associated | relid=0 | w=10
  1146. lorazépam -- r_associated #0: 10 / 0.052 -> en:coriolus versicolor extract
    n1=lorazépam | n2=en:coriolus versicolor extract | rel=r_associated | relid=0 | w=10
  1147. lorazépam -- r_associated #0: 10 / 0.052 -> en:correspond to
    n1=lorazépam | n2=en:correspond to | rel=r_associated | relid=0 | w=10
  1148. lorazépam -- r_associated #0: 10 / 0.052 -> en:corticorelin acetate
    n1=lorazépam | n2=en:corticorelin acetate | rel=r_associated | relid=0 | w=10
  1149. lorazépam -- r_associated #0: 10 / 0.052 -> en:cortifair
    n1=lorazépam | n2=en:cortifair | rel=r_associated | relid=0 | w=10
  1150. lorazépam -- r_associated #0: 10 / 0.052 -> en:cortisol
    n1=lorazépam | n2=en:cortisol | rel=r_associated | relid=0 | w=10
  1151. lorazépam -- r_associated #0: 10 / 0.052 -> en:corynebacterium granulosum p40
    n1=lorazépam | n2=en:corynebacterium granulosum p40 | rel=r_associated | relid=0 | w=10
  1152. lorazépam -- r_associated #0: 10 / 0.052 -> en:coxsackievirus a21
    n1=lorazépam | n2=en:coxsackievirus a21 | rel=r_associated | relid=0 | w=10
  1153. lorazépam -- r_associated #0: 10 / 0.052 -> en:cp 461
    n1=lorazépam | n2=en:cp 461 | rel=r_associated | relid=0 | w=10
  1154. lorazépam -- r_associated #0: 10 / 0.052 -> en:cp-609,754
    n1=lorazépam | n2=en:cp-609,754 | rel=r_associated | relid=0 | w=10
  1155. lorazépam -- r_associated #0: 10 / 0.052 -> en:cp-724,714
    n1=lorazépam | n2=en:cp-724,714 | rel=r_associated | relid=0 | w=10
  1156. lorazépam -- r_associated #0: 10 / 0.052 -> en:cpg-28 oligodeoxynucleotide
    n1=lorazépam | n2=en:cpg-28 oligodeoxynucleotide | rel=r_associated | relid=0 | w=10
  1157. lorazépam -- r_associated #0: 10 / 0.052 -> en:cr2-fh fusion protein tt30
    n1=lorazépam | n2=en:cr2-fh fusion protein tt30 | rel=r_associated | relid=0 | w=10
  1158. lorazépam -- r_associated #0: 10 / 0.052 -> en:creatine monohydrate
    n1=lorazépam | n2=en:creatine monohydrate | rel=r_associated | relid=0 | w=10
  1159. lorazépam -- r_associated #0: 10 / 0.052 -> en:crenolanib
    n1=lorazépam | n2=en:crenolanib | rel=r_associated | relid=0 | w=10
  1160. lorazépam -- r_associated #0: 10 / 0.052 -> en:crenolanib besylate
    n1=lorazépam | n2=en:crenolanib besylate | rel=r_associated | relid=0 | w=10
  1161. lorazépam -- r_associated #0: 10 / 0.052 -> en:cridanimod sodium
    n1=lorazépam | n2=en:cridanimod sodium | rel=r_associated | relid=0 | w=10
  1162. lorazépam -- r_associated #0: 10 / 0.052 -> en:crisnatol mesylate
    n1=lorazépam | n2=en:crisnatol mesylate | rel=r_associated | relid=0 | w=10
  1163. lorazépam -- r_associated #0: 10 / 0.052 -> en:crl 1005
    n1=lorazépam | n2=en:crl 1005 | rel=r_associated | relid=0 | w=10
  1164. lorazépam -- r_associated #0: 10 / 0.052 -> en:crolibulin
    n1=lorazépam | n2=en:crolibulin | rel=r_associated | relid=0 | w=10
  1165. lorazépam -- r_associated #0: 10 / 0.052 -> en:cryoprotective agent
    n1=lorazépam | n2=en:cryoprotective agent | rel=r_associated | relid=0 | w=10
  1166. lorazépam -- r_associated #0: 10 / 0.052 -> en:crystalline genistein formulation axp107-11
    n1=lorazépam | n2=en:crystalline genistein formulation axp107-11 | rel=r_associated | relid=0 | w=10
  1167. lorazépam -- r_associated #0: 10 / 0.052 -> en:ctp-37-dt vaccine
    n1=lorazépam | n2=en:ctp-37-dt vaccine | rel=r_associated | relid=0 | w=10
  1168. lorazépam -- r_associated #0: 10 / 0.052 -> en:ctrp terminology
    n1=lorazépam | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=10
  1169. lorazépam -- r_associated #0: 10 / 0.052 -> en:curcumin
    n1=lorazépam | n2=en:curcumin | rel=r_associated | relid=0 | w=10
  1170. lorazépam -- r_associated #0: 10 / 0.052 -> en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule
    n1=lorazépam | n2=en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule | rel=r_associated | relid=0 | w=10
  1171. lorazépam -- r_associated #0: 10 / 0.052 -> en:custirsen sodium
    n1=lorazépam | n2=en:custirsen sodium | rel=r_associated | relid=0 | w=10
  1172. lorazépam -- r_associated #0: 10 / 0.052 -> en:cxc chemokine receptor 2 antagonist azd5069
    n1=lorazépam | n2=en:cxc chemokine receptor 2 antagonist azd5069 | rel=r_associated | relid=0 | w=10
  1173. lorazépam -- r_associated #0: 10 / 0.052 -> en:cxcr4 antagonist bl-8040
    n1=lorazépam | n2=en:cxcr4 antagonist bl-8040 | rel=r_associated | relid=0 | w=10
  1174. lorazépam -- r_associated #0: 10 / 0.052 -> en:cxcr4 inhibitor x4p-001
    n1=lorazépam | n2=en:cxcr4 inhibitor x4p-001 | rel=r_associated | relid=0 | w=10
  1175. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1176. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyclizine lactate
    n1=lorazépam | n2=en:cyclizine lactate | rel=r_associated | relid=0 | w=10
  1177. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyclodextrin-based polymer-camptothecin crlx101
    n1=lorazépam | n2=en:cyclodextrin-based polymer-camptothecin crlx101 | rel=r_associated | relid=0 | w=10
  1178. lorazépam -- r_associated #0: 10 / 0.052 -> en:cycloleucine
    n1=lorazépam | n2=en:cycloleucine | rel=r_associated | relid=0 | w=10
  1179. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyclopentenyl cytosine
    n1=lorazépam | n2=en:cyclopentenyl cytosine | rel=r_associated | relid=0 | w=10
  1180. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyclophosphamide
    n1=lorazépam | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=10
  1181. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyclophosphamide/dactinomycin/vincristine
    n1=lorazépam | n2=en:cyclophosphamide/dactinomycin/vincristine | rel=r_associated | relid=0 | w=10
  1182. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyclosporine ophthalmic emulsion
    n1=lorazépam | n2=en:cyclosporine ophthalmic emulsion | rel=r_associated | relid=0 | w=10
  1183. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyl-02 plasmid dna
    n1=lorazépam | n2=en:cyl-02 plasmid dna | rel=r_associated | relid=0 | w=10
  1184. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyp17 inhibitor cfg920
    n1=lorazépam | n2=en:cyp17 inhibitor cfg920 | rel=r_associated | relid=0 | w=10
  1185. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyp17 inhibitor vt-464
    n1=lorazépam | n2=en:cyp17 inhibitor vt-464 | rel=r_associated | relid=0 | w=10
  1186. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyp17 lyase inhibitor asn001
    n1=lorazépam | n2=en:cyp17 lyase inhibitor asn001 | rel=r_associated | relid=0 | w=10
  1187. lorazépam -- r_associated #0: 10 / 0.052 -> en:cyproheptadine hydrochloride
    n1=lorazépam | n2=en:cyproheptadine hydrochloride | rel=r_associated | relid=0 | w=10
  1188. lorazépam -- r_associated #0: 10 / 0.052 -> en:cystemustine
    n1=lorazépam | n2=en:cystemustine | rel=r_associated | relid=0 | w=10
  1189. lorazépam -- r_associated #0: 10 / 0.052 -> en:cytembena
    n1=lorazépam | n2=en:cytembena | rel=r_associated | relid=0 | w=10
  1190. lorazépam -- r_associated #0: 10 / 0.052 -> en:cytidine analog rx-3117
    n1=lorazépam | n2=en:cytidine analog rx-3117 | rel=r_associated | relid=0 | w=10
  1191. lorazépam -- r_associated #0: 10 / 0.052 -> en:cytochlor
    n1=lorazépam | n2=en:cytochlor | rel=r_associated | relid=0 | w=10
  1192. lorazépam -- r_associated #0: 10 / 0.052 -> en:cytokine-induced killer cells
    n1=lorazépam | n2=en:cytokine-induced killer cells | rel=r_associated | relid=0 | w=10
  1193. lorazépam -- r_associated #0: 10 / 0.052 -> en:cytomegalovirus pp65-specific cytotoxic t lymphocytes
    n1=lorazépam | n2=en:cytomegalovirus pp65-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  1194. lorazépam -- r_associated #0: 10 / 0.052 -> en:d1/3-mage-3-his fusion protein
    n1=lorazépam | n2=en:d1/3-mage-3-his fusion protein | rel=r_associated | relid=0 | w=10
  1195. lorazépam -- r_associated #0: 10 / 0.052 -> en:dab389 epidermal growth factor
    n1=lorazépam | n2=en:dab389 epidermal growth factor | rel=r_associated | relid=0 | w=10
  1196. lorazépam -- r_associated #0: 10 / 0.052 -> en:dabrafenib
    n1=lorazépam | n2=en:dabrafenib | rel=r_associated | relid=0 | w=10
  1197. lorazépam -- r_associated #0: 10 / 0.052 -> en:dacetuzumab
    n1=lorazépam | n2=en:dacetuzumab | rel=r_associated | relid=0 | w=10
  1198. lorazépam -- r_associated #0: 10 / 0.052 -> en:dach polymer platinate ap5346
    n1=lorazépam | n2=en:dach polymer platinate ap5346 | rel=r_associated | relid=0 | w=10
  1199. lorazépam -- r_associated #0: 10 / 0.052 -> en:dach-platin micelle nc-4016
    n1=lorazépam | n2=en:dach-platin micelle nc-4016 | rel=r_associated | relid=0 | w=10
  1200. lorazépam -- r_associated #0: 10 / 0.052 -> en:daclatasvir
    n1=lorazépam | n2=en:daclatasvir | rel=r_associated | relid=0 | w=10
  1201. lorazépam -- r_associated #0: 10 / 0.052 -> en:daclizumab
    n1=lorazépam | n2=en:daclizumab | rel=r_associated | relid=0 | w=10
  1202. lorazépam -- r_associated #0: 10 / 0.052 -> en:dactinomycin
    n1=lorazépam | n2=en:dactinomycin | rel=r_associated | relid=0 | w=10
  1203. lorazépam -- r_associated #0: 10 / 0.052 -> en:daflon 500
    n1=lorazépam | n2=en:daflon 500 | rel=r_associated | relid=0 | w=10
  1204. lorazépam -- r_associated #0: 10 / 0.052 -> en:dakins solution
    n1=lorazépam | n2=en:dakins solution | rel=r_associated | relid=0 | w=10
  1205. lorazépam -- r_associated #0: 10 / 0.052 -> en:dalantercept
    n1=lorazépam | n2=en:dalantercept | rel=r_associated | relid=0 | w=10
  1206. lorazépam -- r_associated #0: 10 / 0.052 -> en:dalbavancin
    n1=lorazépam | n2=en:dalbavancin | rel=r_associated | relid=0 | w=10
  1207. lorazépam -- r_associated #0: 10 / 0.052 -> en:dalteparin
    n1=lorazépam | n2=en:dalteparin | rel=r_associated | relid=0 | w=10
  1208. lorazépam -- r_associated #0: 10 / 0.052 -> en:daniquidone
    n1=lorazépam | n2=en:daniquidone | rel=r_associated | relid=0 | w=10
  1209. lorazépam -- r_associated #0: 10 / 0.052 -> en:danusertib
    n1=lorazépam | n2=en:danusertib | rel=r_associated | relid=0 | w=10
  1210. lorazépam -- r_associated #0: 10 / 0.052 -> en:daporinad
    n1=lorazépam | n2=en:daporinad | rel=r_associated | relid=0 | w=10
  1211. lorazépam -- r_associated #0: 10 / 0.052 -> en:dapsone
    n1=lorazépam | n2=en:dapsone | rel=r_associated | relid=0 | w=10
  1212. lorazépam -- r_associated #0: 10 / 0.052 -> en:darbepoetin alfa
    n1=lorazépam | n2=en:darbepoetin alfa | rel=r_associated | relid=0 | w=10
  1213. lorazépam -- r_associated #0: 10 / 0.052 -> en:darinaparsin
    n1=lorazépam | n2=en:darinaparsin | rel=r_associated | relid=0 | w=10
  1214. lorazépam -- r_associated #0: 10 / 0.052 -> en:dasatinib
    n1=lorazépam | n2=en:dasatinib | rel=r_associated | relid=0 | w=10
  1215. lorazépam -- r_associated #0: 10 / 0.052 -> en:daunorubicin hydrochloride
    n1=lorazépam | n2=en:daunorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  1216. lorazépam -- r_associated #0: 10 / 0.052 -> en:dbve-pc regimen
    n1=lorazépam | n2=en:dbve-pc regimen | rel=r_associated | relid=0 | w=10
  1217. lorazépam -- r_associated #0: 10 / 0.052 -> en:dc-cholesterol liposome
    n1=lorazépam | n2=en:dc-cholesterol liposome | rel=r_associated | relid=0 | w=10
  1218. lorazépam -- r_associated #0: 10 / 0.052 -> en:dc-ova vaccine
    n1=lorazépam | n2=en:dc-ova vaccine | rel=r_associated | relid=0 | w=10
  1219. lorazépam -- r_associated #0: 10 / 0.052 -> en:dcds0780a
    n1=lorazépam | n2=en:dcds0780a | rel=r_associated | relid=0 | w=10
  1220. lorazépam -- r_associated #0: 10 / 0.052 -> en:dec-205/ny-eso-1 fusion protein cdx-1401
    n1=lorazépam | n2=en:dec-205/ny-eso-1 fusion protein cdx-1401 | rel=r_associated | relid=0 | w=10
  1221. lorazépam -- r_associated #0: 10 / 0.052 -> en:decitabine
    n1=lorazépam | n2=en:decitabine | rel=r_associated | relid=0 | w=10
  1222. lorazépam -- r_associated #0: 10 / 0.052 -> en:defined green tea catechin extract
    n1=lorazépam | n2=en:defined green tea catechin extract | rel=r_associated | relid=0 | w=10
  1223. lorazépam -- r_associated #0: 10 / 0.052 -> en:degarelix
    n1=lorazépam | n2=en:degarelix | rel=r_associated | relid=0 | w=10
  1224. lorazépam -- r_associated #0: 10 / 0.052 -> en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins
    n1=lorazépam | n2=en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins | rel=r_associated | relid=0 | w=10
  1225. lorazépam -- r_associated #0: 10 / 0.052 -> en:dehydrated human amnion/chorion membrane
    n1=lorazépam | n2=en:dehydrated human amnion/chorion membrane | rel=r_associated | relid=0 | w=10
  1226. lorazépam -- r_associated #0: 10 / 0.052 -> en:delanzomib
    n1=lorazépam | n2=en:delanzomib | rel=r_associated | relid=0 | w=10
  1227. lorazépam -- r_associated #0: 10 / 0.052 -> en:delorazepam
    n1=lorazépam | n2=en:delorazepam | rel=r_associated | relid=0 | w=10
  1228. lorazépam -- r_associated #0: 10 / 0.052 -> en:delta-8-tetrahydrocannabinol
    n1=lorazépam | n2=en:delta-8-tetrahydrocannabinol | rel=r_associated | relid=0 | w=10
  1229. lorazépam -- r_associated #0: 10 / 0.052 -> en:delta-tocotrienol
    n1=lorazépam | n2=en:delta-tocotrienol | rel=r_associated | relid=0 | w=10
  1230. lorazépam -- r_associated #0: 10 / 0.052 -> en:dendritic cell-autologous lung tumor vaccine
    n1=lorazépam | n2=en:dendritic cell-autologous lung tumor vaccine | rel=r_associated | relid=0 | w=10
  1231. lorazépam -- r_associated #0: 10 / 0.052 -> en:dendritic cell-cea peptide vaccine
    n1=lorazépam | n2=en:dendritic cell-cea peptide vaccine | rel=r_associated | relid=0 | w=10
  1232. lorazépam -- r_associated #0: 10 / 0.052 -> en:dendritic cell-gp100-mart-1 antigen vaccine
    n1=lorazépam | n2=en:dendritic cell-gp100-mart-1 antigen vaccine | rel=r_associated | relid=0 | w=10
  1233. lorazépam -- r_associated #0: 10 / 0.052 -> en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
    n1=lorazépam | n2=en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine | rel=r_associated | relid=0 | w=10
  1234. lorazépam -- r_associated #0: 10 / 0.052 -> en:dendritic cell-precision multiple antigen t-lymphocytes
    n1=lorazépam | n2=en:dendritic cell-precision multiple antigen t-lymphocytes | rel=r_associated | relid=0 | w=10
  1235. lorazépam -- r_associated #0: 10 / 0.052 -> en:dendritic cell-targeting lentiviral vector id-lv305
    n1=lorazépam | n2=en:dendritic cell-targeting lentiviral vector id-lv305 | rel=r_associated | relid=0 | w=10
  1236. lorazépam -- r_associated #0: 10 / 0.052 -> en:denenicokin
    n1=lorazépam | n2=en:denenicokin | rel=r_associated | relid=0 | w=10
  1237. lorazépam -- r_associated #0: 10 / 0.052 -> en:denibulin hydrochloride
    n1=lorazépam | n2=en:denibulin hydrochloride | rel=r_associated | relid=0 | w=10
  1238. lorazépam -- r_associated #0: 10 / 0.052 -> en:denileukin diftitox
    n1=lorazépam | n2=en:denileukin diftitox | rel=r_associated | relid=0 | w=10
  1239. lorazépam -- r_associated #0: 10 / 0.052 -> en:denosumab
    n1=lorazépam | n2=en:denosumab | rel=r_associated | relid=0 | w=10
  1240. lorazépam -- r_associated #0: 10 / 0.052 -> en:depatuxizumab
    n1=lorazépam | n2=en:depatuxizumab | rel=r_associated | relid=0 | w=10
  1241. lorazépam -- r_associated #0: 10 / 0.052 -> en:depdc1/mphosh1 peptide vaccine
    n1=lorazépam | n2=en:depdc1/mphosh1 peptide vaccine | rel=r_associated | relid=0 | w=10
  1242. lorazépam -- r_associated #0: 10 / 0.052 -> en:desmopressin acetate
    n1=lorazépam | n2=en:desmopressin acetate | rel=r_associated | relid=0 | w=10
  1243. lorazépam -- r_associated #0: 10 / 0.052 -> en:desoxydemoxepam
    n1=lorazépam | n2=en:desoxydemoxepam | rel=r_associated | relid=0 | w=10
  1244. lorazépam -- r_associated #0: 10 / 0.052 -> en:detorubicin
    n1=lorazépam | n2=en:detorubicin | rel=r_associated | relid=0 | w=10
  1245. lorazépam -- r_associated #0: 10 / 0.052 -> en:devazepide
    n1=lorazépam | n2=en:devazepide | rel=r_associated | relid=0 | w=10
  1246. lorazépam -- r_associated #0: 10 / 0.052 -> en:dextran
    n1=lorazépam | n2=en:dextran | rel=r_associated | relid=0 | w=10
  1247. lorazépam -- r_associated #0: 10 / 0.052 -> en:dextroamphetamine-amphetamine
    n1=lorazépam | n2=en:dextroamphetamine-amphetamine | rel=r_associated | relid=0 | w=10
  1248. lorazépam -- r_associated #0: 10 / 0.052 -> en:dextromethorphan hydrobromide
    n1=lorazépam | n2=en:dextromethorphan hydrobromide | rel=r_associated | relid=0 | w=10
  1249. lorazépam -- r_associated #0: 10 / 0.052 -> en:dezaguanine
    n1=lorazépam | n2=en:dezaguanine | rel=r_associated | relid=0 | w=10
  1250. lorazépam -- r_associated #0: 10 / 0.052 -> en:dha-paclitaxel
    n1=lorazépam | n2=en:dha-paclitaxel | rel=r_associated | relid=0 | w=10
  1251. lorazépam -- r_associated #0: 10 / 0.052 -> en:dhap regimen
    n1=lorazépam | n2=en:dhap regimen | rel=r_associated | relid=0 | w=10
  1252. lorazépam -- r_associated #0: 10 / 0.052 -> en:dher2 vaccine+as15 adjuvant
    n1=lorazépam | n2=en:dher2 vaccine+as15 adjuvant | rel=r_associated | relid=0 | w=10
  1253. lorazépam -- r_associated #0: 10 / 0.052 -> en:di-leu16-il2 immunocytokine
    n1=lorazépam | n2=en:di-leu16-il2 immunocytokine | rel=r_associated | relid=0 | w=10
  1254. lorazépam -- r_associated #0: 10 / 0.052 -> en:dianhydrogalactitol
    n1=lorazépam | n2=en:dianhydrogalactitol | rel=r_associated | relid=0 | w=10
  1255. lorazépam -- r_associated #0: 10 / 0.052 -> en:diaziquone
    n1=lorazépam | n2=en:diaziquone | rel=r_associated | relid=0 | w=10
  1256. lorazépam -- r_associated #0: 10 / 0.052 -> en:dichloromethotrexate
    n1=lorazépam | n2=en:dichloromethotrexate | rel=r_associated | relid=0 | w=10
  1257. lorazépam -- r_associated #0: 10 / 0.052 -> en:dicumarol
    n1=lorazépam | n2=en:dicumarol | rel=r_associated | relid=0 | w=10
  1258. lorazépam -- r_associated #0: 10 / 0.052 -> en:didox
    n1=lorazépam | n2=en:didox | rel=r_associated | relid=0 | w=10
  1259. lorazépam -- r_associated #0: 10 / 0.052 -> en:dienogest
    n1=lorazépam | n2=en:dienogest | rel=r_associated | relid=0 | w=10
  1260. lorazépam -- r_associated #0: 10 / 0.052 -> en:diethylstilbestrol
    n1=lorazépam | n2=en:diethylstilbestrol | rel=r_associated | relid=0 | w=10
  1261. lorazépam -- r_associated #0: 10 / 0.052 -> en:diflomotecan
    n1=lorazépam | n2=en:diflomotecan | rel=r_associated | relid=0 | w=10
  1262. lorazépam -- r_associated #0: 10 / 0.052 -> en:digitoxin
    n1=lorazépam | n2=en:digitoxin | rel=r_associated | relid=0 | w=10
  1263. lorazépam -- r_associated #0: 10 / 0.052 -> en:dihydro-5-azacytidine
    n1=lorazépam | n2=en:dihydro-5-azacytidine | rel=r_associated | relid=0 | w=10
  1264. lorazépam -- r_associated #0: 10 / 0.052 -> en:diindolylmethane
    n1=lorazépam | n2=en:diindolylmethane | rel=r_associated | relid=0 | w=10
  1265. lorazépam -- r_associated #0: 10 / 0.052 -> en:dimethyl sulfoxide
    n1=lorazépam | n2=en:dimethyl sulfoxide | rel=r_associated | relid=0 | w=10
  1266. lorazépam -- r_associated #0: 10 / 0.052 -> en:dimethylmyleran
    n1=lorazépam | n2=en:dimethylmyleran | rel=r_associated | relid=0 | w=10
  1267. lorazépam -- r_associated #0: 10 / 0.052 -> en:dinaciclib
    n1=lorazépam | n2=en:dinaciclib | rel=r_associated | relid=0 | w=10
  1268. lorazépam -- r_associated #0: 10 / 0.052 -> en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine
    n1=lorazépam | n2=en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine | rel=r_associated | relid=0 | w=10
  1269. lorazépam -- r_associated #0: 10 / 0.052 -> en:diphenhydramine
    n1=lorazépam | n2=en:diphenhydramine | rel=r_associated | relid=0 | w=10
  1270. lorazépam -- r_associated #0: 10 / 0.052 -> en:diphenhydramine hydrochloride
    n1=lorazépam | n2=en:diphenhydramine hydrochloride | rel=r_associated | relid=0 | w=10
  1271. lorazépam -- r_associated #0: 10 / 0.052 -> en:diphtheria toxin fragment-interleukin-2 fusion protein e7777
    n1=lorazépam | n2=en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 | rel=r_associated | relid=0 | w=10
  1272. lorazépam -- r_associated #0: 10 / 0.052 -> en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed
    n1=lorazépam | n2=en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed | rel=r_associated | relid=0 | w=10
  1273. lorazépam -- r_associated #0: 10 / 0.052 -> en:distilled water
    n1=lorazépam | n2=en:distilled water | rel=r_associated | relid=0 | w=10
  1274. lorazépam -- r_associated #0: 10 / 0.052 -> en:divaplon
    n1=lorazépam | n2=en:divaplon | rel=r_associated | relid=0 | w=10
  1275. lorazépam -- r_associated #0: 10 / 0.052 -> en:dkk1-neutralizing monoclonal antibody dkn-01
    n1=lorazépam | n2=en:dkk1-neutralizing monoclonal antibody dkn-01 | rel=r_associated | relid=0 | w=10
  1276. lorazépam -- r_associated #0: 10 / 0.052 -> en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
    n1=lorazépam | n2=en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1277. lorazépam -- r_associated #0: 10 / 0.052 -> en:dm4-conjugated anti-cripto monoclonal antibody biib015
    n1=lorazépam | n2=en:dm4-conjugated anti-cripto monoclonal antibody biib015 | rel=r_associated | relid=0 | w=10
  1278. lorazépam -- r_associated #0: 10 / 0.052 -> en:dmuc4064a
    n1=lorazépam | n2=en:dmuc4064a | rel=r_associated | relid=0 | w=10
  1279. lorazépam -- r_associated #0: 10 / 0.052 -> en:dn-101
    n1=lorazépam | n2=en:dn-101 | rel=r_associated | relid=0 | w=10
  1280. lorazépam -- r_associated #0: 10 / 0.052 -> en:dna interference oligonucleotide pnt2258
    n1=lorazépam | n2=en:dna interference oligonucleotide pnt2258 | rel=r_associated | relid=0 | w=10
  1281. lorazépam -- r_associated #0: 10 / 0.052 -> en:dna minor groove binding agent pm060184
    n1=lorazépam | n2=en:dna minor groove binding agent pm060184 | rel=r_associated | relid=0 | w=10
  1282. lorazépam -- r_associated #0: 10 / 0.052 -> en:dna minor groove binding agent sg2000
    n1=lorazépam | n2=en:dna minor groove binding agent sg2000 | rel=r_associated | relid=0 | w=10
  1283. lorazépam -- r_associated #0: 10 / 0.052 -> en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112
    n1=lorazépam | n2=en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 | rel=r_associated | relid=0 | w=10
  1284. lorazépam -- r_associated #0: 10 / 0.052 -> en:dna-pk inhibitor msc2490484a
    n1=lorazépam | n2=en:dna-pk inhibitor msc2490484a | rel=r_associated | relid=0 | w=10
  1285. lorazépam -- r_associated #0: 10 / 0.052 -> en:dna-pk/tor kinase inhibitor cc-115
    n1=lorazépam | n2=en:dna-pk/tor kinase inhibitor cc-115 | rel=r_associated | relid=0 | w=10
  1286. lorazépam -- r_associated #0: 10 / 0.052 -> en:dobutamine
    n1=lorazépam | n2=en:dobutamine | rel=r_associated | relid=0 | w=10
  1287. lorazépam -- r_associated #0: 10 / 0.052 -> en:docetaxel emulsion anx-514
    n1=lorazépam | n2=en:docetaxel emulsion anx-514 | rel=r_associated | relid=0 | w=10
  1288. lorazépam -- r_associated #0: 10 / 0.052 -> en:docetaxel formulation ckd-810
    n1=lorazépam | n2=en:docetaxel formulation ckd-810 | rel=r_associated | relid=0 | w=10
  1289. lorazépam -- r_associated #0: 10 / 0.052 -> en:docetaxel lipid microspheres
    n1=lorazépam | n2=en:docetaxel lipid microspheres | rel=r_associated | relid=0 | w=10
  1290. lorazépam -- r_associated #0: 10 / 0.052 -> en:docetaxel-loaded nanopharmaceutical crlx301
    n1=lorazépam | n2=en:docetaxel-loaded nanopharmaceutical crlx301 | rel=r_associated | relid=0 | w=10
  1291. lorazépam -- r_associated #0: 10 / 0.052 -> en:doconexent
    n1=lorazépam | n2=en:doconexent | rel=r_associated | relid=0 | w=10
  1292. lorazépam -- r_associated #0: 10 / 0.052 -> en:docosahexaenoic acid
    n1=lorazépam | n2=en:docosahexaenoic acid | rel=r_associated | relid=0 | w=10
  1293. lorazépam -- r_associated #0: 10 / 0.052 -> en:docusate
    n1=lorazépam | n2=en:docusate | rel=r_associated | relid=0 | w=10
  1294. lorazépam -- r_associated #0: 10 / 0.052 -> en:dolastatin 10
    n1=lorazépam | n2=en:dolastatin 10 | rel=r_associated | relid=0 | w=10
  1295. lorazépam -- r_associated #0: 10 / 0.052 -> en:donafenib
    n1=lorazépam | n2=en:donafenib | rel=r_associated | relid=0 | w=10
  1296. lorazépam -- r_associated #0: 10 / 0.052 -> en:donepezil + memantine
    n1=lorazépam | n2=en:donepezil + memantine | rel=r_associated | relid=0 | w=10
  1297. lorazépam -- r_associated #0: 10 / 0.052 -> en:donor lymphocytes
    n1=lorazépam | n2=en:donor lymphocytes | rel=r_associated | relid=0 | w=10
  1298. lorazépam -- r_associated #0: 10 / 0.052 -> en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes
    n1=lorazépam | n2=en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes | rel=r_associated | relid=0 | w=10
  1299. lorazépam -- r_associated #0: 10 / 0.052 -> en:dopamine-somatostatin chimeric molecule bim-23a760
    n1=lorazépam | n2=en:dopamine-somatostatin chimeric molecule bim-23a760 | rel=r_associated | relid=0 | w=10
  1300. lorazépam -- r_associated #0: 10 / 0.052 -> en:dornase alfa
    n1=lorazépam | n2=en:dornase alfa | rel=r_associated | relid=0 | w=10
  1301. lorazépam -- r_associated #0: 10 / 0.052 -> en:dotap:cholesterol-fus1 liposome complex
    n1=lorazépam | n2=en:dotap:cholesterol-fus1 liposome complex | rel=r_associated | relid=0 | w=10
  1302. lorazépam -- r_associated #0: 10 / 0.052 -> en:dovitinib lactate
    n1=lorazépam | n2=en:dovitinib lactate | rel=r_associated | relid=0 | w=10
  1303. lorazépam -- r_associated #0: 10 / 0.052 -> en:doxefazepam
    n1=lorazépam | n2=en:doxefazepam | rel=r_associated | relid=0 | w=10
  1304. lorazépam -- r_associated #0: 10 / 0.052 -> en:doxercalciferol
    n1=lorazépam | n2=en:doxercalciferol | rel=r_associated | relid=0 | w=10
  1305. lorazépam -- r_associated #0: 10 / 0.052 -> en:doxorubicin hydrochloride
    n1=lorazépam | n2=en:doxorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  1306. lorazépam -- r_associated #0: 10 / 0.052 -> en:doxorubicin-hpma conjugate
    n1=lorazépam | n2=en:doxorubicin-hpma conjugate | rel=r_associated | relid=0 | w=10
  1307. lorazépam -- r_associated #0: 10 / 0.052 -> en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine
    n1=lorazépam | n2=en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine | rel=r_associated | relid=0 | w=10
  1308. lorazépam -- r_associated #0: 10 / 0.052 -> en:dr5-targeting tetrameric nanobody agonist tas266
    n1=lorazépam | n2=en:dr5-targeting tetrameric nanobody agonist tas266 | rel=r_associated | relid=0 | w=10
  1309. lorazépam -- r_associated #0: 10 / 0.052 -> en:dronabinol
    n1=lorazépam | n2=en:dronabinol | rel=r_associated | relid=0 | w=10
  1310. lorazépam -- r_associated #0: 10 / 0.052 -> en:dronabinol 2.5mg capsule
    n1=lorazépam | n2=en:dronabinol 2.5mg capsule | rel=r_associated | relid=0 | w=10
  1311. lorazépam -- r_associated #0: 10 / 0.052 -> en:drotrecogin alfa (activated)
    n1=lorazépam | n2=en:drotrecogin alfa (activated) | rel=r_associated | relid=0 | w=10
  1312. lorazépam -- r_associated #0: 10 / 0.052 -> en:drug allergy
    n1=lorazépam | n2=en:drug allergy | rel=r_associated | relid=0 | w=10
  1313. lorazépam -- r_associated #0: 10 / 0.052 -> en:drug products by fda established pharmacologic class
    n1=lorazépam | n2=en:drug products by fda established pharmacologic class | rel=r_associated | relid=0 | w=10
  1314. lorazépam -- r_associated #0: 10 / 0.052 -> en:drug products by va class
    n1=lorazépam | n2=en:drug products by va class | rel=r_associated | relid=0 | w=10
  1315. lorazépam -- r_associated #0: 10 / 0.052 -> en:drugs, chinese herbal
    n1=lorazépam | n2=en:drugs, chinese herbal | rel=r_associated | relid=0 | w=10
  1316. lorazépam -- r_associated #0: 10 / 0.052 -> en:dt(388)il3 fusion protein sl-401
    n1=lorazépam | n2=en:dt(388)il3 fusion protein sl-401 | rel=r_associated | relid=0 | w=10
  1317. lorazépam -- r_associated #0: 10 / 0.052 -> en:dta-h19 plasmid
    n1=lorazépam | n2=en:dta-h19 plasmid | rel=r_associated | relid=0 | w=10
  1318. lorazépam -- r_associated #0: 10 / 0.052 -> en:dual igf-1r/insr inhibitor bms-754807
    n1=lorazépam | n2=en:dual igf-1r/insr inhibitor bms-754807 | rel=r_associated | relid=0 | w=10
  1319. lorazépam -- r_associated #0: 10 / 0.052 -> en:dual pi3 kinase/mtor inhibitor gdc-0980
    n1=lorazépam | n2=en:dual pi3 kinase/mtor inhibitor gdc-0980 | rel=r_associated | relid=0 | w=10
  1320. lorazépam -- r_associated #0: 10 / 0.052 -> en:dual variable domain immunoglobulin abt-165
    n1=lorazépam | n2=en:dual variable domain immunoglobulin abt-165 | rel=r_associated | relid=0 | w=10
  1321. lorazépam -- r_associated #0: 10 / 0.052 -> en:duborimycin
    n1=lorazépam | n2=en:duborimycin | rel=r_associated | relid=0 | w=10
  1322. lorazépam -- r_associated #0: 10 / 0.052 -> en:dulanermin
    n1=lorazépam | n2=en:dulanermin | rel=r_associated | relid=0 | w=10
  1323. lorazépam -- r_associated #0: 10 / 0.052 -> en:duligotuzumab
    n1=lorazépam | n2=en:duligotuzumab | rel=r_associated | relid=0 | w=10
  1324. lorazépam -- r_associated #0: 10 / 0.052 -> en:durvalumab
    n1=lorazépam | n2=en:durvalumab | rel=r_associated | relid=0 | w=10
  1325. lorazépam -- r_associated #0: 10 / 0.052 -> en:dutasteride
    n1=lorazépam | n2=en:dutasteride | rel=r_associated | relid=0 | w=10
  1326. lorazépam -- r_associated #0: 10 / 0.052 -> en:e-selectin antagonist gmi-1271
    n1=lorazépam | n2=en:e-selectin antagonist gmi-1271 | rel=r_associated | relid=0 | w=10
  1327. lorazépam -- r_associated #0: 10 / 0.052 -> en:e-z scrub
    n1=lorazépam | n2=en:e-z scrub | rel=r_associated | relid=0 | w=10
  1328. lorazépam -- r_associated #0: 10 / 0.052 -> en:e1a lipid complex
    n1=lorazépam | n2=en:e1a lipid complex | rel=r_associated | relid=0 | w=10
  1329. lorazépam -- r_associated #0: 10 / 0.052 -> en:e1m184v peptide vaccine
    n1=lorazépam | n2=en:e1m184v peptide vaccine | rel=r_associated | relid=0 | w=10
  1330. lorazépam -- r_associated #0: 10 / 0.052 -> en:e7820
    n1=lorazépam | n2=en:e7820 | rel=r_associated | relid=0 | w=10
  1331. lorazépam -- r_associated #0: 10 / 0.052 -> en:east indian sandalwood oil mouth rinse
    n1=lorazépam | n2=en:east indian sandalwood oil mouth rinse | rel=r_associated | relid=0 | w=10
  1332. lorazépam -- r_associated #0: 10 / 0.052 -> en:ebselen-containing oral capsule spi-1005
    n1=lorazépam | n2=en:ebselen-containing oral capsule spi-1005 | rel=r_associated | relid=0 | w=10
  1333. lorazépam -- r_associated #0: 10 / 0.052 -> en:echinomycin
    n1=lorazépam | n2=en:echinomycin | rel=r_associated | relid=0 | w=10
  1334. lorazépam -- r_associated #0: 10 / 0.052 -> en:ecromeximab
    n1=lorazépam | n2=en:ecromeximab | rel=r_associated | relid=0 | w=10
  1335. lorazépam -- r_associated #0: 10 / 0.052 -> en:eculizumab
    n1=lorazépam | n2=en:eculizumab | rel=r_associated | relid=0 | w=10
  1336. lorazépam -- r_associated #0: 10 / 0.052 -> en:edelfosine
    n1=lorazépam | n2=en:edelfosine | rel=r_associated | relid=0 | w=10
  1337. lorazépam -- r_associated #0: 10 / 0.052 -> en:edetate calcium disodium
    n1=lorazépam | n2=en:edetate calcium disodium | rel=r_associated | relid=0 | w=10
  1338. lorazépam -- r_associated #0: 10 / 0.052 -> en:edotecarin
    n1=lorazépam | n2=en:edotecarin | rel=r_associated | relid=0 | w=10
  1339. lorazépam -- r_associated #0: 10 / 0.052 -> en:edrecolomab
    n1=lorazépam | n2=en:edrecolomab | rel=r_associated | relid=0 | w=10
  1340. lorazépam -- r_associated #0: 10 / 0.052 -> en:efatutazone dihydrochloride
    n1=lorazépam | n2=en:efatutazone dihydrochloride | rel=r_associated | relid=0 | w=10
  1341. lorazépam -- r_associated #0: 10 / 0.052 -> en:eg5 kinesin-related motor protein inhibitor 4sc-205
    n1=lorazépam | n2=en:eg5 kinesin-related motor protein inhibitor 4sc-205 | rel=r_associated | relid=0 | w=10
  1342. lorazépam -- r_associated #0: 10 / 0.052 -> en:eg5 kinesin-related motor protein inhibitor arq 621
    n1=lorazépam | n2=en:eg5 kinesin-related motor protein inhibitor arq 621 | rel=r_associated | relid=0 | w=10
  1343. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr antagonist hemay022
    n1=lorazépam | n2=en:egfr antagonist hemay022 | rel=r_associated | relid=0 | w=10
  1344. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr antisense dna
    n1=lorazépam | n2=en:egfr antisense dna | rel=r_associated | relid=0 | w=10
  1345. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=lorazépam | n2=en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1346. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr inhibitor abt-414
    n1=lorazépam | n2=en:egfr inhibitor abt-414 | rel=r_associated | relid=0 | w=10
  1347. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr inhibitor asp8273
    n1=lorazépam | n2=en:egfr inhibitor asp8273 | rel=r_associated | relid=0 | w=10
  1348. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr inhibitor azd3759
    n1=lorazépam | n2=en:egfr inhibitor azd3759 | rel=r_associated | relid=0 | w=10
  1349. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr inhibitor hm61713
    n1=lorazépam | n2=en:egfr inhibitor hm61713 | rel=r_associated | relid=0 | w=10
  1350. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr t790m inhibitor pf-06747775
    n1=lorazépam | n2=en:egfr t790m inhibitor pf-06747775 | rel=r_associated | relid=0 | w=10
  1351. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr/her2 inhibitor ap32788
    n1=lorazépam | n2=en:egfr/her2 inhibitor ap32788 | rel=r_associated | relid=0 | w=10
  1352. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr/her2 inhibitor av-412
    n1=lorazépam | n2=en:egfr/her2 inhibitor av-412 | rel=r_associated | relid=0 | w=10
  1353. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfr/her2 kinase inhibitor tak-285
    n1=lorazépam | n2=en:egfr/her2 kinase inhibitor tak-285 | rel=r_associated | relid=0 | w=10
  1354. lorazépam -- r_associated #0: 10 / 0.052 -> en:egfrviii-specific car-transduced autologous t lymphocytes
    n1=lorazépam | n2=en:egfrviii-specific car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  1355. lorazépam -- r_associated #0: 10 / 0.052 -> en:eicosapentaenoic acid
    n1=lorazépam | n2=en:eicosapentaenoic acid | rel=r_associated | relid=0 | w=10
  1356. lorazépam -- r_associated #0: 10 / 0.052 -> en:eicosapentaenoic acid-enriched nutritional supplement
    n1=lorazépam | n2=en:eicosapentaenoic acid-enriched nutritional supplement | rel=r_associated | relid=0 | w=10
  1357. lorazépam -- r_associated #0: 10 / 0.052 -> en:eif4e antisense oligonucleotide isis 183750
    n1=lorazépam | n2=en:eif4e antisense oligonucleotide isis 183750 | rel=r_associated | relid=0 | w=10
  1358. lorazépam -- r_associated #0: 10 / 0.052 -> en:elacytarabine
    n1=lorazépam | n2=en:elacytarabine | rel=r_associated | relid=0 | w=10
  1359. lorazépam -- r_associated #0: 10 / 0.052 -> en:electrolyte-free parenteral nutrition emulsion
    n1=lorazépam | n2=en:electrolyte-free parenteral nutrition emulsion | rel=r_associated | relid=0 | w=10
  1360. lorazépam -- r_associated #0: 10 / 0.052 -> en:elesclomol
    n1=lorazépam | n2=en:elesclomol | rel=r_associated | relid=0 | w=10
  1361. lorazépam -- r_associated #0: 10 / 0.052 -> en:elesclomol sodium
    n1=lorazépam | n2=en:elesclomol sodium | rel=r_associated | relid=0 | w=10
  1362. lorazépam -- r_associated #0: 10 / 0.052 -> en:elinafide
    n1=lorazépam | n2=en:elinafide | rel=r_associated | relid=0 | w=10
  1363. lorazépam -- r_associated #0: 10 / 0.052 -> en:ellagic acid/annona muricata supplement
    n1=lorazépam | n2=en:ellagic acid/annona muricata supplement | rel=r_associated | relid=0 | w=10
  1364. lorazépam -- r_associated #0: 10 / 0.052 -> en:elliptinium acetate
    n1=lorazépam | n2=en:elliptinium acetate | rel=r_associated | relid=0 | w=10
  1365. lorazépam -- r_associated #0: 10 / 0.052 -> en:elotuzumab
    n1=lorazépam | n2=en:elotuzumab | rel=r_associated | relid=0 | w=10
  1366. lorazépam -- r_associated #0: 10 / 0.052 -> en:elsamitrucin
    n1=lorazépam | n2=en:elsamitrucin | rel=r_associated | relid=0 | w=10
  1367. lorazépam -- r_associated #0: 10 / 0.052 -> en:eltrombopag olamine
    n1=lorazépam | n2=en:eltrombopag olamine | rel=r_associated | relid=0 | w=10
  1368. lorazépam -- r_associated #0: 10 / 0.052 -> en:emepepimut-s
    n1=lorazépam | n2=en:emepepimut-s | rel=r_associated | relid=0 | w=10
  1369. lorazépam -- r_associated #0: 10 / 0.052 -> en:emitefur
    n1=lorazépam | n2=en:emitefur | rel=r_associated | relid=0 | w=10
  1370. lorazépam -- r_associated #0: 10 / 0.052 -> en:emricasan
    n1=lorazépam | n2=en:emricasan | rel=r_associated | relid=0 | w=10
  1371. lorazépam -- r_associated #0: 10 / 0.052 -> en:emtricitabine
    n1=lorazépam | n2=en:emtricitabine | rel=r_associated | relid=0 | w=10
  1372. lorazépam -- r_associated #0: 10 / 0.052 -> en:enadenotucirev
    n1=lorazépam | n2=en:enadenotucirev | rel=r_associated | relid=0 | w=10
  1373. lorazépam -- r_associated #0: 10 / 0.052 -> en:enavatuzumab
    n1=lorazépam | n2=en:enavatuzumab | rel=r_associated | relid=0 | w=10
  1374. lorazépam -- r_associated #0: 10 / 0.052 -> en:ensituximab
    n1=lorazépam | n2=en:ensituximab | rel=r_associated | relid=0 | w=10
  1375. lorazépam -- r_associated #0: 10 / 0.052 -> en:entecavir
    n1=lorazépam | n2=en:entecavir | rel=r_associated | relid=0 | w=10
  1376. lorazépam -- r_associated #0: 10 / 0.052 -> en:enteric-coated trpm8 agonist d-3263 hydrochloride
    n1=lorazépam | n2=en:enteric-coated trpm8 agonist d-3263 hydrochloride | rel=r_associated | relid=0 | w=10
  1377. lorazépam -- r_associated #0: 10 / 0.052 -> en:entinostat
    n1=lorazépam | n2=en:entinostat | rel=r_associated | relid=0 | w=10
  1378. lorazépam -- r_associated #0: 10 / 0.052 -> en:entolimod
    n1=lorazépam | n2=en:entolimod | rel=r_associated | relid=0 | w=10
  1379. lorazépam -- r_associated #0: 10 / 0.052 -> en:enzalutamide
    n1=lorazépam | n2=en:enzalutamide | rel=r_associated | relid=0 | w=10
  1380. lorazépam -- r_associated #0: 10 / 0.052 -> en:enzastaurin hydrochloride
    n1=lorazépam | n2=en:enzastaurin hydrochloride | rel=r_associated | relid=0 | w=10
  1381. lorazépam -- r_associated #0: 10 / 0.052 -> en:enzymatically-hydrolyzed whey protein-based nutritional supplement
    n1=lorazépam | n2=en:enzymatically-hydrolyzed whey protein-based nutritional supplement | rel=r_associated | relid=0 | w=10
  1382. lorazépam -- r_associated #0: 10 / 0.052 -> en:enzyme inhibitor
    n1=lorazépam | n2=en:enzyme inhibitor | rel=r_associated | relid=0 | w=10
  1383. lorazépam -- r_associated #0: 10 / 0.052 -> en:ep4 receptor antagonist aat-007
    n1=lorazépam | n2=en:ep4 receptor antagonist aat-007 | rel=r_associated | relid=0 | w=10
  1384. lorazépam -- r_associated #0: 10 / 0.052 -> en:epidermal growth factor ointment
    n1=lorazépam | n2=en:epidermal growth factor ointment | rel=r_associated | relid=0 | w=10
  1385. lorazépam -- r_associated #0: 10 / 0.052 -> en:eplerenone
    n1=lorazépam | n2=en:eplerenone | rel=r_associated | relid=0 | w=10
  1386. lorazépam -- r_associated #0: 10 / 0.052 -> en:epoetin alfa
    n1=lorazépam | n2=en:epoetin alfa | rel=r_associated | relid=0 | w=10
  1387. lorazépam -- r_associated #0: 10 / 0.052 -> en:epothilone analog utd1
    n1=lorazépam | n2=en:epothilone analog utd1 | rel=r_associated | relid=0 | w=10
  1388. lorazépam -- r_associated #0: 10 / 0.052 -> en:epratuzumab
    n1=lorazépam | n2=en:epratuzumab | rel=r_associated | relid=0 | w=10
  1389. lorazépam -- r_associated #0: 10 / 0.052 -> en:Epsom salt
    n1=lorazépam | n2=en:Epsom salt | rel=r_associated | relid=0 | w=10
  1390. lorazépam -- r_associated #0: 10 / 0.052 -> en:epsom salt
    n1=lorazépam | n2=en:epsom salt | rel=r_associated | relid=0 | w=10
  1391. lorazépam -- r_associated #0: 10 / 0.052 -> en:era36 modulator icaritin
    n1=lorazépam | n2=en:era36 modulator icaritin | rel=r_associated | relid=0 | w=10
  1392. lorazépam -- r_associated #0: 10 / 0.052 -> en:erastin analogue prlx 93936
    n1=lorazépam | n2=en:erastin analogue prlx 93936 | rel=r_associated | relid=0 | w=10
  1393. lorazépam -- r_associated #0: 10 / 0.052 -> en:erbb-2 inhibitor arry-380
    n1=lorazépam | n2=en:erbb-2 inhibitor arry-380 | rel=r_associated | relid=0 | w=10
  1394. lorazépam -- r_associated #0: 10 / 0.052 -> en:eritoran tetrasodium
    n1=lorazépam | n2=en:eritoran tetrasodium | rel=r_associated | relid=0 | w=10
  1395. lorazépam -- r_associated #0: 10 / 0.052 -> en:erk inhibitor cc-90003
    n1=lorazépam | n2=en:erk inhibitor cc-90003 | rel=r_associated | relid=0 | w=10
  1396. lorazépam -- r_associated #0: 10 / 0.052 -> en:erk inhibitor gdc-0994
    n1=lorazépam | n2=en:erk inhibitor gdc-0994 | rel=r_associated | relid=0 | w=10
  1397. lorazépam -- r_associated #0: 10 / 0.052 -> en:erk inhibitor ltt462
    n1=lorazépam | n2=en:erk inhibitor ltt462 | rel=r_associated | relid=0 | w=10
  1398. lorazépam -- r_associated #0: 10 / 0.052 -> en:erk inhibitor mk-8353
    n1=lorazépam | n2=en:erk inhibitor mk-8353 | rel=r_associated | relid=0 | w=10
  1399. lorazépam -- r_associated #0: 10 / 0.052 -> en:estazolam
    n1=lorazépam | n2=en:estazolam | rel=r_associated | relid=0 | w=10
  1400. lorazépam -- r_associated #0: 10 / 0.052 -> en:estradiol/norethindrone acetate tablet
    n1=lorazépam | n2=en:estradiol/norethindrone acetate tablet | rel=r_associated | relid=0 | w=10
  1401. lorazépam -- r_associated #0: 10 / 0.052 -> en:estriol vaginal gel
    n1=lorazépam | n2=en:estriol vaginal gel | rel=r_associated | relid=0 | w=10
  1402. lorazépam -- r_associated #0: 10 / 0.052 -> en:eszopiclone
    n1=lorazépam | n2=en:eszopiclone | rel=r_associated | relid=0 | w=10
  1403. lorazépam -- r_associated #0: 10 / 0.052 -> en:etaracizumab
    n1=lorazépam | n2=en:etaracizumab | rel=r_associated | relid=0 | w=10
  1404. lorazépam -- r_associated #0: 10 / 0.052 -> en:ethaselen
    n1=lorazépam | n2=en:ethaselen | rel=r_associated | relid=0 | w=10
  1405. lorazépam -- r_associated #0: 10 / 0.052 -> en:ethinyl estradiol
    n1=lorazépam | n2=en:ethinyl estradiol | rel=r_associated | relid=0 | w=10
  1406. lorazépam -- r_associated #0: 10 / 0.052 -> en:ethosuximide
    n1=lorazépam | n2=en:ethosuximide | rel=r_associated | relid=0 | w=10
  1407. lorazépam -- r_associated #0: 10 / 0.052 -> en:ethylchlorformate vaccine
    n1=lorazépam | n2=en:ethylchlorformate vaccine | rel=r_associated | relid=0 | w=10
  1408. lorazépam -- r_associated #0: 10 / 0.052 -> en:etizolam
    n1=lorazépam | n2=en:etizolam | rel=r_associated | relid=0 | w=10
  1409. lorazépam -- r_associated #0: 10 / 0.052 -> en:etoperidone hydrochloride
    n1=lorazépam | n2=en:etoperidone hydrochloride | rel=r_associated | relid=0 | w=10
  1410. lorazépam -- r_associated #0: 10 / 0.052 -> en:etoricoxib
    n1=lorazépam | n2=en:etoricoxib | rel=r_associated | relid=0 | w=10
  1411. lorazépam -- r_associated #0: 10 / 0.052 -> en:everolimus
    n1=lorazépam | n2=en:everolimus | rel=r_associated | relid=0 | w=10
  1412. lorazépam -- r_associated #0: 10 / 0.052 -> en:ex vivo-expanded her2-specific t cells
    n1=lorazépam | n2=en:ex vivo-expanded her2-specific t cells | rel=r_associated | relid=0 | w=10
  1413. lorazépam -- r_associated #0: 10 / 0.052 -> en:exemestane
    n1=lorazépam | n2=en:exemestane | rel=r_associated | relid=0 | w=10
  1414. lorazépam -- r_associated #0: 10 / 0.052 -> en:exenatide
    n1=lorazépam | n2=en:exenatide | rel=r_associated | relid=0 | w=10
  1415. lorazépam -- r_associated #0: 10 / 0.052 -> en:exposure as collected domain
    n1=lorazépam | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=10
  1416. lorazépam -- r_associated #0: 10 / 0.052 -> en:extended release flucytosine
    n1=lorazépam | n2=en:extended release flucytosine | rel=r_associated | relid=0 | w=10
  1417. lorazépam -- r_associated #0: 10 / 0.052 -> en:ezatiostat hydrochloride
    n1=lorazépam | n2=en:ezatiostat hydrochloride | rel=r_associated | relid=0 | w=10
  1418. lorazépam -- r_associated #0: 10 / 0.052 -> en:ezetimibe
    n1=lorazépam | n2=en:ezetimibe | rel=r_associated | relid=0 | w=10
  1419. lorazépam -- r_associated #0: 10 / 0.052 -> en:ezetimibe/simvastatin
    n1=lorazépam | n2=en:ezetimibe/simvastatin | rel=r_associated | relid=0 | w=10
  1420. lorazépam -- r_associated #0: 10 / 0.052 -> en:f-18 fluoroethyltyrosine
    n1=lorazépam | n2=en:f-18 fluoroethyltyrosine | rel=r_associated | relid=0 | w=10
  1421. lorazépam -- r_associated #0: 10 / 0.052 -> en:f16-il2 fusion protein
    n1=lorazépam | n2=en:f16-il2 fusion protein | rel=r_associated | relid=0 | w=10
  1422. lorazépam -- r_associated #0: 10 / 0.052 -> en:factor viia inhibitor pci-27483
    n1=lorazépam | n2=en:factor viia inhibitor pci-27483 | rel=r_associated | relid=0 | w=10
  1423. lorazépam -- r_associated #0: 10 / 0.052 -> en:fak inhibitor gsk2256098
    n1=lorazépam | n2=en:fak inhibitor gsk2256098 | rel=r_associated | relid=0 | w=10
  1424. lorazépam -- r_associated #0: 10 / 0.052 -> en:fak inhibitor vs-4718
    n1=lorazépam | n2=en:fak inhibitor vs-4718 | rel=r_associated | relid=0 | w=10
  1425. lorazépam -- r_associated #0: 10 / 0.052 -> en:famitinib
    n1=lorazépam | n2=en:famitinib | rel=r_associated | relid=0 | w=10
  1426. lorazépam -- r_associated #0: 10 / 0.052 -> en:fap-specific cd8-positive t cells
    n1=lorazépam | n2=en:fap-specific cd8-positive t cells | rel=r_associated | relid=0 | w=10
  1427. lorazépam -- r_associated #0: 10 / 0.052 -> en:farletuzumab
    n1=lorazépam | n2=en:farletuzumab | rel=r_associated | relid=0 | w=10
  1428. lorazépam -- r_associated #0: 10 / 0.052 -> en:fas receptor agonist apo010
    n1=lorazépam | n2=en:fas receptor agonist apo010 | rel=r_associated | relid=0 | w=10
  1429. lorazépam -- r_associated #0: 10 / 0.052 -> en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111
    n1=lorazépam | n2=en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 | rel=r_associated | relid=0 | w=10
  1430. lorazépam -- r_associated #0: 10 / 0.052 -> en:fat emulsion
    n1=lorazépam | n2=en:fat emulsion | rel=r_associated | relid=0 | w=10
  1431. lorazépam -- r_associated #0: 10 / 0.052 -> en:fda established names and unique ingredient identifier codes terminology
    n1=lorazépam | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=10
  1432. lorazépam -- r_associated #0: 10 / 0.052 -> en:fenretinide lipid matrix
    n1=lorazépam | n2=en:fenretinide lipid matrix | rel=r_associated | relid=0 | w=10
  1433. lorazépam -- r_associated #0: 10 / 0.052 -> en:fermented wheat germ extract
    n1=lorazépam | n2=en:fermented wheat germ extract | rel=r_associated | relid=0 | w=10
  1434. lorazépam -- r_associated #0: 10 / 0.052 -> en:ferric carboxymaltose solution
    n1=lorazépam | n2=en:ferric carboxymaltose solution | rel=r_associated | relid=0 | w=10
  1435. lorazépam -- r_associated #0: 10 / 0.052 -> en:ferrous sulfate
    n1=lorazépam | n2=en:ferrous sulfate | rel=r_associated | relid=0 | w=10
  1436. lorazépam -- r_associated #0: 10 / 0.052 -> en:fgfr inhibitor asp5878
    n1=lorazépam | n2=en:fgfr inhibitor asp5878 | rel=r_associated | relid=0 | w=10
  1437. lorazépam -- r_associated #0: 10 / 0.052 -> en:fgfr inhibitor debio 1347
    n1=lorazépam | n2=en:fgfr inhibitor debio 1347 | rel=r_associated | relid=0 | w=10
  1438. lorazépam -- r_associated #0: 10 / 0.052 -> en:fgfr inhibitor incb054828
    n1=lorazépam | n2=en:fgfr inhibitor incb054828 | rel=r_associated | relid=0 | w=10
  1439. lorazépam -- r_associated #0: 10 / 0.052 -> en:fgfr inhibitor tas-120
    n1=lorazépam | n2=en:fgfr inhibitor tas-120 | rel=r_associated | relid=0 | w=10
  1440. lorazépam -- r_associated #0: 10 / 0.052 -> en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999
    n1=lorazépam | n2=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | rel=r_associated | relid=0 | w=10
  1441. lorazépam -- r_associated #0: 10 / 0.052 -> en:fibrin sealant
    n1=lorazépam | n2=en:fibrin sealant | rel=r_associated | relid=0 | w=10
  1442. lorazépam -- r_associated #0: 10 / 0.052 -> en:fidaxomicin
    n1=lorazépam | n2=en:fidaxomicin | rel=r_associated | relid=0 | w=10
  1443. lorazépam -- r_associated #0: 10 / 0.052 -> en:filgrastim
    n1=lorazépam | n2=en:filgrastim | rel=r_associated | relid=0 | w=10
  1444. lorazépam -- r_associated #0: 10 / 0.052 -> en:filgrastim-primed peripheral blood progenitor cells
    n1=lorazépam | n2=en:filgrastim-primed peripheral blood progenitor cells | rel=r_associated | relid=0 | w=10
  1445. lorazépam -- r_associated #0: 10 / 0.052 -> en:finasteride
    n1=lorazépam | n2=en:finasteride | rel=r_associated | relid=0 | w=10
  1446. lorazépam -- r_associated #0: 10 / 0.052 -> en:fingolimod hydrochloride
    n1=lorazépam | n2=en:fingolimod hydrochloride | rel=r_associated | relid=0 | w=10
  1447. lorazépam -- r_associated #0: 10 / 0.052 -> en:firtecan pegol
    n1=lorazépam | n2=en:firtecan pegol | rel=r_associated | relid=0 | w=10
  1448. lorazépam -- r_associated #0: 10 / 0.052 -> en:flaxseed
    n1=lorazépam | n2=en:flaxseed | rel=r_associated | relid=0 | w=10
  1449. lorazépam -- r_associated #0: 10 / 0.052 -> en:fletazepam
    n1=lorazépam | n2=en:fletazepam | rel=r_associated | relid=0 | w=10
  1450. lorazépam -- r_associated #0: 10 / 0.052 -> en:flt3/kit kinase inhibitor akn-028
    n1=lorazépam | n2=en:flt3/kit kinase inhibitor akn-028 | rel=r_associated | relid=0 | w=10
  1451. lorazépam -- r_associated #0: 10 / 0.052 -> en:flu matrix peptide p58-66
    n1=lorazépam | n2=en:flu matrix peptide p58-66 | rel=r_associated | relid=0 | w=10
  1452. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluciclatide f-18
    n1=lorazépam | n2=en:fluciclatide f-18 | rel=r_associated | relid=0 | w=10
  1453. lorazépam -- r_associated #0: 10 / 0.052 -> en:flucytosine
    n1=lorazépam | n2=en:flucytosine | rel=r_associated | relid=0 | w=10
  1454. lorazépam -- r_associated #0: 10 / 0.052 -> en:fludarabine phosphate
    n1=lorazépam | n2=en:fludarabine phosphate | rel=r_associated | relid=0 | w=10
  1455. lorazépam -- r_associated #0: 10 / 0.052 -> en:fludiazepam
    n1=lorazépam | n2=en:fludiazepam | rel=r_associated | relid=0 | w=10
  1456. lorazépam -- r_associated #0: 10 / 0.052 -> en:flumazenil
    n1=lorazépam | n2=en:flumazenil | rel=r_associated | relid=0 | w=10
  1457. lorazépam -- r_associated #0: 10 / 0.052 -> en:flumazénil
    n1=lorazépam | n2=en:flumazénil | rel=r_associated | relid=0 | w=10
  1458. lorazépam -- r_associated #0: 10 / 0.052 -> en:flunitrazepam
    n1=lorazépam | n2=en:flunitrazepam | rel=r_associated | relid=0 | w=10
  1459. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 5-fluoro-2-deoxycytidine
    n1=lorazépam | n2=en:fluorine f 18 5-fluoro-2-deoxycytidine | rel=r_associated | relid=0 | w=10
  1460. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 alfatide ii
    n1=lorazépam | n2=en:fluorine f 18 alfatide ii | rel=r_associated | relid=0 | w=10
  1461. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 choline
    n1=lorazépam | n2=en:fluorine f 18 choline | rel=r_associated | relid=0 | w=10
  1462. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 dcfpyl
    n1=lorazépam | n2=en:fluorine f 18 dcfpyl | rel=r_associated | relid=0 | w=10
  1463. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 ef5
    n1=lorazépam | n2=en:fluorine f 18 ef5 | rel=r_associated | relid=0 | w=10
  1464. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 feqa
    n1=lorazépam | n2=en:fluorine f 18 feqa | rel=r_associated | relid=0 | w=10
  1465. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 fmdht
    n1=lorazépam | n2=en:fluorine f 18 fmdht | rel=r_associated | relid=0 | w=10
  1466. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 galacto-rgd peptide
    n1=lorazépam | n2=en:fluorine f 18 galacto-rgd peptide | rel=r_associated | relid=0 | w=10
  1467. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18 sodium fluoride
    n1=lorazépam | n2=en:fluorine f 18 sodium fluoride | rel=r_associated | relid=0 | w=10
  1468. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f 18-av-133
    n1=lorazépam | n2=en:fluorine f 18-av-133 | rel=r_associated | relid=0 | w=10
  1469. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f-18 6-fluorodopamine
    n1=lorazépam | n2=en:fluorine f-18 6-fluorodopamine | rel=r_associated | relid=0 | w=10
  1470. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorine f-18 fluoropaclitaxel
    n1=lorazépam | n2=en:fluorine f-18 fluoropaclitaxel | rel=r_associated | relid=0 | w=10
  1471. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluorouracil
    n1=lorazépam | n2=en:fluorouracil | rel=r_associated | relid=0 | w=10
  1472. lorazépam -- r_associated #0: 10 / 0.052 -> en:flutazolam
    n1=lorazépam | n2=en:flutazolam | rel=r_associated | relid=0 | w=10
  1473. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluvastatin sodium
    n1=lorazépam | n2=en:fluvastatin sodium | rel=r_associated | relid=0 | w=10
  1474. lorazépam -- r_associated #0: 10 / 0.052 -> en:fluzoparib
    n1=lorazépam | n2=en:fluzoparib | rel=r_associated | relid=0 | w=10
  1475. lorazépam -- r_associated #0: 10 / 0.052 -> en:folate binding protein e39 peptide vaccine
    n1=lorazépam | n2=en:folate binding protein e39 peptide vaccine | rel=r_associated | relid=0 | w=10
  1476. lorazépam -- r_associated #0: 10 / 0.052 -> en:folate binding protein j65 peptide vaccine
    n1=lorazépam | n2=en:folate binding protein j65 peptide vaccine | rel=r_associated | relid=0 | w=10
  1477. lorazépam -- r_associated #0: 10 / 0.052 -> en:folate receptor-targeted tubulysin conjugate ec1456
    n1=lorazépam | n2=en:folate receptor-targeted tubulysin conjugate ec1456 | rel=r_associated | relid=0 | w=10
  1478. lorazépam -- r_associated #0: 10 / 0.052 -> en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225
    n1=lorazépam | n2=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | rel=r_associated | relid=0 | w=10
  1479. lorazépam -- r_associated #0: 10 / 0.052 -> en:foretinib
    n1=lorazépam | n2=en:foretinib | rel=r_associated | relid=0 | w=10
  1480. lorazépam -- r_associated #0: 10 / 0.052 -> en:fork wrench
    n1=lorazépam | n2=en:fork wrench | rel=r_associated | relid=0 | w=10
  1481. lorazépam -- r_associated #0: 10 / 0.052 -> en:form a pair with something
    n1=lorazépam | n2=en:form a pair with something | rel=r_associated | relid=0 | w=10
  1482. lorazépam -- r_associated #0: 10 / 0.052 -> en:fosazepam
    n1=lorazépam | n2=en:fosazepam | rel=r_associated | relid=0 | w=10
  1483. lorazépam -- r_associated #0: 10 / 0.052 -> en:fosbretabulin disodium
    n1=lorazépam | n2=en:fosbretabulin disodium | rel=r_associated | relid=0 | w=10
  1484. lorazépam -- r_associated #0: 10 / 0.052 -> en:fosbretabulin tromethamine
    n1=lorazépam | n2=en:fosbretabulin tromethamine | rel=r_associated | relid=0 | w=10
  1485. lorazépam -- r_associated #0: 10 / 0.052 -> en:fostriecin
    n1=lorazépam | n2=en:fostriecin | rel=r_associated | relid=0 | w=10
  1486. lorazépam -- r_associated #0: 10 / 0.052 -> en:fowlpox virus vaccine vector
    n1=lorazépam | n2=en:fowlpox virus vaccine vector | rel=r_associated | relid=0 | w=10
  1487. lorazépam -- r_associated #0: 10 / 0.052 -> en:fowlpox-ny-eso-1 vaccine
    n1=lorazépam | n2=en:fowlpox-ny-eso-1 vaccine | rel=r_associated | relid=0 | w=10
  1488. lorazépam -- r_associated #0: 10 / 0.052 -> en:fu-lv regimen
    n1=lorazépam | n2=en:fu-lv regimen | rel=r_associated | relid=0 | w=10
  1489. lorazépam -- r_associated #0: 10 / 0.052 -> en:fulvestrant
    n1=lorazépam | n2=en:fulvestrant | rel=r_associated | relid=0 | w=10
  1490. lorazépam -- r_associated #0: 10 / 0.052 -> en:g-quadruplex stabilizer bmvc
    n1=lorazépam | n2=en:g-quadruplex stabilizer bmvc | rel=r_associated | relid=0 | w=10
  1491. lorazépam -- r_associated #0: 10 / 0.052 -> en:g207
    n1=lorazépam | n2=en:g207 | rel=r_associated | relid=0 | w=10
  1492. lorazépam -- r_associated #0: 10 / 0.052 -> en:gabapentin
    n1=lorazépam | n2=en:gabapentin | rel=r_associated | relid=0 | w=10
  1493. lorazépam -- r_associated #0: 10 / 0.052 -> en:gabapentin enacarbil
    n1=lorazépam | n2=en:gabapentin enacarbil | rel=r_associated | relid=0 | w=10
  1494. lorazépam -- r_associated #0: 10 / 0.052 -> en:gadolinium-chelate
    n1=lorazépam | n2=en:gadolinium-chelate | rel=r_associated | relid=0 | w=10
  1495. lorazépam -- r_associated #0: 10 / 0.052 -> en:galactomannan derivative
    n1=lorazépam | n2=en:galactomannan derivative | rel=r_associated | relid=0 | w=10
  1496. lorazépam -- r_associated #0: 10 / 0.052 -> en:galectin inhibitor gr-md-02
    n1=lorazépam | n2=en:galectin inhibitor gr-md-02 | rel=r_associated | relid=0 | w=10
  1497. lorazépam -- r_associated #0: 10 / 0.052 -> en:galectin-1 inhibitor otx008
    n1=lorazépam | n2=en:galectin-1 inhibitor otx008 | rel=r_associated | relid=0 | w=10
  1498. lorazépam -- r_associated #0: 10 / 0.052 -> en:galeterone
    n1=lorazépam | n2=en:galeterone | rel=r_associated | relid=0 | w=10
  1499. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68 citrate
    n1=lorazépam | n2=en:gallium ga 68 citrate | rel=r_associated | relid=0 | w=10
  1500. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68 ops202
    n1=lorazépam | n2=en:gallium ga 68 ops202 | rel=r_associated | relid=0 | w=10
  1501. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68-dotatate
    n1=lorazépam | n2=en:gallium ga 68-dotatate | rel=r_associated | relid=0 | w=10
  1502. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68-labeled affibody aby-025
    n1=lorazépam | n2=en:gallium ga 68-labeled affibody aby-025 | rel=r_associated | relid=0 | w=10
  1503. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68-labeled psma-11
    n1=lorazépam | n2=en:gallium ga 68-labeled psma-11 | rel=r_associated | relid=0 | w=10
  1504. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68-labeled-nodaga-mj9
    n1=lorazépam | n2=en:gallium ga 68-labeled-nodaga-mj9 | rel=r_associated | relid=0 | w=10
  1505. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68-neb
    n1=lorazépam | n2=en:gallium ga 68-neb | rel=r_associated | relid=0 | w=10
  1506. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium ga 68-rgd
    n1=lorazépam | n2=en:gallium ga 68-rgd | rel=r_associated | relid=0 | w=10
  1507. lorazépam -- r_associated #0: 10 / 0.052 -> en:gallium maltolate
    n1=lorazépam | n2=en:gallium maltolate | rel=r_associated | relid=0 | w=10
  1508. lorazépam -- r_associated #0: 10 / 0.052 -> en:galunisertib
    n1=lorazépam | n2=en:galunisertib | rel=r_associated | relid=0 | w=10
  1509. lorazépam -- r_associated #0: 10 / 0.052 -> en:gamma secretase inhibitor pf-03084014
    n1=lorazépam | n2=en:gamma secretase inhibitor pf-03084014 | rel=r_associated | relid=0 | w=10
  1510. lorazépam -- r_associated #0: 10 / 0.052 -> en:gamma-secretase inhibitor ly3039478
    n1=lorazépam | n2=en:gamma-secretase inhibitor ly3039478 | rel=r_associated | relid=0 | w=10
  1511. lorazépam -- r_associated #0: 10 / 0.052 -> en:ganglioside gd2
    n1=lorazépam | n2=en:ganglioside gd2 | rel=r_associated | relid=0 | w=10
  1512. lorazépam -- r_associated #0: 10 / 0.052 -> en:ganitumab
    n1=lorazépam | n2=en:ganitumab | rel=r_associated | relid=0 | w=10
  1513. lorazépam -- r_associated #0: 10 / 0.052 -> en:garlic extract
    n1=lorazépam | n2=en:garlic extract | rel=r_associated | relid=0 | w=10
  1514. lorazépam -- r_associated #0: 10 / 0.052 -> en:gastrin immunotoxin
    n1=lorazépam | n2=en:gastrin immunotoxin | rel=r_associated | relid=0 | w=10
  1515. lorazépam -- r_associated #0: 10 / 0.052 -> en:gastroenteral dosage form product
    n1=lorazépam | n2=en:gastroenteral dosage form product | rel=r_associated | relid=0 | w=10
  1516. lorazépam -- r_associated #0: 10 / 0.052 -> en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine
    n1=lorazépam | n2=en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine | rel=r_associated | relid=0 | w=10
  1517. lorazépam -- r_associated #0: 10 / 0.052 -> en:gd2-car-expressing autologous t-lymphocytes
    n1=lorazépam | n2=en:gd2-car-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1518. lorazépam -- r_associated #0: 10 / 0.052 -> en:gd2-klh vaccine
    n1=lorazépam | n2=en:gd2-klh vaccine | rel=r_associated | relid=0 | w=10
  1519. lorazépam -- r_associated #0: 10 / 0.052 -> en:gel protein, gelonium multiflorum
    n1=lorazépam | n2=en:gel protein, gelonium multiflorum | rel=r_associated | relid=0 | w=10
  1520. lorazépam -- r_associated #0: 10 / 0.052 -> en:gelatin sponge, absorbable
    n1=lorazépam | n2=en:gelatin sponge, absorbable | rel=r_associated | relid=0 | w=10
  1521. lorazépam -- r_associated #0: 10 / 0.052 -> en:gemcitabine elaidate
    n1=lorazépam | n2=en:gemcitabine elaidate | rel=r_associated | relid=0 | w=10
  1522. lorazépam -- r_associated #0: 10 / 0.052 -> en:gemcitabine hydrochloride
    n1=lorazépam | n2=en:gemcitabine hydrochloride | rel=r_associated | relid=0 | w=10
  1523. lorazépam -- r_associated #0: 10 / 0.052 -> en:gemcitabine prodrug ly2334737
    n1=lorazépam | n2=en:gemcitabine prodrug ly2334737 | rel=r_associated | relid=0 | w=10
  1524. lorazépam -- r_associated #0: 10 / 0.052 -> en:gemcitabine-cisplatin regimen
    n1=lorazépam | n2=en:gemcitabine-cisplatin regimen | rel=r_associated | relid=0 | w=10
  1525. lorazépam -- r_associated #0: 10 / 0.052 -> en:gemcitabine-phosphoramidate hydrochloride nuc-1031
    n1=lorazépam | n2=en:gemcitabine-phosphoramidate hydrochloride nuc-1031 | rel=r_associated | relid=0 | w=10
  1526. lorazépam -- r_associated #0: 10 / 0.052 -> en:genistein
    n1=lorazépam | n2=en:genistein | rel=r_associated | relid=0 | w=10
  1527. lorazépam -- r_associated #0: 10 / 0.052 -> en:get acquainted with somebody
    n1=lorazépam | n2=en:get acquainted with somebody | rel=r_associated | relid=0 | w=10
  1528. lorazépam -- r_associated #0: 10 / 0.052 -> en:get to know somebody
    n1=lorazépam | n2=en:get to know somebody | rel=r_associated | relid=0 | w=10
  1529. lorazépam -- r_associated #0: 10 / 0.052 -> en:ghrelin peptide analogue
    n1=lorazépam | n2=en:ghrelin peptide analogue | rel=r_associated | relid=0 | w=10
  1530. lorazépam -- r_associated #0: 10 / 0.052 -> en:gimatecan
    n1=lorazépam | n2=en:gimatecan | rel=r_associated | relid=0 | w=10
  1531. lorazépam -- r_associated #0: 10 / 0.052 -> en:ginger extract
    n1=lorazépam | n2=en:ginger extract | rel=r_associated | relid=0 | w=10
  1532. lorazépam -- r_associated #0: 10 / 0.052 -> en:girentuximab
    n1=lorazépam | n2=en:girentuximab | rel=r_associated | relid=0 | w=10
  1533. lorazépam -- r_associated #0: 10 / 0.052 -> en:givinostat
    n1=lorazépam | n2=en:givinostat | rel=r_associated | relid=0 | w=10
  1534. lorazépam -- r_associated #0: 10 / 0.052 -> en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1535. lorazépam -- r_associated #0: 10 / 0.052 -> en:glioma-associated peptide-loaded dendritic cell vaccine sl-701
    n1=lorazépam | n2=en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 | rel=r_associated | relid=0 | w=10
  1536. lorazépam -- r_associated #0: 10 / 0.052 -> en:globo h-dt vaccine obi-833
    n1=lorazépam | n2=en:globo h-dt vaccine obi-833 | rel=r_associated | relid=0 | w=10
  1537. lorazépam -- r_associated #0: 10 / 0.052 -> en:globo h-klh immunostimulant opt-822
    n1=lorazépam | n2=en:globo h-klh immunostimulant opt-822 | rel=r_associated | relid=0 | w=10
  1538. lorazépam -- r_associated #0: 10 / 0.052 -> en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine
    n1=lorazépam | n2=en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  1539. lorazépam -- r_associated #0: 10 / 0.052 -> en:globulin component macrophage-activating factor
    n1=lorazépam | n2=en:globulin component macrophage-activating factor | rel=r_associated | relid=0 | w=10
  1540. lorazépam -- r_associated #0: 10 / 0.052 -> en:glucosamine sulfate/chondroitin sulfate tablet
    n1=lorazépam | n2=en:glucosamine sulfate/chondroitin sulfate tablet | rel=r_associated | relid=0 | w=10
  1541. lorazépam -- r_associated #0: 10 / 0.052 -> en:glufosfamide
    n1=lorazépam | n2=en:glufosfamide | rel=r_associated | relid=0 | w=10
  1542. lorazépam -- r_associated #0: 10 / 0.052 -> en:glutathione
    n1=lorazépam | n2=en:glutathione | rel=r_associated | relid=0 | w=10
  1543. lorazépam -- r_associated #0: 10 / 0.052 -> en:gluten-free compact nutritional supplement drink
    n1=lorazépam | n2=en:gluten-free compact nutritional supplement drink | rel=r_associated | relid=0 | w=10
  1544. lorazépam -- r_associated #0: 10 / 0.052 -> en:gluten-free/fiber-enriched compact nutritional supplement drink
    n1=lorazépam | n2=en:gluten-free/fiber-enriched compact nutritional supplement drink | rel=r_associated | relid=0 | w=10
  1545. lorazépam -- r_associated #0: 10 / 0.052 -> en:glycine
    n1=lorazépam | n2=en:glycine | rel=r_associated | relid=0 | w=10
  1546. lorazépam -- r_associated #0: 10 / 0.052 -> en:glymidine
    n1=lorazépam | n2=en:glymidine | rel=r_associated | relid=0 | w=10
  1547. lorazépam -- r_associated #0: 10 / 0.052 -> en:gm-csf-encoding oncolytic adenovirus cgtg-102
    n1=lorazépam | n2=en:gm-csf-encoding oncolytic adenovirus cgtg-102 | rel=r_associated | relid=0 | w=10
  1548. lorazépam -- r_associated #0: 10 / 0.052 -> en:gm.cd40l cell vaccine
    n1=lorazépam | n2=en:gm.cd40l cell vaccine | rel=r_associated | relid=0 | w=10
  1549. lorazépam -- r_associated #0: 10 / 0.052 -> en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine
    n1=lorazépam | n2=en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine | rel=r_associated | relid=0 | w=10
  1550. lorazépam -- r_associated #0: 10 / 0.052 -> en:go well together
    n1=lorazépam | n2=en:go well together | rel=r_associated | relid=0 | w=10
  1551. lorazépam -- r_associated #0: 10 / 0.052 -> en:go with something
    n1=lorazépam | n2=en:go with something | rel=r_associated | relid=0 | w=10
  1552. lorazépam -- r_associated #0: 10 / 0.052 -> en:gold sodium thiomalate
    n1=lorazépam | n2=en:gold sodium thiomalate | rel=r_associated | relid=0 | w=10
  1553. lorazépam -- r_associated #0: 10 / 0.052 -> en:golnerminogene pradenovec
    n1=lorazépam | n2=en:golnerminogene pradenovec | rel=r_associated | relid=0 | w=10
  1554. lorazépam -- r_associated #0: 10 / 0.052 -> en:golotimod
    n1=lorazépam | n2=en:golotimod | rel=r_associated | relid=0 | w=10
  1555. lorazépam -- r_associated #0: 10 / 0.052 -> en:gonadotropin-releasing hormone analog
    n1=lorazépam | n2=en:gonadotropin-releasing hormone analog | rel=r_associated | relid=0 | w=10
  1556. lorazépam -- r_associated #0: 10 / 0.052 -> en:gp100-fowlpox vaccine
    n1=lorazépam | n2=en:gp100-fowlpox vaccine | rel=r_associated | relid=0 | w=10
  1557. lorazépam -- r_associated #0: 10 / 0.052 -> en:gp100:154-162 peptide vaccine
    n1=lorazépam | n2=en:gp100:154-162 peptide vaccine | rel=r_associated | relid=0 | w=10
  1558. lorazépam -- r_associated #0: 10 / 0.052 -> en:gp100:209-217(210m) peptide vaccine
    n1=lorazépam | n2=en:gp100:209-217(210m) peptide vaccine | rel=r_associated | relid=0 | w=10
  1559. lorazépam -- r_associated #0: 10 / 0.052 -> en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410
    n1=lorazépam | n2=en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 | rel=r_associated | relid=0 | w=10
  1560. lorazépam -- r_associated #0: 10 / 0.052 -> en:gpi-0100
    n1=lorazépam | n2=en:gpi-0100 | rel=r_associated | relid=0 | w=10
  1561. lorazépam -- r_associated #0: 10 / 0.052 -> en:granisetron hydrochloride
    n1=lorazépam | n2=en:granisetron hydrochloride | rel=r_associated | relid=0 | w=10
  1562. lorazépam -- r_associated #0: 10 / 0.052 -> en:green tea
    n1=lorazépam | n2=en:green tea | rel=r_associated | relid=0 | w=10
  1563. lorazépam -- r_associated #0: 10 / 0.052 -> en:gti-2040
    n1=lorazépam | n2=en:gti-2040 | rel=r_associated | relid=0 | w=10
  1564. lorazépam -- r_associated #0: 10 / 0.052 -> en:gusperimus trihydrochloride
    n1=lorazépam | n2=en:gusperimus trihydrochloride | rel=r_associated | relid=0 | w=10
  1565. lorazépam -- r_associated #0: 10 / 0.052 -> en:gvax pancreatic cancer vaccine
    n1=lorazépam | n2=en:gvax pancreatic cancer vaccine | rel=r_associated | relid=0 | w=10
  1566. lorazépam -- r_associated #0: 10 / 0.052 -> en:gvax prostate cancer vaccine
    n1=lorazépam | n2=en:gvax prostate cancer vaccine | rel=r_associated | relid=0 | w=10
  1567. lorazépam -- r_associated #0: 10 / 0.052 -> en:haemato fu
    n1=lorazépam | n2=en:haemato fu | rel=r_associated | relid=0 | w=10
  1568. lorazépam -- r_associated #0: 10 / 0.052 -> en:haemophilus influenzae b vaccine
    n1=lorazépam | n2=en:haemophilus influenzae b vaccine | rel=r_associated | relid=0 | w=10
  1569. lorazépam -- r_associated #0: 10 / 0.052 -> en:haloxazolam
    n1=lorazépam | n2=en:haloxazolam | rel=r_associated | relid=0 | w=10
  1570. lorazépam -- r_associated #0: 10 / 0.052 -> en:hcv dna vaccine ino-8000
    n1=lorazépam | n2=en:hcv dna vaccine ino-8000 | rel=r_associated | relid=0 | w=10
  1571. lorazépam -- r_associated #0: 10 / 0.052 -> en:hdac inhibitor 4sc-202
    n1=lorazépam | n2=en:hdac inhibitor 4sc-202 | rel=r_associated | relid=0 | w=10
  1572. lorazépam -- r_associated #0: 10 / 0.052 -> en:hdac inhibitor ar-42
    n1=lorazépam | n2=en:hdac inhibitor ar-42 | rel=r_associated | relid=0 | w=10
  1573. lorazépam -- r_associated #0: 10 / 0.052 -> en:hdac inhibitor chr-3996
    n1=lorazépam | n2=en:hdac inhibitor chr-3996 | rel=r_associated | relid=0 | w=10
  1574. lorazépam -- r_associated #0: 10 / 0.052 -> en:hdac inhibitor cxd101
    n1=lorazépam | n2=en:hdac inhibitor cxd101 | rel=r_associated | relid=0 | w=10
  1575. lorazépam -- r_associated #0: 10 / 0.052 -> en:hdac inhibitor shp-141
    n1=lorazépam | n2=en:hdac inhibitor shp-141 | rel=r_associated | relid=0 | w=10
  1576. lorazépam -- r_associated #0: 10 / 0.052 -> en:hdac/egfr/her2 inhibitor cudc-101
    n1=lorazépam | n2=en:hdac/egfr/her2 inhibitor cudc-101 | rel=r_associated | relid=0 | w=10
  1577. lorazépam -- r_associated #0: 10 / 0.052 -> en:hedgehog inhibitor pf-04449913
    n1=lorazépam | n2=en:hedgehog inhibitor pf-04449913 | rel=r_associated | relid=0 | w=10
  1578. lorazépam -- r_associated #0: 10 / 0.052 -> en:henatinib maleate
    n1=lorazépam | n2=en:henatinib maleate | rel=r_associated | relid=0 | w=10
  1579. lorazépam -- r_associated #0: 10 / 0.052 -> en:heparin derivative sst0001
    n1=lorazépam | n2=en:heparin derivative sst0001 | rel=r_associated | relid=0 | w=10
  1580. lorazépam -- r_associated #0: 10 / 0.052 -> en:hepatitis A vaccine
    n1=lorazépam | n2=en:hepatitis A vaccine | rel=r_associated | relid=0 | w=10
  1581. lorazépam -- r_associated #0: 10 / 0.052 -> en:hepatitis a vaccine
    n1=lorazépam | n2=en:hepatitis a vaccine | rel=r_associated | relid=0 | w=10
  1582. lorazépam -- r_associated #0: 10 / 0.052 -> en:hepatitis b vaccine
    n1=lorazépam | n2=en:hepatitis b vaccine | rel=r_associated | relid=0 | w=10
  1583. lorazépam -- r_associated #0: 10 / 0.052 -> en:hepatitis B vaccine
    n1=lorazépam | n2=en:hepatitis B vaccine | rel=r_associated | relid=0 | w=10
  1584. lorazépam -- r_associated #0: 10 / 0.052 -> en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine
    n1=lorazépam | n2=en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine | rel=r_associated | relid=0 | w=10
  1585. lorazépam -- r_associated #0: 10 / 0.052 -> en:her-2/neu intracellular domain protein
    n1=lorazépam | n2=en:her-2/neu intracellular domain protein | rel=r_associated | relid=0 | w=10
  1586. lorazépam -- r_associated #0: 10 / 0.052 -> en:her2-targeted liposomal doxorubicin hydrochloride mm-302
    n1=lorazépam | n2=en:her2-targeted liposomal doxorubicin hydrochloride mm-302 | rel=r_associated | relid=0 | w=10
  1587. lorazépam -- r_associated #0: 10 / 0.052 -> en:herba scutellaria barbata
    n1=lorazépam | n2=en:herba scutellaria barbata | rel=r_associated | relid=0 | w=10
  1588. lorazépam -- r_associated #0: 10 / 0.052 -> en:hexamethylene bisacetamide
    n1=lorazépam | n2=en:hexamethylene bisacetamide | rel=r_associated | relid=0 | w=10
  1589. lorazépam -- r_associated #0: 10 / 0.052 -> en:hexaminolevulinate
    n1=lorazépam | n2=en:hexaminolevulinate | rel=r_associated | relid=0 | w=10
  1590. lorazépam -- r_associated #0: 10 / 0.052 -> en:hexaminolevulinate hydrochloride
    n1=lorazépam | n2=en:hexaminolevulinate hydrochloride | rel=r_associated | relid=0 | w=10
  1591. lorazépam -- r_associated #0: 10 / 0.052 -> en:high-selenium baker's yeast
    n1=lorazépam | n2=en:high-selenium baker's yeast | rel=r_associated | relid=0 | w=10
  1592. lorazépam -- r_associated #0: 10 / 0.052 -> en:high-titer rsv immune globulin ri-001
    n1=lorazépam | n2=en:high-titer rsv immune globulin ri-001 | rel=r_associated | relid=0 | w=10
  1593. lorazépam -- r_associated #0: 10 / 0.052 -> en:histamine dihydrochloride
    n1=lorazépam | n2=en:histamine dihydrochloride | rel=r_associated | relid=0 | w=10
  1594. lorazépam -- r_associated #0: 10 / 0.052 -> en:histrelin acetate
    n1=lorazépam | n2=en:histrelin acetate | rel=r_associated | relid=0 | w=10
  1595. lorazépam -- r_associated #0: 10 / 0.052 -> en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine
    n1=lorazépam | n2=en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine | rel=r_associated | relid=0 | w=10
  1596. lorazépam -- r_associated #0: 10 / 0.052 -> en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine
    n1=lorazépam | n2=en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  1597. lorazépam -- r_associated #0: 10 / 0.052 -> en:hla-a*2402-restricted vegfr1 peptide vaccine
    n1=lorazépam | n2=en:hla-a*2402-restricted vegfr1 peptide vaccine | rel=r_associated | relid=0 | w=10
  1598. lorazépam -- r_associated #0: 10 / 0.052 -> en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine
    n1=lorazépam | n2=en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  1599. lorazépam -- r_associated #0: 10 / 0.052 -> en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine
    n1=lorazépam | n2=en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine | rel=r_associated | relid=0 | w=10
  1600. lorazépam -- r_associated #0: 10 / 0.052 -> en:holmium ho 166 poly(l-lactic acid) microspheres
    n1=lorazépam | n2=en:holmium ho 166 poly(l-lactic acid) microspheres | rel=r_associated | relid=0 | w=10
  1601. lorazépam -- r_associated #0: 10 / 0.052 -> en:honey
    n1=lorazépam | n2=en:honey | rel=r_associated | relid=0 | w=10
  1602. lorazépam -- r_associated #0: 10 / 0.052 -> en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c
    n1=lorazépam | n2=en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c | rel=r_associated | relid=0 | w=10
  1603. lorazépam -- r_associated #0: 10 / 0.052 -> en:hpv dna plasmids therapeutic vaccine vgx-3100
    n1=lorazépam | n2=en:hpv dna plasmids therapeutic vaccine vgx-3100 | rel=r_associated | relid=0 | w=10
  1604. lorazépam -- r_associated #0: 10 / 0.052 -> en:hpv e6/e7 dna vaccine gx-188e
    n1=lorazépam | n2=en:hpv e6/e7 dna vaccine gx-188e | rel=r_associated | relid=0 | w=10
  1605. lorazépam -- r_associated #0: 10 / 0.052 -> en:hpv-16 e6 peptides vaccine/candida albicans extract
    n1=lorazépam | n2=en:hpv-16 e6 peptides vaccine/candida albicans extract | rel=r_associated | relid=0 | w=10
  1606. lorazépam -- r_associated #0: 10 / 0.052 -> en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin
    n1=lorazépam | n2=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | rel=r_associated | relid=0 | w=10
  1607. lorazépam -- r_associated #0: 10 / 0.052 -> en:hsp90 antagonist kw-2478
    n1=lorazépam | n2=en:hsp90 antagonist kw-2478 | rel=r_associated | relid=0 | w=10
  1608. lorazépam -- r_associated #0: 10 / 0.052 -> en:hsp90 inhibitor auy922
    n1=lorazépam | n2=en:hsp90 inhibitor auy922 | rel=r_associated | relid=0 | w=10
  1609. lorazépam -- r_associated #0: 10 / 0.052 -> en:hsp90 inhibitor debio 0932
    n1=lorazépam | n2=en:hsp90 inhibitor debio 0932 | rel=r_associated | relid=0 | w=10
  1610. lorazépam -- r_associated #0: 10 / 0.052 -> en:hsp90 inhibitor ds-2248
    n1=lorazépam | n2=en:hsp90 inhibitor ds-2248 | rel=r_associated | relid=0 | w=10
  1611. lorazépam -- r_associated #0: 10 / 0.052 -> en:hsp90 inhibitor hsp990
    n1=lorazépam | n2=en:hsp90 inhibitor hsp990 | rel=r_associated | relid=0 | w=10
  1612. lorazépam -- r_associated #0: 10 / 0.052 -> en:hsv-1 hf10
    n1=lorazépam | n2=en:hsv-1 hf10 | rel=r_associated | relid=0 | w=10
  1613. lorazépam -- r_associated #0: 10 / 0.052 -> en:htert vaccine v934/v935
    n1=lorazépam | n2=en:htert vaccine v934/v935 | rel=r_associated | relid=0 | w=10
  1614. lorazépam -- r_associated #0: 10 / 0.052 -> en:htert/survivin/cmv multipeptide vaccine
    n1=lorazépam | n2=en:htert/survivin/cmv multipeptide vaccine | rel=r_associated | relid=0 | w=10
  1615. lorazépam -- r_associated #0: 10 / 0.052 -> en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine
    n1=lorazépam | n2=en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1616. lorazépam -- r_associated #0: 10 / 0.052 -> en:hu14.18-il2 fusion protein
    n1=lorazépam | n2=en:hu14.18-il2 fusion protein | rel=r_associated | relid=0 | w=10
  1617. lorazépam -- r_associated #0: 10 / 0.052 -> en:huachansu
    n1=lorazépam | n2=en:huachansu | rel=r_associated | relid=0 | w=10
  1618. lorazépam -- r_associated #0: 10 / 0.052 -> en:human combinatorial antibody library-based monoclonal antibody vay736
    n1=lorazépam | n2=en:human combinatorial antibody library-based monoclonal antibody vay736 | rel=r_associated | relid=0 | w=10
  1619. lorazépam -- r_associated #0: 10 / 0.052 -> en:human gp100 plasmid dna vaccine
    n1=lorazépam | n2=en:human gp100 plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  1620. lorazépam -- r_associated #0: 10 / 0.052 -> en:human menopausal gonadotrophin
    n1=lorazépam | n2=en:human menopausal gonadotrophin | rel=r_associated | relid=0 | w=10
  1621. lorazépam -- r_associated #0: 10 / 0.052 -> en:human menopausal gonadotropin
    n1=lorazépam | n2=en:human menopausal gonadotropin | rel=r_associated | relid=0 | w=10
  1622. lorazépam -- r_associated #0: 10 / 0.052 -> en:human mhc non-restricted cytotoxic t-cell line tall-104
    n1=lorazépam | n2=en:human mhc non-restricted cytotoxic t-cell line tall-104 | rel=r_associated | relid=0 | w=10
  1623. lorazépam -- r_associated #0: 10 / 0.052 -> en:human monoclonal antibody 216
    n1=lorazépam | n2=en:human monoclonal antibody 216 | rel=r_associated | relid=0 | w=10
  1624. lorazépam -- r_associated #0: 10 / 0.052 -> en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307
    n1=lorazépam | n2=en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 | rel=r_associated | relid=0 | w=10
  1625. lorazépam -- r_associated #0: 10 / 0.052 -> en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine
    n1=lorazépam | n2=en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine | rel=r_associated | relid=0 | w=10
  1626. lorazépam -- r_associated #0: 10 / 0.052 -> en:human prostate-specific membrane antigen plasmid dna vaccine
    n1=lorazépam | n2=en:human prostate-specific membrane antigen plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  1627. lorazépam -- r_associated #0: 10 / 0.052 -> en:hyaluronic acid-containing topical cream
    n1=lorazépam | n2=en:hyaluronic acid-containing topical cream | rel=r_associated | relid=0 | w=10
  1628. lorazépam -- r_associated #0: 10 / 0.052 -> en:hyb2055
    n1=lorazépam | n2=en:hyb2055 | rel=r_associated | relid=0 | w=10
  1629. lorazépam -- r_associated #0: 10 / 0.052 -> en:hydralazine hydrochloride
    n1=lorazépam | n2=en:hydralazine hydrochloride | rel=r_associated | relid=0 | w=10
  1630. lorazépam -- r_associated #0: 10 / 0.052 -> en:hydrazine sulfate
    n1=lorazépam | n2=en:hydrazine sulfate | rel=r_associated | relid=0 | w=10
  1631. lorazépam -- r_associated #0: 10 / 0.052 -> en:hydrocortisone
    n1=lorazépam | n2=en:hydrocortisone | rel=r_associated | relid=0 | w=10
  1632. lorazépam -- r_associated #0: 10 / 0.052 -> en:hydromorphone hydrochloride
    n1=lorazépam | n2=en:hydromorphone hydrochloride | rel=r_associated | relid=0 | w=10
  1633. lorazépam -- r_associated #0: 10 / 0.052 -> en:hydroxyethylflurazepam
    n1=lorazépam | n2=en:hydroxyethylflurazepam | rel=r_associated | relid=0 | w=10
  1634. lorazépam -- r_associated #0: 10 / 0.052 -> en:hydroxytyrosol
    n1=lorazépam | n2=en:hydroxytyrosol | rel=r_associated | relid=0 | w=10
  1635. lorazépam -- r_associated #0: 10 / 0.052 -> en:hyperglycemic agent
    n1=lorazépam | n2=en:hyperglycemic agent | rel=r_associated | relid=0 | w=10
  1636. lorazépam -- r_associated #0: 10 / 0.052 -> en:hyperpolarized carbon c 13 pyruvate
    n1=lorazépam | n2=en:hyperpolarized carbon c 13 pyruvate | rel=r_associated | relid=0 | w=10
  1637. lorazépam -- r_associated #0: 10 / 0.052 -> en:hyperpolarized helium 3
    n1=lorazépam | n2=en:hyperpolarized helium 3 | rel=r_associated | relid=0 | w=10
  1638. lorazépam -- r_associated #0: 10 / 0.052 -> en:hypoglycemic agents
    n1=lorazépam | n2=en:hypoglycemic agents | rel=r_associated | relid=0 | w=10
  1639. lorazépam -- r_associated #0: 10 / 0.052 -> en:hypoxia-activated prodrug th-302
    n1=lorazépam | n2=en:hypoxia-activated prodrug th-302 | rel=r_associated | relid=0 | w=10
  1640. lorazépam -- r_associated #0: 10 / 0.052 -> en:i 131 antiferritin immunoglobulin
    n1=lorazépam | n2=en:i 131 antiferritin immunoglobulin | rel=r_associated | relid=0 | w=10
  1641. lorazépam -- r_associated #0: 10 / 0.052 -> en:i 131 monoclonal antibody f19
    n1=lorazépam | n2=en:i 131 monoclonal antibody f19 | rel=r_associated | relid=0 | w=10
  1642. lorazépam -- r_associated #0: 10 / 0.052 -> en:i 131 monoclonal antibody lym-1
    n1=lorazépam | n2=en:i 131 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=10
  1643. lorazépam -- r_associated #0: 10 / 0.052 -> en:iap inhibitor hgs1029
    n1=lorazépam | n2=en:iap inhibitor hgs1029 | rel=r_associated | relid=0 | w=10
  1644. lorazépam -- r_associated #0: 10 / 0.052 -> en:iapa-based dendritic cells/cytotoxic t lymphocytes
    n1=lorazépam | n2=en:iapa-based dendritic cells/cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  1645. lorazépam -- r_associated #0: 10 / 0.052 -> en:ibandronate sodium
    n1=lorazépam | n2=en:ibandronate sodium | rel=r_associated | relid=0 | w=10
  1646. lorazépam -- r_associated #0: 10 / 0.052 -> en:ibritumomab tiuxetan
    n1=lorazépam | n2=en:ibritumomab tiuxetan | rel=r_associated | relid=0 | w=10
  1647. lorazépam -- r_associated #0: 10 / 0.052 -> en:ibrutinib
    n1=lorazépam | n2=en:ibrutinib | rel=r_associated | relid=0 | w=10
  1648. lorazépam -- r_associated #0: 10 / 0.052 -> en:ibuprofen injection
    n1=lorazépam | n2=en:ibuprofen injection | rel=r_associated | relid=0 | w=10
  1649. lorazépam -- r_associated #0: 10 / 0.052 -> en:iclazepam
    n1=lorazépam | n2=en:iclazepam | rel=r_associated | relid=0 | w=10
  1650. lorazépam -- r_associated #0: 10 / 0.052 -> en:idh1 inhibitor ag-120
    n1=lorazépam | n2=en:idh1 inhibitor ag-120 | rel=r_associated | relid=0 | w=10
  1651. lorazépam -- r_associated #0: 10 / 0.052 -> en:idh2 inhibitor ag-221
    n1=lorazépam | n2=en:idh2 inhibitor ag-221 | rel=r_associated | relid=0 | w=10
  1652. lorazépam -- r_associated #0: 10 / 0.052 -> en:ido inhibitor nlg919
    n1=lorazépam | n2=en:ido inhibitor nlg919 | rel=r_associated | relid=0 | w=10
  1653. lorazépam -- r_associated #0: 10 / 0.052 -> en:idronoxil
    n1=lorazépam | n2=en:idronoxil | rel=r_associated | relid=0 | w=10
  1654. lorazépam -- r_associated #0: 10 / 0.052 -> en:ih636 grape seed proanthocyanidin extract
    n1=lorazépam | n2=en:ih636 grape seed proanthocyanidin extract | rel=r_associated | relid=0 | w=10
  1655. lorazépam -- r_associated #0: 10 / 0.052 -> en:il-10 immunomodulator mk-1966
    n1=lorazépam | n2=en:il-10 immunomodulator mk-1966 | rel=r_associated | relid=0 | w=10
  1656. lorazépam -- r_associated #0: 10 / 0.052 -> en:il-12-expressing hsv-1
    n1=lorazépam | n2=en:il-12-expressing hsv-1 | rel=r_associated | relid=0 | w=10
  1657. lorazépam -- r_associated #0: 10 / 0.052 -> en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine
    n1=lorazépam | n2=en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine | rel=r_associated | relid=0 | w=10
  1658. lorazépam -- r_associated #0: 10 / 0.052 -> en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes
    n1=lorazépam | n2=en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1659. lorazépam -- r_associated #0: 10 / 0.052 -> en:ilx-295501
    n1=lorazépam | n2=en:ilx-295501 | rel=r_associated | relid=0 | w=10
  1660. lorazépam -- r_associated #0: 10 / 0.052 -> en:ilx23-7553
    n1=lorazépam | n2=en:ilx23-7553 | rel=r_associated | relid=0 | w=10
  1661. lorazépam -- r_associated #0: 10 / 0.052 -> en:imatinib mesylate
    n1=lorazépam | n2=en:imatinib mesylate | rel=r_associated | relid=0 | w=10
  1662. lorazépam -- r_associated #0: 10 / 0.052 -> en:imetelstat sodium
    n1=lorazépam | n2=en:imetelstat sodium | rel=r_associated | relid=0 | w=10
  1663. lorazépam -- r_associated #0: 10 / 0.052 -> en:imexon
    n1=lorazépam | n2=en:imexon | rel=r_associated | relid=0 | w=10
  1664. lorazépam -- r_associated #0: 10 / 0.052 -> en:imidazolyl ethanamide pentandioic acid
    n1=lorazépam | n2=en:imidazolyl ethanamide pentandioic acid | rel=r_associated | relid=0 | w=10
  1665. lorazépam -- r_associated #0: 10 / 0.052 -> en:imisopasem manganese
    n1=lorazépam | n2=en:imisopasem manganese | rel=r_associated | relid=0 | w=10
  1666. lorazépam -- r_associated #0: 10 / 0.052 -> en:immediate-release tablet afuresertib
    n1=lorazépam | n2=en:immediate-release tablet afuresertib | rel=r_associated | relid=0 | w=10
  1667. lorazépam -- r_associated #0: 10 / 0.052 -> en:immunoconjugate ro5479599
    n1=lorazépam | n2=en:immunoconjugate ro5479599 | rel=r_associated | relid=0 | w=10
  1668. lorazépam -- r_associated #0: 10 / 0.052 -> en:immunocytokine nhs-il12
    n1=lorazépam | n2=en:immunocytokine nhs-il12 | rel=r_associated | relid=0 | w=10
  1669. lorazépam -- r_associated #0: 10 / 0.052 -> en:immunocytokine nhs-il2-lt
    n1=lorazépam | n2=en:immunocytokine nhs-il2-lt | rel=r_associated | relid=0 | w=10
  1670. lorazépam -- r_associated #0: 10 / 0.052 -> en:immunomodulator ohr/avr118
    n1=lorazépam | n2=en:immunomodulator ohr/avr118 | rel=r_associated | relid=0 | w=10
  1671. lorazépam -- r_associated #0: 10 / 0.052 -> en:immunomodulators
    n1=lorazépam | n2=en:immunomodulators | rel=r_associated | relid=0 | w=10
  1672. lorazépam -- r_associated #0: 10 / 0.052 -> en:immunotherapy regimen mkc-1106-mt
    n1=lorazépam | n2=en:immunotherapy regimen mkc-1106-mt | rel=r_associated | relid=0 | w=10
  1673. lorazépam -- r_associated #0: 10 / 0.052 -> en:imp321
    n1=lorazépam | n2=en:imp321 | rel=r_associated | relid=0 | w=10
  1674. lorazépam -- r_associated #0: 10 / 0.052 -> en:in 111 folic acid
    n1=lorazépam | n2=en:in 111 folic acid | rel=r_associated | relid=0 | w=10
  1675. lorazépam -- r_associated #0: 10 / 0.052 -> en:in 111 monoclonal antibody b3
    n1=lorazépam | n2=en:in 111 monoclonal antibody b3 | rel=r_associated | relid=0 | w=10
  1676. lorazépam -- r_associated #0: 10 / 0.052 -> en:in 111 monoclonal antibody ll2
    n1=lorazépam | n2=en:in 111 monoclonal antibody ll2 | rel=r_associated | relid=0 | w=10
  1677. lorazépam -- r_associated #0: 10 / 0.052 -> en:in 111 monoclonal antibody lym-1
    n1=lorazépam | n2=en:in 111 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=10
  1678. lorazépam -- r_associated #0: 10 / 0.052 -> en:inalimarev
    n1=lorazépam | n2=en:inalimarev | rel=r_associated | relid=0 | w=10
  1679. lorazépam -- r_associated #0: 10 / 0.052 -> en:indibulin
    n1=lorazépam | n2=en:indibulin | rel=r_associated | relid=0 | w=10
  1680. lorazépam -- r_associated #0: 10 / 0.052 -> en:indisulam
    n1=lorazépam | n2=en:indisulam | rel=r_associated | relid=0 | w=10
  1681. lorazépam -- r_associated #0: 10 / 0.052 -> en:indium in 111 bevacizumab
    n1=lorazépam | n2=en:indium in 111 bevacizumab | rel=r_associated | relid=0 | w=10
  1682. lorazépam -- r_associated #0: 10 / 0.052 -> en:indium in 111 capromab pendetide
    n1=lorazépam | n2=en:indium in 111 capromab pendetide | rel=r_associated | relid=0 | w=10
  1683. lorazépam -- r_associated #0: 10 / 0.052 -> en:indium in 111 chimeric monoclonal antibody 806
    n1=lorazépam | n2=en:indium in 111 chimeric monoclonal antibody 806 | rel=r_associated | relid=0 | w=10
  1684. lorazépam -- r_associated #0: 10 / 0.052 -> en:indium in 111-dota-biotin
    n1=lorazépam | n2=en:indium in 111-dota-biotin | rel=r_associated | relid=0 | w=10
  1685. lorazépam -- r_associated #0: 10 / 0.052 -> en:indole-3-carbinol
    n1=lorazépam | n2=en:indole-3-carbinol | rel=r_associated | relid=0 | w=10
  1686. lorazépam -- r_associated #0: 10 / 0.052 -> en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule
    n1=lorazépam | n2=en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule | rel=r_associated | relid=0 | w=10
  1687. lorazépam -- r_associated #0: 10 / 0.052 -> en:indoleamine 2,3-dioxygenase peptide vaccine
    n1=lorazépam | n2=en:indoleamine 2,3-dioxygenase peptide vaccine | rel=r_associated | relid=0 | w=10
  1688. lorazépam -- r_associated #0: 10 / 0.052 -> en:indomethacin
    n1=lorazépam | n2=en:indomethacin | rel=r_associated | relid=0 | w=10
  1689. lorazépam -- r_associated #0: 10 / 0.052 -> en:ingenol mebutate
    n1=lorazépam | n2=en:ingenol mebutate | rel=r_associated | relid=0 | w=10
  1690. lorazépam -- r_associated #0: 10 / 0.052 -> en:ingenol mebutate gel
    n1=lorazépam | n2=en:ingenol mebutate gel | rel=r_associated | relid=0 | w=10
  1691. lorazépam -- r_associated #0: 10 / 0.052 -> en:iniparib
    n1=lorazépam | n2=en:iniparib | rel=r_associated | relid=0 | w=10
  1692. lorazépam -- r_associated #0: 10 / 0.052 -> en:innate immunostimulator rbbx-01
    n1=lorazépam | n2=en:innate immunostimulator rbbx-01 | rel=r_associated | relid=0 | w=10
  1693. lorazépam -- r_associated #0: 10 / 0.052 -> en:ino-1001
    n1=lorazépam | n2=en:ino-1001 | rel=r_associated | relid=0 | w=10
  1694. lorazépam -- r_associated #0: 10 / 0.052 -> en:inositol
    n1=lorazépam | n2=en:inositol | rel=r_associated | relid=0 | w=10
  1695. lorazépam -- r_associated #0: 10 / 0.052 -> en:inotuzumab ozogamicin
    n1=lorazépam | n2=en:inotuzumab ozogamicin | rel=r_associated | relid=0 | w=10
  1696. lorazépam -- r_associated #0: 10 / 0.052 -> en:ins316
    n1=lorazépam | n2=en:ins316 | rel=r_associated | relid=0 | w=10
  1697. lorazépam -- r_associated #0: 10 / 0.052 -> en:insulin glargine
    n1=lorazépam | n2=en:insulin glargine | rel=r_associated | relid=0 | w=10
  1698. lorazépam -- r_associated #0: 10 / 0.052 -> en:insulin, regular
    n1=lorazépam | n2=en:insulin, regular | rel=r_associated | relid=0 | w=10
  1699. lorazépam -- r_associated #0: 10 / 0.052 -> en:interferon alfacon-1
    n1=lorazépam | n2=en:interferon alfacon-1 | rel=r_associated | relid=0 | w=10
  1700. lorazépam -- r_associated #0: 10 / 0.052 -> en:interleukin-12 gene
    n1=lorazépam | n2=en:interleukin-12 gene | rel=r_associated | relid=0 | w=10
  1701. lorazépam -- r_associated #0: 10 / 0.052 -> en:interleukin-2 gene
    n1=lorazépam | n2=en:interleukin-2 gene | rel=r_associated | relid=0 | w=10
  1702. lorazépam -- r_associated #0: 10 / 0.052 -> en:interleukin-4 pe38kdel immunotoxin
    n1=lorazépam | n2=en:interleukin-4 pe38kdel immunotoxin | rel=r_associated | relid=0 | w=10
  1703. lorazépam -- r_associated #0: 10 / 0.052 -> en:inulin
    n1=lorazépam | n2=en:inulin | rel=r_associated | relid=0 | w=10
  1704. lorazépam -- r_associated #0: 10 / 0.052 -> en:iobenguane i-131
    n1=lorazépam | n2=en:iobenguane i-131 | rel=r_associated | relid=0 | w=10
  1705. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 123 anti-cea recombinant diabody t84.66
    n1=lorazépam | n2=en:iodine i 123 anti-cea recombinant diabody t84.66 | rel=r_associated | relid=0 | w=10
  1706. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 123 monoclonal antibody 81c6
    n1=lorazépam | n2=en:iodine i 123 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=10
  1707. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 124-crgdy-peg-c dots
    n1=lorazépam | n2=en:iodine i 124-crgdy-peg-c dots | rel=r_associated | relid=0 | w=10
  1708. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 ethiodized oil
    n1=lorazépam | n2=en:iodine i 131 ethiodized oil | rel=r_associated | relid=0 | w=10
  1709. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 monoclonal antibody 81c6
    n1=lorazépam | n2=en:iodine i 131 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=10
  1710. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 monoclonal antibody bc8
    n1=lorazépam | n2=en:iodine i 131 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=10
  1711. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 monoclonal antibody f16sip
    n1=lorazépam | n2=en:iodine i 131 monoclonal antibody f16sip | rel=r_associated | relid=0 | w=10
  1712. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 monoclonal antibody tnt-1/b
    n1=lorazépam | n2=en:iodine i 131 monoclonal antibody tnt-1/b | rel=r_associated | relid=0 | w=10
  1713. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 rituximab
    n1=lorazépam | n2=en:iodine i 131 rituximab | rel=r_associated | relid=0 | w=10
  1714. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 tenatumomab
    n1=lorazépam | n2=en:iodine i 131 tenatumomab | rel=r_associated | relid=0 | w=10
  1715. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 tm-601
    n1=lorazépam | n2=en:iodine i 131 tm-601 | rel=r_associated | relid=0 | w=10
  1716. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i 131 tositumomab
    n1=lorazépam | n2=en:iodine i 131 tositumomab | rel=r_associated | relid=0 | w=10
  1717. lorazépam -- r_associated #0: 10 / 0.052 -> en:iodine i-125
    n1=lorazépam | n2=en:iodine i-125 | rel=r_associated | relid=0 | w=10
  1718. lorazépam -- r_associated #0: 10 / 0.052 -> en:ioflubenzamide i-131
    n1=lorazépam | n2=en:ioflubenzamide i-131 | rel=r_associated | relid=0 | w=10
  1719. lorazépam -- r_associated #0: 10 / 0.052 -> en:ionomycin
    n1=lorazépam | n2=en:ionomycin | rel=r_associated | relid=0 | w=10
  1720. lorazépam -- r_associated #0: 10 / 0.052 -> en:ipatasertib
    n1=lorazépam | n2=en:ipatasertib | rel=r_associated | relid=0 | w=10
  1721. lorazépam -- r_associated #0: 10 / 0.052 -> en:ipilimumab
    n1=lorazépam | n2=en:ipilimumab | rel=r_associated | relid=0 | w=10
  1722. lorazépam -- r_associated #0: 10 / 0.052 -> en:iratumumab
    n1=lorazépam | n2=en:iratumumab | rel=r_associated | relid=0 | w=10
  1723. lorazépam -- r_associated #0: 10 / 0.052 -> en:irinotecan hydrochloride
    n1=lorazépam | n2=en:irinotecan hydrochloride | rel=r_associated | relid=0 | w=10
  1724. lorazépam -- r_associated #0: 10 / 0.052 -> en:irinotecan-eluting beads
    n1=lorazépam | n2=en:irinotecan-eluting beads | rel=r_associated | relid=0 | w=10
  1725. lorazépam -- r_associated #0: 10 / 0.052 -> en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet
    n1=lorazépam | n2=en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet | rel=r_associated | relid=0 | w=10
  1726. lorazépam -- r_associated #0: 10 / 0.052 -> en:irofulven
    n1=lorazépam | n2=en:irofulven | rel=r_associated | relid=0 | w=10
  1727. lorazépam -- r_associated #0: 10 / 0.052 -> en:iron dextran complex
    n1=lorazépam | n2=en:iron dextran complex | rel=r_associated | relid=0 | w=10
  1728. lorazépam -- r_associated #0: 10 / 0.052 -> en:iron isomaltoside 1000
    n1=lorazépam | n2=en:iron isomaltoside 1000 | rel=r_associated | relid=0 | w=10
  1729. lorazépam -- r_associated #0: 10 / 0.052 -> en:iron sucrose injection
    n1=lorazépam | n2=en:iron sucrose injection | rel=r_associated | relid=0 | w=10
  1730. lorazépam -- r_associated #0: 10 / 0.052 -> en:isavuconazole
    n1=lorazépam | n2=en:isavuconazole | rel=r_associated | relid=0 | w=10
  1731. lorazépam -- r_associated #0: 10 / 0.052 -> en:iseganan hydrochloride
    n1=lorazépam | n2=en:iseganan hydrochloride | rel=r_associated | relid=0 | w=10
  1732. lorazépam -- r_associated #0: 10 / 0.052 -> en:isis 2503
    n1=lorazépam | n2=en:isis 2503 | rel=r_associated | relid=0 | w=10
  1733. lorazépam -- r_associated #0: 10 / 0.052 -> en:iso-fludelone
    n1=lorazépam | n2=en:iso-fludelone | rel=r_associated | relid=0 | w=10
  1734. lorazépam -- r_associated #0: 10 / 0.052 -> en:iso-sulfan blue
    n1=lorazépam | n2=en:iso-sulfan blue | rel=r_associated | relid=0 | w=10
  1735. lorazépam -- r_associated #0: 10 / 0.052 -> en:isoflurane
    n1=lorazépam | n2=en:isoflurane | rel=r_associated | relid=0 | w=10
  1736. lorazépam -- r_associated #0: 10 / 0.052 -> en:isoniazid
    n1=lorazépam | n2=en:isoniazid | rel=r_associated | relid=0 | w=10
  1737. lorazépam -- r_associated #0: 10 / 0.052 -> en:isopréniques
    n1=lorazépam | n2=en:isopréniques | rel=r_associated | relid=0 | w=10
  1738. lorazépam -- r_associated #0: 10 / 0.052 -> en:isoquercetin
    n1=lorazépam | n2=en:isoquercetin | rel=r_associated | relid=0 | w=10
  1739. lorazépam -- r_associated #0: 10 / 0.052 -> en:isosulfan blue
    n1=lorazépam | n2=en:isosulfan blue | rel=r_associated | relid=0 | w=10
  1740. lorazépam -- r_associated #0: 10 / 0.052 -> en:isotretinoin
    n1=lorazépam | n2=en:isotretinoin | rel=r_associated | relid=0 | w=10
  1741. lorazépam -- r_associated #0: 10 / 0.052 -> en:iss 1018 cpg oligodeoxynucleotide
    n1=lorazépam | n2=en:iss 1018 cpg oligodeoxynucleotide | rel=r_associated | relid=0 | w=10
  1742. lorazépam -- r_associated #0: 10 / 0.052 -> en:ivac mutanome vaccine
    n1=lorazépam | n2=en:ivac mutanome vaccine | rel=r_associated | relid=0 | w=10
  1743. lorazépam -- r_associated #0: 10 / 0.052 -> en:ixazomib citrate
    n1=lorazépam | n2=en:ixazomib citrate | rel=r_associated | relid=0 | w=10
  1744. lorazépam -- r_associated #0: 10 / 0.052 -> en:jak inhibitor incb047986
    n1=lorazépam | n2=en:jak inhibitor incb047986 | rel=r_associated | relid=0 | w=10
  1745. lorazépam -- r_associated #0: 10 / 0.052 -> en:jak1 inhibitor incb039110
    n1=lorazépam | n2=en:jak1 inhibitor incb039110 | rel=r_associated | relid=0 | w=10
  1746. lorazépam -- r_associated #0: 10 / 0.052 -> en:jak1 inhibitor incb052793
    n1=lorazépam | n2=en:jak1 inhibitor incb052793 | rel=r_associated | relid=0 | w=10
  1747. lorazépam -- r_associated #0: 10 / 0.052 -> en:jak2 inhibitor azd1480
    n1=lorazépam | n2=en:jak2 inhibitor azd1480 | rel=r_associated | relid=0 | w=10
  1748. lorazépam -- r_associated #0: 10 / 0.052 -> en:jak2 inhibitor bms-911543
    n1=lorazépam | n2=en:jak2 inhibitor bms-911543 | rel=r_associated | relid=0 | w=10
  1749. lorazépam -- r_associated #0: 10 / 0.052 -> en:jak2 inhibitor wp1066
    n1=lorazépam | n2=en:jak2 inhibitor wp1066 | rel=r_associated | relid=0 | w=10
  1750. lorazépam -- r_associated #0: 10 / 0.052 -> en:jak2 inhibitor xl019
    n1=lorazépam | n2=en:jak2 inhibitor xl019 | rel=r_associated | relid=0 | w=10
  1751. lorazépam -- r_associated #0: 10 / 0.052 -> en:jeb regimen
    n1=lorazépam | n2=en:jeb regimen | rel=r_associated | relid=0 | w=10
  1752. lorazépam -- r_associated #0: 10 / 0.052 -> en:jin fu kang
    n1=lorazépam | n2=en:jin fu kang | rel=r_associated | relid=0 | w=10
  1753. lorazépam -- r_associated #0: 10 / 0.052 -> en:kanglaite
    n1=lorazépam | n2=en:kanglaite | rel=r_associated | relid=0 | w=10
  1754. lorazépam -- r_associated #0: 10 / 0.052 -> en:kava-based supplement
    n1=lorazépam | n2=en:kava-based supplement | rel=r_associated | relid=0 | w=10
  1755. lorazépam -- r_associated #0: 10 / 0.052 -> en:ketazolam
    n1=lorazépam | n2=en:ketazolam | rel=r_associated | relid=0 | w=10
  1756. lorazépam -- r_associated #0: 10 / 0.052 -> en:key moment
    n1=lorazépam | n2=en:key moment | rel=r_associated | relid=0 | w=10
  1757. lorazépam -- r_associated #0: 10 / 0.052 -> en:kit/pdgfr inhibitor dcc-2618
    n1=lorazépam | n2=en:kit/pdgfr inhibitor dcc-2618 | rel=r_associated | relid=0 | w=10
  1758. lorazépam -- r_associated #0: 10 / 0.052 -> en:ksp inhibitor arry-520
    n1=lorazépam | n2=en:ksp inhibitor arry-520 | rel=r_associated | relid=0 | w=10
  1759. lorazépam -- r_associated #0: 10 / 0.052 -> en:ksp inhibitor azd4877
    n1=lorazépam | n2=en:ksp inhibitor azd4877 | rel=r_associated | relid=0 | w=10
  1760. lorazépam -- r_associated #0: 10 / 0.052 -> en:kunecatechins ointment
    n1=lorazépam | n2=en:kunecatechins ointment | rel=r_associated | relid=0 | w=10
  1761. lorazépam -- r_associated #0: 10 / 0.052 -> en:l-377,202
    n1=lorazépam | n2=en:l-377,202 | rel=r_associated | relid=0 | w=10
  1762. lorazépam -- r_associated #0: 10 / 0.052 -> en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement
    n1=lorazépam | n2=en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement | rel=r_associated | relid=0 | w=10
  1763. lorazépam -- r_associated #0: 10 / 0.052 -> en:l-carnitine l-tartrate
    n1=lorazépam | n2=en:l-carnitine l-tartrate | rel=r_associated | relid=0 | w=10
  1764. lorazépam -- r_associated #0: 10 / 0.052 -> en:l-gossypol
    n1=lorazépam | n2=en:l-gossypol | rel=r_associated | relid=0 | w=10
  1765. lorazépam -- r_associated #0: 10 / 0.052 -> en:l-lysine
    n1=lorazépam | n2=en:l-lysine | rel=r_associated | relid=0 | w=10
  1766. lorazépam -- r_associated #0: 10 / 0.052 -> en:l-ornithine l-aspartate
    n1=lorazépam | n2=en:l-ornithine l-aspartate | rel=r_associated | relid=0 | w=10
  1767. lorazépam -- r_associated #0: 10 / 0.052 -> en:l19-il2 monoclonal antibody-cytokine fusion protein
    n1=lorazépam | n2=en:l19-il2 monoclonal antibody-cytokine fusion protein | rel=r_associated | relid=0 | w=10
  1768. lorazépam -- r_associated #0: 10 / 0.052 -> en:lacidipine
    n1=lorazépam | n2=en:lacidipine | rel=r_associated | relid=0 | w=10
  1769. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactase
    n1=lorazépam | n2=en:lactase | rel=r_associated | relid=0 | w=10
  1770. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactic acid
    n1=lorazépam | n2=en:lactic acid | rel=r_associated | relid=0 | w=10
  1771. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactobacillus
    n1=lorazépam | n2=en:lactobacillus | rel=r_associated | relid=0 | w=10
  1772. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement
    n1=lorazépam | n2=en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement | rel=r_associated | relid=0 | w=10
  1773. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactobacillus fermented extract
    n1=lorazépam | n2=en:lactobacillus fermented extract | rel=r_associated | relid=0 | w=10
  1774. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactobacillus plantarum strain 299
    n1=lorazépam | n2=en:lactobacillus plantarum strain 299 | rel=r_associated | relid=0 | w=10
  1775. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactobacillus plantarum strain 299v
    n1=lorazépam | n2=en:lactobacillus plantarum strain 299v | rel=r_associated | relid=0 | w=10
  1776. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactobacillus rhamnosus gg
    n1=lorazépam | n2=en:lactobacillus rhamnosus gg | rel=r_associated | relid=0 | w=10
  1777. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement
    n1=lorazépam | n2=en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement | rel=r_associated | relid=0 | w=10
  1778. lorazépam -- r_associated #0: 10 / 0.052 -> en:lactoferrin-derived lytic peptide ltx-315
    n1=lorazépam | n2=en:lactoferrin-derived lytic peptide ltx-315 | rel=r_associated | relid=0 | w=10
  1779. lorazépam -- r_associated #0: 10 / 0.052 -> en:laetrile
    n1=lorazépam | n2=en:laetrile | rel=r_associated | relid=0 | w=10
  1780. lorazépam -- r_associated #0: 10 / 0.052 -> en:laminaria angustata extract
    n1=lorazépam | n2=en:laminaria angustata extract | rel=r_associated | relid=0 | w=10
  1781. lorazépam -- r_associated #0: 10 / 0.052 -> en:lamivudine
    n1=lorazépam | n2=en:lamivudine | rel=r_associated | relid=0 | w=10
  1782. lorazépam -- r_associated #0: 10 / 0.052 -> en:lanreotide acetate
    n1=lorazépam | n2=en:lanreotide acetate | rel=r_associated | relid=0 | w=10
  1783. lorazépam -- r_associated #0: 10 / 0.052 -> en:lanreotide long-acting aqueous gel
    n1=lorazépam | n2=en:lanreotide long-acting aqueous gel | rel=r_associated | relid=0 | w=10
  1784. lorazépam -- r_associated #0: 10 / 0.052 -> en:lapachone
    n1=lorazépam | n2=en:lapachone | rel=r_associated | relid=0 | w=10
  1785. lorazépam -- r_associated #0: 10 / 0.052 -> en:lapatinib ditosylate
    n1=lorazépam | n2=en:lapatinib ditosylate | rel=r_associated | relid=0 | w=10
  1786. lorazépam -- r_associated #0: 10 / 0.052 -> en:lapuleucel-t
    n1=lorazépam | n2=en:lapuleucel-t | rel=r_associated | relid=0 | w=10
  1787. lorazépam -- r_associated #0: 10 / 0.052 -> en:largetrifoliolious bugbane rhizome supplement
    n1=lorazépam | n2=en:largetrifoliolious bugbane rhizome supplement | rel=r_associated | relid=0 | w=10
  1788. lorazépam -- r_associated #0: 10 / 0.052 -> en:laromustine
    n1=lorazépam | n2=en:laromustine | rel=r_associated | relid=0 | w=10
  1789. lorazépam -- r_associated #0: 10 / 0.052 -> en:laronidase
    n1=lorazépam | n2=en:laronidase | rel=r_associated | relid=0 | w=10
  1790. lorazépam -- r_associated #0: 10 / 0.052 -> en:larotaxel
    n1=lorazépam | n2=en:larotaxel | rel=r_associated | relid=0 | w=10
  1791. lorazépam -- r_associated #0: 10 / 0.052 -> en:lauric diethanolamide
    n1=lorazépam | n2=en:lauric diethanolamide | rel=r_associated | relid=0 | w=10
  1792. lorazépam -- r_associated #0: 10 / 0.052 -> en:ledipasvir
    n1=lorazépam | n2=en:ledipasvir | rel=r_associated | relid=0 | w=10
  1793. lorazépam -- r_associated #0: 10 / 0.052 -> en:ledipasvir, sofosbuvir drug combination
    n1=lorazépam | n2=en:ledipasvir, sofosbuvir drug combination | rel=r_associated | relid=0 | w=10
  1794. lorazépam -- r_associated #0: 10 / 0.052 -> en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
    n1=lorazépam | n2=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | rel=r_associated | relid=0 | w=10
  1795. lorazépam -- r_associated #0: 10 / 0.052 -> en:lenvatinib
    n1=lorazépam | n2=en:lenvatinib | rel=r_associated | relid=0 | w=10
  1796. lorazépam -- r_associated #0: 10 / 0.052 -> en:lenvatinib mesylate
    n1=lorazépam | n2=en:lenvatinib mesylate | rel=r_associated | relid=0 | w=10
  1797. lorazépam -- r_associated #0: 10 / 0.052 -> en:leridistim
    n1=lorazépam | n2=en:leridistim | rel=r_associated | relid=0 | w=10
  1798. lorazépam -- r_associated #0: 10 / 0.052 -> en:lerisetron
    n1=lorazépam | n2=en:lerisetron | rel=r_associated | relid=0 | w=10
  1799. lorazépam -- r_associated #0: 10 / 0.052 -> en:leucine-enhanced essential amino acid dietary supplement
    n1=lorazépam | n2=en:leucine-enhanced essential amino acid dietary supplement | rel=r_associated | relid=0 | w=10
  1800. lorazépam -- r_associated #0: 10 / 0.052 -> en:leukemic apoptotic corpse-pulsed autologous dendritic cells
    n1=lorazépam | n2=en:leukemic apoptotic corpse-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=10
  1801. lorazépam -- r_associated #0: 10 / 0.052 -> en:levamisole hydrochloride
    n1=lorazépam | n2=en:levamisole hydrochloride | rel=r_associated | relid=0 | w=10
  1802. lorazépam -- r_associated #0: 10 / 0.052 -> en:levocarnitine
    n1=lorazépam | n2=en:levocarnitine | rel=r_associated | relid=0 | w=10
  1803. lorazépam -- r_associated #0: 10 / 0.052 -> en:levocarnitine tartrate
    n1=lorazépam | n2=en:levocarnitine tartrate | rel=r_associated | relid=0 | w=10
  1804. lorazépam -- r_associated #0: 10 / 0.052 -> en:levofloxacin
    n1=lorazépam | n2=en:levofloxacin | rel=r_associated | relid=0 | w=10
  1805. lorazépam -- r_associated #0: 10 / 0.052 -> en:levoleucovorin calcium
    n1=lorazépam | n2=en:levoleucovorin calcium | rel=r_associated | relid=0 | w=10
  1806. lorazépam -- r_associated #0: 10 / 0.052 -> en:lexatumumab
    n1=lorazépam | n2=en:lexatumumab | rel=r_associated | relid=0 | w=10
  1807. lorazépam -- r_associated #0: 10 / 0.052 -> en:lexibulin
    n1=lorazépam | n2=en:lexibulin | rel=r_associated | relid=0 | w=10
  1808. lorazépam -- r_associated #0: 10 / 0.052 -> en:liarozole fumarate
    n1=lorazépam | n2=en:liarozole fumarate | rel=r_associated | relid=0 | w=10
  1809. lorazépam -- r_associated #0: 10 / 0.052 -> en:licartin
    n1=lorazépam | n2=en:licartin | rel=r_associated | relid=0 | w=10
  1810. lorazépam -- r_associated #0: 10 / 0.052 -> en:licorice
    n1=lorazépam | n2=en:licorice | rel=r_associated | relid=0 | w=10
  1811. lorazépam -- r_associated #0: 10 / 0.052 -> en:linoleyl carbonate-paclitaxel
    n1=lorazépam | n2=en:linoleyl carbonate-paclitaxel | rel=r_associated | relid=0 | w=10
  1812. lorazépam -- r_associated #0: 10 / 0.052 -> en:linsitinib
    n1=lorazépam | n2=en:linsitinib | rel=r_associated | relid=0 | w=10
  1813. lorazépam -- r_associated #0: 10 / 0.052 -> en:lintuzumab
    n1=lorazépam | n2=en:lintuzumab | rel=r_associated | relid=0 | w=10
  1814. lorazépam -- r_associated #0: 10 / 0.052 -> en:lipase
    n1=lorazépam | n2=en:lipase | rel=r_associated | relid=0 | w=10
  1815. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal c-raf antisense oligonucleotide
    n1=lorazépam | n2=en:liposomal c-raf antisense oligonucleotide | rel=r_associated | relid=0 | w=10
  1816. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal cytarabine-daunorubicin cpx-351
    n1=lorazépam | n2=en:liposomal cytarabine-daunorubicin cpx-351 | rel=r_associated | relid=0 | w=10
  1817. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal daunorubicin citrate
    n1=lorazépam | n2=en:liposomal daunorubicin citrate | rel=r_associated | relid=0 | w=10
  1818. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal eribulin mesylate
    n1=lorazépam | n2=en:liposomal eribulin mesylate | rel=r_associated | relid=0 | w=10
  1819. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal irinotecan
    n1=lorazépam | n2=en:liposomal irinotecan | rel=r_associated | relid=0 | w=10
  1820. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal muc1/pet-lipid a vaccine
    n1=lorazépam | n2=en:liposomal muc1/pet-lipid a vaccine | rel=r_associated | relid=0 | w=10
  1821. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal nddp
    n1=lorazépam | n2=en:liposomal nddp | rel=r_associated | relid=0 | w=10
  1822. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposomal rhenium re 186
    n1=lorazépam | n2=en:liposomal rhenium re 186 | rel=r_associated | relid=0 | w=10
  1823. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94
    n1=lorazépam | n2=en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 | rel=r_associated | relid=0 | w=10
  1824. lorazépam -- r_associated #0: 10 / 0.052 -> en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase
    n1=lorazépam | n2=en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase | rel=r_associated | relid=0 | w=10
  1825. lorazépam -- r_associated #0: 10 / 0.052 -> en:liraglutide
    n1=lorazépam | n2=en:liraglutide | rel=r_associated | relid=0 | w=10
  1826. lorazépam -- r_associated #0: 10 / 0.052 -> en:lirilumab
    n1=lorazépam | n2=en:lirilumab | rel=r_associated | relid=0 | w=10
  1827. lorazépam -- r_associated #0: 10 / 0.052 -> en:lisdexamfetamine dimesylate
    n1=lorazépam | n2=en:lisdexamfetamine dimesylate | rel=r_associated | relid=0 | w=10
  1828. lorazépam -- r_associated #0: 10 / 0.052 -> en:lisinopril
    n1=lorazépam | n2=en:lisinopril | rel=r_associated | relid=0 | w=10
  1829. lorazépam -- r_associated #0: 10 / 0.052 -> en:listeria monocytogenes-llo-psa vaccine adxs31-142
    n1=lorazépam | n2=en:listeria monocytogenes-llo-psa vaccine adxs31-142 | rel=r_associated | relid=0 | w=10
  1830. lorazépam -- r_associated #0: 10 / 0.052 -> en:lithium carbonate
    n1=lorazépam | n2=en:lithium carbonate | rel=r_associated | relid=0 | w=10
  1831. lorazépam -- r_associated #0: 10 / 0.052 -> en:litronesib
    n1=lorazépam | n2=en:litronesib | rel=r_associated | relid=0 | w=10
  1832. lorazépam -- r_associated #0: 10 / 0.052 -> en:live attenuated measles virus vaccine
    n1=lorazépam | n2=en:live attenuated measles virus vaccine | rel=r_associated | relid=0 | w=10
  1833. lorazépam -- r_associated #0: 10 / 0.052 -> en:live freeze-dried lactic acid bacteria probiotic
    n1=lorazépam | n2=en:live freeze-dried lactic acid bacteria probiotic | rel=r_associated | relid=0 | w=10
  1834. lorazépam -- r_associated #0: 10 / 0.052 -> en:live-attenuated listeria encoding human mesothelin vaccine crs-207
    n1=lorazépam | n2=en:live-attenuated listeria encoding human mesothelin vaccine crs-207 | rel=r_associated | relid=0 | w=10
  1835. lorazépam -- r_associated #0: 10 / 0.052 -> en:lmb-1 immunotoxin
    n1=lorazépam | n2=en:lmb-1 immunotoxin | rel=r_associated | relid=0 | w=10
  1836. lorazépam -- r_associated #0: 10 / 0.052 -> en:lmb-7 immunotoxin
    n1=lorazépam | n2=en:lmb-7 immunotoxin | rel=r_associated | relid=0 | w=10
  1837. lorazépam -- r_associated #0: 10 / 0.052 -> en:lmp-2:419-427 peptide vaccine
    n1=lorazépam | n2=en:lmp-2:419-427 peptide vaccine | rel=r_associated | relid=0 | w=10
  1838. lorazépam -- r_associated #0: 10 / 0.052 -> en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes
    n1=lorazépam | n2=en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  1839. lorazépam -- r_associated #0: 10 / 0.052 -> en:lmp2a-specific cytotoxic t-lymphocytes
    n1=lorazépam | n2=en:lmp2a-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  1840. lorazépam -- r_associated #0: 10 / 0.052 -> en:lometrexol
    n1=lorazépam | n2=en:lometrexol | rel=r_associated | relid=0 | w=10
  1841. lorazépam -- r_associated #0: 10 / 0.052 -> en:lonidamine
    n1=lorazépam | n2=en:lonidamine | rel=r_associated | relid=0 | w=10
  1842. lorazépam -- r_associated #0: 10 / 0.052 -> en:lopirazepam
    n1=lorazépam | n2=en:lopirazepam | rel=r_associated | relid=0 | w=10
  1843. lorazépam -- r_associated #0: 10 / 0.052 -> en:loprazolam
    n1=lorazépam | n2=en:loprazolam | rel=r_associated | relid=0 | w=10
  1844. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorazepam 2 mg oral tablet
    n1=lorazépam | n2=en:lorazepam 2 mg oral tablet | rel=r_associated | relid=0 | w=10
  1845. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorazepam 2 mg/ml includes injectable solution and injection
    n1=lorazépam | n2=en:lorazepam 2 mg/ml includes injectable solution and injection | rel=r_associated | relid=0 | w=10
  1846. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorazepam 2 mg/ml injectable solution [ativan]
    n1=lorazépam | n2=en:lorazepam 2 mg/ml injectable solution [ativan] | rel=r_associated | relid=0 | w=10
  1847. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorazepam 2.5mg tablet
    n1=lorazépam | n2=en:lorazepam 2.5mg tablet | rel=r_associated | relid=0 | w=10
  1848. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorazepam 4 mg/ml injectable solution [ativan]
    n1=lorazépam | n2=en:lorazepam 4 mg/ml injectable solution [ativan] | rel=r_associated | relid=0 | w=10
  1849. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorazepam measurement
    n1=lorazépam | n2=en:lorazepam measurement | rel=r_associated | relid=0 | w=10
  1850. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorazepam oral tablet [ativan]
    n1=lorazépam | n2=en:lorazepam oral tablet [ativan] | rel=r_associated | relid=0 | w=10
  1851. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorlatinib
    n1=lorazépam | n2=en:lorlatinib | rel=r_associated | relid=0 | w=10
  1852. lorazépam -- r_associated #0: 10 / 0.052 -> en:lormetazepam
    n1=lorazépam | n2=en:lormetazepam | rel=r_associated | relid=0 | w=10
  1853. lorazépam -- r_associated #0: 10 / 0.052 -> en:lorvotuzumab mertansine
    n1=lorazépam | n2=en:lorvotuzumab mertansine | rel=r_associated | relid=0 | w=10
  1854. lorazépam -- r_associated #0: 10 / 0.052 -> en:losoxantrone
    n1=lorazépam | n2=en:losoxantrone | rel=r_associated | relid=0 | w=10
  1855. lorazépam -- r_associated #0: 10 / 0.052 -> en:lovastatin
    n1=lorazépam | n2=en:lovastatin | rel=r_associated | relid=0 | w=10
  1856. lorazépam -- r_associated #0: 10 / 0.052 -> en:lubricant
    n1=lorazépam | n2=en:lubricant | rel=r_associated | relid=0 | w=10
  1857. lorazépam -- r_associated #0: 10 / 0.052 -> en:lung-targeted immunomodulator qbkpn
    n1=lorazépam | n2=en:lung-targeted immunomodulator qbkpn | rel=r_associated | relid=0 | w=10
  1858. lorazépam -- r_associated #0: 10 / 0.052 -> en:lutetium lu 177 dota-biotin
    n1=lorazépam | n2=en:lutetium lu 177 dota-biotin | rel=r_associated | relid=0 | w=10
  1859. lorazépam -- r_associated #0: 10 / 0.052 -> en:lutetium lu 177 dota-jr11
    n1=lorazépam | n2=en:lutetium lu 177 dota-jr11 | rel=r_associated | relid=0 | w=10
  1860. lorazépam -- r_associated #0: 10 / 0.052 -> en:lutetium lu 177 monoclonal antibody cc49
    n1=lorazépam | n2=en:lutetium lu 177 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=10
  1861. lorazépam -- r_associated #0: 10 / 0.052 -> en:lutetium lu 177 monoclonal antibody j591
    n1=lorazépam | n2=en:lutetium lu 177 monoclonal antibody j591 | rel=r_associated | relid=0 | w=10
  1862. lorazépam -- r_associated #0: 10 / 0.052 -> en:lutetium lu-177 capromab
    n1=lorazépam | n2=en:lutetium lu-177 capromab | rel=r_associated | relid=0 | w=10
  1863. lorazépam -- r_associated #0: 10 / 0.052 -> en:ly2624587
    n1=lorazépam | n2=en:ly2624587 | rel=r_associated | relid=0 | w=10
  1864. lorazépam -- r_associated #0: 10 / 0.052 -> en:ly6k/vegfr1/vegfr2 multipeptide vaccine
    n1=lorazépam | n2=en:ly6k/vegfr1/vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  1865. lorazépam -- r_associated #0: 10 / 0.052 -> en:lycoperdon utriforme fruiting body extract
    n1=lorazépam | n2=en:lycoperdon utriforme fruiting body extract | rel=r_associated | relid=0 | w=10
  1866. lorazépam -- r_associated #0: 10 / 0.052 -> en:lymphokine-activated killer cells
    n1=lorazépam | n2=en:lymphokine-activated killer cells | rel=r_associated | relid=0 | w=10
  1867. lorazépam -- r_associated #0: 10 / 0.052 -> en:lyophilized black raspberry lozenge
    n1=lorazépam | n2=en:lyophilized black raspberry lozenge | rel=r_associated | relid=0 | w=10
  1868. lorazépam -- r_associated #0: 10 / 0.052 -> en:lyophilized black raspberry saliva substitute
    n1=lorazépam | n2=en:lyophilized black raspberry saliva substitute | rel=r_associated | relid=0 | w=10
  1869. lorazépam -- r_associated #0: 10 / 0.052 -> en:m87o-transduced cd34+ peripheral blood stem cells
    n1=lorazépam | n2=en:m87o-transduced cd34+ peripheral blood stem cells | rel=r_associated | relid=0 | w=10
  1870. lorazépam -- r_associated #0: 10 / 0.052 -> en:mac321
    n1=lorazépam | n2=en:mac321 | rel=r_associated | relid=0 | w=10
  1871. lorazépam -- r_associated #0: 10 / 0.052 -> en:macitentan
    n1=lorazépam | n2=en:macitentan | rel=r_associated | relid=0 | w=10
  1872. lorazépam -- r_associated #0: 10 / 0.052 -> en:mage-a3 peptide vaccine
    n1=lorazépam | n2=en:mage-a3 peptide vaccine | rel=r_associated | relid=0 | w=10
  1873. lorazépam -- r_associated #0: 10 / 0.052 -> en:mage-a3 reactive t cell receptor-transduced autologous t cells
    n1=lorazépam | n2=en:mage-a3 reactive t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  1874. lorazépam -- r_associated #0: 10 / 0.052 -> en:mage-a3-expressing adenovirus type 5 vaccine
    n1=lorazépam | n2=en:mage-a3-expressing adenovirus type 5 vaccine | rel=r_associated | relid=0 | w=10
  1875. lorazépam -- r_associated #0: 10 / 0.052 -> en:mage-a3/12-specific tcr gene-transduced autologous pbls
    n1=lorazépam | n2=en:mage-a3/12-specific tcr gene-transduced autologous pbls | rel=r_associated | relid=0 | w=10
  1876. lorazépam -- r_associated #0: 10 / 0.052 -> en:mage-a3/hpv 16 peptide vaccine
    n1=lorazépam | n2=en:mage-a3/hpv 16 peptide vaccine | rel=r_associated | relid=0 | w=10
  1877. lorazépam -- r_associated #0: 10 / 0.052 -> en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201
    n1=lorazépam | n2=en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 | rel=r_associated | relid=0 | w=10
  1878. lorazépam -- r_associated #0: 10 / 0.052 -> en:magnesium citrate
    n1=lorazépam | n2=en:magnesium citrate | rel=r_associated | relid=0 | w=10
  1879. lorazépam -- r_associated #0: 10 / 0.052 -> en:magnesium isoglycyrrhizinate
    n1=lorazépam | n2=en:magnesium isoglycyrrhizinate | rel=r_associated | relid=0 | w=10
  1880. lorazépam -- r_associated #0: 10 / 0.052 -> en:magnesium oxide
    n1=lorazépam | n2=en:magnesium oxide | rel=r_associated | relid=0 | w=10
  1881. lorazépam -- r_associated #0: 10 / 0.052 -> en:magnesium sulfate
    n1=lorazépam | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=10
  1882. lorazépam -- r_associated #0: 10 / 0.052 -> en:magnesium sulphate
    n1=lorazépam | n2=en:magnesium sulphate | rel=r_associated | relid=0 | w=10
  1883. lorazépam -- r_associated #0: 10 / 0.052 -> en:magnesium valproate
    n1=lorazépam | n2=en:magnesium valproate | rel=r_associated | relid=0 | w=10
  1884. lorazépam -- r_associated #0: 10 / 0.052 -> en:maitake mushroom extract
    n1=lorazépam | n2=en:maitake mushroom extract | rel=r_associated | relid=0 | w=10
  1885. lorazépam -- r_associated #0: 10 / 0.052 -> en:make a counterpart to something
    n1=lorazépam | n2=en:make a counterpart to something | rel=r_associated | relid=0 | w=10
  1886. lorazépam -- r_associated #0: 10 / 0.052 -> en:make a pair with something
    n1=lorazépam | n2=en:make a pair with something | rel=r_associated | relid=0 | w=10
  1887. lorazépam -- r_associated #0: 10 / 0.052 -> en:make somebody 's acquaintance
    n1=lorazépam | n2=en:make somebody 's acquaintance | rel=r_associated | relid=0 | w=10
  1888. lorazépam -- r_associated #0: 10 / 0.052 -> en:make somebody's acquaintance
    n1=lorazépam | n2=en:make somebody's acquaintance | rel=r_associated | relid=0 | w=10
  1889. lorazépam -- r_associated #0: 10 / 0.052 -> en:mammaglobin-a dna vaccine
    n1=lorazépam | n2=en:mammaglobin-a dna vaccine | rel=r_associated | relid=0 | w=10
  1890. lorazépam -- r_associated #0: 10 / 0.052 -> en:manuka honey
    n1=lorazépam | n2=en:manuka honey | rel=r_associated | relid=0 | w=10
  1891. lorazépam -- r_associated #0: 10 / 0.052 -> en:mapatumumab
    n1=lorazépam | n2=en:mapatumumab | rel=r_associated | relid=0 | w=10
  1892. lorazépam -- r_associated #0: 10 / 0.052 -> en:maribavir
    n1=lorazépam | n2=en:maribavir | rel=r_associated | relid=0 | w=10
  1893. lorazépam -- r_associated #0: 10 / 0.052 -> en:mart-1 reactive cd8+ lymphocytes
    n1=lorazépam | n2=en:mart-1 reactive cd8+ lymphocytes | rel=r_associated | relid=0 | w=10
  1894. lorazépam -- r_associated #0: 10 / 0.052 -> en:mart-1:26-35(27l) peptide vaccine
    n1=lorazépam | n2=en:mart-1:26-35(27l) peptide vaccine | rel=r_associated | relid=0 | w=10
  1895. lorazépam -- r_associated #0: 10 / 0.052 -> en:masitinib mesylate
    n1=lorazépam | n2=en:masitinib mesylate | rel=r_associated | relid=0 | w=10
  1896. lorazépam -- r_associated #0: 10 / 0.052 -> en:masoprocol
    n1=lorazépam | n2=en:masoprocol | rel=r_associated | relid=0 | w=10
  1897. lorazépam -- r_associated #0: 10 / 0.052 -> en:match
    n1=lorazépam | n2=en:match | rel=r_associated | relid=0 | w=10
  1898. lorazépam -- r_associated #0: 10 / 0.052 -> en:matuzumab
    n1=lorazépam | n2=en:matuzumab | rel=r_associated | relid=0 | w=10
  1899. lorazépam -- r_associated #0: 10 / 0.052 -> en:maxzide
    n1=lorazépam | n2=en:maxzide | rel=r_associated | relid=0 | w=10
  1900. lorazépam -- r_associated #0: 10 / 0.052 -> en:mcl-1 inhibitor amg 176
    n1=lorazépam | n2=en:mcl-1 inhibitor amg 176 | rel=r_associated | relid=0 | w=10
  1901. lorazépam -- r_associated #0: 10 / 0.052 -> en:mcpyv tag-specific polyclonal autologous cd8-positive t cells
    n1=lorazépam | n2=en:mcpyv tag-specific polyclonal autologous cd8-positive t cells | rel=r_associated | relid=0 | w=10
  1902. lorazépam -- r_associated #0: 10 / 0.052 -> en:mct/lct/fish oil omega-3 fatty acid lipid emulsion
    n1=lorazépam | n2=en:mct/lct/fish oil omega-3 fatty acid lipid emulsion | rel=r_associated | relid=0 | w=10
  1903. lorazépam -- r_associated #0: 10 / 0.052 -> en:mdx-1379 melanoma vaccine
    n1=lorazépam | n2=en:mdx-1379 melanoma vaccine | rel=r_associated | relid=0 | w=10
  1904. lorazépam -- r_associated #0: 10 / 0.052 -> en:me-143
    n1=lorazépam | n2=en:me-143 | rel=r_associated | relid=0 | w=10
  1905. lorazépam -- r_associated #0: 10 / 0.052 -> en:measles/mumps/rubella vaccine
    n1=lorazépam | n2=en:measles/mumps/rubella vaccine | rel=r_associated | relid=0 | w=10
  1906. lorazépam -- r_associated #0: 10 / 0.052 -> en:mechanism of action qualifier
    n1=lorazépam | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=10
  1907. lorazépam -- r_associated #0: 10 / 0.052 -> en:meclocycline sulfosalicylate
    n1=lorazépam | n2=en:meclocycline sulfosalicylate | rel=r_associated | relid=0 | w=10
  1908. lorazépam -- r_associated #0: 10 / 0.052 -> en:medazepam
    n1=lorazépam | n2=en:medazepam | rel=r_associated | relid=0 | w=10
  1909. lorazépam -- r_associated #0: 10 / 0.052 -> en:medazepam hydrochloride
    n1=lorazépam | n2=en:medazepam hydrochloride | rel=r_associated | relid=0 | w=10
  1910. lorazépam -- r_associated #0: 10 / 0.052 -> en:medical marijuana
    n1=lorazépam | n2=en:medical marijuana | rel=r_associated | relid=0 | w=10
  1911. lorazépam -- r_associated #0: 10 / 0.052 -> en:medication
    n1=lorazépam | n2=en:medication | rel=r_associated | relid=0 | w=10
  1912. lorazépam -- r_associated #0: 10 / 0.052 -> en:meet
    n1=lorazépam | n2=en:meet | rel=r_associated | relid=0 | w=10
  1913. lorazépam -- r_associated #0: 10 / 0.052 -> en:mek 1/2 inhibitor as703988/msc2015103b
    n1=lorazépam | n2=en:mek 1/2 inhibitor as703988/msc2015103b | rel=r_associated | relid=0 | w=10
  1914. lorazépam -- r_associated #0: 10 / 0.052 -> en:mek inhibitor ci-1040
    n1=lorazépam | n2=en:mek inhibitor ci-1040 | rel=r_associated | relid=0 | w=10
  1915. lorazépam -- r_associated #0: 10 / 0.052 -> en:mek inhibitor wx-554
    n1=lorazépam | n2=en:mek inhibitor wx-554 | rel=r_associated | relid=0 | w=10
  1916. lorazépam -- r_associated #0: 10 / 0.052 -> en:melan-a vlp vaccine
    n1=lorazépam | n2=en:melan-a vlp vaccine | rel=r_associated | relid=0 | w=10
  1917. lorazépam -- r_associated #0: 10 / 0.052 -> en:melanoma antigen recognized by t-cells 1, human
    n1=lorazépam | n2=en:melanoma antigen recognized by t-cells 1, human | rel=r_associated | relid=0 | w=10
  1918. lorazépam -- r_associated #0: 10 / 0.052 -> en:melphalan hydrochloride
    n1=lorazépam | n2=en:melphalan hydrochloride | rel=r_associated | relid=0 | w=10
  1919. lorazépam -- r_associated #0: 10 / 0.052 -> en:menadione topical lotion
    n1=lorazépam | n2=en:menadione topical lotion | rel=r_associated | relid=0 | w=10
  1920. lorazépam -- r_associated #0: 10 / 0.052 -> en:menitrazepam
    n1=lorazépam | n2=en:menitrazepam | rel=r_associated | relid=0 | w=10
  1921. lorazépam -- r_associated #0: 10 / 0.052 -> en:mesna
    n1=lorazépam | n2=en:mesna | rel=r_associated | relid=0 | w=10
  1922. lorazépam -- r_associated #0: 10 / 0.052 -> en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes
    n1=lorazépam | n2=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  1923. lorazépam -- r_associated #0: 10 / 0.052 -> en:met tyrosine kinase inhibitor bms-777607
    n1=lorazépam | n2=en:met tyrosine kinase inhibitor bms-777607 | rel=r_associated | relid=0 | w=10
  1924. lorazépam -- r_associated #0: 10 / 0.052 -> en:metahexamide
    n1=lorazépam | n2=en:metahexamide | rel=r_associated | relid=0 | w=10
  1925. lorazépam -- r_associated #0: 10 / 0.052 -> en:methoxsalen
    n1=lorazépam | n2=en:methoxsalen | rel=r_associated | relid=0 | w=10
  1926. lorazépam -- r_associated #0: 10 / 0.052 -> en:methoxy polyethylene glycol-epoetin beta
    n1=lorazépam | n2=en:methoxy polyethylene glycol-epoetin beta | rel=r_associated | relid=0 | w=10
  1927. lorazépam -- r_associated #0: 10 / 0.052 -> en:methyl-gag
    n1=lorazépam | n2=en:methyl-gag | rel=r_associated | relid=0 | w=10
  1928. lorazépam -- r_associated #0: 10 / 0.052 -> en:methylene dimethane sulfonate
    n1=lorazépam | n2=en:methylene dimethane sulfonate | rel=r_associated | relid=0 | w=10
  1929. lorazépam -- r_associated #0: 10 / 0.052 -> en:methyllorazepam
    n1=lorazépam | n2=en:methyllorazepam | rel=r_associated | relid=0 | w=10
  1930. lorazépam -- r_associated #0: 10 / 0.052 -> en:metoclophen-modified nausea suppository
    n1=lorazépam | n2=en:metoclophen-modified nausea suppository | rel=r_associated | relid=0 | w=10
  1931. lorazépam -- r_associated #0: 10 / 0.052 -> en:metoprine
    n1=lorazépam | n2=en:metoprine | rel=r_associated | relid=0 | w=10
  1932. lorazépam -- r_associated #0: 10 / 0.052 -> en:metreleptin
    n1=lorazépam | n2=en:metreleptin | rel=r_associated | relid=0 | w=10
  1933. lorazépam -- r_associated #0: 10 / 0.052 -> en:metronidazole hydrochloride
    n1=lorazépam | n2=en:metronidazole hydrochloride | rel=r_associated | relid=0 | w=10
  1934. lorazépam -- r_associated #0: 10 / 0.052 -> en:mexazolam
    n1=lorazépam | n2=en:mexazolam | rel=r_associated | relid=0 | w=10
  1935. lorazépam -- r_associated #0: 10 / 0.052 -> en:micafungin
    n1=lorazépam | n2=en:micafungin | rel=r_associated | relid=0 | w=10
  1936. lorazépam -- r_associated #0: 10 / 0.052 -> en:micronutrient-fortified probiotic yogurt
    n1=lorazépam | n2=en:micronutrient-fortified probiotic yogurt | rel=r_associated | relid=0 | w=10
  1937. lorazépam -- r_associated #0: 10 / 0.052 -> en:mifamurtide
    n1=lorazépam | n2=en:mifamurtide | rel=r_associated | relid=0 | w=10
  1938. lorazépam -- r_associated #0: 10 / 0.052 -> en:milatuzumab
    n1=lorazépam | n2=en:milatuzumab | rel=r_associated | relid=0 | w=10
  1939. lorazépam -- r_associated #0: 10 / 0.052 -> en:milk protein-based energy drink
    n1=lorazépam | n2=en:milk protein-based energy drink | rel=r_associated | relid=0 | w=10
  1940. lorazépam -- r_associated #0: 10 / 0.052 -> en:minocycline-edta
    n1=lorazépam | n2=en:minocycline-edta | rel=r_associated | relid=0 | w=10
  1941. lorazépam -- r_associated #0: 10 / 0.052 -> en:miracle mouthwash plus hydrocortisone
    n1=lorazépam | n2=en:miracle mouthwash plus hydrocortisone | rel=r_associated | relid=0 | w=10
  1942. lorazépam -- r_associated #0: 10 / 0.052 -> en:mitogen
    n1=lorazépam | n2=en:mitogen | rel=r_associated | relid=0 | w=10
  1943. lorazépam -- r_associated #0: 10 / 0.052 -> en:mitoguazone
    n1=lorazépam | n2=en:mitoguazone | rel=r_associated | relid=0 | w=10
  1944. lorazépam -- r_associated #0: 10 / 0.052 -> en:mk-4280
    n1=lorazépam | n2=en:mk-4280 | rel=r_associated | relid=0 | w=10
  1945. lorazépam -- r_associated #0: 10 / 0.052 -> en:mknk1 inhibitor bay 1143269
    n1=lorazépam | n2=en:mknk1 inhibitor bay 1143269 | rel=r_associated | relid=0 | w=10
  1946. lorazépam -- r_associated #0: 10 / 0.052 -> en:mnk1/2 inhibitor eft508
    n1=lorazépam | n2=en:mnk1/2 inhibitor eft508 | rel=r_associated | relid=0 | w=10
  1947. lorazépam -- r_associated #0: 10 / 0.052 -> en:mnsod mimetic bmx-001
    n1=lorazépam | n2=en:mnsod mimetic bmx-001 | rel=r_associated | relid=0 | w=10
  1948. lorazépam -- r_associated #0: 10 / 0.052 -> en:modafinil
    n1=lorazépam | n2=en:modafinil | rel=r_associated | relid=0 | w=10
  1949. lorazépam -- r_associated #0: 10 / 0.052 -> en:modified citrus pectin supplement
    n1=lorazépam | n2=en:modified citrus pectin supplement | rel=r_associated | relid=0 | w=10
  1950. lorazépam -- r_associated #0: 10 / 0.052 -> en:mogamulizumab
    n1=lorazépam | n2=en:mogamulizumab | rel=r_associated | relid=0 | w=10
  1951. lorazépam -- r_associated #0: 10 / 0.052 -> en:monkey wrench
    n1=lorazépam | n2=en:monkey wrench | rel=r_associated | relid=0 | w=10
  1952. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoacetyldiglyceride ec-18
    n1=lorazépam | n2=en:monoacetyldiglyceride ec-18 | rel=r_associated | relid=0 | w=10
  1953. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody 11d10 anti-idiotype vaccine
    n1=lorazépam | n2=en:monoclonal antibody 11d10 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  1954. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody 3622w94
    n1=lorazépam | n2=en:monoclonal antibody 3622w94 | rel=r_associated | relid=0 | w=10
  1955. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody a1g4 anti-idiotype vaccine
    n1=lorazépam | n2=en:monoclonal antibody a1g4 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  1956. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody agent
    n1=lorazépam | n2=en:monoclonal antibody agent | rel=r_associated | relid=0 | w=10
  1957. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody cal
    n1=lorazépam | n2=en:monoclonal antibody cal | rel=r_associated | relid=0 | w=10
  1958. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody cc49
    n1=lorazépam | n2=en:monoclonal antibody cc49 | rel=r_associated | relid=0 | w=10
  1959. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody cc49-streptavidin conjugate
    n1=lorazépam | n2=en:monoclonal antibody cc49-streptavidin conjugate | rel=r_associated | relid=0 | w=10
  1960. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody cd19
    n1=lorazépam | n2=en:monoclonal antibody cd19 | rel=r_associated | relid=0 | w=10
  1961. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody cep-37250/khk2804
    n1=lorazépam | n2=en:monoclonal antibody cep-37250/khk2804 | rel=r_associated | relid=0 | w=10
  1962. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody f19
    n1=lorazépam | n2=en:monoclonal antibody f19 | rel=r_associated | relid=0 | w=10
  1963. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody hu3s193
    n1=lorazépam | n2=en:monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=10
  1964. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody huhmfg1
    n1=lorazépam | n2=en:monoclonal antibody huhmfg1 | rel=r_associated | relid=0 | w=10
  1965. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody huj591
    n1=lorazépam | n2=en:monoclonal antibody huj591 | rel=r_associated | relid=0 | w=10
  1966. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody hupam4
    n1=lorazépam | n2=en:monoclonal antibody hupam4 | rel=r_associated | relid=0 | w=10
  1967. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody ing-1
    n1=lorazépam | n2=en:monoclonal antibody ing-1 | rel=r_associated | relid=0 | w=10
  1968. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody me1-14 f(ab')2
    n1=lorazépam | n2=en:monoclonal antibody me1-14 f(ab')2 | rel=r_associated | relid=0 | w=10
  1969. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody mono-dga-rfb4
    n1=lorazépam | n2=en:monoclonal antibody mono-dga-rfb4 | rel=r_associated | relid=0 | w=10
  1970. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody rav12
    n1=lorazépam | n2=en:monoclonal antibody rav12 | rel=r_associated | relid=0 | w=10
  1971. lorazépam -- r_associated #0: 10 / 0.052 -> en:monoclonal antibody sgn-30
    n1=lorazépam | n2=en:monoclonal antibody sgn-30 | rel=r_associated | relid=0 | w=10
  1972. lorazépam -- r_associated #0: 10 / 0.052 -> en:motexafin gadolinium
    n1=lorazépam | n2=en:motexafin gadolinium | rel=r_associated | relid=0 | w=10
  1973. lorazépam -- r_associated #0: 10 / 0.052 -> en:motrazepam
    n1=lorazépam | n2=en:motrazepam | rel=r_associated | relid=0 | w=10
  1974. lorazépam -- r_associated #0: 10 / 0.052 -> en:moxetumomab pasudotox
    n1=lorazépam | n2=en:moxetumomab pasudotox | rel=r_associated | relid=0 | w=10
  1975. lorazépam -- r_associated #0: 10 / 0.052 -> en:mps1 kinase inhibitor bay1161909
    n1=lorazépam | n2=en:mps1 kinase inhibitor bay1161909 | rel=r_associated | relid=0 | w=10
  1976. lorazépam -- r_associated #0: 10 / 0.052 -> en:mtf-1 inhibitor apto-253 hcl
    n1=lorazépam | n2=en:mtf-1 inhibitor apto-253 hcl | rel=r_associated | relid=0 | w=10
  1977. lorazépam -- r_associated #0: 10 / 0.052 -> en:mtor kinase inhibitor azd8055
    n1=lorazépam | n2=en:mtor kinase inhibitor azd8055 | rel=r_associated | relid=0 | w=10
  1978. lorazépam -- r_associated #0: 10 / 0.052 -> en:mtorc1/2 kinase inhibitor bi 860585
    n1=lorazépam | n2=en:mtorc1/2 kinase inhibitor bi 860585 | rel=r_associated | relid=0 | w=10
  1979. lorazépam -- r_associated #0: 10 / 0.052 -> en:muc-2-globo h-klh conjugate vaccine
    n1=lorazépam | n2=en:muc-2-globo h-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  1980. lorazépam -- r_associated #0: 10 / 0.052 -> en:muc-2-klh vaccine
    n1=lorazépam | n2=en:muc-2-klh vaccine | rel=r_associated | relid=0 | w=10
  1981. lorazépam -- r_associated #0: 10 / 0.052 -> en:muc1 peptide-poly-iclc adjuvant vaccine
    n1=lorazépam | n2=en:muc1 peptide-poly-iclc adjuvant vaccine | rel=r_associated | relid=0 | w=10
  1982. lorazépam -- r_associated #0: 10 / 0.052 -> en:mucoadhesive oral wound rinse
    n1=lorazépam | n2=en:mucoadhesive oral wound rinse | rel=r_associated | relid=0 | w=10
  1983. lorazépam -- r_associated #0: 10 / 0.052 -> en:multicarotenoid supplement mcs-8
    n1=lorazépam | n2=en:multicarotenoid supplement mcs-8 | rel=r_associated | relid=0 | w=10
  1984. lorazépam -- r_associated #0: 10 / 0.052 -> en:multidrug resistance modulator
    n1=lorazépam | n2=en:multidrug resistance modulator | rel=r_associated | relid=0 | w=10
  1985. lorazépam -- r_associated #0: 10 / 0.052 -> en:multifunctional/multitargeted anticancer agent omn54
    n1=lorazépam | n2=en:multifunctional/multitargeted anticancer agent omn54 | rel=r_associated | relid=0 | w=10
  1986. lorazépam -- r_associated #0: 10 / 0.052 -> en:multikinase inhibitor arry614
    n1=lorazépam | n2=en:multikinase inhibitor arry614 | rel=r_associated | relid=0 | w=10
  1987. lorazépam -- r_associated #0: 10 / 0.052 -> en:multikinase inhibitor sar103168
    n1=lorazépam | n2=en:multikinase inhibitor sar103168 | rel=r_associated | relid=0 | w=10
  1988. lorazépam -- r_associated #0: 10 / 0.052 -> en:multipeptide vaccine s-588210
    n1=lorazépam | n2=en:multipeptide vaccine s-588210 | rel=r_associated | relid=0 | w=10
  1989. lorazépam -- r_associated #0: 10 / 0.052 -> en:multitargeted tyrosine kinase inhibitor jnj-26483327
    n1=lorazépam | n2=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | rel=r_associated | relid=0 | w=10
  1990. lorazépam -- r_associated #0: 10 / 0.052 -> en:muscadine grape skin extract
    n1=lorazépam | n2=en:muscadine grape skin extract | rel=r_associated | relid=0 | w=10
  1991. lorazépam -- r_associated #0: 10 / 0.052 -> en:muscle relaxant
    n1=lorazépam | n2=en:muscle relaxant | rel=r_associated | relid=0 | w=10
  1992. lorazépam -- r_associated #0: 10 / 0.052 -> en:mutagen
    n1=lorazépam | n2=en:mutagen | rel=r_associated | relid=0 | w=10
  1993. lorazépam -- r_associated #0: 10 / 0.052 -> en:mycobacterium tuberculosis arabinomannan z-100
    n1=lorazépam | n2=en:mycobacterium tuberculosis arabinomannan z-100 | rel=r_associated | relid=0 | w=10
  1994. lorazépam -- r_associated #0: 10 / 0.052 -> en:mycophenolic acid
    n1=lorazépam | n2=en:mycophenolic acid | rel=r_associated | relid=0 | w=10
  1995. lorazépam -- r_associated #0: 10 / 0.052 -> en:n-(2-hydroxyethyl)lorazepam
    n1=lorazépam | n2=en:n-(2-hydroxyethyl)lorazepam | rel=r_associated | relid=0 | w=10
  1996. lorazépam -- r_associated #0: 10 / 0.052 -> en:n-methylformamide
    n1=lorazépam | n2=en:n-methylformamide | rel=r_associated | relid=0 | w=10
  1997. lorazépam -- r_associated #0: 10 / 0.052 -> en:nab-paclitaxel
    n1=lorazépam | n2=en:nab-paclitaxel | rel=r_associated | relid=0 | w=10
  1998. lorazépam -- r_associated #0: 10 / 0.052 -> en:nadolol
    n1=lorazépam | n2=en:nadolol | rel=r_associated | relid=0 | w=10
  1999. lorazépam -- r_associated #0: 10 / 0.052 -> en:nadroparin calcium
    n1=lorazépam | n2=en:nadroparin calcium | rel=r_associated | relid=0 | w=10
  2000. lorazépam -- r_associated #0: 10 / 0.052 -> en:nanoparticle-encapsulated doxorubicin hydrochloride
    n1=lorazépam | n2=en:nanoparticle-encapsulated doxorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  2001. lorazépam -- r_associated #0: 10 / 0.052 -> en:naproxen
    n1=lorazépam | n2=en:naproxen | rel=r_associated | relid=0 | w=10
  2002. lorazépam -- r_associated #0: 10 / 0.052 -> en:nasal saline irrigation solution
    n1=lorazépam | n2=en:nasal saline irrigation solution | rel=r_associated | relid=0 | w=10
  2003. lorazépam -- r_associated #0: 10 / 0.052 -> en:natalizumab
    n1=lorazépam | n2=en:natalizumab | rel=r_associated | relid=0 | w=10
  2004. lorazépam -- r_associated #0: 10 / 0.052 -> en:nd-420
    n1=lorazépam | n2=en:nd-420 | rel=r_associated | relid=0 | w=10
  2005. lorazépam -- r_associated #0: 10 / 0.052 -> en:necitumumab
    n1=lorazépam | n2=en:necitumumab | rel=r_associated | relid=0 | w=10
  2006. lorazépam -- r_associated #0: 10 / 0.052 -> en:nelfinavir mesylate
    n1=lorazépam | n2=en:nelfinavir mesylate | rel=r_associated | relid=0 | w=10
  2007. lorazépam -- r_associated #0: 10 / 0.052 -> en:nelipepimut-s plus gm-csf vaccine
    n1=lorazépam | n2=en:nelipepimut-s plus gm-csf vaccine | rel=r_associated | relid=0 | w=10
  2008. lorazépam -- r_associated #0: 10 / 0.052 -> en:netazepide
    n1=lorazépam | n2=en:netazepide | rel=r_associated | relid=0 | w=10
  2009. lorazépam -- r_associated #0: 10 / 0.052 -> en:netupitant
    n1=lorazépam | n2=en:netupitant | rel=r_associated | relid=0 | w=10
  2010. lorazépam -- r_associated #0: 10 / 0.052 -> en:neuromuscular blocking agents
    n1=lorazépam | n2=en:neuromuscular blocking agents | rel=r_associated | relid=0 | w=10
  2011. lorazépam -- r_associated #0: 10 / 0.052 -> en:neutrophil activation probe imaging agent
    n1=lorazépam | n2=en:neutrophil activation probe imaging agent | rel=r_associated | relid=0 | w=10
  2012. lorazépam -- r_associated #0: 10 / 0.052 -> en:niacinamide
    n1=lorazépam | n2=en:niacinamide | rel=r_associated | relid=0 | w=10
  2013. lorazépam -- r_associated #0: 10 / 0.052 -> en:nicotinamide
    n1=lorazépam | n2=en:nicotinamide | rel=r_associated | relid=0 | w=10
  2014. lorazépam -- r_associated #0: 10 / 0.052 -> en:nicotine
    n1=lorazépam | n2=en:nicotine | rel=r_associated | relid=0 | w=10
  2015. lorazépam -- r_associated #0: 10 / 0.052 -> en:nicotine lozenge
    n1=lorazépam | n2=en:nicotine lozenge | rel=r_associated | relid=0 | w=10
  2016. lorazépam -- r_associated #0: 10 / 0.052 -> en:nicotine nasal spray
    n1=lorazépam | n2=en:nicotine nasal spray | rel=r_associated | relid=0 | w=10
  2017. lorazépam -- r_associated #0: 10 / 0.052 -> en:nicotine patch
    n1=lorazépam | n2=en:nicotine patch | rel=r_associated | relid=0 | w=10
  2018. lorazépam -- r_associated #0: 10 / 0.052 -> en:nilandron
    n1=lorazépam | n2=en:nilandron | rel=r_associated | relid=0 | w=10
  2019. lorazépam -- r_associated #0: 10 / 0.052 -> en:nilotinib
    n1=lorazépam | n2=en:nilotinib | rel=r_associated | relid=0 | w=10
  2020. lorazépam -- r_associated #0: 10 / 0.052 -> en:nimetazepam
    n1=lorazépam | n2=en:nimetazepam | rel=r_associated | relid=0 | w=10
  2021. lorazépam -- r_associated #0: 10 / 0.052 -> en:nimotuzumab
    n1=lorazépam | n2=en:nimotuzumab | rel=r_associated | relid=0 | w=10
  2022. lorazépam -- r_associated #0: 10 / 0.052 -> en:nintedanib
    n1=lorazépam | n2=en:nintedanib | rel=r_associated | relid=0 | w=10
  2023. lorazépam -- r_associated #0: 10 / 0.052 -> en:nitric oxide-releasing acetylsalicylic acid derivative
    n1=lorazépam | n2=en:nitric oxide-releasing acetylsalicylic acid derivative | rel=r_associated | relid=0 | w=10
  2024. lorazépam -- r_associated #0: 10 / 0.052 -> en:nitroglycerin transdermal patch
    n1=lorazépam | n2=en:nitroglycerin transdermal patch | rel=r_associated | relid=0 | w=10
  2025. lorazépam -- r_associated #0: 10 / 0.052 -> en:nitroglycerin/sodium citrate/ethanol solution
    n1=lorazépam | n2=en:nitroglycerin/sodium citrate/ethanol solution | rel=r_associated | relid=0 | w=10
  2026. lorazépam -- r_associated #0: 10 / 0.052 -> en:nolatrexed dihydrochloride
    n1=lorazépam | n2=en:nolatrexed dihydrochloride | rel=r_associated | relid=0 | w=10
  2027. lorazépam -- r_associated #0: 10 / 0.052 -> en:nordazepam
    n1=lorazépam | n2=en:nordazepam | rel=r_associated | relid=0 | w=10
  2028. lorazépam -- r_associated #0: 10 / 0.052 -> en:norepinephrine, dl-
    n1=lorazépam | n2=en:norepinephrine, dl- | rel=r_associated | relid=0 | w=10
  2029. lorazépam -- r_associated #0: 10 / 0.052 -> en:notch signaling inhibitor pf-06650808
    n1=lorazépam | n2=en:notch signaling inhibitor pf-06650808 | rel=r_associated | relid=0 | w=10
  2030. lorazépam -- r_associated #0: 10 / 0.052 -> en:novobiocin
    n1=lorazépam | n2=en:novobiocin | rel=r_associated | relid=0 | w=10
  2031. lorazépam -- r_associated #0: 10 / 0.052 -> en:ns-9
    n1=lorazépam | n2=en:ns-9 | rel=r_associated | relid=0 | w=10
  2032. lorazépam -- r_associated #0: 10 / 0.052 -> en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes
    n1=lorazépam | n2=en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes | rel=r_associated | relid=0 | w=10
  2033. lorazépam -- r_associated #0: 10 / 0.052 -> en:nutraceutical tbl-12
    n1=lorazépam | n2=en:nutraceutical tbl-12 | rel=r_associated | relid=0 | w=10
  2034. lorazépam -- r_associated #0: 10 / 0.052 -> en:nutritional supplement drink
    n1=lorazépam | n2=en:nutritional supplement drink | rel=r_associated | relid=0 | w=10
  2035. lorazépam -- r_associated #0: 10 / 0.052 -> en:nx-1207
    n1=lorazépam | n2=en:nx-1207 | rel=r_associated | relid=0 | w=10
  2036. lorazépam -- r_associated #0: 10 / 0.052 -> en:ny-eso-1 protein vaccine plus montanide isa-51 vg
    n1=lorazépam | n2=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | rel=r_associated | relid=0 | w=10
  2037. lorazépam -- r_associated #0: 10 / 0.052 -> en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine
    n1=lorazépam | n2=en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2038. lorazépam -- r_associated #0: 10 / 0.052 -> en:ny-eso-1/lage-1 peptide vaccine
    n1=lorazépam | n2=en:ny-eso-1/lage-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  2039. lorazépam -- r_associated #0: 10 / 0.052 -> en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine
    n1=lorazépam | n2=en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  2040. lorazépam -- r_associated #0: 10 / 0.052 -> en:ny-eso-1b peptide vaccine
    n1=lorazépam | n2=en:ny-eso-1b peptide vaccine | rel=r_associated | relid=0 | w=10
  2041. lorazépam -- r_associated #0: 10 / 0.052 -> en:ocaratuzumab
    n1=lorazépam | n2=en:ocaratuzumab | rel=r_associated | relid=0 | w=10
  2042. lorazépam -- r_associated #0: 10 / 0.052 -> en:ocrelizumab
    n1=lorazépam | n2=en:ocrelizumab | rel=r_associated | relid=0 | w=10
  2043. lorazépam -- r_associated #0: 10 / 0.052 -> en:octreotide acetate
    n1=lorazépam | n2=en:octreotide acetate | rel=r_associated | relid=0 | w=10
  2044. lorazépam -- r_associated #0: 10 / 0.052 -> en:odanacatib
    n1=lorazépam | n2=en:odanacatib | rel=r_associated | relid=0 | w=10
  2045. lorazépam -- r_associated #0: 10 / 0.052 -> en:olanzapine
    n1=lorazépam | n2=en:olanzapine | rel=r_associated | relid=0 | w=10
  2046. lorazépam -- r_associated #0: 10 / 0.052 -> en:olaparib
    n1=lorazépam | n2=en:olaparib | rel=r_associated | relid=0 | w=10
  2047. lorazépam -- r_associated #0: 10 / 0.052 -> en:olive oil extract/curcumin-based capsule
    n1=lorazépam | n2=en:olive oil extract/curcumin-based capsule | rel=r_associated | relid=0 | w=10
  2048. lorazépam -- r_associated #0: 10 / 0.052 -> en:olive oil/soya oil/egg lecithin-based emulsion
    n1=lorazépam | n2=en:olive oil/soya oil/egg lecithin-based emulsion | rel=r_associated | relid=0 | w=10
  2049. lorazépam -- r_associated #0: 10 / 0.052 -> en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion
    n1=lorazépam | n2=en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion | rel=r_associated | relid=0 | w=10
  2050. lorazépam -- r_associated #0: 10 / 0.052 -> en:olodaterol
    n1=lorazépam | n2=en:olodaterol | rel=r_associated | relid=0 | w=10
  2051. lorazépam -- r_associated #0: 10 / 0.052 -> en:omalizumab
    n1=lorazépam | n2=en:omalizumab | rel=r_associated | relid=0 | w=10
  2052. lorazépam -- r_associated #0: 10 / 0.052 -> en:omeprazole
    n1=lorazépam | n2=en:omeprazole | rel=r_associated | relid=0 | w=10
  2053. lorazépam -- r_associated #0: 10 / 0.052 -> en:onartuzumab
    n1=lorazépam | n2=en:onartuzumab | rel=r_associated | relid=0 | w=10
  2054. lorazépam -- r_associated #0: 10 / 0.052 -> en:oncolytic adenovirus encoding gm-csf
    n1=lorazépam | n2=en:oncolytic adenovirus encoding gm-csf | rel=r_associated | relid=0 | w=10
  2055. lorazépam -- r_associated #0: 10 / 0.052 -> en:onyx-015
    n1=lorazépam | n2=en:onyx-015 | rel=r_associated | relid=0 | w=10
  2056. lorazépam -- r_associated #0: 10 / 0.052 -> en:opb-111001
    n1=lorazépam | n2=en:opb-111001 | rel=r_associated | relid=0 | w=10
  2057. lorazépam -- r_associated #0: 10 / 0.052 -> en:open end wrench
    n1=lorazépam | n2=en:open end wrench | rel=r_associated | relid=0 | w=10
  2058. lorazépam -- r_associated #0: 10 / 0.052 -> en:open-end wrench
    n1=lorazépam | n2=en:open-end wrench | rel=r_associated | relid=0 | w=10
  2059. lorazépam -- r_associated #0: 10 / 0.052 -> en:open-ended spanner
    n1=lorazépam | n2=en:open-ended spanner | rel=r_associated | relid=0 | w=10
  2060. lorazépam -- r_associated #0: 10 / 0.052 -> en:opioid agonist gic-1001
    n1=lorazépam | n2=en:opioid agonist gic-1001 | rel=r_associated | relid=0 | w=10
  2061. lorazépam -- r_associated #0: 10 / 0.052 -> en:oppa regimen
    n1=lorazépam | n2=en:oppa regimen | rel=r_associated | relid=0 | w=10
  2062. lorazépam -- r_associated #0: 10 / 0.052 -> en:oprelvekin
    n1=lorazépam | n2=en:oprelvekin | rel=r_associated | relid=0 | w=10
  2063. lorazépam -- r_associated #0: 10 / 0.052 -> en:oral dosage form product
    n1=lorazépam | n2=en:oral dosage form product | rel=r_associated | relid=0 | w=10
  2064. lorazépam -- r_associated #0: 10 / 0.052 -> en:oral form lorazepam
    n1=lorazépam | n2=en:oral form lorazepam | rel=r_associated | relid=0 | w=10
  2065. lorazépam -- r_associated #0: 10 / 0.052 -> en:oral sodium phenylbutyrate
    n1=lorazépam | n2=en:oral sodium phenylbutyrate | rel=r_associated | relid=0 | w=10
  2066. lorazépam -- r_associated #0: 10 / 0.052 -> en:orantinib
    n1=lorazépam | n2=en:orantinib | rel=r_associated | relid=0 | w=10
  2067. lorazépam -- r_associated #0: 10 / 0.052 -> en:orteronel
    n1=lorazépam | n2=en:orteronel | rel=r_associated | relid=0 | w=10
  2068. lorazépam -- r_associated #0: 10 / 0.052 -> en:oseltamivir phosphate
    n1=lorazépam | n2=en:oseltamivir phosphate | rel=r_associated | relid=0 | w=10
  2069. lorazépam -- r_associated #0: 10 / 0.052 -> en:oteracil potassium
    n1=lorazépam | n2=en:oteracil potassium | rel=r_associated | relid=0 | w=10
  2070. lorazépam -- r_associated #0: 10 / 0.052 -> en:over the counter product
    n1=lorazépam | n2=en:over the counter product | rel=r_associated | relid=0 | w=10
  2071. lorazépam -- r_associated #0: 10 / 0.052 -> en:oxitriptan
    n1=lorazépam | n2=en:oxitriptan | rel=r_associated | relid=0 | w=10
  2072. lorazépam -- r_associated #0: 10 / 0.052 -> en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet
    n1=lorazépam | n2=en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet | rel=r_associated | relid=0 | w=10
  2073. lorazépam -- r_associated #0: 10 / 0.052 -> en:oxymetholone
    n1=lorazépam | n2=en:oxymetholone | rel=r_associated | relid=0 | w=10
  2074. lorazépam -- r_associated #0: 10 / 0.052 -> en:p-tefb inhibitor bay1143572
    n1=lorazépam | n2=en:p-tefb inhibitor bay1143572 | rel=r_associated | relid=0 | w=10
  2075. lorazépam -- r_associated #0: 10 / 0.052 -> en:p16_37-63 peptide vaccine
    n1=lorazépam | n2=en:p16_37-63 peptide vaccine | rel=r_associated | relid=0 | w=10
  2076. lorazépam -- r_associated #0: 10 / 0.052 -> en:p53 peptide vaccine
    n1=lorazépam | n2=en:p53 peptide vaccine | rel=r_associated | relid=0 | w=10
  2077. lorazépam -- r_associated #0: 10 / 0.052 -> en:p53-synthetic long peptides vaccine
    n1=lorazépam | n2=en:p53-synthetic long peptides vaccine | rel=r_associated | relid=0 | w=10
  2078. lorazépam -- r_associated #0: 10 / 0.052 -> en:paclitaxel trevatide
    n1=lorazépam | n2=en:paclitaxel trevatide | rel=r_associated | relid=0 | w=10
  2079. lorazépam -- r_associated #0: 10 / 0.052 -> en:pad regimen
    n1=lorazépam | n2=en:pad regimen | rel=r_associated | relid=0 | w=10
  2080. lorazépam -- r_associated #0: 10 / 0.052 -> en:padre-cmv fusion peptide vaccine
    n1=lorazépam | n2=en:padre-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=10
  2081. lorazépam -- r_associated #0: 10 / 0.052 -> en:pak4 inhibitor pf-03758309
    n1=lorazépam | n2=en:pak4 inhibitor pf-03758309 | rel=r_associated | relid=0 | w=10
  2082. lorazépam -- r_associated #0: 10 / 0.052 -> en:palbociclib
    n1=lorazépam | n2=en:palbociclib | rel=r_associated | relid=0 | w=10
  2083. lorazépam -- r_associated #0: 10 / 0.052 -> en:palivizumab
    n1=lorazépam | n2=en:palivizumab | rel=r_associated | relid=0 | w=10
  2084. lorazépam -- r_associated #0: 10 / 0.052 -> en:palladium-bacteriopheophorbide
    n1=lorazépam | n2=en:palladium-bacteriopheophorbide | rel=r_associated | relid=0 | w=10
  2085. lorazépam -- r_associated #0: 10 / 0.052 -> en:palm extract phytonutrient supplement
    n1=lorazépam | n2=en:palm extract phytonutrient supplement | rel=r_associated | relid=0 | w=10
  2086. lorazépam -- r_associated #0: 10 / 0.052 -> en:palonosetron hydrochloride
    n1=lorazépam | n2=en:palonosetron hydrochloride | rel=r_associated | relid=0 | w=10
  2087. lorazépam -- r_associated #0: 10 / 0.052 -> en:pamidronate disodium
    n1=lorazépam | n2=en:pamidronate disodium | rel=r_associated | relid=0 | w=10
  2088. lorazépam -- r_associated #0: 10 / 0.052 -> en:pan-her kinase inhibitor ac480
    n1=lorazépam | n2=en:pan-her kinase inhibitor ac480 | rel=r_associated | relid=0 | w=10
  2089. lorazépam -- r_associated #0: 10 / 0.052 -> en:pan-pi3k/mtor inhibitor sf1126
    n1=lorazépam | n2=en:pan-pi3k/mtor inhibitor sf1126 | rel=r_associated | relid=0 | w=10
  2090. lorazépam -- r_associated #0: 10 / 0.052 -> en:pan-selectin antagonist gmi-1070
    n1=lorazépam | n2=en:pan-selectin antagonist gmi-1070 | rel=r_associated | relid=0 | w=10
  2091. lorazépam -- r_associated #0: 10 / 0.052 -> en:panitumumab
    n1=lorazépam | n2=en:panitumumab | rel=r_associated | relid=0 | w=10
  2092. lorazépam -- r_associated #0: 10 / 0.052 -> en:panitumumab-irdye800
    n1=lorazépam | n2=en:panitumumab-irdye800 | rel=r_associated | relid=0 | w=10
  2093. lorazépam -- r_associated #0: 10 / 0.052 -> en:pantoprazole sodium
    n1=lorazépam | n2=en:pantoprazole sodium | rel=r_associated | relid=0 | w=10
  2094. lorazépam -- r_associated #0: 10 / 0.052 -> en:parathyroid hormone-related protein (1-36)
    n1=lorazépam | n2=en:parathyroid hormone-related protein (1-36) | rel=r_associated | relid=0 | w=10
  2095. lorazépam -- r_associated #0: 10 / 0.052 -> en:parenteral dosage form product
    n1=lorazépam | n2=en:parenteral dosage form product | rel=r_associated | relid=0 | w=10
  2096. lorazépam -- r_associated #0: 10 / 0.052 -> en:parenteral form dexamethasone
    n1=lorazépam | n2=en:parenteral form dexamethasone | rel=r_associated | relid=0 | w=10
  2097. lorazépam -- r_associated #0: 10 / 0.052 -> en:paricalcitol
    n1=lorazépam | n2=en:paricalcitol | rel=r_associated | relid=0 | w=10
  2098. lorazépam -- r_associated #0: 10 / 0.052 -> en:paroxetine hydrochloride
    n1=lorazépam | n2=en:paroxetine hydrochloride | rel=r_associated | relid=0 | w=10
  2099. lorazépam -- r_associated #0: 10 / 0.052 -> en:parp inhibitor azd2461
    n1=lorazépam | n2=en:parp inhibitor azd2461 | rel=r_associated | relid=0 | w=10
  2100. lorazépam -- r_associated #0: 10 / 0.052 -> en:parp inhibitor cep-9722
    n1=lorazépam | n2=en:parp inhibitor cep-9722 | rel=r_associated | relid=0 | w=10
  2101. lorazépam -- r_associated #0: 10 / 0.052 -> en:parp-1/2 inhibitor abt-767
    n1=lorazépam | n2=en:parp-1/2 inhibitor abt-767 | rel=r_associated | relid=0 | w=10
  2102. lorazépam -- r_associated #0: 10 / 0.052 -> en:parvovirus h-1
    n1=lorazépam | n2=en:parvovirus h-1 | rel=r_associated | relid=0 | w=10
  2103. lorazépam -- r_associated #0: 10 / 0.052 -> en:patritumab
    n1=lorazépam | n2=en:patritumab | rel=r_associated | relid=0 | w=10
  2104. lorazépam -- r_associated #0: 10 / 0.052 -> en:patupilone
    n1=lorazépam | n2=en:patupilone | rel=r_associated | relid=0 | w=10
  2105. lorazépam -- r_associated #0: 10 / 0.052 -> en:pazopanib hydrochloride
    n1=lorazépam | n2=en:pazopanib hydrochloride | rel=r_associated | relid=0 | w=10
  2106. lorazépam -- r_associated #0: 10 / 0.052 -> en:pbcar3 phosphopeptide-tetanus peptide vaccine
    n1=lorazépam | n2=en:pbcar3 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=10
  2107. lorazépam -- r_associated #0: 10 / 0.052 -> en:pd0325901
    n1=lorazépam | n2=en:pd0325901 | rel=r_associated | relid=0 | w=10
  2108. lorazépam -- r_associated #0: 10 / 0.052 -> en:pdcd-1 knockout autologous t-lymphocytes
    n1=lorazépam | n2=en:pdcd-1 knockout autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  2109. lorazépam -- r_associated #0: 10 / 0.052 -> en:pdgfr alpha/kit mutant-specific inhibitor blu-285
    n1=lorazépam | n2=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | rel=r_associated | relid=0 | w=10
  2110. lorazépam -- r_associated #0: 10 / 0.052 -> en:pdm08
    n1=lorazépam | n2=en:pdm08 | rel=r_associated | relid=0 | w=10
  2111. lorazépam -- r_associated #0: 10 / 0.052 -> en:pediatric nutritional supplement drink
    n1=lorazépam | n2=en:pediatric nutritional supplement drink | rel=r_associated | relid=0 | w=10
  2112. lorazépam -- r_associated #0: 10 / 0.052 -> en:peg recombinant human megakaryocyte growth and development factor
    n1=lorazépam | n2=en:peg recombinant human megakaryocyte growth and development factor | rel=r_associated | relid=0 | w=10
  2113. lorazépam -- r_associated #0: 10 / 0.052 -> en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative
    n1=lorazépam | n2=en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative | rel=r_associated | relid=0 | w=10
  2114. lorazépam -- r_associated #0: 10 / 0.052 -> en:pegamotecan
    n1=lorazépam | n2=en:pegamotecan | rel=r_associated | relid=0 | w=10
  2115. lorazépam -- r_associated #0: 10 / 0.052 -> en:pegylated anti-gfr antibody fragment
    n1=lorazépam | n2=en:pegylated anti-gfr antibody fragment | rel=r_associated | relid=0 | w=10
  2116. lorazépam -- r_associated #0: 10 / 0.052 -> en:pegylated arginine deiminase
    n1=lorazépam | n2=en:pegylated arginine deiminase | rel=r_associated | relid=0 | w=10
  2117. lorazépam -- r_associated #0: 10 / 0.052 -> en:pegylated granulocyte colony stimulating factor maxy-g34
    n1=lorazépam | n2=en:pegylated granulocyte colony stimulating factor maxy-g34 | rel=r_associated | relid=0 | w=10
  2118. lorazépam -- r_associated #0: 10 / 0.052 -> en:pegylated human recombinant arginase 1 aeb1102
    n1=lorazépam | n2=en:pegylated human recombinant arginase 1 aeb1102 | rel=r_associated | relid=0 | w=10
  2119. lorazépam -- r_associated #0: 10 / 0.052 -> en:pegylated recombinant l-asparaginase erwinia chrysanthemi
    n1=lorazépam | n2=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=10
  2120. lorazépam -- r_associated #0: 10 / 0.052 -> en:penicillamine
    n1=lorazépam | n2=en:penicillamine | rel=r_associated | relid=0 | w=10
  2121. lorazépam -- r_associated #0: 10 / 0.052 -> en:penicillin v potassium
    n1=lorazépam | n2=en:penicillin v potassium | rel=r_associated | relid=0 | w=10
  2122. lorazépam -- r_associated #0: 10 / 0.052 -> en:pentamidine
    n1=lorazépam | n2=en:pentamidine | rel=r_associated | relid=0 | w=10
  2123. lorazépam -- r_associated #0: 10 / 0.052 -> en:pentavalent klh conjugate vaccine
    n1=lorazépam | n2=en:pentavalent klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  2124. lorazépam -- r_associated #0: 10 / 0.052 -> en:pentetic acid
    n1=lorazépam | n2=en:pentetic acid | rel=r_associated | relid=0 | w=10
  2125. lorazépam -- r_associated #0: 10 / 0.052 -> en:pentetic acid calcium
    n1=lorazépam | n2=en:pentetic acid calcium | rel=r_associated | relid=0 | w=10
  2126. lorazépam -- r_associated #0: 10 / 0.052 -> en:pentoxifylline
    n1=lorazépam | n2=en:pentoxifylline | rel=r_associated | relid=0 | w=10
  2127. lorazépam -- r_associated #0: 10 / 0.052 -> en:pep-cmv vaccine
    n1=lorazépam | n2=en:pep-cmv vaccine | rel=r_associated | relid=0 | w=10
  2128. lorazépam -- r_associated #0: 10 / 0.052 -> en:peptide hydrolases
    n1=lorazépam | n2=en:peptide hydrolases | rel=r_associated | relid=0 | w=10
  2129. lorazépam -- r_associated #0: 10 / 0.052 -> en:peptides hydrolases
    n1=lorazépam | n2=en:peptides hydrolases | rel=r_associated | relid=0 | w=10
  2130. lorazépam -- r_associated #0: 10 / 0.052 -> en:perflubron
    n1=lorazépam | n2=en:perflubron | rel=r_associated | relid=0 | w=10
  2131. lorazépam -- r_associated #0: 10 / 0.052 -> en:perflutren
    n1=lorazépam | n2=en:perflutren | rel=r_associated | relid=0 | w=10
  2132. lorazépam -- r_associated #0: 10 / 0.052 -> en:perflutren protein-a microsphere
    n1=lorazépam | n2=en:perflutren protein-a microsphere | rel=r_associated | relid=0 | w=10
  2133. lorazépam -- r_associated #0: 10 / 0.052 -> en:perindopril erbumine
    n1=lorazépam | n2=en:perindopril erbumine | rel=r_associated | relid=0 | w=10
  2134. lorazépam -- r_associated #0: 10 / 0.052 -> en:pesticidal
    n1=lorazépam | n2=en:pesticidal | rel=r_associated | relid=0 | w=10
  2135. lorazépam -- r_associated #0: 10 / 0.052 -> en:pesticide
    n1=lorazépam | n2=en:pesticide | rel=r_associated | relid=0 | w=10
  2136. lorazépam -- r_associated #0: 10 / 0.052 -> en:petrolatum-mineral oil-lanolin-ceresin ointment
    n1=lorazépam | n2=en:petrolatum-mineral oil-lanolin-ceresin ointment | rel=r_associated | relid=0 | w=10
  2137. lorazépam -- r_associated #0: 10 / 0.052 -> en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes
    n1=lorazépam | n2=en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  2138. lorazépam -- r_associated #0: 10 / 0.052 -> en:pharmaceutic aids
    n1=lorazépam | n2=en:pharmaceutic aids | rel=r_associated | relid=0 | w=10
  2139. lorazépam -- r_associated #0: 10 / 0.052 -> en:pharmaceutical dosage form
    n1=lorazépam | n2=en:pharmaceutical dosage form | rel=r_associated | relid=0 | w=10
  2140. lorazépam -- r_associated #0: 10 / 0.052 -> en:pharmacokinetic aspects
    n1=lorazépam | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=10
  2141. lorazépam -- r_associated #0: 10 / 0.052 -> en:phenazepam
    n1=lorazépam | n2=en:phenazepam | rel=r_associated | relid=0 | w=10
  2142. lorazépam -- r_associated #0: 10 / 0.052 -> en:phenethyl isothiocyanate
    n1=lorazépam | n2=en:phenethyl isothiocyanate | rel=r_associated | relid=0 | w=10
  2143. lorazépam -- r_associated #0: 10 / 0.052 -> en:phenethyl isothiocyanate-containing watercress juice
    n1=lorazépam | n2=en:phenethyl isothiocyanate-containing watercress juice | rel=r_associated | relid=0 | w=10
  2144. lorazépam -- r_associated #0: 10 / 0.052 -> en:phenformin hydrochloride
    n1=lorazépam | n2=en:phenformin hydrochloride | rel=r_associated | relid=0 | w=10
  2145. lorazépam -- r_associated #0: 10 / 0.052 -> en:phenobarbital
    n1=lorazépam | n2=en:phenobarbital | rel=r_associated | relid=0 | w=10
  2146. lorazépam -- r_associated #0: 10 / 0.052 -> en:phenothiazine
    n1=lorazépam | n2=en:phenothiazine | rel=r_associated | relid=0 | w=10
  2147. lorazépam -- r_associated #0: 10 / 0.052 -> en:phentolamine mesylate
    n1=lorazépam | n2=en:phentolamine mesylate | rel=r_associated | relid=0 | w=10
  2148. lorazépam -- r_associated #0: 10 / 0.052 -> en:phosphaplatin pt-112
    n1=lorazépam | n2=en:phosphaplatin pt-112 | rel=r_associated | relid=0 | w=10
  2149. lorazépam -- r_associated #0: 10 / 0.052 -> en:phosphomannopentaose sulfate
    n1=lorazépam | n2=en:phosphomannopentaose sulfate | rel=r_associated | relid=0 | w=10
  2150. lorazépam -- r_associated #0: 10 / 0.052 -> en:phytomenadione
    n1=lorazépam | n2=en:phytomenadione | rel=r_associated | relid=0 | w=10
  2151. lorazépam -- r_associated #0: 10 / 0.052 -> en:phytonadione
    n1=lorazépam | n2=en:phytonadione | rel=r_associated | relid=0 | w=10
  2152. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k alpha inhibitor mln1117
    n1=lorazépam | n2=en:pi3k alpha inhibitor mln1117 | rel=r_associated | relid=0 | w=10
  2153. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k delta/gamma inhibitor ipi-145
    n1=lorazépam | n2=en:pi3k delta/gamma inhibitor ipi-145 | rel=r_associated | relid=0 | w=10
  2154. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k delta/gamma inhibitor rp6530
    n1=lorazépam | n2=en:pi3k delta/gamma inhibitor rp6530 | rel=r_associated | relid=0 | w=10
  2155. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k family kinase inhibitor xl147
    n1=lorazépam | n2=en:pi3k family kinase inhibitor xl147 | rel=r_associated | relid=0 | w=10
  2156. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor acp-319
    n1=lorazépam | n2=en:pi3k inhibitor acp-319 | rel=r_associated | relid=0 | w=10
  2157. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor ch5132799
    n1=lorazépam | n2=en:pi3k inhibitor ch5132799 | rel=r_associated | relid=0 | w=10
  2158. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor gdc-0084
    n1=lorazépam | n2=en:pi3k inhibitor gdc-0084 | rel=r_associated | relid=0 | w=10
  2159. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor gdc-0941 bismesylate
    n1=lorazépam | n2=en:pi3k inhibitor gdc-0941 bismesylate | rel=r_associated | relid=0 | w=10
  2160. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor gsk1059615
    n1=lorazépam | n2=en:pi3k inhibitor gsk1059615 | rel=r_associated | relid=0 | w=10
  2161. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor gsk2126458
    n1=lorazépam | n2=en:pi3k inhibitor gsk2126458 | rel=r_associated | relid=0 | w=10
  2162. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor px-866
    n1=lorazépam | n2=en:pi3k inhibitor px-866 | rel=r_associated | relid=0 | w=10
  2163. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor wx-037
    n1=lorazépam | n2=en:pi3k inhibitor wx-037 | rel=r_associated | relid=0 | w=10
  2164. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k inhibitor zstk474
    n1=lorazépam | n2=en:pi3k inhibitor zstk474 | rel=r_associated | relid=0 | w=10
  2165. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k p110beta/delta inhibitor ka2237
    n1=lorazépam | n2=en:pi3k p110beta/delta inhibitor ka2237 | rel=r_associated | relid=0 | w=10
  2166. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k-beta inhibitor gsk2636771
    n1=lorazépam | n2=en:pi3k-beta inhibitor gsk2636771 | rel=r_associated | relid=0 | w=10
  2167. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k-delta inhibitor incb050465
    n1=lorazépam | n2=en:pi3k-delta inhibitor incb050465 | rel=r_associated | relid=0 | w=10
  2168. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k-delta inhibitor tgr-1202
    n1=lorazépam | n2=en:pi3k-delta inhibitor tgr-1202 | rel=r_associated | relid=0 | w=10
  2169. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k/mtor inhibitor bez235
    n1=lorazépam | n2=en:pi3k/mtor inhibitor bez235 | rel=r_associated | relid=0 | w=10
  2170. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k/mtor kinase inhibitor ds-7423
    n1=lorazépam | n2=en:pi3k/mtor kinase inhibitor ds-7423 | rel=r_associated | relid=0 | w=10
  2171. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k/mtor kinase inhibitor pf-04691502
    n1=lorazépam | n2=en:pi3k/mtor kinase inhibitor pf-04691502 | rel=r_associated | relid=0 | w=10
  2172. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k/mtor/alk-1/dna-pk inhibitor p7170
    n1=lorazépam | n2=en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 | rel=r_associated | relid=0 | w=10
  2173. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901
    n1=lorazépam | n2=en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 | rel=r_associated | relid=0 | w=10
  2174. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3kbeta inhibitor azd8186
    n1=lorazépam | n2=en:pi3kbeta inhibitor azd8186 | rel=r_associated | relid=0 | w=10
  2175. lorazépam -- r_associated #0: 10 / 0.052 -> en:pi3kdelta inhibitor incb040093
    n1=lorazépam | n2=en:pi3kdelta inhibitor incb040093 | rel=r_associated | relid=0 | w=10
  2176. lorazépam -- r_associated #0: 10 / 0.052 -> en:picropodophyllin
    n1=lorazépam | n2=en:picropodophyllin | rel=r_associated | relid=0 | w=10
  2177. lorazépam -- r_associated #0: 10 / 0.052 -> en:pidilizumab
    n1=lorazépam | n2=en:pidilizumab | rel=r_associated | relid=0 | w=10
  2178. lorazépam -- r_associated #0: 10 / 0.052 -> en:pim kinase inhibitor sgi-1776
    n1=lorazépam | n2=en:pim kinase inhibitor sgi-1776 | rel=r_associated | relid=0 | w=10
  2179. lorazépam -- r_associated #0: 10 / 0.052 -> en:pimasertib
    n1=lorazépam | n2=en:pimasertib | rel=r_associated | relid=0 | w=10
  2180. lorazépam -- r_associated #0: 10 / 0.052 -> en:pimecrolimus
    n1=lorazépam | n2=en:pimecrolimus | rel=r_associated | relid=0 | w=10
  2181. lorazépam -- r_associated #0: 10 / 0.052 -> en:pimonidazole
    n1=lorazépam | n2=en:pimonidazole | rel=r_associated | relid=0 | w=10
  2182. lorazépam -- r_associated #0: 10 / 0.052 -> en:pinaverium bromide
    n1=lorazépam | n2=en:pinaverium bromide | rel=r_associated | relid=0 | w=10
  2183. lorazépam -- r_associated #0: 10 / 0.052 -> en:pinazepam
    n1=lorazépam | n2=en:pinazepam | rel=r_associated | relid=0 | w=10
  2184. lorazépam -- r_associated #0: 10 / 0.052 -> en:pipamazine
    n1=lorazépam | n2=en:pipamazine | rel=r_associated | relid=0 | w=10
  2185. lorazépam -- r_associated #0: 10 / 0.052 -> en:piperacillin sodium
    n1=lorazépam | n2=en:piperacillin sodium | rel=r_associated | relid=0 | w=10
  2186. lorazépam -- r_associated #0: 10 / 0.052 -> en:piperazinedione
    n1=lorazépam | n2=en:piperazinedione | rel=r_associated | relid=0 | w=10
  2187. lorazépam -- r_associated #0: 10 / 0.052 -> en:piritrexim
    n1=lorazépam | n2=en:piritrexim | rel=r_associated | relid=0 | w=10
  2188. lorazépam -- r_associated #0: 10 / 0.052 -> en:pirotinib
    n1=lorazépam | n2=en:pirotinib | rel=r_associated | relid=0 | w=10
  2189. lorazépam -- r_associated #0: 10 / 0.052 -> en:piroxicam
    n1=lorazépam | n2=en:piroxicam | rel=r_associated | relid=0 | w=10
  2190. lorazépam -- r_associated #0: 10 / 0.052 -> en:pirs2 phosphopeptide-tetanus peptide vaccine
    n1=lorazépam | n2=en:pirs2 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=10
  2191. lorazépam -- r_associated #0: 10 / 0.052 -> en:pivotal moment
    n1=lorazépam | n2=en:pivotal moment | rel=r_associated | relid=0 | w=10
  2192. lorazépam -- r_associated #0: 10 / 0.052 -> en:pivoxazepam
    n1=lorazépam | n2=en:pivoxazepam | rel=r_associated | relid=0 | w=10
  2193. lorazépam -- r_associated #0: 10 / 0.052 -> en:plectin-1 targeting agent ptp-01
    n1=lorazépam | n2=en:plectin-1 targeting agent ptp-01 | rel=r_associated | relid=0 | w=10
  2194. lorazépam -- r_associated #0: 10 / 0.052 -> en:pled-based mnsod mimetic
    n1=lorazépam | n2=en:pled-based mnsod mimetic | rel=r_associated | relid=0 | w=10
  2195. lorazépam -- r_associated #0: 10 / 0.052 -> en:pleiotropic pathway modifier cc-122 hydrochloride
    n1=lorazépam | n2=en:pleiotropic pathway modifier cc-122 hydrochloride | rel=r_associated | relid=0 | w=10
  2196. lorazépam -- r_associated #0: 10 / 0.052 -> en:plevitrexed
    n1=lorazépam | n2=en:plevitrexed | rel=r_associated | relid=0 | w=10
  2197. lorazépam -- r_associated #0: 10 / 0.052 -> en:plozalizumab
    n1=lorazépam | n2=en:plozalizumab | rel=r_associated | relid=0 | w=10
  2198. lorazépam -- r_associated #0: 10 / 0.052 -> en:plx73086
    n1=lorazépam | n2=en:plx73086 | rel=r_associated | relid=0 | w=10
  2199. lorazépam -- r_associated #0: 10 / 0.052 -> en:pneumococcal 13-valent conjugate vaccine
    n1=lorazépam | n2=en:pneumococcal 13-valent conjugate vaccine | rel=r_associated | relid=0 | w=10
  2200. lorazépam -- r_associated #0: 10 / 0.052 -> en:pneumococcal polyvalent vaccine
    n1=lorazépam | n2=en:pneumococcal polyvalent vaccine | rel=r_associated | relid=0 | w=10
  2201. lorazépam -- r_associated #0: 10 / 0.052 -> en:pnp-expressing ovine atadenovirus fp253
    n1=lorazépam | n2=en:pnp-expressing ovine atadenovirus fp253 | rel=r_associated | relid=0 | w=10
  2202. lorazépam -- r_associated #0: 10 / 0.052 -> en:pol i inhibitor cx5461
    n1=lorazépam | n2=en:pol i inhibitor cx5461 | rel=r_associated | relid=0 | w=10
  2203. lorazépam -- r_associated #0: 10 / 0.052 -> en:polaprezinc
    n1=lorazépam | n2=en:polaprezinc | rel=r_associated | relid=0 | w=10
  2204. lorazépam -- r_associated #0: 10 / 0.052 -> en:polihexanide solution
    n1=lorazépam | n2=en:polihexanide solution | rel=r_associated | relid=0 | w=10
  2205. lorazépam -- r_associated #0: 10 / 0.052 -> en:polo-like kinase 1 inhibitor nms-1286937
    n1=lorazépam | n2=en:polo-like kinase 1 inhibitor nms-1286937 | rel=r_associated | relid=0 | w=10
  2206. lorazépam -- r_associated #0: 10 / 0.052 -> en:poly iclc
    n1=lorazépam | n2=en:poly iclc | rel=r_associated | relid=0 | w=10
  2207. lorazépam -- r_associated #0: 10 / 0.052 -> en:poly-alendronate dextran-guanidine conjugate
    n1=lorazépam | n2=en:poly-alendronate dextran-guanidine conjugate | rel=r_associated | relid=0 | w=10
  2208. lorazépam -- r_associated #0: 10 / 0.052 -> en:poly-gamma glutamic acid
    n1=lorazépam | n2=en:poly-gamma glutamic acid | rel=r_associated | relid=0 | w=10
  2209. lorazépam -- r_associated #0: 10 / 0.052 -> en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer
    n1=lorazépam | n2=en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer | rel=r_associated | relid=0 | w=10
  2210. lorazépam -- r_associated #0: 10 / 0.052 -> en:polydextrose
    n1=lorazépam | n2=en:polydextrose | rel=r_associated | relid=0 | w=10
  2211. lorazépam -- r_associated #0: 10 / 0.052 -> en:polyethylene glycol
    n1=lorazépam | n2=en:polyethylene glycol | rel=r_associated | relid=0 | w=10
  2212. lorazépam -- r_associated #0: 10 / 0.052 -> en:polyéthylène glycol
    n1=lorazépam | n2=en:polyéthylène glycol | rel=r_associated | relid=0 | w=10
  2213. lorazépam -- r_associated #0: 10 / 0.052 -> en:polyethylene glycol polymer surgical sealant
    n1=lorazépam | n2=en:polyethylene glycol polymer surgical sealant | rel=r_associated | relid=0 | w=10
  2214. lorazépam -- r_associated #0: 10 / 0.052 -> en:polyglutamate camptothecin
    n1=lorazépam | n2=en:polyglutamate camptothecin | rel=r_associated | relid=0 | w=10
  2215. lorazépam -- r_associated #0: 10 / 0.052 -> en:polysaccharide-k
    n1=lorazépam | n2=en:polysaccharide-k | rel=r_associated | relid=0 | w=10
  2216. lorazépam -- r_associated #0: 10 / 0.052 -> en:polyvinylpyrrolidone-sodium hyaluronate gel
    n1=lorazépam | n2=en:polyvinylpyrrolidone-sodium hyaluronate gel | rel=r_associated | relid=0 | w=10
  2217. lorazépam -- r_associated #0: 10 / 0.052 -> en:pomegranate-extract pill
    n1=lorazépam | n2=en:pomegranate-extract pill | rel=r_associated | relid=0 | w=10
  2218. lorazépam -- r_associated #0: 10 / 0.052 -> en:ponatinib hydrochloride
    n1=lorazépam | n2=en:ponatinib hydrochloride | rel=r_associated | relid=0 | w=10
  2219. lorazépam -- r_associated #0: 10 / 0.052 -> en:ponesimod
    n1=lorazépam | n2=en:ponesimod | rel=r_associated | relid=0 | w=10
  2220. lorazépam -- r_associated #0: 10 / 0.052 -> en:porcupine inhibitor wnt974
    n1=lorazépam | n2=en:porcupine inhibitor wnt974 | rel=r_associated | relid=0 | w=10
  2221. lorazépam -- r_associated #0: 10 / 0.052 -> en:posaconazole
    n1=lorazépam | n2=en:posaconazole | rel=r_associated | relid=0 | w=10
  2222. lorazépam -- r_associated #0: 10 / 0.052 -> en:powder [sth]
    n1=lorazépam | n2=en:powder [sth] | rel=r_associated | relid=0 | w=10
  2223. lorazépam -- r_associated #0: 10 / 0.052 -> en:poziotinib
    n1=lorazépam | n2=en:poziotinib | rel=r_associated | relid=0 | w=10
  2224. lorazépam -- r_associated #0: 10 / 0.052 -> en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701
    n1=lorazépam | n2=en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 | rel=r_associated | relid=0 | w=10
  2225. lorazépam -- r_associated #0: 10 / 0.052 -> en:pramipexole dihydrochloride
    n1=lorazépam | n2=en:pramipexole dihydrochloride | rel=r_associated | relid=0 | w=10
  2226. lorazépam -- r_associated #0: 10 / 0.052 -> en:prasterone
    n1=lorazépam | n2=en:prasterone | rel=r_associated | relid=0 | w=10
  2227. lorazépam -- r_associated #0: 10 / 0.052 -> en:pregabalin
    n1=lorazépam | n2=en:pregabalin | rel=r_associated | relid=0 | w=10
  2228. lorazépam -- r_associated #0: 10 / 0.052 -> en:preimplantation factor pif-1
    n1=lorazépam | n2=en:preimplantation factor pif-1 | rel=r_associated | relid=0 | w=10
  2229. lorazépam -- r_associated #0: 10 / 0.052 -> en:prescription drugs
    n1=lorazépam | n2=en:prescription drugs | rel=r_associated | relid=0 | w=10
  2230. lorazépam -- r_associated #0: 10 / 0.052 -> en:prima-1 analog apr-246
    n1=lorazépam | n2=en:prima-1 analog apr-246 | rel=r_associated | relid=0 | w=10
  2231. lorazépam -- r_associated #0: 10 / 0.052 -> en:prochlorperazine
    n1=lorazépam | n2=en:prochlorperazine | rel=r_associated | relid=0 | w=10
  2232. lorazépam -- r_associated #0: 10 / 0.052 -> en:proflavine
    n1=lorazépam | n2=en:proflavine | rel=r_associated | relid=0 | w=10
  2233. lorazépam -- r_associated #0: 10 / 0.052 -> en:proflavine hemisulfate
    n1=lorazépam | n2=en:proflavine hemisulfate | rel=r_associated | relid=0 | w=10
  2234. lorazépam -- r_associated #0: 10 / 0.052 -> en:progestin
    n1=lorazépam | n2=en:progestin | rel=r_associated | relid=0 | w=10
  2235. lorazépam -- r_associated #0: 10 / 0.052 -> en:prohibitin-targeting peptide 1
    n1=lorazépam | n2=en:prohibitin-targeting peptide 1 | rel=r_associated | relid=0 | w=10
  2236. lorazépam -- r_associated #0: 10 / 0.052 -> en:prostate health cocktail dietary supplement
    n1=lorazépam | n2=en:prostate health cocktail dietary supplement | rel=r_associated | relid=0 | w=10
  2237. lorazépam -- r_associated #0: 10 / 0.052 -> en:protein phosphatase 2a inhibitor lb-100
    n1=lorazépam | n2=en:protein phosphatase 2a inhibitor lb-100 | rel=r_associated | relid=0 | w=10
  2238. lorazépam -- r_associated #0: 10 / 0.052 -> en:pseudomonas aeruginosa preparation
    n1=lorazépam | n2=en:pseudomonas aeruginosa preparation | rel=r_associated | relid=0 | w=10
  2239. lorazépam -- r_associated #0: 10 / 0.052 -> en:psychopharmacologic agent
    n1=lorazépam | n2=en:psychopharmacologic agent | rel=r_associated | relid=0 | w=10
  2240. lorazépam -- r_associated #0: 10 / 0.052 -> en:puffball
    n1=lorazépam | n2=en:puffball | rel=r_associated | relid=0 | w=10
  2241. lorazépam -- r_associated #0: 10 / 0.052 -> en:put powder on something
    n1=lorazépam | n2=en:put powder on something | rel=r_associated | relid=0 | w=10
  2242. lorazépam -- r_associated #0: 10 / 0.052 -> en:put talc on something
    n1=lorazépam | n2=en:put talc on something | rel=r_associated | relid=0 | w=10
  2243. lorazépam -- r_associated #0: 10 / 0.052 -> en:pva microporous hydrospheres/doxorubicin hydrochloride
    n1=lorazépam | n2=en:pva microporous hydrospheres/doxorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  2244. lorazépam -- r_associated #0: 10 / 0.052 -> en:pyroxamide
    n1=lorazépam | n2=en:pyroxamide | rel=r_associated | relid=0 | w=10
  2245. lorazépam -- r_associated #0: 10 / 0.052 -> en:quazepam
    n1=lorazépam | n2=en:quazepam | rel=r_associated | relid=0 | w=10
  2246. lorazépam -- r_associated #0: 10 / 0.052 -> en:quizartinib
    n1=lorazépam | n2=en:quizartinib | rel=r_associated | relid=0 | w=10
  2247. lorazépam -- r_associated #0: 10 / 0.052 -> en:rabusertib
    n1=lorazépam | n2=en:rabusertib | rel=r_associated | relid=0 | w=10
  2248. lorazépam -- r_associated #0: 10 / 0.052 -> en:radioprotective agent
    n1=lorazépam | n2=en:radioprotective agent | rel=r_associated | relid=0 | w=10
  2249. lorazépam -- r_associated #0: 10 / 0.052 -> en:radiosensitizing agent
    n1=lorazépam | n2=en:radiosensitizing agent | rel=r_associated | relid=0 | w=10
  2250. lorazépam -- r_associated #0: 10 / 0.052 -> en:raf kinase inhibitor lgx818
    n1=lorazépam | n2=en:raf kinase inhibitor lgx818 | rel=r_associated | relid=0 | w=10
  2251. lorazépam -- r_associated #0: 10 / 0.052 -> en:raloxifene
    n1=lorazépam | n2=en:raloxifene | rel=r_associated | relid=0 | w=10
  2252. lorazépam -- r_associated #0: 10 / 0.052 -> en:raltitrexed
    n1=lorazépam | n2=en:raltitrexed | rel=r_associated | relid=0 | w=10
  2253. lorazépam -- r_associated #0: 10 / 0.052 -> en:ramipril
    n1=lorazépam | n2=en:ramipril | rel=r_associated | relid=0 | w=10
  2254. lorazépam -- r_associated #0: 10 / 0.052 -> en:ramucirumab
    n1=lorazépam | n2=en:ramucirumab | rel=r_associated | relid=0 | w=10
  2255. lorazépam -- r_associated #0: 10 / 0.052 -> en:rar-alpha agonist vtp195183
    n1=lorazépam | n2=en:rar-alpha agonist vtp195183 | rel=r_associated | relid=0 | w=10
  2256. lorazépam -- r_associated #0: 10 / 0.052 -> en:raralpha agonist irx5183
    n1=lorazépam | n2=en:raralpha agonist irx5183 | rel=r_associated | relid=0 | w=10
  2257. lorazépam -- r_associated #0: 10 / 0.052 -> en:ras peptide cancer vaccine
    n1=lorazépam | n2=en:ras peptide cancer vaccine | rel=r_associated | relid=0 | w=10
  2258. lorazépam -- r_associated #0: 10 / 0.052 -> en:rebastinib tosylate
    n1=lorazépam | n2=en:rebastinib tosylate | rel=r_associated | relid=0 | w=10
  2259. lorazépam -- r_associated #0: 10 / 0.052 -> en:receptor tyrosine kinase inhibitor r1530
    n1=lorazépam | n2=en:receptor tyrosine kinase inhibitor r1530 | rel=r_associated | relid=0 | w=10
  2260. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand
    n1=lorazépam | n2=en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand | rel=r_associated | relid=0 | w=10
  2261. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant adenovirus-hifn-beta
    n1=lorazépam | n2=en:recombinant adenovirus-hifn-beta | rel=r_associated | relid=0 | w=10
  2262. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant adenovirus-interferon/syn3
    n1=lorazépam | n2=en:recombinant adenovirus-interferon/syn3 | rel=r_associated | relid=0 | w=10
  2263. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant adenovirus-l523s vaccine
    n1=lorazépam | n2=en:recombinant adenovirus-l523s vaccine | rel=r_associated | relid=0 | w=10
  2264. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant adenovirus-p53 sch-58500
    n1=lorazépam | n2=en:recombinant adenovirus-p53 sch-58500 | rel=r_associated | relid=0 | w=10
  2265. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant bispecific single-chain antibody rm28
    n1=lorazépam | n2=en:recombinant bispecific single-chain antibody rm28 | rel=r_associated | relid=0 | w=10
  2266. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant dher2 vaccine
    n1=lorazépam | n2=en:recombinant dher2 vaccine | rel=r_associated | relid=0 | w=10
  2267. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant human chorionic gonadotropin
    n1=lorazépam | n2=en:recombinant human chorionic gonadotropin | rel=r_associated | relid=0 | w=10
  2268. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant human serum amyloid p/pentraxin 2
    n1=lorazépam | n2=en:recombinant human serum amyloid p/pentraxin 2 | rel=r_associated | relid=0 | w=10
  2269. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant interleukin-6
    n1=lorazépam | n2=en:recombinant interleukin-6 | rel=r_associated | relid=0 | w=10
  2270. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant mip1-alpha variant eci301
    n1=lorazépam | n2=en:recombinant mip1-alpha variant eci301 | rel=r_associated | relid=0 | w=10
  2271. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant oxytocin
    n1=lorazépam | n2=en:recombinant oxytocin | rel=r_associated | relid=0 | w=10
  2272. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant thymosin
    n1=lorazépam | n2=en:recombinant thymosin | rel=r_associated | relid=0 | w=10
  2273. lorazépam -- r_associated #0: 10 / 0.052 -> en:recombinant transforming growth factor-beta 2
    n1=lorazépam | n2=en:recombinant transforming growth factor-beta 2 | rel=r_associated | relid=0 | w=10
  2274. lorazépam -- r_associated #0: 10 / 0.052 -> en:refametinib
    n1=lorazépam | n2=en:refametinib | rel=r_associated | relid=0 | w=10
  2275. lorazépam -- r_associated #0: 10 / 0.052 -> en:refills prescribed:num:pt:medication:qn
    n1=lorazépam | n2=en:refills prescribed:num:pt:medication:qn | rel=r_associated | relid=0 | w=10
  2276. lorazépam -- r_associated #0: 10 / 0.052 -> en:regular insulin
    n1=lorazépam | n2=en:regular insulin | rel=r_associated | relid=0 | w=10
  2277. lorazépam -- r_associated #0: 10 / 0.052 -> en:remestemcel-l
    n1=lorazépam | n2=en:remestemcel-l | rel=r_associated | relid=0 | w=10
  2278. lorazépam -- r_associated #0: 10 / 0.052 -> en:reply to
    n1=lorazépam | n2=en:reply to | rel=r_associated | relid=0 | w=10
  2279. lorazépam -- r_associated #0: 10 / 0.052 -> en:reply to somebody
    n1=lorazépam | n2=en:reply to somebody | rel=r_associated | relid=0 | w=10
  2280. lorazépam -- r_associated #0: 10 / 0.052 -> en:resistant starch
    n1=lorazépam | n2=en:resistant starch | rel=r_associated | relid=0 | w=10
  2281. lorazépam -- r_associated #0: 10 / 0.052 -> en:resminostat
    n1=lorazépam | n2=en:resminostat | rel=r_associated | relid=0 | w=10
  2282. lorazépam -- r_associated #0: 10 / 0.052 -> en:respiratory arrest
    n1=lorazépam | n2=en:respiratory arrest | rel=r_associated | relid=0 | w=10
  2283. lorazépam -- r_associated #0: 10 / 0.052 -> en:respiratory depression
    n1=lorazépam | n2=en:respiratory depression | rel=r_associated | relid=0 | w=10
  2284. lorazépam -- r_associated #0: 10 / 0.052 -> en:respiratory failure
    n1=lorazépam | n2=en:respiratory failure | rel=r_associated | relid=0 | w=10
  2285. lorazépam -- r_associated #0: 10 / 0.052 -> en:respiratory form tiotropium
    n1=lorazépam | n2=en:respiratory form tiotropium | rel=r_associated | relid=0 | w=10
  2286. lorazépam -- r_associated #0: 10 / 0.052 -> en:respiratory insufficiency
    n1=lorazépam | n2=en:respiratory insufficiency | rel=r_associated | relid=0 | w=10
  2287. lorazépam -- r_associated #0: 10 / 0.052 -> en:respond
    n1=lorazépam | n2=en:respond | rel=r_associated | relid=0 | w=10
  2288. lorazépam -- r_associated #0: 10 / 0.052 -> en:respond to somebody
    n1=lorazépam | n2=en:respond to somebody | rel=r_associated | relid=0 | w=10
  2289. lorazépam -- r_associated #0: 10 / 0.052 -> en:retinoic acid agent
    n1=lorazépam | n2=en:retinoic acid agent | rel=r_associated | relid=0 | w=10
  2290. lorazépam -- r_associated #0: 10 / 0.052 -> en:rhenium re 188 p2045
    n1=lorazépam | n2=en:rhenium re 188 p2045 | rel=r_associated | relid=0 | w=10
  2291. lorazépam -- r_associated #0: 10 / 0.052 -> en:rhenium re-186 hydroxyethylidene diphosphonate
    n1=lorazépam | n2=en:rhenium re-186 hydroxyethylidene diphosphonate | rel=r_associated | relid=0 | w=10
  2292. lorazépam -- r_associated #0: 10 / 0.052 -> en:rhenium re-188 ethiodized oil
    n1=lorazépam | n2=en:rhenium re-188 ethiodized oil | rel=r_associated | relid=0 | w=10
  2293. lorazépam -- r_associated #0: 10 / 0.052 -> en:rhubarb/licorice herbal supplement
    n1=lorazépam | n2=en:rhubarb/licorice herbal supplement | rel=r_associated | relid=0 | w=10
  2294. lorazépam -- r_associated #0: 10 / 0.052 -> en:ribociclib
    n1=lorazépam | n2=en:ribociclib | rel=r_associated | relid=0 | w=10
  2295. lorazépam -- r_associated #0: 10 / 0.052 -> en:ribozyme rpi.4610
    n1=lorazépam | n2=en:ribozyme rpi.4610 | rel=r_associated | relid=0 | w=10
  2296. lorazépam -- r_associated #0: 10 / 0.052 -> en:ricin immunoconjugate
    n1=lorazépam | n2=en:ricin immunoconjugate | rel=r_associated | relid=0 | w=10
  2297. lorazépam -- r_associated #0: 10 / 0.052 -> en:rifaximin
    n1=lorazépam | n2=en:rifaximin | rel=r_associated | relid=0 | w=10
  2298. lorazépam -- r_associated #0: 10 / 0.052 -> en:rimiducid
    n1=lorazépam | n2=en:rimiducid | rel=r_associated | relid=0 | w=10
  2299. lorazépam -- r_associated #0: 10 / 0.052 -> en:rintatolimod
    n1=lorazépam | n2=en:rintatolimod | rel=r_associated | relid=0 | w=10
  2300. lorazépam -- r_associated #0: 10 / 0.052 -> en:ripazepam
    n1=lorazépam | n2=en:ripazepam | rel=r_associated | relid=0 | w=10
  2301. lorazépam -- r_associated #0: 10 / 0.052 -> en:rituximab
    n1=lorazépam | n2=en:rituximab | rel=r_associated | relid=0 | w=10
  2302. lorazépam -- r_associated #0: 10 / 0.052 -> en:rivaroxaban
    n1=lorazépam | n2=en:rivaroxaban | rel=r_associated | relid=0 | w=10
  2303. lorazépam -- r_associated #0: 10 / 0.052 -> en:rk-0202
    n1=lorazépam | n2=en:rk-0202 | rel=r_associated | relid=0 | w=10
  2304. lorazépam -- r_associated #0: 10 / 0.052 -> en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=lorazépam | n2=en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  2305. lorazépam -- r_associated #0: 10 / 0.052 -> en:romidepsin
    n1=lorazépam | n2=en:romidepsin | rel=r_associated | relid=0 | w=10
  2306. lorazépam -- r_associated #0: 10 / 0.052 -> en:rotavirus vaccine, live, oral
    n1=lorazépam | n2=en:rotavirus vaccine, live, oral | rel=r_associated | relid=0 | w=10
  2307. lorazépam -- r_associated #0: 10 / 0.052 -> en:rucaparib
    n1=lorazépam | n2=en:rucaparib | rel=r_associated | relid=0 | w=10
  2308. lorazépam -- r_associated #0: 10 / 0.052 -> en:rucaparib phosphate
    n1=lorazépam | n2=en:rucaparib phosphate | rel=r_associated | relid=0 | w=10
  2309. lorazépam -- r_associated #0: 10 / 0.052 -> en:s1p receptor agonist krp203
    n1=lorazépam | n2=en:s1p receptor agonist krp203 | rel=r_associated | relid=0 | w=10
  2310. lorazépam -- r_associated #0: 10 / 0.052 -> en:sacituzumab govitecan
    n1=lorazépam | n2=en:sacituzumab govitecan | rel=r_associated | relid=0 | w=10
  2311. lorazépam -- r_associated #0: 10 / 0.052 -> en:salmonella vnp20009
    n1=lorazépam | n2=en:salmonella vnp20009 | rel=r_associated | relid=0 | w=10
  2312. lorazépam -- r_associated #0: 10 / 0.052 -> en:sardomozide
    n1=lorazépam | n2=en:sardomozide | rel=r_associated | relid=0 | w=10
  2313. lorazépam -- r_associated #0: 10 / 0.052 -> en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant
    n1=lorazépam | n2=en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant | rel=r_associated | relid=0 | w=10
  2314. lorazépam -- r_associated #0: 10 / 0.052 -> en:sargramostim plasmid dna melanoma vaccine adjuvant
    n1=lorazépam | n2=en:sargramostim plasmid dna melanoma vaccine adjuvant | rel=r_associated | relid=0 | w=10
  2315. lorazépam -- r_associated #0: 10 / 0.052 -> en:sargramostim plasmid dna sarcoma vaccine
    n1=lorazépam | n2=en:sargramostim plasmid dna sarcoma vaccine | rel=r_associated | relid=0 | w=10
  2316. lorazépam -- r_associated #0: 10 / 0.052 -> en:saxagliptin hydrochloride
    n1=lorazépam | n2=en:saxagliptin hydrochloride | rel=r_associated | relid=0 | w=10
  2317. lorazépam -- r_associated #0: 10 / 0.052 -> en:sch 23390
    n1=lorazépam | n2=en:sch 23390 | rel=r_associated | relid=0 | w=10
  2318. lorazépam -- r_associated #0: 10 / 0.052 -> en:sdf-1-targeted agent nox-a12
    n1=lorazépam | n2=en:sdf-1-targeted agent nox-a12 | rel=r_associated | relid=0 | w=10
  2319. lorazépam -- r_associated #0: 10 / 0.052 -> en:semaxanib
    n1=lorazépam | n2=en:semaxanib | rel=r_associated | relid=0 | w=10
  2320. lorazépam -- r_associated #0: 10 / 0.052 -> en:seribantumab
    n1=lorazépam | n2=en:seribantumab | rel=r_associated | relid=0 | w=10
  2321. lorazépam -- r_associated #0: 10 / 0.052 -> en:shark cartilage extract ae-941
    n1=lorazépam | n2=en:shark cartilage extract ae-941 | rel=r_associated | relid=0 | w=10
  2322. lorazépam -- r_associated #0: 10 / 0.052 -> en:sheddase inhibitor incb007839
    n1=lorazépam | n2=en:sheddase inhibitor incb007839 | rel=r_associated | relid=0 | w=10
  2323. lorazépam -- r_associated #0: 10 / 0.052 -> en:sheng-mai san
    n1=lorazépam | n2=en:sheng-mai san | rel=r_associated | relid=0 | w=10
  2324. lorazépam -- r_associated #0: 10 / 0.052 -> en:sheng-yu-tang
    n1=lorazépam | n2=en:sheng-yu-tang | rel=r_associated | relid=0 | w=10
  2325. lorazépam -- r_associated #0: 10 / 0.052 -> en:short-acting benzodiazepines
    n1=lorazépam | n2=en:short-acting benzodiazepines | rel=r_associated | relid=0 | w=10
  2326. lorazépam -- r_associated #0: 10 / 0.052 -> en:shu yu wan formula
    n1=lorazépam | n2=en:shu yu wan formula | rel=r_associated | relid=0 | w=10
  2327. lorazépam -- r_associated #0: 10 / 0.052 -> en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine
    n1=lorazépam | n2=en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine | rel=r_associated | relid=0 | w=10
  2328. lorazépam -- r_associated #0: 10 / 0.052 -> en:sildenafil citrate
    n1=lorazépam | n2=en:sildenafil citrate | rel=r_associated | relid=0 | w=10
  2329. lorazépam -- r_associated #0: 10 / 0.052 -> en:sipuleucel-t
    n1=lorazépam | n2=en:sipuleucel-t | rel=r_associated | relid=0 | w=10
  2330. lorazépam -- r_associated #0: 10 / 0.052 -> en:sirpa-fc fusion protein tti-621
    n1=lorazépam | n2=en:sirpa-fc fusion protein tti-621 | rel=r_associated | relid=0 | w=10
  2331. lorazépam -- r_associated #0: 10 / 0.052 -> en:sivifene
    n1=lorazépam | n2=en:sivifene | rel=r_associated | relid=0 | w=10
  2332. lorazépam -- r_associated #0: 10 / 0.052 -> en:smac mimetic lcl161
    n1=lorazépam | n2=en:smac mimetic lcl161 | rel=r_associated | relid=0 | w=10
  2333. lorazépam -- r_associated #0: 10 / 0.052 -> en:smokeless tobacco
    n1=lorazépam | n2=en:smokeless tobacco | rel=r_associated | relid=0 | w=10
  2334. lorazépam -- r_associated #0: 10 / 0.052 -> en:soapstone
    n1=lorazépam | n2=en:soapstone | rel=r_associated | relid=0 | w=10
  2335. lorazépam -- r_associated #0: 10 / 0.052 -> en:sodium butyrate
    n1=lorazépam | n2=en:sodium butyrate | rel=r_associated | relid=0 | w=10
  2336. lorazépam -- r_associated #0: 10 / 0.052 -> en:sodium dibunate
    n1=lorazépam | n2=en:sodium dibunate | rel=r_associated | relid=0 | w=10
  2337. lorazépam -- r_associated #0: 10 / 0.052 -> en:sodium ferric gluconate complex in sucrose
    n1=lorazépam | n2=en:sodium ferric gluconate complex in sucrose | rel=r_associated | relid=0 | w=10
  2338. lorazépam -- r_associated #0: 10 / 0.052 -> en:sodium phenylbutyrate
    n1=lorazépam | n2=en:sodium phenylbutyrate | rel=r_associated | relid=0 | w=10
  2339. lorazépam -- r_associated #0: 10 / 0.052 -> en:sodium selenite
    n1=lorazépam | n2=en:sodium selenite | rel=r_associated | relid=0 | w=10
  2340. lorazépam -- r_associated #0: 10 / 0.052 -> en:solitomab
    n1=lorazépam | n2=en:solitomab | rel=r_associated | relid=0 | w=10
  2341. lorazépam -- r_associated #0: 10 / 0.052 -> en:solution
    n1=lorazépam | n2=en:solution | rel=r_associated | relid=0 | w=10
  2342. lorazépam -- r_associated #0: 10 / 0.052 -> en:sonepcizumab
    n1=lorazépam | n2=en:sonepcizumab | rel=r_associated | relid=0 | w=10
  2343. lorazépam -- r_associated #0: 10 / 0.052 -> en:sorafenib tosylate
    n1=lorazépam | n2=en:sorafenib tosylate | rel=r_associated | relid=0 | w=10
  2344. lorazépam -- r_associated #0: 10 / 0.052 -> en:sorghum bicolor supplement
    n1=lorazépam | n2=en:sorghum bicolor supplement | rel=r_associated | relid=0 | w=10
  2345. lorazépam -- r_associated #0: 10 / 0.052 -> en:sotagliflozin
    n1=lorazépam | n2=en:sotagliflozin | rel=r_associated | relid=0 | w=10
  2346. lorazépam -- r_associated #0: 10 / 0.052 -> en:source code
    n1=lorazépam | n2=en:source code | rel=r_associated | relid=0 | w=10
  2347. lorazépam -- r_associated #0: 10 / 0.052 -> en:source text
    n1=lorazépam | n2=en:source text | rel=r_associated | relid=0 | w=10
  2348. lorazépam -- r_associated #0: 10 / 0.052 -> en:soy isoflavones
    n1=lorazépam | n2=en:soy isoflavones | rel=r_associated | relid=0 | w=10
  2349. lorazépam -- r_associated #0: 10 / 0.052 -> en:soy protein isolate
    n1=lorazépam | n2=en:soy protein isolate | rel=r_associated | relid=0 | w=10
  2350. lorazépam -- r_associated #0: 10 / 0.052 -> en:spanner
    n1=lorazépam | n2=en:spanner | rel=r_associated | relid=0 | w=10
  2351. lorazépam -- r_associated #0: 10 / 0.052 -> en:sphingosine kinase-2 inhibitor abc294640
    n1=lorazépam | n2=en:sphingosine kinase-2 inhibitor abc294640 | rel=r_associated | relid=0 | w=10
  2352. lorazépam -- r_associated #0: 10 / 0.052 -> en:squalamine lactate
    n1=lorazépam | n2=en:squalamine lactate | rel=r_associated | relid=0 | w=10
  2353. lorazépam -- r_associated #0: 10 / 0.052 -> en:sr31747a
    n1=lorazépam | n2=en:sr31747a | rel=r_associated | relid=0 | w=10
  2354. lorazépam -- r_associated #0: 10 / 0.052 -> en:src/tubulin inhibitor kx02
    n1=lorazépam | n2=en:src/tubulin inhibitor kx02 | rel=r_associated | relid=0 | w=10
  2355. lorazépam -- r_associated #0: 10 / 0.052 -> en:standards characteristics
    n1=lorazépam | n2=en:standards characteristics | rel=r_associated | relid=0 | w=10
  2356. lorazépam -- r_associated #0: 10 / 0.052 -> en:steatite
    n1=lorazépam | n2=en:steatite | rel=r_associated | relid=0 | w=10
  2357. lorazépam -- r_associated #0: 10 / 0.052 -> en:strawberry-blackberry-black raspberry-blueberry mixture
    n1=lorazépam | n2=en:strawberry-blackberry-black raspberry-blueberry mixture | rel=r_associated | relid=0 | w=10
  2358. lorazépam -- r_associated #0: 10 / 0.052 -> en:sun's soup
    n1=lorazépam | n2=en:sun's soup | rel=r_associated | relid=0 | w=10
  2359. lorazépam -- r_associated #0: 10 / 0.052 -> en:sunitinib malate
    n1=lorazépam | n2=en:sunitinib malate | rel=r_associated | relid=0 | w=10
  2360. lorazépam -- r_associated #0: 10 / 0.052 -> en:surface-active agent
    n1=lorazépam | n2=en:surface-active agent | rel=r_associated | relid=0 | w=10
  2361. lorazépam -- r_associated #0: 10 / 0.052 -> en:surfactant agent
    n1=lorazépam | n2=en:surfactant agent | rel=r_associated | relid=0 | w=10
  2362. lorazépam -- r_associated #0: 10 / 0.052 -> en:syk inhibitor hmpl-523
    n1=lorazépam | n2=en:syk inhibitor hmpl-523 | rel=r_associated | relid=0 | w=10
  2363. lorazépam -- r_associated #0: 10 / 0.052 -> en:t1e28z car-expressing autologous cd4-positive t lymphocytes
    n1=lorazépam | n2=en:t1e28z car-expressing autologous cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=10
  2364. lorazépam -- r_associated #0: 10 / 0.052 -> en:t4n5 liposomal lotion
    n1=lorazépam | n2=en:t4n5 liposomal lotion | rel=r_associated | relid=0 | w=10
  2365. lorazépam -- r_associated #0: 10 / 0.052 -> en:tabalumab
    n1=lorazépam | n2=en:tabalumab | rel=r_associated | relid=0 | w=10
  2366. lorazépam -- r_associated #0: 10 / 0.052 -> en:tablet
    n1=lorazépam | n2=en:tablet | rel=r_associated | relid=0 | w=10
  2367. lorazépam -- r_associated #0: 10 / 0.052 -> en:talazoparib
    n1=lorazépam | n2=en:talazoparib | rel=r_associated | relid=0 | w=10
  2368. lorazépam -- r_associated #0: 10 / 0.052 -> en:talc
    n1=lorazépam | n2=en:talc | rel=r_associated | relid=0 | w=10
  2369. lorazépam -- r_associated #0: 10 / 0.052 -> en:talcum
    n1=lorazépam | n2=en:talcum | rel=r_associated | relid=0 | w=10
  2370. lorazépam -- r_associated #0: 10 / 0.052 -> en:talcum powder
    n1=lorazépam | n2=en:talcum powder | rel=r_associated | relid=0 | w=10
  2371. lorazépam -- r_associated #0: 10 / 0.052 -> en:taliglucerase alfa
    n1=lorazépam | n2=en:taliglucerase alfa | rel=r_associated | relid=0 | w=10
  2372. lorazépam -- r_associated #0: 10 / 0.052 -> en:talimogene laherparepvec
    n1=lorazépam | n2=en:talimogene laherparepvec | rel=r_associated | relid=0 | w=10
  2373. lorazépam -- r_associated #0: 10 / 0.052 -> en:talmapimod
    n1=lorazépam | n2=en:talmapimod | rel=r_associated | relid=0 | w=10
  2374. lorazépam -- r_associated #0: 10 / 0.052 -> en:tandutinib
    n1=lorazépam | n2=en:tandutinib | rel=r_associated | relid=0 | w=10
  2375. lorazépam -- r_associated #0: 10 / 0.052 -> en:tanezumab
    n1=lorazépam | n2=en:tanezumab | rel=r_associated | relid=0 | w=10
  2376. lorazépam -- r_associated #0: 10 / 0.052 -> en:tasisulam sodium
    n1=lorazépam | n2=en:tasisulam sodium | rel=r_associated | relid=0 | w=10
  2377. lorazépam -- r_associated #0: 10 / 0.052 -> en:tasquinimod
    n1=lorazépam | n2=en:tasquinimod | rel=r_associated | relid=0 | w=10
  2378. lorazépam -- r_associated #0: 10 / 0.052 -> en:tc 99m monoclonal antibody 170
    n1=lorazépam | n2=en:tc 99m monoclonal antibody 170 | rel=r_associated | relid=0 | w=10
  2379. lorazépam -- r_associated #0: 10 / 0.052 -> en:technetium tc 99m galactosyl human serum albumin
    n1=lorazépam | n2=en:technetium tc 99m galactosyl human serum albumin | rel=r_associated | relid=0 | w=10
  2380. lorazépam -- r_associated #0: 10 / 0.052 -> en:technetium tc 99m-3prgd2
    n1=lorazépam | n2=en:technetium tc 99m-3prgd2 | rel=r_associated | relid=0 | w=10
  2381. lorazépam -- r_associated #0: 10 / 0.052 -> en:technetium tc-99m
    n1=lorazépam | n2=en:technetium tc-99m | rel=r_associated | relid=0 | w=10
  2382. lorazépam -- r_associated #0: 10 / 0.052 -> en:technetium tc-99m ethylenedicysteine-deoxyglucose
    n1=lorazépam | n2=en:technetium tc-99m ethylenedicysteine-deoxyglucose | rel=r_associated | relid=0 | w=10
  2383. lorazépam -- r_associated #0: 10 / 0.052 -> en:technetium tc-99m mebrofenin
    n1=lorazépam | n2=en:technetium tc-99m mebrofenin | rel=r_associated | relid=0 | w=10
  2384. lorazépam -- r_associated #0: 10 / 0.052 -> en:technetium tc-99m sodium pertechnetate
    n1=lorazépam | n2=en:technetium tc-99m sodium pertechnetate | rel=r_associated | relid=0 | w=10
  2385. lorazépam -- r_associated #0: 10 / 0.052 -> en:technetium tc-99m-nc100692
    n1=lorazépam | n2=en:technetium tc-99m-nc100692 | rel=r_associated | relid=0 | w=10
  2386. lorazépam -- r_associated #0: 10 / 0.052 -> en:tegafur-gimeracil-oteracil potassium
    n1=lorazépam | n2=en:tegafur-gimeracil-oteracil potassium | rel=r_associated | relid=0 | w=10
  2387. lorazépam -- r_associated #0: 10 / 0.052 -> en:telomerase-specific type 5 adenovirus obp-301
    n1=lorazépam | n2=en:telomerase-specific type 5 adenovirus obp-301 | rel=r_associated | relid=0 | w=10
  2388. lorazépam -- r_associated #0: 10 / 0.052 -> en:temsirolimus
    n1=lorazépam | n2=en:temsirolimus | rel=r_associated | relid=0 | w=10
  2389. lorazépam -- r_associated #0: 10 / 0.052 -> en:teniposide
    n1=lorazépam | n2=en:teniposide | rel=r_associated | relid=0 | w=10
  2390. lorazépam -- r_associated #0: 10 / 0.052 -> en:tenofovir disoproxil fumarate
    n1=lorazépam | n2=en:tenofovir disoproxil fumarate | rel=r_associated | relid=0 | w=10
  2391. lorazépam -- r_associated #0: 10 / 0.052 -> en:teprotumumab
    n1=lorazépam | n2=en:teprotumumab | rel=r_associated | relid=0 | w=10
  2392. lorazépam -- r_associated #0: 10 / 0.052 -> en:teratogen
    n1=lorazépam | n2=en:teratogen | rel=r_associated | relid=0 | w=10
  2393. lorazépam -- r_associated #0: 10 / 0.052 -> en:tesetaxel
    n1=lorazépam | n2=en:tesetaxel | rel=r_associated | relid=0 | w=10
  2394. lorazépam -- r_associated #0: 10 / 0.052 -> en:testosterone gel
    n1=lorazépam | n2=en:testosterone gel | rel=r_associated | relid=0 | w=10
  2395. lorazépam -- r_associated #0: 10 / 0.052 -> en:tetanus-cmv fusion peptide vaccine
    n1=lorazépam | n2=en:tetanus-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=10
  2396. lorazépam -- r_associated #0: 10 / 0.052 -> en:tetracycline hydrochloride
    n1=lorazépam | n2=en:tetracycline hydrochloride | rel=r_associated | relid=0 | w=10
  2397. lorazépam -- r_associated #0: 10 / 0.052 -> en:tetrazepam
    n1=lorazépam | n2=en:tetrazepam | rel=r_associated | relid=0 | w=10
  2398. lorazépam -- r_associated #0: 10 / 0.052 -> en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes
    n1=lorazépam | n2=en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=10
  2399. lorazépam -- r_associated #0: 10 / 0.052 -> en:thalicarpine
    n1=lorazépam | n2=en:thalicarpine | rel=r_associated | relid=0 | w=10
  2400. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic angiotensin-(1-7)
    n1=lorazépam | n2=en:therapeutic angiotensin-(1-7) | rel=r_associated | relid=0 | w=10
  2401. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic autologous lymphocytes
    n1=lorazépam | n2=en:therapeutic autologous lymphocytes | rel=r_associated | relid=0 | w=10
  2402. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic cortisone
    n1=lorazépam | n2=en:therapeutic cortisone | rel=r_associated | relid=0 | w=10
  2403. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic epinephrine
    n1=lorazépam | n2=en:therapeutic epinephrine | rel=r_associated | relid=0 | w=10
  2404. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic estrone
    n1=lorazépam | n2=en:therapeutic estrone | rel=r_associated | relid=0 | w=10
  2405. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic hydrocortisone
    n1=lorazépam | n2=en:therapeutic hydrocortisone | rel=r_associated | relid=0 | w=10
  2406. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic testosterone
    n1=lorazépam | n2=en:therapeutic testosterone | rel=r_associated | relid=0 | w=10
  2407. lorazépam -- r_associated #0: 10 / 0.052 -> en:therapeutic use - qualifier
    n1=lorazépam | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=10
  2408. lorazépam -- r_associated #0: 10 / 0.052 -> en:thiamine
    n1=lorazépam | n2=en:thiamine | rel=r_associated | relid=0 | w=10
  2409. lorazépam -- r_associated #0: 10 / 0.052 -> en:thiethylperazine maleate
    n1=lorazépam | n2=en:thiethylperazine maleate | rel=r_associated | relid=0 | w=10
  2410. lorazépam -- r_associated #0: 10 / 0.052 -> en:thioureidobutyronitrile
    n1=lorazépam | n2=en:thioureidobutyronitrile | rel=r_associated | relid=0 | w=10
  2411. lorazépam -- r_associated #0: 10 / 0.052 -> en:thrombopoietin receptor agonist lgd-4665
    n1=lorazépam | n2=en:thrombopoietin receptor agonist lgd-4665 | rel=r_associated | relid=0 | w=10
  2412. lorazépam -- r_associated #0: 10 / 0.052 -> en:tiazofurin
    n1=lorazépam | n2=en:tiazofurin | rel=r_associated | relid=0 | w=10
  2413. lorazépam -- r_associated #0: 10 / 0.052 -> en:tigapotide
    n1=lorazépam | n2=en:tigapotide | rel=r_associated | relid=0 | w=10
  2414. lorazépam -- r_associated #0: 10 / 0.052 -> en:tigatuzumab
    n1=lorazépam | n2=en:tigatuzumab | rel=r_associated | relid=0 | w=10
  2415. lorazépam -- r_associated #0: 10 / 0.052 -> en:tigecycline
    n1=lorazépam | n2=en:tigecycline | rel=r_associated | relid=0 | w=10
  2416. lorazépam -- r_associated #0: 10 / 0.052 -> en:tin sn 117m dtpa
    n1=lorazépam | n2=en:tin sn 117m dtpa | rel=r_associated | relid=0 | w=10
  2417. lorazépam -- r_associated #0: 10 / 0.052 -> en:tiomolibdate diammonium
    n1=lorazépam | n2=en:tiomolibdate diammonium | rel=r_associated | relid=0 | w=10
  2418. lorazépam -- r_associated #0: 10 / 0.052 -> en:tivantinib
    n1=lorazépam | n2=en:tivantinib | rel=r_associated | relid=0 | w=10
  2419. lorazépam -- r_associated #0: 10 / 0.052 -> en:tlr 7/8 agonist medi9197
    n1=lorazépam | n2=en:tlr 7/8 agonist medi9197 | rel=r_associated | relid=0 | w=10
  2420. lorazépam -- r_associated #0: 10 / 0.052 -> en:tlr9 agonist duk-cpg-001
    n1=lorazépam | n2=en:tlr9 agonist duk-cpg-001 | rel=r_associated | relid=0 | w=10
  2421. lorazépam -- r_associated #0: 10 / 0.052 -> en:tlr9 agonist emd 1201081
    n1=lorazépam | n2=en:tlr9 agonist emd 1201081 | rel=r_associated | relid=0 | w=10
  2422. lorazépam -- r_associated #0: 10 / 0.052 -> en:tlr9 agonist sd-101
    n1=lorazépam | n2=en:tlr9 agonist sd-101 | rel=r_associated | relid=0 | w=10
  2423. lorazépam -- r_associated #0: 10 / 0.052 -> en:to answer sb back
    n1=lorazépam | n2=en:to answer sb back | rel=r_associated | relid=0 | w=10
  2424. lorazépam -- r_associated #0: 10 / 0.052 -> en:to be the counterpart of
    n1=lorazépam | n2=en:to be the counterpart of | rel=r_associated | relid=0 | w=10
  2425. lorazépam -- r_associated #0: 10 / 0.052 -> en:to correspond to
    n1=lorazépam | n2=en:to correspond to | rel=r_associated | relid=0 | w=10
  2426. lorazépam -- r_associated #0: 10 / 0.052 -> en:to match
    n1=lorazépam | n2=en:to match | rel=r_associated | relid=0 | w=10
  2427. lorazépam -- r_associated #0: 10 / 0.052 -> en:to meet
    n1=lorazépam | n2=en:to meet | rel=r_associated | relid=0 | w=10
  2428. lorazépam -- r_associated #0: 10 / 0.052 -> en:to reply to
    n1=lorazépam | n2=en:to reply to | rel=r_associated | relid=0 | w=10
  2429. lorazépam -- r_associated #0: 10 / 0.052 -> en:tocilizumab
    n1=lorazépam | n2=en:tocilizumab | rel=r_associated | relid=0 | w=10
  2430. lorazépam -- r_associated #0: 10 / 0.052 -> en:tocotrienol-rich fraction
    n1=lorazépam | n2=en:tocotrienol-rich fraction | rel=r_associated | relid=0 | w=10
  2431. lorazépam -- r_associated #0: 10 / 0.052 -> en:topical betulinic acid
    n1=lorazépam | n2=en:topical betulinic acid | rel=r_associated | relid=0 | w=10
  2432. lorazépam -- r_associated #0: 10 / 0.052 -> en:topical pvdf/sirolimus
    n1=lorazépam | n2=en:topical pvdf/sirolimus | rel=r_associated | relid=0 | w=10
  2433. lorazépam -- r_associated #0: 10 / 0.052 -> en:topoisomerase i/ii inhibitor nev-801
    n1=lorazépam | n2=en:topoisomerase i/ii inhibitor nev-801 | rel=r_associated | relid=0 | w=10
  2434. lorazépam -- r_associated #0: 10 / 0.052 -> en:tositumomab
    n1=lorazépam | n2=en:tositumomab | rel=r_associated | relid=0 | w=10
  2435. lorazépam -- r_associated #0: 10 / 0.052 -> en:total tumor rna-loaded dendritic cell vaccine
    n1=lorazépam | n2=en:total tumor rna-loaded dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2436. lorazépam -- r_associated #0: 10 / 0.052 -> en:tranexamic acid
    n1=lorazépam | n2=en:tranexamic acid | rel=r_associated | relid=0 | w=10
  2437. lorazépam -- r_associated #0: 10 / 0.052 -> en:transferrin receptor-targeted anti-rrm2 sirna calaa-01
    n1=lorazépam | n2=en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 | rel=r_associated | relid=0 | w=10
  2438. lorazépam -- r_associated #0: 10 / 0.052 -> en:transgenic lymphocyte immunization vaccine
    n1=lorazépam | n2=en:transgenic lymphocyte immunization vaccine | rel=r_associated | relid=0 | w=10
  2439. lorazépam -- r_associated #0: 10 / 0.052 -> en:trastuzumab
    n1=lorazépam | n2=en:trastuzumab | rel=r_associated | relid=0 | w=10
  2440. lorazépam -- r_associated #0: 10 / 0.052 -> en:trastuzumab emtansine
    n1=lorazépam | n2=en:trastuzumab emtansine | rel=r_associated | relid=0 | w=10
  2441. lorazépam -- r_associated #0: 10 / 0.052 -> en:trastuzumab vc-seco-duba
    n1=lorazépam | n2=en:trastuzumab vc-seco-duba | rel=r_associated | relid=0 | w=10
  2442. lorazépam -- r_associated #0: 10 / 0.052 -> en:tremelimumab
    n1=lorazépam | n2=en:tremelimumab | rel=r_associated | relid=0 | w=10
  2443. lorazépam -- r_associated #0: 10 / 0.052 -> en:tretinoin
    n1=lorazépam | n2=en:tretinoin | rel=r_associated | relid=0 | w=10
  2444. lorazépam -- r_associated #0: 10 / 0.052 -> en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes
    n1=lorazépam | n2=en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  2445. lorazépam -- r_associated #0: 10 / 0.052 -> en:triazinate
    n1=lorazépam | n2=en:triazinate | rel=r_associated | relid=0 | w=10
  2446. lorazépam -- r_associated #0: 10 / 0.052 -> en:trimethobenzamide hydrochloride
    n1=lorazépam | n2=en:trimethobenzamide hydrochloride | rel=r_associated | relid=0 | w=10
  2447. lorazépam -- r_associated #0: 10 / 0.052 -> en:trivalent live-attenuated influenza vaccine
    n1=lorazépam | n2=en:trivalent live-attenuated influenza vaccine | rel=r_associated | relid=0 | w=10
  2448. lorazépam -- r_associated #0: 10 / 0.052 -> en:trk inhibitor azd6918
    n1=lorazépam | n2=en:trk inhibitor azd6918 | rel=r_associated | relid=0 | w=10
  2449. lorazépam -- r_associated #0: 10 / 0.052 -> en:tubulin inhibitor alb 109564(a)
    n1=lorazépam | n2=en:tubulin inhibitor alb 109564(a) | rel=r_associated | relid=0 | w=10
  2450. lorazépam -- r_associated #0: 10 / 0.052 -> en:tyroserleutide
    n1=lorazépam | n2=en:tyroserleutide | rel=r_associated | relid=0 | w=10
  2451. lorazépam -- r_associated #0: 10 / 0.052 -> en:tyrosine kinase inhibitor xl228
    n1=lorazépam | n2=en:tyrosine kinase inhibitor xl228 | rel=r_associated | relid=0 | w=10
  2452. lorazépam -- r_associated #0: 10 / 0.052 -> en:ublituximab
    n1=lorazépam | n2=en:ublituximab | rel=r_associated | relid=0 | w=10
  2453. lorazépam -- r_associated #0: 10 / 0.052 -> en:uldazepam
    n1=lorazépam | n2=en:uldazepam | rel=r_associated | relid=0 | w=10
  2454. lorazépam -- r_associated #0: 10 / 0.052 -> en:ulvwf multimer-targeting agent arc1779
    n1=lorazépam | n2=en:ulvwf multimer-targeting agent arc1779 | rel=r_associated | relid=0 | w=10
  2455. lorazépam -- r_associated #0: 10 / 0.052 -> en:urea/lactic acid-based topical cream
    n1=lorazépam | n2=en:urea/lactic acid-based topical cream | rel=r_associated | relid=0 | w=10
  2456. lorazépam -- r_associated #0: 10 / 0.052 -> en:ustekinumab
    n1=lorazépam | n2=en:ustekinumab | rel=r_associated | relid=0 | w=10
  2457. lorazépam -- r_associated #0: 10 / 0.052 -> en:uv1 telomerase peptide vaccine
    n1=lorazépam | n2=en:uv1 telomerase peptide vaccine | rel=r_associated | relid=0 | w=10
  2458. lorazépam -- r_associated #0: 10 / 0.052 -> en:v930 vaccine
    n1=lorazépam | n2=en:v930 vaccine | rel=r_associated | relid=0 | w=10
  2459. lorazépam -- r_associated #0: 10 / 0.052 -> en:vadastuximab talirine
    n1=lorazépam | n2=en:vadastuximab talirine | rel=r_associated | relid=0 | w=10
  2460. lorazépam -- r_associated #0: 10 / 0.052 -> en:valacyclovir
    n1=lorazépam | n2=en:valacyclovir | rel=r_associated | relid=0 | w=10
  2461. lorazépam -- r_associated #0: 10 / 0.052 -> en:valerian
    n1=lorazépam | n2=en:valerian | rel=r_associated | relid=0 | w=10
  2462. lorazépam -- r_associated #0: 10 / 0.052 -> en:valproic acid
    n1=lorazépam | n2=en:valproic acid | rel=r_associated | relid=0 | w=10
  2463. lorazépam -- r_associated #0: 10 / 0.052 -> en:vancomycin
    n1=lorazépam | n2=en:vancomycin | rel=r_associated | relid=0 | w=10
  2464. lorazépam -- r_associated #0: 10 / 0.052 -> en:vandetanib
    n1=lorazépam | n2=en:vandetanib | rel=r_associated | relid=0 | w=10
  2465. lorazépam -- r_associated #0: 10 / 0.052 -> en:vardenafil hydrochloride trihydrate
    n1=lorazépam | n2=en:vardenafil hydrochloride trihydrate | rel=r_associated | relid=0 | w=10
  2466. lorazépam -- r_associated #0: 10 / 0.052 -> en:vcl-cb01 vaccine
    n1=lorazépam | n2=en:vcl-cb01 vaccine | rel=r_associated | relid=0 | w=10
  2467. lorazépam -- r_associated #0: 10 / 0.052 -> en:vedolizumab
    n1=lorazépam | n2=en:vedolizumab | rel=r_associated | relid=0 | w=10
  2468. lorazépam -- r_associated #0: 10 / 0.052 -> en:vegfr inhibitor krn951
    n1=lorazépam | n2=en:vegfr inhibitor krn951 | rel=r_associated | relid=0 | w=10
  2469. lorazépam -- r_associated #0: 10 / 0.052 -> en:vegfr/pdgfr tyrosine kinase inhibitor tak-593
    n1=lorazépam | n2=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | rel=r_associated | relid=0 | w=10
  2470. lorazépam -- r_associated #0: 10 / 0.052 -> en:vegfr1-1084 peptide vaccine
    n1=lorazépam | n2=en:vegfr1-1084 peptide vaccine | rel=r_associated | relid=0 | w=10
  2471. lorazépam -- r_associated #0: 10 / 0.052 -> en:veliparib
    n1=lorazépam | n2=en:veliparib | rel=r_associated | relid=0 | w=10
  2472. lorazépam -- r_associated #0: 10 / 0.052 -> en:veltuzumab
    n1=lorazépam | n2=en:veltuzumab | rel=r_associated | relid=0 | w=10
  2473. lorazépam -- r_associated #0: 10 / 0.052 -> en:verteporfin
    n1=lorazépam | n2=en:verteporfin | rel=r_associated | relid=0 | w=10
  2474. lorazépam -- r_associated #0: 10 / 0.052 -> en:veterinary drugs
    n1=lorazépam | n2=en:veterinary drugs | rel=r_associated | relid=0 | w=10
  2475. lorazépam -- r_associated #0: 10 / 0.052 -> en:viagenpumatucel-l
    n1=lorazépam | n2=en:viagenpumatucel-l | rel=r_associated | relid=0 | w=10
  2476. lorazépam -- r_associated #0: 10 / 0.052 -> en:vinblastine
    n1=lorazépam | n2=en:vinblastine | rel=r_associated | relid=0 | w=10
  2477. lorazépam -- r_associated #0: 10 / 0.052 -> en:vinblastine sulfate
    n1=lorazépam | n2=en:vinblastine sulfate | rel=r_associated | relid=0 | w=10
  2478. lorazépam -- r_associated #0: 10 / 0.052 -> en:vincristine sulfate liposome
    n1=lorazépam | n2=en:vincristine sulfate liposome | rel=r_associated | relid=0 | w=10
  2479. lorazépam -- r_associated #0: 10 / 0.052 -> en:vinflunine
    n1=lorazépam | n2=en:vinflunine | rel=r_associated | relid=0 | w=10
  2480. lorazépam -- r_associated #0: 10 / 0.052 -> en:vinfosiltine
    n1=lorazépam | n2=en:vinfosiltine | rel=r_associated | relid=0 | w=10
  2481. lorazépam -- r_associated #0: 10 / 0.052 -> en:visilizumab
    n1=lorazépam | n2=en:visilizumab | rel=r_associated | relid=0 | w=10
  2482. lorazépam -- r_associated #0: 10 / 0.052 -> en:vistusertib
    n1=lorazépam | n2=en:vistusertib | rel=r_associated | relid=0 | w=10
  2483. lorazépam -- r_associated #0: 10 / 0.052 -> en:vitamin a compound
    n1=lorazépam | n2=en:vitamin a compound | rel=r_associated | relid=0 | w=10
  2484. lorazépam -- r_associated #0: 10 / 0.052 -> en:vitamin e compound
    n1=lorazépam | n2=en:vitamin e compound | rel=r_associated | relid=0 | w=10
  2485. lorazépam -- r_associated #0: 10 / 0.052 -> en:vitespen
    n1=lorazépam | n2=en:vitespen | rel=r_associated | relid=0 | w=10
  2486. lorazépam -- r_associated #0: 10 / 0.052 -> en:volasertib
    n1=lorazépam | n2=en:volasertib | rel=r_associated | relid=0 | w=10
  2487. lorazépam -- r_associated #0: 10 / 0.052 -> en:voxtalisib
    n1=lorazépam | n2=en:voxtalisib | rel=r_associated | relid=0 | w=10
  2488. lorazépam -- r_associated #0: 10 / 0.052 -> en:warfarin
    n1=lorazépam | n2=en:warfarin | rel=r_associated | relid=0 | w=10
  2489. lorazépam -- r_associated #0: 10 / 0.052 -> en:water purified
    n1=lorazépam | n2=en:water purified | rel=r_associated | relid=0 | w=10
  2490. lorazépam -- r_associated #0: 10 / 0.052 -> en:weight control agent
    n1=lorazépam | n2=en:weight control agent | rel=r_associated | relid=0 | w=10
  2491. lorazépam -- r_associated #0: 10 / 0.052 -> en:whey protein isolate
    n1=lorazépam | n2=en:whey protein isolate | rel=r_associated | relid=0 | w=10
  2492. lorazépam -- r_associated #0: 10 / 0.052 -> en:wrench
    n1=lorazépam | n2=en:wrench | rel=r_associated | relid=0 | w=10
  2493. lorazépam -- r_associated #0: 10 / 0.052 -> en:wt1 124-138 peptide vaccine
    n1=lorazépam | n2=en:wt1 124-138 peptide vaccine | rel=r_associated | relid=0 | w=10
  2494. lorazépam -- r_associated #0: 10 / 0.052 -> en:wt1 mrna-electroporated autologous dendritic cell vaccine
    n1=lorazépam | n2=en:wt1 mrna-electroporated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2495. lorazépam -- r_associated #0: 10 / 0.052 -> en:wt1 protein-derived peptide vaccine dsp-7888
    n1=lorazépam | n2=en:wt1 protein-derived peptide vaccine dsp-7888 | rel=r_associated | relid=0 | w=10
  2496. lorazépam -- r_associated #0: 10 / 0.052 -> en:xenogeneic tyrosinase dna vaccine
    n1=lorazépam | n2=en:xenogeneic tyrosinase dna vaccine | rel=r_associated | relid=0 | w=10
  2497. lorazépam -- r_associated #0: 10 / 0.052 -> en:y 90 monoclonal antibody hmfg1
    n1=lorazépam | n2=en:y 90 monoclonal antibody hmfg1 | rel=r_associated | relid=0 | w=10
  2498. lorazépam -- r_associated #0: 10 / 0.052 -> en:y 90 monoclonal antibody m170
    n1=lorazépam | n2=en:y 90 monoclonal antibody m170 | rel=r_associated | relid=0 | w=10
  2499. lorazépam -- r_associated #0: 10 / 0.052 -> en:ym598
    n1=lorazépam | n2=en:ym598 | rel=r_associated | relid=0 | w=10
  2500. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y 90 daclizumab
    n1=lorazépam | n2=en:yttrium y 90 daclizumab | rel=r_associated | relid=0 | w=10
  2501. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y 90 dota anti-cea monoclonal antibody m5a
    n1=lorazépam | n2=en:yttrium y 90 dota anti-cea monoclonal antibody m5a | rel=r_associated | relid=0 | w=10
  2502. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y 90 monoclonal antibody hu3s193
    n1=lorazépam | n2=en:yttrium y 90 monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=10
  2503. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y 90 monoclonal antibody mn-14
    n1=lorazépam | n2=en:yttrium y 90 monoclonal antibody mn-14 | rel=r_associated | relid=0 | w=10
  2504. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y 90 resin microspheres
    n1=lorazépam | n2=en:yttrium y 90 resin microspheres | rel=r_associated | relid=0 | w=10
  2505. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y 90-dota-di-hsg peptide imp-288
    n1=lorazépam | n2=en:yttrium y 90-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=10
  2506. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y-90 epratuzumab tetraxetan
    n1=lorazépam | n2=en:yttrium y-90 epratuzumab tetraxetan | rel=r_associated | relid=0 | w=10
  2507. lorazépam -- r_associated #0: 10 / 0.052 -> en:yttrium y-90 ibritumomab tiuxetan
    n1=lorazépam | n2=en:yttrium y-90 ibritumomab tiuxetan | rel=r_associated | relid=0 | w=10
  2508. lorazépam -- r_associated #0: 10 / 0.052 -> en:zalutumumab
    n1=lorazépam | n2=en:zalutumumab | rel=r_associated | relid=0 | w=10
  2509. lorazépam -- r_associated #0: 10 / 0.052 -> en:zanolimumab
    n1=lorazépam | n2=en:zanolimumab | rel=r_associated | relid=0 | w=10
  2510. lorazépam -- r_associated #0: 10 / 0.052 -> en:zidovudine
    n1=lorazépam | n2=en:zidovudine | rel=r_associated | relid=0 | w=10
  2511. lorazépam -- r_associated #0: 10 / 0.052 -> en:zinc gluconate
    n1=lorazépam | n2=en:zinc gluconate | rel=r_associated | relid=0 | w=10
  2512. lorazépam -- r_associated #0: 10 / 0.052 -> en:zinc sulfate
    n1=lorazépam | n2=en:zinc sulfate | rel=r_associated | relid=0 | w=10
  2513. lorazépam -- r_associated #0: 10 / 0.052 -> en:zinc sulphate
    n1=lorazépam | n2=en:zinc sulphate | rel=r_associated | relid=0 | w=10
  2514. lorazépam -- r_associated #0: 10 / 0.052 -> en:zirconium zr 89 bevacizumab
    n1=lorazépam | n2=en:zirconium zr 89 bevacizumab | rel=r_associated | relid=0 | w=10
  2515. lorazépam -- r_associated #0: 10 / 0.052 -> en:zirconium zr 89 df-iab2m
    n1=lorazépam | n2=en:zirconium zr 89 df-iab2m | rel=r_associated | relid=0 | w=10
  2516. lorazépam -- r_associated #0: 10 / 0.052 -> en:zirconium zr 89 girentuximab
    n1=lorazépam | n2=en:zirconium zr 89 girentuximab | rel=r_associated | relid=0 | w=10
  2517. lorazépam -- r_associated #0: 10 / 0.052 -> en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1
    n1=lorazépam | n2=en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=10
  2518. lorazépam -- r_associated #0: 10 / 0.052 -> en:zirconium zr 89-labeled ro5479599
    n1=lorazépam | n2=en:zirconium zr 89-labeled ro5479599 | rel=r_associated | relid=0 | w=10
  2519. lorazépam -- r_associated #0: 10 / 0.052 -> en:zolazepam hydrochloride
    n1=lorazépam | n2=en:zolazepam hydrochloride | rel=r_associated | relid=0 | w=10
  2520. lorazépam -- r_associated #0: 10 / 0.052 -> en:zolmitriptan
    n1=lorazépam | n2=en:zolmitriptan | rel=r_associated | relid=0 | w=10
  2521. lorazépam -- r_associated #0: 10 / 0.052 -> en:zoptarelin doxorubicin
    n1=lorazépam | n2=en:zoptarelin doxorubicin | rel=r_associated | relid=0 | w=10
  2522. lorazépam -- r_associated #0: 10 / 0.052 -> enzalutamide
    n1=lorazépam | n2=enzalutamide | rel=r_associated | relid=0 | w=10
  2523. lorazépam -- r_associated #0: 10 / 0.052 -> eplérénone
    n1=lorazépam | n2=eplérénone | rel=r_associated | relid=0 | w=10
  2524. lorazépam -- r_associated #0: 10 / 0.052 -> éponge de gélatine résorbable
    n1=lorazépam | n2=éponge de gélatine résorbable | rel=r_associated | relid=0 | w=10
  2525. lorazépam -- r_associated #0: 10 / 0.052 -> érythropoïétine
    n1=lorazépam | n2=érythropoïétine | rel=r_associated | relid=0 | w=10
  2526. lorazépam -- r_associated #0: 10 / 0.052 -> estazolam
    n1=lorazépam | n2=estazolam | rel=r_associated | relid=0 | w=10
  2527. lorazépam -- r_associated #0: 10 / 0.052 -> éthinyl oestradiol
    n1=lorazépam | n2=éthinyl oestradiol | rel=r_associated | relid=0 | w=10
  2528. lorazépam -- r_associated #0: 10 / 0.052 -> éthosuximide
    n1=lorazépam | n2=éthosuximide | rel=r_associated | relid=0 | w=10
  2529. lorazépam -- r_associated #0: 10 / 0.052 -> ézétimibe
    n1=lorazépam | n2=ézétimibe | rel=r_associated | relid=0 | w=10
  2530. lorazépam -- r_associated #0: 10 / 0.052 -> facteurs biologiques
    n1=lorazépam | n2=facteurs biologiques | rel=r_associated | relid=0 | w=10
  2531. lorazépam -- r_associated #0: 10 / 0.052 -> faire connaissance
    n1=lorazépam | n2=faire connaissance | rel=r_associated | relid=0 | w=10
  2532. lorazépam -- r_associated #0: 10 / 0.052 -> faire connaissance avec
    n1=lorazépam | n2=faire connaissance avec | rel=r_associated | relid=0 | w=10
  2533. lorazépam -- r_associated #0: 10 / 0.052 -> faire connaissance avec [qqn]
    n1=lorazépam | n2=faire connaissance avec [qqn] | rel=r_associated | relid=0 | w=10
  2534. lorazépam -- r_associated #0: 10 / 0.052 -> faire connaissance avec quelqu'un
    n1=lorazépam | n2=faire connaissance avec quelqu'un | rel=r_associated | relid=0 | w=10
  2535. lorazépam -- r_associated #0: 10 / 0.052 -> faire connaissance de
    n1=lorazépam | n2=faire connaissance de | rel=r_associated | relid=0 | w=10
  2536. lorazépam -- r_associated #0: 10 / 0.052 -> faire connaissance de [qqn]
    n1=lorazépam | n2=faire connaissance de [qqn] | rel=r_associated | relid=0 | w=10
  2537. lorazépam -- r_associated #0: 10 / 0.052 -> faire connaissance de quelqu'un
    n1=lorazépam | n2=faire connaissance de quelqu'un | rel=r_associated | relid=0 | w=10
  2538. lorazépam -- r_associated #0: 10 / 0.052 -> faire pendant
    n1=lorazépam | n2=faire pendant | rel=r_associated | relid=0 | w=10
  2539. lorazépam -- r_associated #0: 10 / 0.052 -> faire pendant à
    n1=lorazépam | n2=faire pendant à | rel=r_associated | relid=0 | w=10
  2540. lorazépam -- r_associated #0: 10 / 0.052 -> famitinib
    n1=lorazépam | n2=famitinib | rel=r_associated | relid=0 | w=10
  2541. lorazépam -- r_associated #0: 10 / 0.052 -> filgrastim
    n1=lorazépam | n2=filgrastim | rel=r_associated | relid=0 | w=10
  2542. lorazépam -- r_associated #0: 10 / 0.052 -> finastéride
    n1=lorazépam | n2=finastéride | rel=r_associated | relid=0 | w=10
  2543. lorazépam -- r_associated #0: 10 / 0.052 -> flucytosine
    n1=lorazépam | n2=flucytosine | rel=r_associated | relid=0 | w=10
  2544. lorazépam -- r_associated #0: 10 / 0.052 -> flumazénil
    n1=lorazépam | n2=flumazénil | rel=r_associated | relid=0 | w=10
  2545. lorazépam -- r_associated #0: 10 / 0.052 -> flunitrazépam
    n1=lorazépam | n2=flunitrazépam | rel=r_associated | relid=0 | w=10
  2546. lorazépam -- r_associated #0: 10 / 0.052 -> fluoro-uracile
    n1=lorazépam | n2=fluoro-uracile | rel=r_associated | relid=0 | w=10
  2547. lorazépam -- r_associated #0: 10 / 0.052 -> fluorouracile
    n1=lorazépam | n2=fluorouracile | rel=r_associated | relid=0 | w=10
  2548. lorazépam -- r_associated #0: 10 / 0.052 -> fonction pulmonaire diminuée
    n1=lorazépam | n2=fonction pulmonaire diminuée | rel=r_associated | relid=0 | w=10
  2549. lorazépam -- r_associated #0: 10 / 0.052 -> fonction respiratoire anormale
    n1=lorazépam | n2=fonction respiratoire anormale | rel=r_associated | relid=0 | w=10
  2550. lorazépam -- r_associated #0: 10 / 0.052 -> gabapentine
    n1=lorazépam | n2=gabapentine | rel=r_associated | relid=0 | w=10
  2551. lorazépam -- r_associated #0: 10 / 0.052 -> génistéine
    n1=lorazépam | n2=génistéine | rel=r_associated | relid=0 | w=10
  2552. lorazépam -- r_associated #0: 10 / 0.052 -> girentuximab
    n1=lorazépam | n2=girentuximab | rel=r_associated | relid=0 | w=10
  2553. lorazépam -- r_associated #0: 10 / 0.052 -> gluconate de cuivre
    n1=lorazépam | n2=gluconate de cuivre | rel=r_associated | relid=0 | w=10
  2554. lorazépam -- r_associated #0: 10 / 0.052 -> glutathion
    n1=lorazépam | n2=glutathion | rel=r_associated | relid=0 | w=10
  2555. lorazépam -- r_associated #0: 10 / 0.052 -> glycol polyéthylénique
    n1=lorazépam | n2=glycol polyéthylénique | rel=r_associated | relid=0 | w=10
  2556. lorazépam -- r_associated #0: 10 / 0.052 -> gonadotrophine ménopausique humaine
    n1=lorazépam | n2=gonadotrophine ménopausique humaine | rel=r_associated | relid=0 | w=10
  2557. lorazépam -- r_associated #0: 10 / 0.052 -> graisse de machines
    n1=lorazépam | n2=graisse de machines | rel=r_associated | relid=0 | w=10
  2558. lorazépam -- r_associated #0: 10 / 0.052 -> hormone gonadotrope ménopausique humaine
    n1=lorazépam | n2=hormone gonadotrope ménopausique humaine | rel=r_associated | relid=0 | w=10
  2559. lorazépam -- r_associated #0: 10 / 0.052 -> hydrocortisone
    n1=lorazépam | n2=hydrocortisone | rel=r_associated | relid=0 | w=10
  2560. lorazépam -- r_associated #0: 10 / 0.052 -> hydrocortisones
    n1=lorazépam | n2=hydrocortisones | rel=r_associated | relid=0 | w=10
  2561. lorazépam -- r_associated #0: 10 / 0.052 -> hydroxytyrosol
    n1=lorazépam | n2=hydroxytyrosol | rel=r_associated | relid=0 | w=10
  2562. lorazépam -- r_associated #0: 10 / 0.052 -> ibrutinib
    n1=lorazépam | n2=ibrutinib | rel=r_associated | relid=0 | w=10
  2563. lorazépam -- r_associated #0: 10 / 0.052 -> immuno-modulateurs
    n1=lorazépam | n2=immuno-modulateurs | rel=r_associated | relid=0 | w=10
  2564. lorazépam -- r_associated #0: 10 / 0.052 -> immunomodulateurs
    n1=lorazépam | n2=immunomodulateurs | rel=r_associated | relid=0 | w=10
  2565. lorazépam -- r_associated #0: 10 / 0.052 -> indométacine
    n1=lorazépam | n2=indométacine | rel=r_associated | relid=0 | w=10
  2566. lorazépam -- r_associated #0: 10 / 0.052 -> indométhacine
    n1=lorazépam | n2=indométhacine | rel=r_associated | relid=0 | w=10
  2567. lorazépam -- r_associated #0: 10 / 0.052 -> inhibiteur d'enzymes
    n1=lorazépam | n2=inhibiteur d'enzymes | rel=r_associated | relid=0 | w=10
  2568. lorazépam -- r_associated #0: 10 / 0.052 -> inhibiteur des canaux calciques
    n1=lorazépam | n2=inhibiteur des canaux calciques | rel=r_associated | relid=0 | w=10
  2569. lorazépam -- r_associated #0: 10 / 0.052 -> inhibiteur enzymatique
    n1=lorazépam | n2=inhibiteur enzymatique | rel=r_associated | relid=0 | w=10
  2570. lorazépam -- r_associated #0: 10 / 0.052 -> inositol
    n1=lorazépam | n2=inositol | rel=r_associated | relid=0 | w=10
  2571. lorazépam -- r_associated #0: 10 / 0.052 -> insuffisance respiratoire
    n1=lorazépam | n2=insuffisance respiratoire | rel=r_associated | relid=0 | w=10
  2572. lorazépam -- r_associated #0: 10 / 0.052 -> Insuffisance respiratoire
    n1=lorazépam | n2=Insuffisance respiratoire | rel=r_associated | relid=0 | w=10
  2573. lorazépam -- r_associated #0: 10 / 0.052 -> insuffisance respiratoire chronique
    n1=lorazépam | n2=insuffisance respiratoire chronique | rel=r_associated | relid=0 | w=10
  2574. lorazépam -- r_associated #0: 10 / 0.052 -> insuffisances respiratoires
    n1=lorazépam | n2=insuffisances respiratoires | rel=r_associated | relid=0 | w=10
  2575. lorazépam -- r_associated #0: 10 / 0.052 -> insuline glargine
    n1=lorazépam | n2=insuline glargine | rel=r_associated | relid=0 | w=10
  2576. lorazépam -- r_associated #0: 10 / 0.052 -> insuline normale
    n1=lorazépam | n2=insuline normale | rel=r_associated | relid=0 | w=10
  2577. lorazépam -- r_associated #0: 10 / 0.052 -> insuline ordinaire
    n1=lorazépam | n2=insuline ordinaire | rel=r_associated | relid=0 | w=10
  2578. lorazépam -- r_associated #0: 10 / 0.052 -> inuline
    n1=lorazépam | n2=inuline | rel=r_associated | relid=0 | w=10
  2579. lorazépam -- r_associated #0: 10 / 0.052 -> ionomycine
    n1=lorazépam | n2=ionomycine | rel=r_associated | relid=0 | w=10
  2580. lorazépam -- r_associated #0: 10 / 0.052 -> ipilimumab
    n1=lorazépam | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  2581. lorazépam -- r_associated #0: 10 / 0.052 -> isavuconazole
    n1=lorazépam | n2=isavuconazole | rel=r_associated | relid=0 | w=10
  2582. lorazépam -- r_associated #0: 10 / 0.052 -> isoflurane
    n1=lorazépam | n2=isoflurane | rel=r_associated | relid=0 | w=10
  2583. lorazépam -- r_associated #0: 10 / 0.052 -> isoniazide
    n1=lorazépam | n2=isoniazide | rel=r_associated | relid=0 | w=10
  2584. lorazépam -- r_associated #0: 10 / 0.052 -> isotrétinoïne
    n1=lorazépam | n2=isotrétinoïne | rel=r_associated | relid=0 | w=10
  2585. lorazépam -- r_associated #0: 10 / 0.052 -> lacidipine
    n1=lorazépam | n2=lacidipine | rel=r_associated | relid=0 | w=10
  2586. lorazépam -- r_associated #0: 10 / 0.052 -> lactase
    n1=lorazépam | n2=lactase | rel=r_associated | relid=0 | w=10
  2587. lorazépam -- r_associated #0: 10 / 0.052 -> lactobacillus
    n1=lorazépam | n2=lactobacillus | rel=r_associated | relid=0 | w=10
  2588. lorazépam -- r_associated #0: 10 / 0.052 -> lamivudine
    n1=lorazépam | n2=lamivudine | rel=r_associated | relid=0 | w=10
  2589. lorazépam -- r_associated #0: 10 / 0.052 -> langage de programmation
    n1=lorazépam | n2=langage de programmation | rel=r_associated | relid=0 | w=10
  2590. lorazépam -- r_associated #0: 10 / 0.052 -> langage informatique
    n1=lorazépam | n2=langage informatique | rel=r_associated | relid=0 | w=10
  2591. lorazépam -- r_associated #0: 10 / 0.052 -> Langage informatique
    n1=lorazépam | n2=Langage informatique | rel=r_associated | relid=0 | w=10
  2592. lorazépam -- r_associated #0: 10 / 0.052 -> lenvatinib
    n1=lorazépam | n2=lenvatinib | rel=r_associated | relid=0 | w=10
  2593. lorazépam -- r_associated #0: 10 / 0.052 -> lévofloxacine
    n1=lorazépam | n2=lévofloxacine | rel=r_associated | relid=0 | w=10
  2594. lorazépam -- r_associated #0: 10 / 0.052 -> licorice
    n1=lorazépam | n2=licorice | rel=r_associated | relid=0 | w=10
  2595. lorazépam -- r_associated #0: 10 / 0.052 -> lier connaissance avec
    n1=lorazépam | n2=lier connaissance avec | rel=r_associated | relid=0 | w=10
  2596. lorazépam -- r_associated #0: 10 / 0.052 -> lier connaissance avec [qqn]
    n1=lorazépam | n2=lier connaissance avec [qqn] | rel=r_associated | relid=0 | w=10
  2597. lorazépam -- r_associated #0: 10 / 0.052 -> lier connaissance avec qn
    n1=lorazépam | n2=lier connaissance avec qn | rel=r_associated | relid=0 | w=10
  2598. lorazépam -- r_associated #0: 10 / 0.052 -> lier connaissance avec quelqu'un
    n1=lorazépam | n2=lier connaissance avec quelqu'un | rel=r_associated | relid=0 | w=10
  2599. lorazépam -- r_associated #0: 10 / 0.052 -> lipase
    n1=lorazépam | n2=lipase | rel=r_associated | relid=0 | w=10
  2600. lorazépam -- r_associated #0: 10 / 0.052 -> liraglutide
    n1=lorazépam | n2=liraglutide | rel=r_associated | relid=0 | w=10
  2601. lorazépam -- r_associated #0: 10 / 0.052 -> lisinopril
    n1=lorazépam | n2=lisinopril | rel=r_associated | relid=0 | w=10
  2602. lorazépam -- r_associated #0: 10 / 0.052 -> Looser-Milkman
    n1=lorazépam | n2=Looser-Milkman | rel=r_associated | relid=0 | w=10
  2603. lorazépam -- r_associated #0: 10 / 0.052 -> lophotriche
    n1=lorazépam | n2=lophotriche | rel=r_associated | relid=0 | w=10
  2604. lorazépam -- r_associated #0: 10 / 0.052 -> lopinavir
    n1=lorazépam | n2=lopinavir | rel=r_associated | relid=0 | w=10
  2605. lorazépam -- r_associated #0: 10 / 0.052 -> loprazolam
    n1=lorazépam | n2=loprazolam | rel=r_associated | relid=0 | w=10
  2606. lorazépam -- r_associated #0: 10 / 0.052 -> lormétazépam
    n1=lorazépam | n2=lormétazépam | rel=r_associated | relid=0 | w=10
  2607. lorazépam -- r_associated #0: 10 / 0.052 -> lovastatine
    n1=lorazépam | n2=lovastatine | rel=r_associated | relid=0 | w=10
  2608. lorazépam -- r_associated #0: 10 / 0.052 -> macitentan
    n1=lorazépam | n2=macitentan | rel=r_associated | relid=0 | w=10
  2609. lorazépam -- r_associated #0: 10 / 0.052 -> mal parler à
    n1=lorazépam | n2=mal parler à | rel=r_associated | relid=0 | w=10
  2610. lorazépam -- r_associated #0: 10 / 0.052 -> medicament
    n1=lorazépam | n2=medicament | rel=r_associated | relid=0 | w=10
  2611. lorazépam -- r_associated #0: 10 / 0.052 -> médicaments animaux
    n1=lorazépam | n2=médicaments animaux | rel=r_associated | relid=0 | w=10
  2612. lorazépam -- r_associated #0: 10 / 0.052 -> médicaments vétérinaires
    n1=lorazépam | n2=médicaments vétérinaires | rel=r_associated | relid=0 | w=10
  2613. lorazépam -- r_associated #0: 10 / 0.052 -> mesna
    n1=lorazépam | n2=mesna | rel=r_associated | relid=0 | w=10
  2614. lorazépam -- r_associated #0: 10 / 0.052 -> méthoxsalène
    n1=lorazépam | n2=méthoxsalène | rel=r_associated | relid=0 | w=10
  2615. lorazépam -- r_associated #0: 10 / 0.052 -> mitogène
    n1=lorazépam | n2=mitogène | rel=r_associated | relid=0 | w=10
  2616. lorazépam -- r_associated #0: 10 / 0.052 -> mitoguazone
    n1=lorazépam | n2=mitoguazone | rel=r_associated | relid=0 | w=10
  2617. lorazépam -- r_associated #0: 10 / 0.052 -> mitoguazones
    n1=lorazépam | n2=mitoguazones | rel=r_associated | relid=0 | w=10
  2618. lorazépam -- r_associated #0: 10 / 0.052 -> modafinil
    n1=lorazépam | n2=modafinil | rel=r_associated | relid=0 | w=10
  2619. lorazépam -- r_associated #0: 10 / 0.052 -> mutagène
    n1=lorazépam | n2=mutagène | rel=r_associated | relid=0 | w=10
  2620. lorazépam -- r_associated #0: 10 / 0.052 -> myorelaxante
    n1=lorazépam | n2=myorelaxante | rel=r_associated | relid=0 | w=10
  2621. lorazépam -- r_associated #0: 10 / 0.052 -> nadolol
    n1=lorazépam | n2=nadolol | rel=r_associated | relid=0 | w=10
  2622. lorazépam -- r_associated #0: 10 / 0.052 -> nadroparine calcique
    n1=lorazépam | n2=nadroparine calcique | rel=r_associated | relid=0 | w=10
  2623. lorazépam -- r_associated #0: 10 / 0.052 -> naproxène
    n1=lorazépam | n2=naproxène | rel=r_associated | relid=0 | w=10
  2624. lorazépam -- r_associated #0: 10 / 0.052 -> natalizumab
    n1=lorazépam | n2=natalizumab | rel=r_associated | relid=0 | w=10
  2625. lorazépam -- r_associated #0: 10 / 0.052 -> niacinamide
    n1=lorazépam | n2=niacinamide | rel=r_associated | relid=0 | w=10
  2626. lorazépam -- r_associated #0: 10 / 0.052 -> nicotinamide
    n1=lorazépam | n2=nicotinamide | rel=r_associated | relid=0 | w=10
  2627. lorazépam -- r_associated #0: 10 / 0.052 -> nicotine
    n1=lorazépam | n2=nicotine | rel=r_associated | relid=0 | w=10
  2628. lorazépam -- r_associated #0: 10 / 0.052 -> non précisée, anomalie respiratoire
    n1=lorazépam | n2=non précisée, anomalie respiratoire | rel=r_associated | relid=0 | w=10
  2629. lorazépam -- r_associated #0: 10 / 0.052 -> nordazépam
    n1=lorazépam | n2=nordazépam | rel=r_associated | relid=0 | w=10
  2630. lorazépam -- r_associated #0: 10 / 0.052 -> novobiocine
    n1=lorazépam | n2=novobiocine | rel=r_associated | relid=0 | w=10
  2631. lorazépam -- r_associated #0: 10 / 0.052 -> ocrelizumab
    n1=lorazépam | n2=ocrelizumab | rel=r_associated | relid=0 | w=10
  2632. lorazépam -- r_associated #0: 10 / 0.052 -> olanzapine
    n1=lorazépam | n2=olanzapine | rel=r_associated | relid=0 | w=10
  2633. lorazépam -- r_associated #0: 10 / 0.052 -> olaparib
    n1=lorazépam | n2=olaparib | rel=r_associated | relid=0 | w=10
  2634. lorazépam -- r_associated #0: 10 / 0.052 -> omalizumab
    n1=lorazépam | n2=omalizumab | rel=r_associated | relid=0 | w=10
  2635. lorazépam -- r_associated #0: 10 / 0.052 -> oméprazole
    n1=lorazépam | n2=oméprazole | rel=r_associated | relid=0 | w=10
  2636. lorazépam -- r_associated #0: 10 / 0.052 -> omeprazole
    n1=lorazépam | n2=omeprazole | rel=r_associated | relid=0 | w=10
  2637. lorazépam -- r_associated #0: 10 / 0.052 -> ostéomalacie
    n1=lorazépam | n2=ostéomalacie | rel=r_associated | relid=0 | w=10
  2638. lorazépam -- r_associated #0: 10 / 0.052 -> oxitriptan
    n1=lorazépam | n2=oxitriptan | rel=r_associated | relid=0 | w=10
  2639. lorazépam -- r_associated #0: 10 / 0.052 -> oxyde de magnésium
    n1=lorazépam | n2=oxyde de magnésium | rel=r_associated | relid=0 | w=10
  2640. lorazépam -- r_associated #0: 10 / 0.052 -> oxymétholone
    n1=lorazépam | n2=oxymétholone | rel=r_associated | relid=0 | w=10
  2641. lorazépam -- r_associated #0: 10 / 0.052 -> palbociclib
    n1=lorazépam | n2=palbociclib | rel=r_associated | relid=0 | w=10
  2642. lorazépam -- r_associated #0: 10 / 0.052 -> pénicillamine
    n1=lorazépam | n2=pénicillamine | rel=r_associated | relid=0 | w=10
  2643. lorazépam -- r_associated #0: 10 / 0.052 -> pentamidine
    n1=lorazépam | n2=pentamidine | rel=r_associated | relid=0 | w=10
  2644. lorazépam -- r_associated #0: 10 / 0.052 -> pentoxifylline
    n1=lorazépam | n2=pentoxifylline | rel=r_associated | relid=0 | w=10
  2645. lorazépam -- r_associated #0: 10 / 0.052 -> peptides hydrolases
    n1=lorazépam | n2=peptides hydrolases | rel=r_associated | relid=0 | w=10
  2646. lorazépam -- r_associated #0: 10 / 0.052 -> pesticide
    n1=lorazépam | n2=pesticide | rel=r_associated | relid=0 | w=10
  2647. lorazépam -- r_associated #0: 10 / 0.052 -> phénobarbital
    n1=lorazépam | n2=phénobarbital | rel=r_associated | relid=0 | w=10
  2648. lorazépam -- r_associated #0: 10 / 0.052 -> phénothiazine
    n1=lorazépam | n2=phénothiazine | rel=r_associated | relid=0 | w=10
  2649. lorazépam -- r_associated #0: 10 / 0.052 -> phylloquinone
    n1=lorazépam | n2=phylloquinone | rel=r_associated | relid=0 | w=10
  2650. lorazépam -- r_associated #0: 10 / 0.052 -> phytoménadione
    n1=lorazépam | n2=phytoménadione | rel=r_associated | relid=0 | w=10
  2651. lorazépam -- r_associated #0: 10 / 0.052 -> phytonadione
    n1=lorazépam | n2=phytonadione | rel=r_associated | relid=0 | w=10
  2652. lorazépam -- r_associated #0: 10 / 0.052 -> pierre à savon
    n1=lorazépam | n2=pierre à savon | rel=r_associated | relid=0 | w=10
  2653. lorazépam -- r_associated #0: 10 / 0.052 -> Pierre à savon
    n1=lorazépam | n2=Pierre à savon | rel=r_associated | relid=0 | w=10
  2654. lorazépam -- r_associated #0: 10 / 0.052 -> pimecrolimus
    n1=lorazépam | n2=pimecrolimus | rel=r_associated | relid=0 | w=10
  2655. lorazépam -- r_associated #0: 10 / 0.052 -> piroxicam
    n1=lorazépam | n2=piroxicam | rel=r_associated | relid=0 | w=10
  2656. lorazépam -- r_associated #0: 10 / 0.052 -> polydextrose
    n1=lorazépam | n2=polydextrose | rel=r_associated | relid=0 | w=10
  2657. lorazépam -- r_associated #0: 10 / 0.052 -> polyéthylène glycol
    n1=lorazépam | n2=polyéthylène glycol | rel=r_associated | relid=0 | w=10
  2658. lorazépam -- r_associated #0: 10 / 0.052 -> ponesimod
    n1=lorazépam | n2=ponesimod | rel=r_associated | relid=0 | w=10
  2659. lorazépam -- r_associated #0: 10 / 0.052 -> posaconazole
    n1=lorazépam | n2=posaconazole | rel=r_associated | relid=0 | w=10
  2660. lorazépam -- r_associated #0: 10 / 0.052 -> poudrer
    n1=lorazépam | n2=poudrer | rel=r_associated | relid=0 | w=10
  2661. lorazépam -- r_associated #0: 10 / 0.052 -> prastérone
    n1=lorazépam | n2=prastérone | rel=r_associated | relid=0 | w=10
  2662. lorazépam -- r_associated #0: 10 / 0.052 -> préparation d'hydrocortisone
    n1=lorazépam | n2=préparation d'hydrocortisone | rel=r_associated | relid=0 | w=10
  2663. lorazépam -- r_associated #0: 10 / 0.052 -> préparation de cortisol
    n1=lorazépam | n2=préparation de cortisol | rel=r_associated | relid=0 | w=10
  2664. lorazépam -- r_associated #0: 10 / 0.052 -> préparation du composé f
    n1=lorazépam | n2=préparation du composé f | rel=r_associated | relid=0 | w=10
  2665. lorazépam -- r_associated #0: 10 / 0.052 -> préparation du composé F
    n1=lorazépam | n2=préparation du composé F | rel=r_associated | relid=0 | w=10
  2666. lorazépam -- r_associated #0: 10 / 0.052 -> préparation pharmaceutique
    n1=lorazépam | n2=préparation pharmaceutique | rel=r_associated | relid=0 | w=10
  2667. lorazépam -- r_associated #0: 10 / 0.052 -> prochlorpérazine
    n1=lorazépam | n2=prochlorpérazine | rel=r_associated | relid=0 | w=10
  2668. lorazépam -- r_associated #0: 10 / 0.052 -> produit anesthésiant
    n1=lorazépam | n2=produit anesthésiant | rel=r_associated | relid=0 | w=10
  2669. lorazépam -- r_associated #0: 10 / 0.052 -> proflavine
    n1=lorazépam | n2=proflavine | rel=r_associated | relid=0 | w=10
  2670. lorazépam -- r_associated #0: 10 / 0.052 -> progestérone
    n1=lorazépam | n2=progestérone | rel=r_associated | relid=0 | w=10
  2671. lorazépam -- r_associated #0: 10 / 0.052 -> progestine
    n1=lorazépam | n2=progestine | rel=r_associated | relid=0 | w=10
  2672. lorazépam -- r_associated #0: 10 / 0.052 -> ramipril
    n1=lorazépam | n2=ramipril | rel=r_associated | relid=0 | w=10
  2673. lorazépam -- r_associated #0: 10 / 0.052 -> ramucirumab
    n1=lorazépam | n2=ramucirumab | rel=r_associated | relid=0 | w=10
  2674. lorazépam -- r_associated #0: 10 / 0.052 -> répondre à
    n1=lorazépam | n2=répondre à | rel=r_associated | relid=0 | w=10
  2675. lorazépam -- r_associated #0: 10 / 0.052 -> répondre à [qqn]
    n1=lorazépam | n2=répondre à [qqn] | rel=r_associated | relid=0 | w=10
  2676. lorazépam -- r_associated #0: 10 / 0.052 -> répondre à qn
    n1=lorazépam | n2=répondre à qn | rel=r_associated | relid=0 | w=10
  2677. lorazépam -- r_associated #0: 10 / 0.052 -> répondre à quelqu'un
    n1=lorazépam | n2=répondre à quelqu'un | rel=r_associated | relid=0 | w=10
  2678. lorazépam -- r_associated #0: 10 / 0.052 -> respiration anormale
    n1=lorazépam | n2=respiration anormale | rel=r_associated | relid=0 | w=10
  2679. lorazépam -- r_associated #0: 10 / 0.052 -> respiration déprimée
    n1=lorazépam | n2=respiration déprimée | rel=r_associated | relid=0 | w=10
  2680. lorazépam -- r_associated #0: 10 / 0.052 -> respiration diminuée
    n1=lorazépam | n2=respiration diminuée | rel=r_associated | relid=0 | w=10
  2681. lorazépam -- r_associated #0: 10 / 0.052 -> rituximab
    n1=lorazépam | n2=rituximab | rel=r_associated | relid=0 | w=10
  2682. lorazépam -- r_associated #0: 10 / 0.052 -> rivaroxaban
    n1=lorazépam | n2=rivaroxaban | rel=r_associated | relid=0 | w=10
  2683. lorazépam -- r_associated #0: 10 / 0.052 -> se joindre
    n1=lorazépam | n2=se joindre | rel=r_associated | relid=0 | w=10
  2684. lorazépam -- r_associated #0: 10 / 0.052 -> sel d'Epsom
    n1=lorazépam | n2=sel d'Epsom | rel=r_associated | relid=0 | w=10
  2685. lorazépam -- r_associated #0: 10 / 0.052 -> sel d'epsom
    n1=lorazépam | n2=sel d'epsom | rel=r_associated | relid=0 | w=10
  2686. lorazépam -- r_associated #0: 10 / 0.052 -> spanner
    n1=lorazépam | n2=spanner | rel=r_associated | relid=0 | w=10
  2687. lorazépam -- r_associated #0: 10 / 0.052 -> stéatite
    n1=lorazépam | n2=stéatite | rel=r_associated | relid=0 | w=10
  2688. lorazépam -- r_associated #0: 10 / 0.052 -> strie de Looser-Milkman
    n1=lorazépam | n2=strie de Looser-Milkman | rel=r_associated | relid=0 | w=10
  2689. lorazépam -- r_associated #0: 10 / 0.052 -> sulfate de magnésium
    n1=lorazépam | n2=sulfate de magnésium | rel=r_associated | relid=0 | w=10
  2690. lorazépam -- r_associated #0: 10 / 0.052 -> sulfate de zinc
    n1=lorazépam | n2=sulfate de zinc | rel=r_associated | relid=0 | w=10
  2691. lorazépam -- r_associated #0: 10 / 0.052 -> syndrome
    n1=lorazépam | n2=syndrome | rel=r_associated | relid=0 | w=10
  2692. lorazépam -- r_associated #0: 10 / 0.052 -> syndrome de Looser-Milkman
    n1=lorazépam | n2=syndrome de Looser-Milkman | rel=r_associated | relid=0 | w=10
  2693. lorazépam -- r_associated #0: 10 / 0.052 -> syndrome de Milkman
    n1=lorazépam | n2=syndrome de Milkman | rel=r_associated | relid=0 | w=10
  2694. lorazépam -- r_associated #0: 10 / 0.052 -> talc
    n1=lorazépam | n2=talc | rel=r_associated | relid=0 | w=10
  2695. lorazépam -- r_associated #0: 10 / 0.052 -> talquer [qch]
    n1=lorazépam | n2=talquer [qch] | rel=r_associated | relid=0 | w=10
  2696. lorazépam -- r_associated #0: 10 / 0.052 -> talquer quelque chose
    n1=lorazépam | n2=talquer quelque chose | rel=r_associated | relid=0 | w=10
  2697. lorazépam -- r_associated #0: 10 / 0.052 -> temsirolimus
    n1=lorazépam | n2=temsirolimus | rel=r_associated | relid=0 | w=10
  2698. lorazépam -- r_associated #0: 10 / 0.052 -> téniposide
    n1=lorazépam | n2=téniposide | rel=r_associated | relid=0 | w=10
  2699. lorazépam -- r_associated #0: 10 / 0.052 -> tératogène
    n1=lorazépam | n2=tératogène | rel=r_associated | relid=0 | w=10
  2700. lorazépam -- r_associated #0: 10 / 0.052 -> tétrahydrocannabinol de synthèse
    n1=lorazépam | n2=tétrahydrocannabinol de synthèse | rel=r_associated | relid=0 | w=10
  2701. lorazépam -- r_associated #0: 10 / 0.052 -> tétrahydrocannabinol synthétique
    n1=lorazépam | n2=tétrahydrocannabinol synthétique | rel=r_associated | relid=0 | w=10
  2702. lorazépam -- r_associated #0: 10 / 0.052 -> texte source
    n1=lorazépam | n2=texte source | rel=r_associated | relid=0 | w=10
  2703. lorazépam -- r_associated #0: 10 / 0.052 -> THC de synthèse
    n1=lorazépam | n2=THC de synthèse | rel=r_associated | relid=0 | w=10
  2704. lorazépam -- r_associated #0: 10 / 0.052 -> THC synthétique
    n1=lorazépam | n2=THC synthétique | rel=r_associated | relid=0 | w=10
  2705. lorazépam -- r_associated #0: 10 / 0.052 -> Thé noir
    n1=lorazépam | n2=Thé noir | rel=r_associated | relid=0 | w=10
  2706. lorazépam -- r_associated #0: 10 / 0.052 -> thé noir
    n1=lorazépam | n2=thé noir | rel=r_associated | relid=0 | w=10
  2707. lorazépam -- r_associated #0: 10 / 0.052 -> thiamine
    n1=lorazépam | n2=thiamine | rel=r_associated | relid=0 | w=10
  2708. lorazépam -- r_associated #0: 10 / 0.052 -> timbre anti-tabac
    n1=lorazépam | n2=timbre anti-tabac | rel=r_associated | relid=0 | w=10
  2709. lorazépam -- r_associated #0: 10 / 0.052 -> tocilizumab
    n1=lorazépam | n2=tocilizumab | rel=r_associated | relid=0 | w=10
  2710. lorazépam -- r_associated #0: 10 / 0.052 -> trastuzumab
    n1=lorazépam | n2=trastuzumab | rel=r_associated | relid=0 | w=10
  2711. lorazépam -- r_associated #0: 10 / 0.052 -> trétinoïne
    n1=lorazépam | n2=trétinoïne | rel=r_associated | relid=0 | w=10
  2712. lorazépam -- r_associated #0: 10 / 0.052 -> trioxyde d'arsenic
    n1=lorazépam | n2=trioxyde d'arsenic | rel=r_associated | relid=0 | w=10
  2713. lorazépam -- r_associated #0: 10 / 0.052 -> trouble de la fonction respiratoire
    n1=lorazépam | n2=trouble de la fonction respiratoire | rel=r_associated | relid=0 | w=10
  2714. lorazépam -- r_associated #0: 10 / 0.052 -> trouble de la respiration
    n1=lorazépam | n2=trouble de la respiration | rel=r_associated | relid=0 | w=10
  2715. lorazépam -- r_associated #0: 10 / 0.052 -> trouble fonctions respir
    n1=lorazépam | n2=trouble fonctions respir | rel=r_associated | relid=0 | w=10
  2716. lorazépam -- r_associated #0: 10 / 0.052 -> ustekinumab
    n1=lorazépam | n2=ustekinumab | rel=r_associated | relid=0 | w=10
  2717. lorazépam -- r_associated #0: 10 / 0.052 -> vaccin anti-hépatite A
    n1=lorazépam | n2=vaccin anti-hépatite A | rel=r_associated | relid=0 | w=10
  2718. lorazépam -- r_associated #0: 10 / 0.052 -> vaccin anti-hépatite B
    n1=lorazépam | n2=vaccin anti-hépatite B | rel=r_associated | relid=0 | w=10
  2719. lorazépam -- r_associated #0: 10 / 0.052 -> vaccin anti-hépatite b
    n1=lorazépam | n2=vaccin anti-hépatite b | rel=r_associated | relid=0 | w=10
  2720. lorazépam -- r_associated #0: 10 / 0.052 -> vaccin contre l'hépatite a
    n1=lorazépam | n2=vaccin contre l'hépatite a | rel=r_associated | relid=0 | w=10
  2721. lorazépam -- r_associated #0: 10 / 0.052 -> vaccin contre l'hépatite A
    n1=lorazépam | n2=vaccin contre l'hépatite A | rel=r_associated | relid=0 | w=10
  2722. lorazépam -- r_associated #0: 10 / 0.052 -> vaccin contre l'hépatite b
    n1=lorazépam | n2=vaccin contre l'hépatite b | rel=r_associated | relid=0 | w=10
  2723. lorazépam -- r_associated #0: 10 / 0.052 -> vaccin contre l'hépatite B
    n1=lorazépam | n2=vaccin contre l'hépatite B | rel=r_associated | relid=0 | w=10
  2724. lorazépam -- r_associated #0: 10 / 0.052 -> Vaccin contre l'hépatite B
    n1=lorazépam | n2=Vaccin contre l'hépatite B | rel=r_associated | relid=0 | w=10
  2725. lorazépam -- r_associated #0: 10 / 0.052 -> Valeriana
    n1=lorazépam | n2=Valeriana | rel=r_associated | relid=0 | w=10
  2726. lorazépam -- r_associated #0: 10 / 0.052 -> valériane
    n1=lorazépam | n2=valériane | rel=r_associated | relid=0 | w=10
  2727. lorazépam -- r_associated #0: 10 / 0.052 -> vancomycine
    n1=lorazépam | n2=vancomycine | rel=r_associated | relid=0 | w=10
  2728. lorazépam -- r_associated #0: 10 / 0.052 -> vedolizumab
    n1=lorazépam | n2=vedolizumab | rel=r_associated | relid=0 | w=10
  2729. lorazépam -- r_associated #0: 10 / 0.052 -> vesse de loup
    n1=lorazépam | n2=vesse de loup | rel=r_associated | relid=0 | w=10
  2730. lorazépam -- r_associated #0: 10 / 0.052 -> vinblastine
    n1=lorazépam | n2=vinblastine | rel=r_associated | relid=0 | w=10
  2731. lorazépam -- r_associated #0: 10 / 0.052 -> vitamine B1
    n1=lorazépam | n2=vitamine B1 | rel=r_associated | relid=0 | w=10
  2732. lorazépam -- r_associated #0: 10 / 0.052 -> vitamine K1
    n1=lorazépam | n2=vitamine K1 | rel=r_associated | relid=0 | w=10
  2733. lorazépam -- r_associated #0: 10 / 0.052 -> vitamine k1
    n1=lorazépam | n2=vitamine k1 | rel=r_associated | relid=0 | w=10
  2734. lorazépam -- r_associated #0: 10 / 0.052 -> Vitamine K1
    n1=lorazépam | n2=Vitamine K1 | rel=r_associated | relid=0 | w=10
  2735. lorazépam -- r_associated #0: 10 / 0.052 -> warfarine
    n1=lorazépam | n2=warfarine | rel=r_associated | relid=0 | w=10
  2736. lorazépam -- r_associated #0: 10 / 0.052 -> zidovudine
    n1=lorazépam | n2=zidovudine | rel=r_associated | relid=0 | w=10
  2737. lorazépam -- r_associated #0: 10 / 0.052 -> zolmitriptan
    n1=lorazépam | n2=zolmitriptan | rel=r_associated | relid=0 | w=10
  2738. lorazépam -- r_associated #0: 5 / 0.026 -> en:Looser-Milkman's syndrome
    n1=lorazépam | n2=en:Looser-Milkman's syndrome | rel=r_associated | relid=0 | w=5
  2739. lorazépam -- r_associated #0: 5 / 0.026 -> Looser-Milkman (fissures de)
    n1=lorazépam | n2=Looser-Milkman (fissures de) | rel=r_associated | relid=0 | w=5
  2740. lorazépam -- r_associated #0: 5 / 0.026 -> Médecine
    n1=lorazépam | n2=Médecine | rel=r_associated | relid=0 | w=5
  2741. lorazépam -- r_associated #0: 5 / 0.026 -> substance à analyser
    n1=lorazépam | n2=substance à analyser | rel=r_associated | relid=0 | w=5
  2742. lorazépam -- r_associated #0: 2 / 0.01 -> en:anticonvulsant
    n1=lorazépam | n2=en:anticonvulsant | rel=r_associated | relid=0 | w=2
  2743. lorazépam -- r_associated #0: 1 / 0.005 -> en:analyte
    n1=lorazépam | n2=en:analyte | rel=r_associated | relid=0 | w=1
≈ 277 relations entrantes

  1. médecine --- r_associated #0: 174 --> lorazépam
    n1=médecine | n2=lorazépam | rel=r_associated | relid=0 | w=174
  2. anticonvulsant --- r_associated #0: 94 --> lorazépam
    n1=anticonvulsant | n2=lorazépam | rel=r_associated | relid=0 | w=94
  3. en:anticonvulsant --- r_associated #0: 90 --> lorazépam
    n1=en:anticonvulsant | n2=lorazépam | rel=r_associated | relid=0 | w=90
  4. anxiolytique --- r_associated #0: 70 --> lorazépam
    n1=anxiolytique | n2=lorazépam | rel=r_associated | relid=0 | w=70
  5. sédatif --- r_associated #0: 64 --> lorazépam
    n1=sédatif | n2=lorazépam | rel=r_associated | relid=0 | w=64
  6. hypnotique --- r_associated #0: 56 --> lorazépam
    n1=hypnotique | n2=lorazépam | rel=r_associated | relid=0 | w=56
  7. myorelaxant --- r_associated #0: 54 --> lorazépam
    n1=myorelaxant | n2=lorazépam | rel=r_associated | relid=0 | w=54
  8. psychotrope --- r_associated #0: 51 --> lorazépam
    n1=psychotrope | n2=lorazépam | rel=r_associated | relid=0 | w=51
  9. anticonvulsivant --- r_associated #0: 43 --> lorazépam
    n1=anticonvulsivant | n2=lorazépam | rel=r_associated | relid=0 | w=43
  10. tranquillisant
    (Adj)
     --- r_associated #0: 37 --> lorazépam
    n1=tranquillisant
    (Adj)
    | n2=lorazépam | rel=r_associated | relid=0 | w=37
  11. barbiturique --- r_associated #0: 36 --> lorazépam
    n1=barbiturique | n2=lorazépam | rel=r_associated | relid=0 | w=36
  12. benzodiazépine --- r_associated #0: 36 --> lorazépam
    n1=benzodiazépine | n2=lorazépam | rel=r_associated | relid=0 | w=36
  13. benzodiazépines (effets secondaires des) e --- r_associated #0: 35 --> lorazépam
    n1=benzodiazépines (effets secondaires des) e | n2=lorazépam | rel=r_associated | relid=0 | w=35
  14. en:donix --- r_associated #0: 35 --> lorazépam
    n1=en:donix | n2=lorazépam | rel=r_associated | relid=0 | w=35
  15. en:lorazepam-neuraxpharm --- r_associated #0: 35 --> lorazépam
    n1=en:lorazepam-neuraxpharm | n2=lorazépam | rel=r_associated | relid=0 | w=35
  16. en:sedicepan --- r_associated #0: 35 --> lorazépam
    n1=en:sedicepan | n2=lorazépam | rel=r_associated | relid=0 | w=35
  17. somnifèr --- r_associated #0: 35 --> lorazépam
    n1=somnifèr | n2=lorazépam | rel=r_associated | relid=0 | w=35
  18. en:novo-lorazem --- r_associated #0: 34 --> lorazépam
    n1=en:novo-lorazem | n2=lorazépam | rel=r_associated | relid=0 | w=34
  19. en:sinestron --- r_associated #0: 34 --> lorazépam
    n1=en:sinestron | n2=lorazépam | rel=r_associated | relid=0 | w=34
  20. en:somagerol --- r_associated #0: 34 --> lorazépam
    n1=en:somagerol | n2=lorazépam | rel=r_associated | relid=0 | w=34
  21. médicaments --- r_associated #0: 34 --> lorazépam
    n1=médicaments | n2=lorazépam | rel=r_associated | relid=0 | w=34
  22. en:lorazepam --- r_associated #0: 33 --> lorazépam
    n1=en:lorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=33
  23. en:tolid --- r_associated #0: 32 --> lorazépam
    n1=en:tolid | n2=lorazépam | rel=r_associated | relid=0 | w=32
  24. consolant --- r_associated #0: 31 --> lorazépam
    n1=consolant | n2=lorazépam | rel=r_associated | relid=0 | w=31
  25. en:nu-loraz --- r_associated #0: 31 --> lorazépam
    n1=en:nu-loraz | n2=lorazépam | rel=r_associated | relid=0 | w=31
  26. balsamique --- r_associated #0: 30 --> lorazépam
    n1=balsamique | n2=lorazépam | rel=r_associated | relid=0 | w=30
  27. en:apo-lorazepam --- r_associated #0: 30 --> lorazépam
    n1=en:apo-lorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=30
  28. en:duralozam --- r_associated #0: 30 --> lorazépam
    n1=en:duralozam | n2=lorazépam | rel=r_associated | relid=0 | w=30
  29. en:benzodiazepine compound --- r_associated #0: 29 --> lorazépam
    n1=en:benzodiazepine compound | n2=lorazépam | rel=r_associated | relid=0 | w=29
  30. en:laubeel --- r_associated #0: 29 --> lorazépam
    n1=en:laubeel | n2=lorazépam | rel=r_associated | relid=0 | w=29
  31. en:lorazep von ct --- r_associated #0: 29 --> lorazépam
    n1=en:lorazep von ct | n2=lorazépam | rel=r_associated | relid=0 | w=29
  32. en:lorazepam medical --- r_associated #0: 28 --> lorazépam
    n1=en:lorazepam medical | n2=lorazépam | rel=r_associated | relid=0 | w=28
  33. en:lorazepam-ratiopharm --- r_associated #0: 28 --> lorazépam
    n1=en:lorazepam-ratiopharm | n2=lorazépam | rel=r_associated | relid=0 | w=28
  34. en:solacing --- r_associated #0: 27 --> lorazépam
    n1=en:solacing | n2=lorazépam | rel=r_associated | relid=0 | w=27
  35. en:idalprem --- r_associated #0: 26 --> lorazépam
    n1=en:idalprem | n2=lorazépam | rel=r_associated | relid=0 | w=26
  36. en:temesta --- r_associated #0: 26 --> lorazépam
    n1=en:temesta | n2=lorazépam | rel=r_associated | relid=0 | w=26
  37. en:0.5 ml lorazepam 1 mg/ml prefilled syringe --- r_associated #0: 25 --> lorazépam
    n1=en:0.5 ml lorazepam 1 mg/ml prefilled syringe | n2=lorazépam | rel=r_associated | relid=0 | w=25
  38. en:1 ml lorazepam 2 mg/ml cartridge --- r_associated #0: 25 --> lorazépam
    n1=en:1 ml lorazepam 2 mg/ml cartridge | n2=lorazépam | rel=r_associated | relid=0 | w=25
  39. en:1 ml lorazepam 2 mg/ml injection --- r_associated #0: 25 --> lorazépam
    n1=en:1 ml lorazepam 2 mg/ml injection | n2=lorazépam | rel=r_associated | relid=0 | w=25
  40. en:1 ml lorazepam 2 mg/ml injection [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:1 ml lorazepam 2 mg/ml injection [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  41. en:1 ml lorazepam 4 mg/ml cartridge --- r_associated #0: 25 --> lorazépam
    n1=en:1 ml lorazepam 4 mg/ml cartridge | n2=lorazépam | rel=r_associated | relid=0 | w=25
  42. en:1 ml lorazepam 4 mg/ml injection --- r_associated #0: 25 --> lorazépam
    n1=en:1 ml lorazepam 4 mg/ml injection | n2=lorazépam | rel=r_associated | relid=0 | w=25
  43. en:1 ml lorazepam 4 mg/ml injection [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:1 ml lorazepam 4 mg/ml injection [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  44. en:accidental lorazepam overdose --- r_associated #0: 25 --> lorazépam
    n1=en:accidental lorazepam overdose | n2=lorazépam | rel=r_associated | relid=0 | w=25
  45. en:accidental poisoning by lorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:accidental poisoning by lorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  46. en:clorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:clorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  47. en:delorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:delorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  48. en:injection, lorazepam, 2 mg administered --- r_associated #0: 25 --> lorazépam
    n1=en:injection, lorazepam, 2 mg administered | n2=lorazépam | rel=r_associated | relid=0 | w=25
  49. en:intentional lorazepam overdose --- r_associated #0: 25 --> lorazépam
    n1=en:intentional lorazepam overdose | n2=lorazépam | rel=r_associated | relid=0 | w=25
  50. en:intentional lorazepam poisoning --- r_associated #0: 25 --> lorazépam
    n1=en:intentional lorazepam poisoning | n2=lorazépam | rel=r_associated | relid=0 | w=25
  51. en:lorazepam 0.1 mg/ml injectable solution --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 0.1 mg/ml injectable solution | n2=lorazépam | rel=r_associated | relid=0 | w=25
  52. en:lorazepam 0.2 mg/ml injectable solution --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 0.2 mg/ml injectable solution | n2=lorazépam | rel=r_associated | relid=0 | w=25
  53. en:lorazepam 0.5 mg --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 0.5 mg | n2=lorazépam | rel=r_associated | relid=0 | w=25
  54. en:lorazepam 0.5 mg oral tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 0.5 mg oral tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  55. en:lorazepam 0.5 mg oral tablet [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 0.5 mg oral tablet [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  56. en:lorazepam 0.5 mg sublingual tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 0.5 mg sublingual tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  57. en:lorazepam 1 mg --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1 mg | n2=lorazépam | rel=r_associated | relid=0 | w=25
  58. en:lorazepam 1 mg [almazine] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1 mg [almazine] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  59. en:lorazepam 1 mg oral capsule --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1 mg oral capsule | n2=lorazépam | rel=r_associated | relid=0 | w=25
  60. en:lorazepam 1 mg oral tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1 mg oral tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  61. en:lorazepam 1 mg oral tablet [almazine] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1 mg oral tablet [almazine] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  62. en:lorazepam 1 mg oral tablet [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1 mg oral tablet [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  63. en:lorazepam 1 mg sublingual tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1 mg sublingual tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  64. en:lorazepam 1mg tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1mg tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  65. en:lorazepam 1mg/ml/dextrose 5% inj,bag,100ml --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1mg/ml/dextrose 5% inj,bag,100ml | n2=lorazépam | rel=r_associated | relid=0 | w=25
  66. en:lorazepam 1mg/ml/sodium chloride 0.9% inj,bag,100ml --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 1mg/ml/sodium chloride 0.9% inj,bag,100ml | n2=lorazépam | rel=r_associated | relid=0 | w=25
  67. en:lorazepam 2 mg --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg | n2=lorazépam | rel=r_associated | relid=0 | w=25
  68. en:lorazepam 2 mg extended release oral capsule --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg extended release oral capsule | n2=lorazépam | rel=r_associated | relid=0 | w=25
  69. en:lorazepam 2 mg oral tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg oral tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  70. en:lorazepam 2 mg oral tablet [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg oral tablet [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  71. en:lorazepam 2 mg sublingual tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg sublingual tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  72. en:lorazepam 2 mg/ml --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml | n2=lorazépam | rel=r_associated | relid=0 | w=25
  73. en:lorazepam 2 mg/ml [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  74. en:lorazepam 2 mg/ml cartridge --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml cartridge | n2=lorazépam | rel=r_associated | relid=0 | w=25
  75. en:lorazepam 2 mg/ml includes injectable solution and injection --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml includes injectable solution and injection | n2=lorazépam | rel=r_associated | relid=0 | w=25
  76. en:lorazepam 2 mg/ml injectable solution --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml injectable solution | n2=lorazépam | rel=r_associated | relid=0 | w=25
  77. en:lorazepam 2 mg/ml injectable solution [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml injectable solution [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  78. en:lorazepam 2 mg/ml injection --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml injection | n2=lorazépam | rel=r_associated | relid=0 | w=25
  79. en:lorazepam 2 mg/ml injection [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml injection [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  80. en:lorazepam 2 mg/ml oral solution --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2 mg/ml oral solution | n2=lorazépam | rel=r_associated | relid=0 | w=25
  81. en:lorazepam 2.5 mg --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2.5 mg | n2=lorazépam | rel=r_associated | relid=0 | w=25
  82. en:lorazepam 2.5 mg [almazine] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2.5 mg [almazine] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  83. en:lorazepam 2.5 mg [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2.5 mg [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  84. en:lorazepam 2.5 mg oral tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2.5 mg oral tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  85. en:lorazepam 2.5 mg oral tablet [almazine] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2.5 mg oral tablet [almazine] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  86. en:lorazepam 2.5 mg oral tablet [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2.5 mg oral tablet [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  87. en:lorazepam 2.5mg tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2.5mg tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  88. en:lorazepam 2mg tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 2mg tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  89. en:lorazepam 3 mg --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 3 mg | n2=lorazépam | rel=r_associated | relid=0 | w=25
  90. en:lorazepam 3 mg oral tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 3 mg oral tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  91. en:lorazepam 4 mg/ml --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 4 mg/ml | n2=lorazépam | rel=r_associated | relid=0 | w=25
  92. en:lorazepam 4 mg/ml [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 4 mg/ml [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  93. en:lorazepam 4 mg/ml injectable solution --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 4 mg/ml injectable solution | n2=lorazépam | rel=r_associated | relid=0 | w=25
  94. en:lorazepam 4 mg/ml injectable solution [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 4 mg/ml injectable solution [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  95. en:lorazepam 4 mg/ml injection --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 4 mg/ml injection | n2=lorazépam | rel=r_associated | relid=0 | w=25
  96. en:lorazepam 4 mg/ml injection [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 4 mg/ml injection [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  97. en:lorazepam 500 microgram oral tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 500 microgram oral tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  98. en:lorazepam 500micrograms tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam 500micrograms tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  99. en:lorazepam adverse reaction --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam adverse reaction | n2=lorazépam | rel=r_associated | relid=0 | w=25
  100. en:lorazepam allergy --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam allergy | n2=lorazépam | rel=r_associated | relid=0 | w=25
  101. en:lorazepam cutoff:mcnc:pt:saliva:qn:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam cutoff:mcnc:pt:saliva:qn:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  102. en:lorazepam cutoff:mcnc:pt:urine:qn:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam cutoff:mcnc:pt:urine:qn:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  103. en:lorazepam cutoff:mcnc:pt:urine:qn:screen --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam cutoff:mcnc:pt:urine:qn:screen | n2=lorazépam | rel=r_associated | relid=0 | w=25
  104. en:lorazepam extended release oral capsule --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam extended release oral capsule | n2=lorazépam | rel=r_associated | relid=0 | w=25
  105. en:lorazepam glucuronide:prthr:pt:urine:ord:screen --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam glucuronide:prthr:pt:urine:ord:screen | n2=lorazépam | rel=r_associated | relid=0 | w=25
  106. en:lorazepam in oral dosage form --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam in oral dosage form | n2=lorazépam | rel=r_associated | relid=0 | w=25
  107. en:lorazepam in parenteral dosage form --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam in parenteral dosage form | n2=lorazépam | rel=r_associated | relid=0 | w=25
  108. en:lorazepam induced platelet ab.igg --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam induced platelet ab.igg | n2=lorazépam | rel=r_associated | relid=0 | w=25
  109. en:lorazepam induced platelet ab.igg:pr:pt:ser/plas:ord:flow cytometry --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam induced platelet ab.igg:pr:pt:ser/plas:ord:flow cytometry | n2=lorazépam | rel=r_associated | relid=0 | w=25
  110. en:lorazepam induced platelet ab.igg:prthr:pt:ser/plas:ord:flow cytometry --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam induced platelet ab.igg:prthr:pt:ser/plas:ord:flow cytometry | n2=lorazépam | rel=r_associated | relid=0 | w=25
  111. en:lorazepam induced platelet ab.igm:pr:pt:ser/plas:ord:flow cytometry --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam induced platelet ab.igm:pr:pt:ser/plas:ord:flow cytometry | n2=lorazépam | rel=r_associated | relid=0 | w=25
  112. en:lorazepam induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry | n2=lorazépam | rel=r_associated | relid=0 | w=25
  113. en:lorazepam injectable product --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam injectable product | n2=lorazépam | rel=r_associated | relid=0 | w=25
  114. en:lorazepam injectable solution --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam injectable solution | n2=lorazépam | rel=r_associated | relid=0 | w=25
  115. en:lorazepam injectable solution [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam injectable solution [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  116. en:lorazepam injection [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam injection [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  117. en:lorazepam measurement --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam measurement | n2=lorazépam | rel=r_associated | relid=0 | w=25
  118. en:lorazepam oral capsule --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam oral capsule | n2=lorazépam | rel=r_associated | relid=0 | w=25
  119. en:lorazepam oral liquid product --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam oral liquid product | n2=lorazépam | rel=r_associated | relid=0 | w=25
  120. en:lorazepam oral product --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam oral product | n2=lorazépam | rel=r_associated | relid=0 | w=25
  121. en:lorazepam oral solution --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam oral solution | n2=lorazépam | rel=r_associated | relid=0 | w=25
  122. en:lorazepam oral tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam oral tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  123. en:lorazepam oral tablet [almazine] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam oral tablet [almazine] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  124. en:lorazepam oral tablet [ativan] --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam oral tablet [ativan] | n2=lorazépam | rel=r_associated | relid=0 | w=25
  125. en:lorazepam overdose --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam overdose | n2=lorazépam | rel=r_associated | relid=0 | w=25
  126. en:lorazepam overdose of undetermined intent --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam overdose of undetermined intent | n2=lorazépam | rel=r_associated | relid=0 | w=25
  127. en:lorazepam pill --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam pill | n2=lorazépam | rel=r_associated | relid=0 | w=25
  128. en:lorazepam poisoning of undetermined intent --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam poisoning of undetermined intent | n2=lorazépam | rel=r_associated | relid=0 | w=25
  129. en:lorazepam single use injection --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam single use injection | n2=lorazépam | rel=r_associated | relid=0 | w=25
  130. en:lorazepam sublingual product --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam sublingual product | n2=lorazépam | rel=r_associated | relid=0 | w=25
  131. en:lorazepam sublingual tablet --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam sublingual tablet | n2=lorazépam | rel=r_associated | relid=0 | w=25
  132. en:lorazepam-containing product in oral dose form --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam-containing product in oral dose form | n2=lorazépam | rel=r_associated | relid=0 | w=25
  133. en:lorazepam-containing product in parenteral dose form --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam-containing product in parenteral dose form | n2=lorazépam | rel=r_associated | relid=0 | w=25
  134. en:lorazepam/creatinine:mrto:pt:urine:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam/creatinine:mrto:pt:urine:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  135. en:lorazepam:mass:pt:dose:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mass:pt:dose:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  136. en:lorazepam:mcnc:pt:bld:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:bld:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  137. en:lorazepam:mcnc:pt:bld:qn:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:bld:qn:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  138. en:lorazepam:mcnc:pt:body fld:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:body fld:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  139. en:lorazepam:mcnc:pt:body fld:qn:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:body fld:qn:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  140. en:lorazepam:mcnc:pt:gast fld:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:gast fld:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  141. en:lorazepam:mcnc:pt:saliva:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:saliva:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  142. en:lorazepam:mcnc:pt:saliva:qn:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:saliva:qn:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  143. en:lorazepam:mcnc:pt:ser/plas:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:ser/plas:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  144. en:lorazepam:mcnc:pt:ser/plas:qn:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:ser/plas:qn:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  145. en:lorazepam:mcnc:pt:ser/plas:qn:screen --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:ser/plas:qn:screen | n2=lorazépam | rel=r_associated | relid=0 | w=25
  146. en:lorazepam:mcnc:pt:urine:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:urine:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  147. en:lorazepam:mcnc:pt:urine:qn:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:urine:qn:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  148. en:lorazepam:mcnc:pt:vitr fld:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:vitr fld:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  149. en:lorazepam:mcnc:pt:xxx:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnc:pt:xxx:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  150. en:lorazepam:mcnt:pt:hair:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnt:pt:hair:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  151. en:lorazepam:mcnt:pt:meconium:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnt:pt:meconium:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  152. en:lorazepam:mcnt:pt:stool:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnt:pt:stool:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  153. en:lorazepam:mcnt:pt:tiss:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:mcnt:pt:tiss:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  154. en:lorazepam:prthr:pt:gast fld:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:prthr:pt:gast fld:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  155. en:lorazepam:prthr:pt:ser/plas:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:prthr:pt:ser/plas:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  156. en:lorazepam:prthr:pt:stool:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:prthr:pt:stool:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  157. en:lorazepam:prthr:pt:urine:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:prthr:pt:urine:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  158. en:lorazepam:prthr:pt:urine:ord:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:prthr:pt:urine:ord:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  159. en:lorazepam:prthr:pt:urine:ord:screen --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:prthr:pt:urine:ord:screen | n2=lorazépam | rel=r_associated | relid=0 | w=25
  160. en:lorazepam:prthr:pt:xxx:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:prthr:pt:xxx:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  161. en:lorazepam:scnc:pt:gast fld:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:scnc:pt:gast fld:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  162. en:lorazepam:scnc:pt:ser/plas:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:scnc:pt:ser/plas:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  163. en:lorazepam:scnc:pt:urine:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:scnc:pt:urine:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  164. en:lorazepam:scnc:pt:xxx:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:scnc:pt:xxx:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  165. en:lorazepam:threshold:pt:gast fld:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:threshold:pt:gast fld:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  166. en:lorazepam:threshold:pt:ser/plas:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:threshold:pt:ser/plas:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  167. en:lorazepam:threshold:pt:stool:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:threshold:pt:stool:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  168. en:lorazepam:threshold:pt:urine:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:threshold:pt:urine:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  169. en:lorazepam:threshold:pt:urine:ord:confirm --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:threshold:pt:urine:ord:confirm | n2=lorazépam | rel=r_associated | relid=0 | w=25
  170. en:lorazepam:threshold:pt:urine:ord:screen --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:threshold:pt:urine:ord:screen | n2=lorazépam | rel=r_associated | relid=0 | w=25
  171. en:lorazepam:threshold:pt:xxx:ord --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam:threshold:pt:xxx:ord | n2=lorazépam | rel=r_associated | relid=0 | w=25
  172. en:lorazepam^trough:mcnc:pt:ser/plas:qn --- r_associated #0: 25 --> lorazépam
    n1=en:lorazepam^trough:mcnc:pt:ser/plas:qn | n2=lorazépam | rel=r_associated | relid=0 | w=25
  173. en:medical supplies --- r_associated #0: 25 --> lorazépam
    n1=en:medical supplies | n2=lorazépam | rel=r_associated | relid=0 | w=25
  174. en:methyllorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:methyllorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  175. en:n-(2-hydroxyethyl)lorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:n-(2-hydroxyethyl)lorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  176. en:oral form lorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:oral form lorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  177. en:parenteral form lorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:parenteral form lorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  178. en:poisoning by lorazepam --- r_associated #0: 25 --> lorazépam
    n1=en:poisoning by lorazepam | n2=lorazépam | rel=r_associated | relid=0 | w=25
  179. en:somnium brand of lorazepam and diphenhydrammine --- r_associated #0: 25 --> lorazépam
    n1=en:somnium brand of lorazepam and diphenhydrammine | n2=lorazépam | rel=r_associated | relid=0 | w=25
  180. lorazépam injectable --- r_associated #0: 25 --> lorazépam
    n1=lorazépam injectable | n2=lorazépam | rel=r_associated | relid=0 | w=25
  181. médication --- r_associated #0: 25 --> lorazépam
    n1=médication | n2=lorazépam | rel=r_associated | relid=0 | w=25
  182. en:benzodiazepine --- r_associated #0: 24 --> lorazépam
    n1=en:benzodiazepine | n2=lorazépam | rel=r_associated | relid=0 | w=24
  183. maladie --- r_associated #0: 24 --> lorazépam
    n1=maladie | n2=lorazépam | rel=r_associated | relid=0 | w=24
  184. pharmacovigilance --- r_associated #0: 24 --> lorazépam
    n1=pharmacovigilance | n2=lorazépam | rel=r_associated | relid=0 | w=24
  185. en:consoling --- r_associated #0: 23 --> lorazépam
    n1=en:consoling | n2=lorazépam | rel=r_associated | relid=0 | w=23
  186. prescription --- r_associated #0: 23 --> lorazépam
    n1=prescription | n2=lorazépam | rel=r_associated | relid=0 | w=23
  187. en:a shortage of medicine --- r_associated #0: 22 --> lorazépam
    n1=en:a shortage of medicine | n2=lorazépam | rel=r_associated | relid=0 | w=22
  188. pharmacie --- r_associated #0: 22 --> lorazépam
    n1=pharmacie | n2=lorazépam | rel=r_associated | relid=0 | w=22
  189. calmant --- r_associated #0: 21 --> lorazépam
    n1=calmant | n2=lorazépam | rel=r_associated | relid=0 | w=21
  190. en:medicines --- r_associated #0: 21 --> lorazépam
    n1=en:medicines | n2=lorazépam | rel=r_associated | relid=0 | w=21
  191. somnifère --- r_associated #0: 21 --> lorazépam
    n1=somnifère | n2=lorazépam | rel=r_associated | relid=0 | w=21
  192. tranquillisant --- r_associated #0: 21 --> lorazépam
    n1=tranquillisant | n2=lorazépam | rel=r_associated | relid=0 | w=21
  193. Lexomil --- r_associated #0: 20 --> lorazépam
    n1=Lexomil | n2=lorazépam | rel=r_associated | relid=0 | w=20
  194. agrypnie --- r_associated #0: 20 --> lorazépam
    n1=agrypnie | n2=lorazépam | rel=r_associated | relid=0 | w=20
  195. angoisse --- r_associated #0: 20 --> lorazépam
    n1=angoisse | n2=lorazépam | rel=r_associated | relid=0 | w=20
  196. anti-dépresseur --- r_associated #0: 20 --> lorazépam
    n1=anti-dépresseur | n2=lorazépam | rel=r_associated | relid=0 | w=20
  197. anxiété --- r_associated #0: 20 --> lorazépam
    n1=anxiété | n2=lorazépam | rel=r_associated | relid=0 | w=20
  198. dépendance --- r_associated #0: 20 --> lorazépam
    n1=dépendance | n2=lorazépam | rel=r_associated | relid=0 | w=20
  199. effets secondaires --- r_associated #0: 20 --> lorazépam
    n1=effets secondaires | n2=lorazépam | rel=r_associated | relid=0 | w=20
  200. en:insomnia --- r_associated #0: 20 --> lorazépam
    n1=en:insomnia | n2=lorazépam | rel=r_associated | relid=0 | w=20
  201. hyposomnie --- r_associated #0: 20 --> lorazépam
    n1=hyposomnie | n2=lorazépam | rel=r_associated | relid=0 | w=20
  202. insomnie --- r_associated #0: 20 --> lorazépam
    n1=insomnie | n2=lorazépam | rel=r_associated | relid=0 | w=20
  203. manque de sommeil --- r_associated #0: 20 --> lorazépam
    n1=manque de sommeil | n2=lorazépam | rel=r_associated | relid=0 | w=20
  204. molécule --- r_associated #0: 20 --> lorazépam
    n1=molécule | n2=lorazépam | rel=r_associated | relid=0 | w=20
  205. ordonnance --- r_associated #0: 20 --> lorazépam
    n1=ordonnance | n2=lorazépam | rel=r_associated | relid=0 | w=20
  206. posologie --- r_associated #0: 20 --> lorazépam
    n1=posologie | n2=lorazépam | rel=r_associated | relid=0 | w=20
  207. somnolence --- r_associated #0: 20 --> lorazépam
    n1=somnolence | n2=lorazépam | rel=r_associated | relid=0 | w=20
  208. traitement --- r_associated #0: 20 --> lorazépam
    n1=traitement | n2=lorazépam | rel=r_associated | relid=0 | w=20
  209. trouble endormissement et maintien du sommeil --- r_associated #0: 20 --> lorazépam
    n1=trouble endormissement et maintien du sommeil | n2=lorazépam | rel=r_associated | relid=0 | w=20
  210. trouble insomniaque --- r_associated #0: 20 --> lorazépam
    n1=trouble insomniaque | n2=lorazépam | rel=r_associated | relid=0 | w=20
  211. troubles endormissement et maintien du sommeil --- r_associated #0: 20 --> lorazépam
    n1=troubles endormissement et maintien du sommeil | n2=lorazépam | rel=r_associated | relid=0 | w=20
  212. Looser-Milkman (syndrome de) --- r_associated #0: 15 --> lorazépam
    n1=Looser-Milkman (syndrome de) | n2=lorazépam | rel=r_associated | relid=0 | w=15
  213. antidépresseur --- r_associated #0: 15 --> lorazépam
    n1=antidépresseur | n2=lorazépam | rel=r_associated | relid=0 | w=15
  214. en:sleeplessness --- r_associated #0: 15 --> lorazépam
    n1=en:sleeplessness | n2=lorazépam | rel=r_associated | relid=0 | w=15
  215. syndrome de Looser-Milkman --- r_associated #0: 15 --> lorazépam
    n1=syndrome de Looser-Milkman | n2=lorazépam | rel=r_associated | relid=0 | w=15
  216. Benzodiazépine --- r_associated #0: 11 --> lorazépam
    n1=Benzodiazépine | n2=lorazépam | rel=r_associated | relid=0 | w=11
  217. Anticonvulsant --- r_associated #0: 10 --> lorazépam
    n1=Anticonvulsant | n2=lorazépam | rel=r_associated | relid=0 | w=10
  218. MÉdicaments --- r_associated #0: 10 --> lorazépam
    n1=MÉdicaments | n2=lorazépam | rel=r_associated | relid=0 | w=10
  219. Médicaments --- r_associated #0: 10 --> lorazépam
    n1=Médicaments | n2=lorazépam | rel=r_associated | relid=0 | w=10
  220. Posologie --- r_associated #0: 10 --> lorazépam
    n1=Posologie | n2=lorazépam | rel=r_associated | relid=0 | w=10
  221. en:comforting --- r_associated #0: 10 --> lorazépam
    n1=en:comforting | n2=lorazépam | rel=r_associated | relid=0 | w=10
  222. en:medication --- r_associated #0: 10 --> lorazépam
    n1=en:medication | n2=lorazépam | rel=r_associated | relid=0 | w=10
  223. en:of comfort --- r_associated #0: 10 --> lorazépam
    n1=en:of comfort | n2=lorazépam | rel=r_associated | relid=0 | w=10
  224. en:of some comfort --- r_associated #0: 10 --> lorazépam
    n1=en:of some comfort | n2=lorazépam | rel=r_associated | relid=0 | w=10
  225. en:some consolation --- r_associated #0: 10 --> lorazépam
    n1=en:some consolation | n2=lorazépam | rel=r_associated | relid=0 | w=10
  226. lophotriche --- r_associated #0: 10 --> lorazépam
    n1=lophotriche | n2=lorazépam | rel=r_associated | relid=0 | w=10
  227. lopinavir --- r_associated #0: 10 --> lorazépam
    n1=lopinavir | n2=lorazépam | rel=r_associated | relid=0 | w=10
  228. chimie --- r_associated #0: 7 --> lorazépam
    n1=chimie | n2=lorazépam | rel=r_associated | relid=0 | w=7
  229. Manque de sommeil --- r_associated #0: 5 --> lorazépam
    n1=Manque de sommeil | n2=lorazépam | rel=r_associated | relid=0 | w=5
  230. lorazépam cut off --- r_associated #0: 4 --> lorazépam
    n1=lorazépam cut off | n2=lorazépam | rel=r_associated | relid=0 | w=4
  231. lorazépam taux résiduel --- r_associated #0: 4 --> lorazépam
    n1=lorazépam taux résiduel | n2=lorazépam | rel=r_associated | relid=0 | w=4
  232. plaquettes anticorps igg induits par lorazépam --- r_associated #0: 4 --> lorazépam
    n1=plaquettes anticorps igg induits par lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=4
  233. plaquettes anticorps igm induits par lorazépam --- r_associated #0: 4 --> lorazépam
    n1=plaquettes anticorps igm induits par lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=4
  234. induits par lorazépam --- r_associated #0: 3 --> lorazépam
    n1=induits par lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=3
  235. intoxication par le lorazépam --- r_associated #0: 2 --> lorazépam
    n1=intoxication par le lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=2
  236. détermination de la présence de lorazépam --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=1
  237. détermination de la présence de lorazépam | confirmation | urine | ponctuel | résultat qualitatif | présence/seuil --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | confirmation | urine | ponctuel | résultat qualitatif | présence/seuil | n2=lorazépam | rel=r_associated | relid=0 | w=1
  238. détermination de la présence de lorazépam | dépistage | urine | ponctuel | résultat qualitatif | présence/seuil --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | dépistage | urine | ponctuel | résultat qualitatif | présence/seuil | n2=lorazépam | rel=r_associated | relid=0 | w=1
  239. détermination de la présence de lorazépam | technique indéterminée | liquide gastrique | ponctuel | résultat qualitatif | présence/seuil --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | technique indéterminée | liquide gastrique | ponctuel | résultat qualitatif | présence/seuil | n2=lorazépam | rel=r_associated | relid=0 | w=1
  240. détermination de la présence de lorazépam | technique indéterminée | milieux divers | ponctuel | résultat qualitatif | présence/seuil --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | technique indéterminée | milieux divers | ponctuel | résultat qualitatif | présence/seuil | n2=lorazépam | rel=r_associated | relid=0 | w=1
  241. détermination de la présence de lorazépam | technique indéterminée | selles | ponctuel | résultat qualitatif | présence/seuil --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | technique indéterminée | selles | ponctuel | résultat qualitatif | présence/seuil | n2=lorazépam | rel=r_associated | relid=0 | w=1
  242. détermination de la présence de lorazépam | technique indéterminée | sérum/plasma | ponctuel | résultat qualitatif | présence/seuil --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | technique indéterminée | sérum/plasma | ponctuel | résultat qualitatif | présence/seuil | n2=lorazépam | rel=r_associated | relid=0 | w=1
  243. détermination de la présence de lorazépam | technique indéterminée | urine | ponctuel | résultat qualitatif | présence/seuil --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de lorazépam | technique indéterminée | urine | ponctuel | résultat qualitatif | présence/seuil | n2=lorazépam | rel=r_associated | relid=0 | w=1
  244. détermination de la présence de plaquettes anticorps igg induits par lorazépam --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de plaquettes anticorps igg induits par lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=1
  245. détermination de la présence de plaquettes anticorps igm induits par lorazépam --- r_associated #0: 1 --> lorazépam
    n1=détermination de la présence de plaquettes anticorps igm induits par lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=1
  246. en:medicament --- r_associated #0: 1 --> lorazépam
    n1=en:medicament | n2=lorazépam | rel=r_associated | relid=0 | w=1
  247. mesure de lorazépam --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | n2=lorazépam | rel=r_associated | relid=0 | w=1
  248. mesure de lorazépam cut off --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam cut off | n2=lorazépam | rel=r_associated | relid=0 | w=1
  249. mesure de lorazépam cut off | confirmation | salive | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam cut off | confirmation | salive | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  250. mesure de lorazépam cut off | confirmation | urine | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam cut off | confirmation | urine | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  251. mesure de lorazépam cut off | dépistage | urine | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam cut off | dépistage | urine | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  252. mesure de lorazépam taux résiduel --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam taux résiduel | n2=lorazépam | rel=r_associated | relid=0 | w=1
  253. mesure de lorazépam | confirmation | liquide biologique | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | confirmation | liquide biologique | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  254. mesure de lorazépam | confirmation | salive | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | confirmation | salive | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  255. mesure de lorazépam | confirmation | sang | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | confirmation | sang | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  256. mesure de lorazépam | confirmation | sérum/plasma | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | confirmation | sérum/plasma | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  257. mesure de lorazépam | confirmation | urine | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | confirmation | urine | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  258. mesure de lorazépam | dépistage | sérum/plasma | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | dépistage | sérum/plasma | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  259. mesure de lorazépam | technique indéterminée | cheveux | ponctuel | résultat numérique | masse/masse --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | cheveux | ponctuel | résultat numérique | masse/masse | n2=lorazépam | rel=r_associated | relid=0 | w=1
  260. mesure de lorazépam | technique indéterminée | dose | ponctuel | résultat numérique | masse --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | dose | ponctuel | résultat numérique | masse | n2=lorazépam | rel=r_associated | relid=0 | w=1
  261. mesure de lorazépam | technique indéterminée | liquide biologique | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | liquide biologique | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  262. mesure de lorazépam | technique indéterminée | liquide gastrique | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | liquide gastrique | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  263. mesure de lorazépam | technique indéterminée | liquide gastrique | ponctuel | résultat numérique | moles/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | liquide gastrique | ponctuel | résultat numérique | moles/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  264. mesure de lorazépam | technique indéterminée | liquide vitrée | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | liquide vitrée | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  265. mesure de lorazépam | technique indéterminée | milieux divers | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | milieux divers | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  266. mesure de lorazépam | technique indéterminée | milieux divers | ponctuel | résultat numérique | moles/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | milieux divers | ponctuel | résultat numérique | moles/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  267. mesure de lorazépam | technique indéterminée | méconium | ponctuel | résultat numérique | masse/masse --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | méconium | ponctuel | résultat numérique | masse/masse | n2=lorazépam | rel=r_associated | relid=0 | w=1
  268. mesure de lorazépam | technique indéterminée | salive | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | salive | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  269. mesure de lorazépam | technique indéterminée | sang | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | sang | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  270. mesure de lorazépam | technique indéterminée | selles | ponctuel | résultat numérique | masse/masse --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | selles | ponctuel | résultat numérique | masse/masse | n2=lorazépam | rel=r_associated | relid=0 | w=1
  271. mesure de lorazépam | technique indéterminée | sérum/plasma | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | sérum/plasma | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  272. mesure de lorazépam | technique indéterminée | sérum/plasma | ponctuel | résultat numérique | moles/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | sérum/plasma | ponctuel | résultat numérique | moles/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  273. mesure de lorazépam | technique indéterminée | tissu | ponctuel | résultat numérique | masse/masse --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | tissu | ponctuel | résultat numérique | masse/masse | n2=lorazépam | rel=r_associated | relid=0 | w=1
  274. mesure de lorazépam | technique indéterminée | urine | ponctuel | résultat numérique | masse/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | urine | ponctuel | résultat numérique | masse/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  275. mesure de lorazépam | technique indéterminée | urine | ponctuel | résultat numérique | moles/volume --- r_associated #0: 1 --> lorazépam
    n1=mesure de lorazépam | technique indéterminée | urine | ponctuel | résultat numérique | moles/volume | n2=lorazépam | rel=r_associated | relid=0 | w=1
  276. médicament --- r_associated #0: 1 --> lorazépam
    n1=médicament | n2=lorazépam | rel=r_associated | relid=0 | w=1
  277. toxicologie --- r_associated #0: 1 --> lorazépam
    n1=toxicologie | n2=lorazépam | rel=r_associated | relid=0 | w=1
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr